<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Sucrose analgesia for heel‐lance procedures in neonates - Yamada, J - 2023 | Cochrane Library</title> <meta content="Sucrose analgesia for heel‐lance procedures in neonates - Yamada, J - 2023 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014806/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Sucrose analgesia for heel‐lance procedures in neonates - Yamada, J - 2023 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014806/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD014806" name="dc.identifier" scheme="DOI"/> <meta content="Sucrose analgesia for heel‐lance procedures in neonates" name="citation_title"/> <meta content="Janet Yamada" name="citation_author"/> <meta content="Toronto Metropolitan University" name="citation_author_institution"/> <meta content="Mariana Bueno" name="citation_author"/> <meta content="SickKids Hospital" name="citation_author_institution"/> <meta content="mariana.bueno@sickkids.ca" name="citation_author_email"/> <meta content="Lucia Santos" name="citation_author"/> <meta content="SickKids Hospital" name="citation_author_institution"/> <meta content="Sarah Haliburton" name="citation_author"/> <meta content="The Hospital for Sick Children" name="citation_author_institution"/> <meta content="Marsha Campbell-Yeo" name="citation_author"/> <meta content="Dalhousie University and IWK Health" name="citation_author_institution"/> <meta content="Bonnie Stevens" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD014806" name="citation_doi"/> <meta content="2023" name="citation_date"/> <meta content="2023/08/30" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014806/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014806/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014806/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Analgesia; Glucose [therapeutic use]; *Heel; Milk, Human; Pain [etiology, prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD014806&amp;doi=10.1002/14651858.CD014806&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="z6k50IFd";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD014806\x26doi\x3d10\x2e1002\x2f14651858\x2eCD014806\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014806\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD014806\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","th","ms","ja","fa","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD014806",title:"Sucrose analgesia for heel\\u2010lance procedures in neonates",firstPublishedDate:"Aug 30, 2023 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neonatal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=z6k50IFd&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD014806&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD014806';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD014806/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD014806/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD014806%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD014806/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD014806/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD014806/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD014806/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD014806" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD014806/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD014806" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD014806/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD014806/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2841 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD014806" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014806/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-sec-0141"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-sec-0041"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-sec-0132"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD014806/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014806/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014806/appendices#CD014806-sec-0146"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014806/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014806/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/supinfo/CD014806-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/supinfo/CD014806-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014806/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014806/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD014806/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD014806/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD014806/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD014806/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD014806/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Sucrose analgesia for heel‐lance procedures in neonates</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD014806/information#CD014806-cr-0004">Janet Yamada</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD014806/information#CD014806-cr-0005"><i class="icon corresponding-author fa fa-envelope"></i>Mariana Bueno</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD014806/information#CD014806-cr-0006">Lucia Santos</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD014806/information#CD014806-cr-0007">Sarah Haliburton</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD014806/information#CD014806-cr-0008">Marsha Campbell-Yeo</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD014806/information#CD014806-cr-0009">Bonnie Stevens</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD014806/information/en#CD014806-sec-0165">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 30 August 2023 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD014806/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD014806">https://doi.org/10.1002/14651858.CD014806</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD014806-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD014806-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD014806-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD014806-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD014806-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD014806-abs-0006">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD014806-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD014806-abs-0001" lang="en"> <section id="CD014806-sec-0001"> <h3 class="title" id="CD014806-sec-0001">Background</h3> <p>Sucrose has been examined for calming and pain‐relieving effects in neonates for invasive procedures such as heel lance. </p> </section> <section id="CD014806-sec-0002"> <h3 class="title" id="CD014806-sec-0002">Objectives</h3> <p>To assess the effectiveness of sucrose for relieving pain from heel lance in neonates in terms of immediate and long‐term outcomes </p> </section> <section id="CD014806-sec-0003"> <h3 class="title" id="CD014806-sec-0003">Search methods</h3> <p>We searched (February 2022): CENTRAL, MEDLINE, Embase, PsycINFO, CINAHL, Web of Science, and three trial registries. </p> </section> <section id="CD014806-sec-0004"> <h3 class="title" id="CD014806-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials where term and/or preterm neonates received sucrose for heel lances. Comparison treatments included water/placebo/no intervention, non‐nutritive sucking (NNS), glucose, breastfeeding, breast milk, music, acupuncture, facilitated tucking, and skin‐to‐skin care. </p> </section> <section id="CD014806-sec-0005"> <h3 class="title" id="CD014806-sec-0005">Data collection and analysis</h3> <p>We used standard Cochrane methods. We reported mean differences (MD) with 95% confidence intervals (CI) using the fixed‐effect model for continuous outcome measures. We assessed heterogeneity by the I<sup>2</sup> test. We used GRADE to assess certainty of evidence. </p> </section> <section id="CD014806-sec-0006"> <h3 class="title" id="CD014806-sec-0006">Main results</h3> <p>We included 55 trials (6273 infants): 29 included term neonates, 22 included preterm neonates, and four included both. Heel lance was investigated in 50 trials; 15 investigated other minor painful procedures in addition to lancing. </p> <p><b>Sucrose vs control</b> </p> <p>The evidence suggests that sucrose probably results in a reduction in PIPP scores compared to the control group at 30 seconds (MD ‐1.74 (95% CI ‐2.11 to ‐1.37); I<sup>2</sup> = 62%; moderate‐certainty evidence) and 60 seconds after lancing (MD ‐2.14, 95% CI ‐3.34 to ‐0.94; I<sup>2</sup> = 0%; moderate‐certainty evidence). </p> <p>The evidence is very uncertain about the effects of sucrose on DAN scores compared to water at 30 seconds after lancing (MD ‐1.90, 95% CI ‐8.58 to 4.78; heterogeneity not applicable (N/A); very low‐certainty evidence). </p> <p>The evidence suggests that sucrose probably results in a reduction in NIPS scores compared to water immediately after lancing (MD ‐2.00, 95% CI ‐2.42 to ‐1.58; heterogeneity N/A; moderate‐certainty evidence). </p> <p><b>Sucrose vs NNS</b> </p> <p>The evidence is very uncertain about the effect of sucrose on PIPP scores compared to NNS during the recovery period after lancing (MD 0.60, 95% CI ‐0.30 to 1.50; heterogeneity not applicable; very low‐certainty evidence) and on DAN scores at 30 seconds after lancing (MD ‐1.20, 95% CI ‐7.87 to 5.47; heterogeneity N/A; very low‐certainty evidence). </p> <p><b>Sucrose + NNS vs NNS</b> </p> <p>The evidence is very uncertain about the effect of sucrose + NNS on PIPP scores compared to NNS during lancing (MD ‐4.90, 95% CI ‐5.73 to ‐4.07; heterogeneity not applicable; very low‐certainty evidence) and during recovery after lancing (MD ‐3.80, 95% CI ‐4.47 to ‐3.13; heterogeneity N/A; very low‐certainty evidence). </p> <p>The evidence is very uncertain about the effects of sucrose + NNS on NFCS scores compared to water + NNS during lancing (MD ‐0.60, 95% CI ‐1.47 to 0.27; heterogeneity N/A; very low‐certainty evidence). </p> <p><b>Sucrose vs glucose</b> </p> <p>The evidence suggests that sucrose results in little to no difference in PIPP scores compared to glucose at 30 seconds (MD 0.26, 95% CI ‐0.70 to 1.22; heterogeneity not applicable; low‐certainty evidence) and 60 seconds after lancing (MD ‐0.02, 95% CI ‐0.79 to 0.75; heterogeneity N/A; low‐certainty evidence). </p> <p><b>Sucrose vs breastfeeding</b> </p> <p>The evidence is very uncertain about the effect of sucrose on PIPP scores compared to breastfeeding at 30 seconds after lancing (MD ‐0.70, 95% CI ‐0.49 to 1.88; I<sup>2</sup> = 94%; very low‐certainty evidence). </p> <p>The evidence is very uncertain about the effect of sucrose on COMFORTneo scores compared to breastfeeding after lancing (MD ‐2.60, 95% CI ‐3.06 to ‐2.14; heterogeneity N/A; very low‐certainty evidence). </p> <p><b>Sucrose vs expressed breast milk</b> </p> <p>The evidence suggests that sucrose may result in little to no difference in PIPP‐R scores compared to expressed breast milk during (MD 0.3, 95% CI ‐0.24 to 0.84; heterogeneity not applicable; low‐certainty evidence) and at 30 seconds after lancing (MD 0.3, 95% CI ‐0.11 to 0.71; heterogeneity N/A; low‐certainty evidence). </p> <p>The evidence suggests that sucrose probably may result in slightly increased PIPP‐R scores compared to expressed breast milk 60 seconds after lancing (MD 1.10, 95% CI 0.34 to 1.86; heterogeneity N/A; low‐certainty evidence). </p> <p>The evidence is very uncertain about the effect of sucrose on DAN scores compared to expressed breast milk 30 seconds after lancing (MD ‐1.80, 95% CI ‐8.47 to 4.87; heterogeneity N/A; very low‐certainty evidence). </p> <p><b>Sucrose vs laser acupuncture</b> </p> <p>There was no difference in PIPP‐R scores between sucrose and music groups; however, data were reported as medians and IQRs. </p> <p>The evidence is very uncertain about the effect of sucrose on NIPS scores compared to laser acupuncture during lancing (MD ‐0.86, 95% CI ‐1.43 to ‐0.29; heterogeneity N/A; very low‐certainty evidence). </p> <p><b>Sucrose vs facilitated tucking</b> </p> <p>The evidence is very uncertain about the effect of sucrose on total BPSN scores compared to facilitated tucking during lancing (MD ‐2.27, 95% CI ‐4.66 to 0.12; heterogeneity N/A; very low‐certainty evidence) and during recovery after lancing (MD ‐0.31, 95% CI ‐1.72 to 1.10; heterogeneity N/A; very low‐certainty evidence). </p> <p><b>Sucrose vs skin‐to‐skin + water (repeated lancing)</b> </p> <p>The evidence suggests that sucrose results in little to no difference in PIPP scores compared to skin‐to‐skin + water at 30 seconds after 1st (MD 0.13, 95% CI ‐0.70 to 0.96); 2nd (MD ‐0.56, 95% CI ‐1.57 to 0.45); or 3rd lancing (MD‐0.15, 95% CI ‐1.26 to 0.96); heterogeneity N/A, low‐certainty evidence for all comparisons. </p> <p>The evidence suggests that sucrose results in little to no difference in PIPP scores compared to skin‐to‐skin + water at 60 seconds after 1st (MD –0.61, 95% CI ‐1.55 to 0.33); 2nd (MD ‐0.12, 95% CI ‐0.99 to 0.75); or 3rd lancing (MD‐0.40, 95% CI ‐1.48 to 0.68); heterogeneity N/A, low‐certainty evidence for all comparisons. </p> <p>Minor adverse events required no intervention.</p> </section> <section id="CD014806-sec-0007"> <h3 class="title" id="CD014806-sec-0007">Authors' conclusions</h3> <p>Sucrose compared to control probably results in a reduction of PIPP scores 30 and 60 seconds after single heel lances (moderate‐certainty evidence). Evidence is very uncertain about the effect of sucrose compared to NNS, breastfeeding, laser acupuncture, facilitated tucking, and the effect of sucrose + NNS compared to NNS in reducing pain. Sucrose compared to glucose, expressed breast milk, and skin‐to‐skin care shows little to no difference in pain scores. Sucrose combined with other nonpharmacologic interventions should be used with caution, given the uncertainty of evidence. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD014806-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD014806-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD014806-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD014806-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD014806-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD014806-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD014806-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD014806-abs-0014">Polski</a> </li> <li class="section-language"> <a class="" href="full/th#CD014806-abs-0007">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD014806-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD014806-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD014806-abs-0002" lang="en"> <h3>Sucrose for analgesia (pain relief) in newborn infants undergoing heel lance</h3> <p><b>Key messages</b> </p> <p>‐ Sucrose, compared to control interventions, probably reduces pain for a single painful event (heel lance). </p> <p>‐ There were a few minor immediate adverse events, such as gagging, that resolved without intervention. </p> <p>‐ We need studies that assess the effect of repeated sucrose administration on immediate (pain intensity) and long‐term (neurodevelopmental) outcomes. </p> <p>‐ We need to assess how sucrose affects neonates who are extremely preterm, unstable, or ventilated (or a combination of these factors). </p> <p><b>What is sucrose analgesia?</b> </p> <p>Sucrose (table sugar) is mixed with water in various concentrations (usually 24%) and is given to babies in very small amounts (e.g. a few drops) about two minutes before a painful procedure. Sucrose is also given with other nondrug pain‐relieving interventions such as a pacifier (non‐nutritive sucking ‐ NNS) or when the baby is receiving skin‐to‐skin care. </p> <p><b>Why is this important for newborn babies who are undergoing heel lance procedures?</b> </p> <p>Babies who are sick or immature, and require a stay in hospital, have several painful procedures per day and multiple painful procedures throughout the hospital stay; for most babies, the majority of painful procedures are heel lances. If untreated, pain has immediate and long‐term consequences that can impact their brain and behavioural development. It is important to minimise the number of painful procedures and the associated pain and suffering. </p> <p><b>What did we want to find out?</b> </p> <p>We wanted to know how well sucrose worked to relieve pain in newborn babies who are having heel lance procedures while they were in hospital. We also wanted to know whether there were any safety concerns about using sucrose to relieve pain from single painful events such as heel lance. </p> <p><b>What did we do?</b> </p> <p>We searched for studies that investigated:</p> <p>‐ Sucrose compared to no treatment or standard care;</p> <p>‐ Sucrose compared to water, other sweet solutions (e.g. glucose);</p> <p>‐ Sucrose compared to another nondrug intervention (e.g. NNS);</p> <p>‐ Whether sucrose was effective in decreasing the amount and severity of pain that babies experienced as assessed by baby’s pain responses (e.g. crying, grimacing, heart rate) and by using standardised infant pain scales. </p> <p>We also wanted to know if sucrose was associated with any unwanted effects in preterm or term babies. </p> <p>We compared and summarised the results of the studies and rated our confidence in the evidence, based on factors such as study methods. </p> <p><b>What did we find out?</b> </p> <p>We reviewed 55 studies that included a total of 6273 babies. Twenty‐nine studies had full‐term babies only, 22 had preterm babies only, and four had both full‐term and preterm babies. Heel lance was the painful procedure in 50 studies. Five studies investigated a variety of other minor painful procedures in addition to heel lancing. </p> <p><b>Main results</b> </p> <p>‐ Sucrose compared to the control treatment probably reduces pain from single heel lances in babies. </p> <p>‐ Results are uncertain about the effect of sucrose compared to NNS, breastfeeding, laser acupuncture, and facilitated tucking, in reducing pain scores. </p> <p>‐ Results are uncertain about the effect of sucrose + NNS compared to NNS, in reducing pain. </p> <p>‐ Sucrose does not seem to reduce pain from single heel lances compared to glucose, expressed breast milk, and skin‐to‐skin care. </p> <p>‐ Reported adverse events were minor and resolved without any intervention.</p> <p><b>What are the limitations of the evidence?</b> </p> <p>We have moderate‐certainty evidence that sucrose likely reduces pain from heel lance.</p> <p><b>How up‐to‐date is this evidence?</b> </p> <p>This evidence is up‐to‐date as of February 2022.</p> <p><b>Study funding sources</b> </p> <p>We did not identify any studies that received funding from industry.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD014806-sec-0141" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD014806-sec-0141"></div> <h3 class="title" id="CD014806-sec-0142">Implications for practice</h3> <section id="CD014806-sec-0142"> <p>We included 55 studies in this review. Sucrose compared to water, placebo, or no intervention probably results in a reduction of PIPP scores 30 and 60 seconds after single heel lances (moderate‐certainty evidence) in two meta‐analyses with seven and two studies, respectively. The evidence is very uncertain about the effect of sucrose alone compared to NNS, breastfeeding, laser acupuncture, and facilitated tucking, in reducing pain intensity. The evidence is very uncertain about the effect of sucrose plus NNS compared to NNS. Sucrose compared to glucose, expressed breast milk, and skin‐to‐skin care, shows little to no difference in pain scores. Very small doses of 24% sucrose (e.g. 0.1 mL) were efficacious in preterm infants (<a href="./references#CD014806-bbs2-0048" title="StevensB , YamadaJ , Campbell-YeoM , GibbinsS , HarrisonD , DionneK , et al. The minimally effective dose of sucrose for procedural pain relief in neonates: a randomized controlled trial. BMC Pediatrics2018;18(1):85. [DOI: 10.1186/s12887-018-1026-x] [DOI: 10.1186/s12887-018-1026-x] [PMID: 29475433]">Stevens 2018</a>). Since the review focused on a single heel lance, the effects of repeated use of sucrose on immediate and long‐term neurodevelopmental outcomes are unknown. </p> <p>Although some studies indicate there are no long‐term consequences of repeated use of sucrose, <a href="./references#CD014806-bbs2-0171" title="RangerM , TremblayS , ChauCM , HolstiL , GrunauRE , GoldowitzD . Adverse behavioral changes in adult mice following neonatal repeated exposure to pain and sucrose. Frontiers in Psychology2019;9:2394. [DOI: 10.3389/fpsyg.2018.02394] [PMID: 30719013]">Ranger 2019</a> found that mice exposed to pain during the first week of life demonstrated poorer memory function regardless of sucrose administration, indicating that memory performance is not protected by sucrose administration. Repetitive use of sucrose in the absence of pain also contributed to poorer short‐term memory (<a href="./references#CD014806-bbs2-0171" title="RangerM , TremblayS , ChauCM , HolstiL , GrunauRE , GoldowitzD . Adverse behavioral changes in adult mice following neonatal repeated exposure to pain and sucrose. Frontiers in Psychology2019;9:2394. [DOI: 10.3389/fpsyg.2018.02394] [PMID: 30719013]">Ranger 2019</a>). Given these inconsistencies, the American Academy of Pediatrics has recommended that, when sucrose is used, it should be tracked and documented as a medication (<a href="./references#CD014806-bbs2-0119" title="Committee on Fetus and Newborn and Section on Anesthesiology and Pain Medicine. Prevention and management of procedural pain in the neonate: an update. Pediatrics2016;137(2):e20154271. [DOI: 10.1542/peds.2015-4271] [PMID: 26810788]">AAP 2016</a>; <a href="./references#CD014806-bbs2-0165" title="McPhersonC , MillerSP , El-DibM , MassaroAN , InderTE . The influence of pain, agitation, and their management on the immature brain. Pediatric Research2020;88(2):168-75. [DOI: 10.1038/s41390-019-0744-6] [PMID: 31896130]">McPherson 2020</a>). </p> <p>In addition to sucrose, other nonpharmacological approaches to managing procedural pain such as breastfeeding, skin‐to‐skin care, and facilitated tucking are recommended for incorporation into routine care whenever possible (<a href="./references#CD014806-bbs2-0128" title="BucseaO , Pillai RiddellR . Non-pharmacological pain management in the neonatal intensive care unit: managing neonatal pain without drugs. Seminars in Fetal and Neonatal Medicine2020;24(4):101017. [DOI: 10.1016/j.siny.2019.05.009] [PMID: 31326301]">Bucsea 2020</a>; <a href="./references#CD014806-bbs2-0164" title="McNairC , Campbell-YeoM , JohnstonC , TaddioA . Nonpharmacologic management of pain during common needle puncture procedures in infants: current research evidence and practical considerations: an update. Clinics in Perinatology2019;46(4):709-30. [DOI: 10.1016/j.clp.2019.08.006] [PMID: 31653304]">McNair 2019</a>) and sucrose should be used when these parent‐initiated modalities are not possible (e.g. parent is not available). Also, two of the included studies combined the use of sucrose with adjuvant interventions (i.e. NNS and containment (<a href="./references#CD014806-bbs2-0004" title="BenoitB , NewmanA , Martin-MisenerR , LatimerM , Campbell-YeoM . The influence of breastfeeding on cortical and bio-behavioural indicators of procedural pain in newborns: findings of a randomized controlled trial. Early Human Development2021;154:105308. [DOI: 10.1016/j.earlhumdev.2021.105308] [PMID: 33513546]">Benoit 2021</a>); and sucrose with swaddling (<a href="./references#CD014806-bbs2-0054" title="VelumulaPK , ElbakoushF , Tabb C 2nd, FarooqiA , Lulic-BoticaM , JaniS , et al. Breast milk vs 24% sucrose for procedural pain relief in preterm neonates: a non-inferiority randomized controlled trial. Journal of Perinatology2022;42(7):914-9. [DOI: 10.1038/s41372-022-01352-2] [PMID: 35197549]">Velumula 2020</a>)), which could contribute to overall pain reduction (<a href="./references#CD014806-bbs2-0131" title="Campbell-YeoM , ErikssonM , BenoitB . Assessment and Management of Pain in Preterm Infants: A Practice Update. Children (Basel)2022;9(2):244. [DOI: 10.3390/children9020244] [PMID: 35204964]">Campbell‐Yeo 2022</a>). </p> </section> <h3 class="title" id="CD014806-sec-0143">Implications for research</h3> <section id="CD014806-sec-0143"> <p>Stevens and colleagues identified 0.1 mL of 24% sucrose as the minimally effective dose to treat pain for single heel lances (<a href="./references#CD014806-bbs2-0048" title="StevensB , YamadaJ , Campbell-YeoM , GibbinsS , HarrisonD , DionneK , et al. The minimally effective dose of sucrose for procedural pain relief in neonates: a randomized controlled trial. BMC Pediatrics2018;18(1):85. [DOI: 10.1186/s12887-018-1026-x] [DOI: 10.1186/s12887-018-1026-x] [PMID: 29475433]">Stevens 2018</a>); however, this was only one study targeting one painful procedure and requires replicating to determine the optimal dose in other procedures with term and preterm infants. Researchers should consider more precise and tailored doses based on the infant (e.g. gestational age, PNA, birthweight), and the context (e.g. severity of illness) in which it is used. Optimal sucrose doses could be assessed further using sensitivity/meta‐regression techniques. </p> <p>More research is needed to better understand the underlying analgesic mechanisms and calming effects of sucrose (<a href="./references#CD014806-bbs2-0140" title="EcclestonC , FisherE , HowardRF , SlaterR , ForgeronP , PalermoTM , et al. Delivering transformative action in paediatric pain: a Lancet Child &amp; Adolescent Health Commission. Lancet. Child &amp; Adolescent Health2021;5(1):47-87. [DOI: 10.1016/S2352-4642(20)30277-7]">Eccleston 2021</a>; <a href="./references#CD014806-bbs2-0165" title="McPhersonC , MillerSP , El-DibM , MassaroAN , InderTE . The influence of pain, agitation, and their management on the immature brain. Pediatric Research2020;88(2):168-75. [DOI: 10.1038/s41390-019-0744-6] [PMID: 31896130]">McPherson 2020</a>) and their relationship. Given recent results of animal studies on the long‐term neurodevelopmental effects of sucrose, further investigation of single and repeated doses is required to determine if sucrose is compromising or protective. The effects of sucrose in combination with other nonpharmacological (e.g. facilitated tucking, skin‐to‐skin care, breastfeeding), and pharmacological (e.g. morphine, fentanyl) interventions based on current systematic reviews (<a href="./references#CD014806-bbs2-0158" title="JohnstonC , Campbell-YeoM , DisherT , BenoitB , FernandesA , StreinerD , et al. Skin-to-skin care for procedural pain in neonates. Cochrane Database of Systematic Reviews2017, Issue 2. Art. No: CD008435. [DOI: 10.1002/14651858.CD008435.pub3]">Johnston 2017</a>; <a href="./references#CD014806-bbs2-0164" title="McNairC , Campbell-YeoM , JohnstonC , TaddioA . Nonpharmacologic management of pain during common needle puncture procedures in infants: current research evidence and practical considerations: an update. Clinics in Perinatology2019;46(4):709-30. [DOI: 10.1016/j.clp.2019.08.006] [PMID: 31653304]">McNair 2019</a>) need to be further studied in terms of additional benefits versus risk. However, the considerable variation in infant pain responses makes this integration of evidence difficult. </p> <p>Strengthened study design and methods with particular attention to the adequacy of sample size, conceptualisation of pain, use of validated pain measures to determine outcomes, and consideration of context are required. The revised IASP definition of pain takes pain in infants into consideration such that "verbal description is only one of several behaviours to express pain; inability to communicate does not negate the possibility that a human or a nonhuman animal experiences pain” and that pain and nociception are not the same (<a href="./references#CD014806-bbs2-0169" title="RajaSN , CarrDB , CohenM , FinnerupNB , FlorH , GibsonS , et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain2020;161(9):1976-82. [DOI: 10.1097/j.pain.0000000000001939] [PMID: 32694387]">Raja 2020</a>). Use of sucrose in neonates that are of extremely low birthweight, unstable, ventilated, or a combination of these factors still needs to be addressed for effectiveness and safety. </p> <p>Replication of existing studies of high methodological quality, using a valid pain assessment measure and standard set of validated outcomes would allow for further combination of results in meta‐analyses. Researchers should report means and standard deviations (SD) or standard error (SE) in addition to medians and ranges, if the data are not normally distributed, to allow for the use of meta‐analytic techniques. If researchers choose to present data in graph form, they should include the means and SD/SEs in the text (or in additional appendices). The total volume and concentration of sucrose administered should be reported in relation to body weight (g/kg). Future research should focus on the long‐term effects of repeated sucrose administration on biochemical as well as behavioural impacts in sick and very‐preterm neonates. Results should be presented for individual pain indicators and any composite pain scores constructed from these indicators. The relationship between pain measures and individual physiological and cognitive indicators of nociceptive brain activity should be explored further, factoring in differences in response times. </p> <p>In summary, there is a pressing need for research regarding the neurophysiological impact of pain, as well as the impact of sucrose delivered alone or in combination with other pain‐relieving strategies across repeated administrations on the developing brain. </p> <p>Effective knowledge translation (implementation and dissemination) strategies are required to translate research evidence on sucrose into practice effectively (<a href="./references#CD014806-bbs2-0186" title="StevensB , YamadaJ , PromislowS , StinsonJ , HarrisonD , VictorJC , Members of the CIHR Team in Children’s Pain. Implementation of multidimensional knowledge translation strategies to improve procedural pain in hospitalized children. Implementation Science2014;9:120. [DOI: 10.1186/s13012-014-0120-1] [PMID: 25928349]">Stevens 2014b</a>). For healthcare providers, these strategies could include, in addition to the typical publications and presentations, the use of reminders, interactive education and educational outreach and regular audit, feedback sessions, and social media (e.g. Twitter, Facebook, infographics, webinars etc.). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD014806-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD014806-sec-0008"></div> <div class="table" id="CD014806-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose, with or without NNS) compared to control (water, placebo, or no intervention) for analgesia for heel lancing in neonates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sucrose (any concentration, any dose, with or without NNS) compared to control (water, placebo, or no intervention) for analgesia for heel lancing in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> neonates<br/><b>Setting:</b> neonatal units<br/><b>Intervention:</b> sucrose (any concentration, any dose, with or without NNS)<br/><b>Comparison:</b> control (water, placebo, or no intervention) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with control (water, placebo, or no intervention)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with sucrose (any concentration, any dose, with or without NNS)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 30 seconds after lancing (term and preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 30 seconds<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 30 seconds after lancing (term and preterm infants) ranged from <b>4.9‐13.3</b><sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>1.74 lower</b><br/>(2.11 lower to 1.37 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>547<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose (with or without NNS) compared to control (water, placebo, or no intervention) probably results in a reduction in PIPP scores at 30 seconds after heel lancing in term and preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 30 seconds after heel lancing (term infants)<br/>Scale from: 0 to 21<br/>follow‐up: 30 seconds<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 30 seconds after heel lancing (term infants) ranged from <b>4.9‐8.5</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.87 lower</b><br/>(1.8 lower to 0.06 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>227<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose (with or without NNS) compared to control (water, placebo, or no intervention) results in little to no difference in PIPP scores at 30 seconds after heel lancing in term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 30 seconds after lancing (preterm infants)<br/>Scale from: 0 to 18<br/>follow‐up: 30 seconds<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 30 seconds after lancing (preterm infants) ranged from <b>6.3‐13.3</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>1.88 lower</b><br/>(2.32 lower to 1.44 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>192<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose (with or without NNS) compared to control (water, placebo, or no intervention) results in little to no difference in PIPP scores at 30 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 60 seconds after lancing (preterm and term infants)<br/>Scale from: 0 to 21<br/>follow‐up: 60 seconds<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 60 seconds after lancing (preterm and term infants) ranged from <b>10.54‐11.2</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>2.14 lower</b><br/>(3.34 lower to 0.94 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>164<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose (with or without NNS) compared to control (water, placebo, or no intervention) probably results in a reduction in PIPP scores at 60 seconds after heel lancing in preterm and term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DAN scores at 30 seconds after heel lancing (term infants)<br/>Scale from: 0 to 10<br/>follow‐up: 30 seconds<sup>f</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean DAN scores at 30 seconds after heel lancing (term infants) was <b>9.5</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>1.9 lower</b><br/>(8.58 lower to 4.78 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>g,</sup><sup>h</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose (with or without NNS) compared to control (water, placebo, or no intervention) in DAN scores at 30 seconds after heel lancing in term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NIPS scores immediately after heel lance (term infants)<br/>Scale from: 0 to 7<sup>i,</sup><sup>j</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean NIPS scores immediately after heel lance (term infants) was <b>3</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>2 lower</b><br/>(2.42 lower to 1.58 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose (with or without NNS) compared to control (water, placebo, or no intervention) probably results in a reduction in NIPS scores immediately after heel lancing in term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799338500427522" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799338500427522</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Premature Infant Pain Profile (PIPP).<br/><sup>b</sup> Downgraded one level for serious inconsistency (due to I² = 62%). <br/><sup>c</sup> Downgraded one level for serious inconsistency (due to I² = 47%).<br/><sup>d</sup> Downgraded one level due to wide confidence interval. <br/><sup>e</sup> Downgraded two levels for very serious inconsistency (due to I² = 75%).<br/><sup>f</sup> Douleur Aiguë du Nouveau‐né Scale (DAN).<br/><sup>g</sup> Downgraded two levels due to concerns about performance and detection bias, and unclear risk of bias on allocation, attrition, and reporting bias.<br/><sup>h</sup> Downgraded two levels due to wide confidence interval and small sample size.<br/><sup>i</sup> Neonatal Infant Pain Scale (NIPS). <br/><sup>j</sup> Pain scores were measured immediately after heel lancing according to authors’ description as reported in their study. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD014806-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to NNS for analgesia for heel lancing in neonates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sucrose (any concentration, any dose) compared to NNS for analgesia for heel lancing in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> neonates<br/><b>Setting:</b> neonatal units <br/><b>Intervention:</b> sucrose (any concentration, any dose)<br/><b>Comparison:</b> NNS </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with NNS</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with sucrose (any concentration, any dose)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores during recovery after heel lancing (preterm infants)<br/>Scale from: 0 to 21<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores during recovery after heel lancing (preterm infants) was <b>6.8</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.6 higher</b><br/>(0.3 lower to 1.5 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose compared to NNS in PIPP scores during recovery after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DAN scores at 30 seconds after heel lancing (term infants)<br/>Scale from: 0 to 10<br/>follow‐up: 30 seconds<sup>e</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean DAN scores at 30 seconds after heel lancing (term infants) was <b>8.8</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>1.2 lower</b><br/>(7.87 lower to 5.47 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>d,</sup><sup>f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose compared to NNS in DAN scores at 30 seconds after heel lancing in term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799490342620980" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799490342620980</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Premature Infant Pain Profile (PIPP).<br/><sup>b</sup> Pain scores were measured during recovery after heel lancing according to authors’ description as reported in their study.<br/><sup>c</sup> Downgraded two levels due to concerns about selection, performance, and detection bias. <br/><sup>d</sup> Downgraded two levels due to wide confidence interval and small sample size. <br/><sup>e</sup> Douleur Aiguë du Nouveau‐né Scale (DAN).<br/><sup>f</sup> Downgraded two levels due to concerns about performance and detection bias, and unclear risk of bias on allocation, attrition, and reporting bias. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD014806-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) + NNS compared to NNS (with or without water) for analgesia for heel lancing in neonates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sucrose (any concentration, any dose) + NNS compared to NNS (with or without water) for analgesia for heel lancing in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> neonates<br/><b>Setting:</b> neonatal units<br/><b>Intervention:</b> sucrose (any concentration, any dose) + NNS<br/><b>Comparison:</b> NNS (with or without water) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with NNS (with or without water)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with sucrose (any concentration, any dose) + NNS</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores during heel lancing (preterm infants)<br/>Scale from: 0 to 21<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores during heel lancing (preterm infants) was <b>9.3</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>4.9 lower</b><br/>(5.73 lower to 4.07 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose + NNS compared to NNS in PIPP scores during heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores during recovery after heel lancing (preterm infants)<br/>Scale from: 0 to 21<sup>a,</sup><sup>e</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores during recovery after heel lancing (preterm infants) was <b>6.8</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>3.8 lower</b><br/>(4.47 lower to 3.13 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose + NNS compared to NNS in PIPP scores during recovery after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NFCS during heel lancing (term infants)<br/>Scale from: 0 to 9<sup>f,</sup><sup>g</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean NFCS during heel lancing (term infants) was <b>2.1</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.6 lower</b><br/>(1.47 lower to 0.27 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>h,</sup><sup>i</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose + NNS compared to NNS in NFCS scores during heel lancing in term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799652843327471" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799652843327471</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Premature Infant Pain Profile (PIPP).<br/><sup>b</sup> Pain scores were measured during heel lancing according to authors’ description as reported in their study.<br/><sup>c</sup> Downgraded two levels due to concerns about selection, performance, and detection bias. <br/><sup>d</sup> Downgraded two levels due to wide confidence interval and small sample size. <br/><sup>e</sup> Pain scores were measured during recovery after heel lancing according to authors’ description as reported in their study.<br/><sup>f</sup> Neonatal Facial Coding System (NFCS).<br/><sup>g</sup> Pain scores were measured during heel lancing according to authors' description as reported in their study. <br/><sup>h</sup> Downgraded two levels as five items were deemed unclear for the risk of bias assessment. <br/><sup>i</sup> Downgraded one level due to wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD014806-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to glucose (any concentration, any dose) for heel lancing in neonates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sucrose (any concentration, any dose) compared to glucose (any concentration, any dose) for heel lancing in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> neonates<br/><b>Setting:</b> neonatal units<br/><b>Intervention:</b> sucrose (any concentration, any dose)<br/><b>Comparison:</b> glucose (any concentration, any dose) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with glucose (any concentration, any dose)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with sucrose (any concentration, any dose)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 30 seconds after heel lancing (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 30 seconds<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 30 seconds after heel lancing (preterm infants) was <b>2.74</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.26 higher</b><br/>(0.7 lower to 1.22 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to glucose results in little to no difference in PIPP scores at 30 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 60 seconds after heel lancing (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 60 seconds<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 60 seconds after heel lancing (preterm infants) was <b>1.72</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.02 lower</b><br/>(0.79 lower to 0.75 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to glucose results in little to no difference in PIPP scores at 60 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799782182817780" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799782182817780</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Premature Infant Pain Profile (PIPP). <br/><sup>b</sup> Downgraded one level due to high risk of selective report. <br/><sup>c</sup> Downgraded one level due to wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD014806-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to breastfeeding for analgesia for heel lancing in neonates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sucrose (any concentration, any dose) compared to breastfeeding for analgesia for heel lancing in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> neonates<br/><b>Setting:</b> neonatal units<br/><b>Intervention:</b> sucrose (any concentration, any dose, with or without NNS)<br/><b>Comparison:</b> breastfeeding </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with breastfeeding</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with sucrose (any concentration, any dose, with or without NNS)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 30 seconds after heel lancing (term and preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 30 seconds<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 30 seconds after heel lancing (term and preterm infants) ranged from <b>5‐7</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.7 higher</b><br/>(0.49 lower to 1.88 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>148<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,</sup><sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose compared to breastfeeding in PIPP scores at 30 seconds after heel lancing in preterm and term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>COMFORTneo scores after heel lancing (preterm infants)<br/>Scale from: 6 to 30<sup>e</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean cOMFORTneo scores after heel lancing (preterm infants) was <b>18.6</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>2.6 lower</b><br/>(3.06 lower to 2.14 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>f,</sup><sup>g</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose compared to breastfeeding on COMFORTneo scores after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799948390502701" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799948390502701</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Premature Infant Pain Profile (PIPP).<br/><sup>b</sup> Downgraded one level due to inability to blind outcomes and assessors. <br/><sup>c</sup> Downgraded two levels for very serious inconsistency (due to I²=94%).<br/><sup>d</sup> Downgraded one level due to wide confidence interval. <br/><sup>e</sup> Pain scores were measured after heel lancing according to authors’ description as reported in their study.<br/><sup>f</sup> Downgraded one level due to high risk of performance and detection bias.<br/><sup>g</sup> Downgraded two levels due to wide confidence interval and small sample size. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD014806-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to expressed breast milk for analgesia for heel lancing in neonates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sucrose (any concentration, any dose) compared to expressed breast milk for analgesia for heel lancing in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> neonates<br/><b>Setting:</b> neonatal units<br/><b>Intervention:</b> sucrose(any concentration, any dose)<br/><b>Comparison:</b> expressed breast milk </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with expressed breast milk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with sucrose(any concentration, any dose)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP‐R scores during heel lancing (preterm infants)<br/>Scale from: 0 to 21<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP‐R scores during heel lancing (preterm infants) was <b>0</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.3 higher</b><br/>(0.24 lower to 0.84 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to expressed breast milk may result in little to no difference in PIPP‐R scores during heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP‐R scores at 30 seconds after heel lancing (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 30 seconds<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP‐R scores at 30 seconds after heel lancing (preterm infants) was <b>0</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.3 higher</b><br/>(0.11 lower to 0.71 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to expressed breast milk may result in little to no difference in PIPP‐R scores at 30 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP‐R scores at 60 seconds after heel lancing (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 60 seconds<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP‐R scores at 60 seconds after heel lancing (preterm infants) was <b>0</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>1.1 higher</b><br/>(0.34 higher to 1.86 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to expressed breast milk may result in slightly increased PIPP‐R scores at 60 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DAN scores at 30 seconds after heel lancing (term infants)<br/>Scale from: 0 to 10<br/>follow‐up: 30 seconds<sup>e</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean DAN scores at 30 seconds after heel lancing (term infants) was <b>9.4</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>1.8 lower</b><br/>(8.47 lower to 4.87 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>f,</sup><sup>g</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose compared to expressed breast milk in DAN scores at 30 seconds after heel lancing in term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425800004636643632" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425800004636643632</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Premature Infant Pain Profile ‐ Revised (PIPP‐R). <br/><sup>b</sup> Pain scores were measured during heel lancing according to authors’ description as reported in their study.<br/><sup>c</sup> Velumula 2020, the only study in these analyses, is at unclear risk of performance and detection bias. <br/><sup>d</sup> Downgraded one level due to wide confidence interval. <br/><sup>e</sup> Douleur Aiguë du Nouveau‐né Scale (DAN).<br/><sup>f</sup> Downgraded two levels due to concerns about performance and detection bias, and unclear risk of bias on allocation, attrition, and reporting. <br/><sup>g</sup> Downgraded two levels due to wide confidence interval and small sample size. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD014806-tbl-0007"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to laser acupuncture for analgesia for heel lancing in neonates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sucrose (any concentration, any dose) compared to laser acupuncture for analgesia for heel lancing in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> neonates<br/><b>Setting:</b> neonatal units<br/><b>Intervention:</b> sucrose (any concentration, any dose)<br/><b>Comparison:</b> laser acupuncture </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with laser acupuncture</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with sucrose (any concentration, any dose)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NIPS scores during heel lancing (term infants)<br/>Scale from: 0 to 7<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean NIPS scores during heel lancing (term infants) was <b>4.52</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.86 lower</b><br/>(1.43 lower to 0.29 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose compared to laser acupuncture in NIPS scores during heel lancing in term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425800210284679704" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425800210284679704</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Neonatal Infant Pain Scale (NIPS). <br/><sup>b</sup> Pain scores were measured during heel lancing according to authors’ description as reported in their study.<br/><sup>c</sup> Downgraded two levels due to concerns about high risk of selection and performance bias and unclear risk of random sequence generation and reporting bias.<br/><sup>d</sup> Downgraded two levels due to wide confidence interval and small sample size. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD014806-tbl-0008"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to facilitated tucking for analgesia during repeated heel lancing in neonates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sucrose (any concentration, any dose) compared to facilitated tucking for analgesia during repeated heel lancing in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> neonates<br/><b>Setting:</b> Neonatal units<br/><b>Intervention:</b> sucrose (any concentration, any dose)<br/><b>Comparison:</b> facilitated tucking </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with facilitated tucking</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with sucrose (any concentration, any dose)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BPSN scores during heel lancing (preterm infants)<br/>Scale from: 0 to 27<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean BPSN scores during heel lancing (preterm infants) was <b>9.75</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>2.27 lower</b><br/>(4.66 lower to 0.12 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose compared to facilitated tucking on BPSN scores during heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BPSN scores during recovery after heel lancing (preterm infants)<br/>Scale from: 0 to 27<sup>a,</sup><sup>e</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean BPSN scores during recovery after heel lancing (preterm infants) was <b>5.18</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.31 lower</b><br/>(1.72 lower to 1.1 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose compared to facilitated tucking on BPSN scores after heel lancing in term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425800249217258038" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425800249217258038</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Bernese Pain Scale for Neonates (BPSN).<br/><sup>b</sup> Pain scores were measured during heel lancing according to authors’ description as reported in their study.<br/><sup>c</sup> Downgraded one level due to concerns about performance and detection bias. <br/><sup>d</sup> Downgraded two levels due to wide confidence interval and small sample size. <br/><sup>e</sup> Pain scores were measured during recovery after heel lancing according to authors’ description as reported in their study. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD014806-tbl-0009"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to skin to skin care + water for analgesia during repeated heel lancing in neonates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sucrose (any concentration, any dose) compared to skin to skin care + water for analgesia during repeated heel lancing in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> neonates<br/><b>Setting:</b> Neonatal units<br/><b>Intervention:</b> Sucrose(any concentration, any dose)<br/><b>Comparison:</b> skin to skin care + water </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with skin to skin care + water</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with Sucrose(any concentration, any dose)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 30 seconds after heel lancing ‐ Lancing #1 (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 30 seconds<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 30 seconds after heel lancing ‐ Lancing #1 (preterm infants) was <b>5.76</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.13 higher</b><br/>(0.7 lower to 0.96 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>151<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to skin to skin care results in little to no difference in PIPP scores at 30 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 30 seconds after heel lancing ‐ Lancing #2 (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 30 seconds<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 30 seconds after heel lancing ‐ Lancing #2 (preterm infants) was <b>6.43</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.56 lower</b><br/>(1.57 lower to 0.45 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>144<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to skin to skin care results in little to no difference in PIPP scores at 30 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 30 seconds after heel lancing ‐ Lancing #3 (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 30 seconds<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 30 seconds after heel lancing ‐ Lancing #3 (preterm infants) was <b>6.3</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.15 lower</b><br/>(1.26 lower to 0.96 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>111<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to skin to skin care results in little to no difference in PIPP scores at 30 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 60 seconds after heel lancing ‐ Lancing #1 (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 60 seconds<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 60 seconds after heel lancing ‐ Lancing #1 (preterm infants) was <b>6.39</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.61 lower</b><br/>(1.55 lower to 0.33 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>154<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to skin to skin care results in little to no difference in PIPP scores at 60 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 60 seconds after heel lancing ‐ Lancing #2 (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 60 seconds<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 60 seconds after heel lancing ‐ Lancing #2 (preterm infants) was <b>5.62</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.12 lower</b><br/>(0.99 lower to 0.75 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>143<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to skin to skin care results in little to no difference in PIPP scores at 60 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 60 seconds after heel lancing ‐ Lancing #3 (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 60 seconds<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 60 seconds after heel lancing ‐ Lancing #3 (preterm infants) was <b>5.95</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.4 lower</b><br/>(1.48 lower to 0.68 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>111<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to skin to skin care results in little to no difference in PIPP scores at 60 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425800272531558981" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425800272531558981</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Medically indicated heel lances at 3 different time points throughout the study period of time were observed. Efforts were made to space data collection periods as soon as possible after enrollment (lancing #1), midway through the infant’s hospital stay (lancing #2), and as close as possible to discharge from the NICU (lancing #3). The three procedures were completed a minimum of 24 hours apart<br/><sup>b</sup> Premature Infant Pain Profile (PIPP).<br/><sup>c</sup> Downgraded one level due to concerns about performance and detection bias. <br/><sup>d</sup> Downgraded one level due to wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD014806-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD014806-sec-0009"></div> <section id="CD014806-sec-0010"> <h3 class="title" id="CD014806-sec-0010">Description of the condition</h3> <p>Infants hospitalised in the neonatal intensive care unit (NICU) undergo frequent painful tissue‐damaging procedures for diagnostic and therapeutic purposes. Epidemiological research from audits in NICUs in high‐income countries estimates that neonate infants undergo an average of up to 17 painful exposures per day (<a href="./references#CD014806-bbs2-0137" title="CruzMD , FernandesAM , OliveiraCR . Epidemiology of painful procedures performed in neonates: a systematic review of observational studies. European Journal of Pain2016;20(4):489-98. [DOI: 10.1002/ejp.757] [PMID: 26223408]">Cruz 2016</a>; <a href="./references#CD014806-bbs2-0166" title="OrovecA , DisherT , CaddellK , Campbell-YeoM . Assessment and management of procedural pain during the entire neonatal intensive care unit hospitalization. Pain Management Nursing2019;20(5):503-11. [DOI: 10.1016/j.pmn.2018.11.061] [PMID: 31103509]">Orovec 2019</a>). Similarly, estimates of procedural pain in infants in low‐ and middle‐income countries ‐ including those in South America (<a href="./references#CD014806-bbs2-0170" title="RamosMC , CandidoLK , CostaT , LeiteAC , ManzoBF , DuarteED , et al. Painful procedures and analgesia in hospitalized newborns: a prospective longitudinal study. Journal of Neonatal Nursing2019;25(1):26-31. [DOI: 10.1016/j.jnn.2018.08.003]">Ramos 2019</a>), Asia (<a href="./references#CD014806-bbs2-0135" title="ChenM , ShiX , ChenY , CaoZ , ChengR , XuY , et al. A prospective study of pain experience in a neonatal intensive care unit in China. Clinical Journal of Pain2012;28(8):700-4. [DOI: 10.1097/AJP.0b013e3182400d54] [PMID: 22156826]">Chen 2012</a>; <a href="./references#CD014806-bbs2-0155" title="JeongIS , ParkSM , LeeJM , ChoiYJ , LeeJ . The frequency of painful procedures in neonatal intensive care units in South Korea. International Journal of Nursing Practice2014;20(4):398-407. [DOI: 10.1016/s0140-6736(73)90480-7] [PMID: 24118662]">Jeong 2014</a>), and Africa (<a href="./references#CD014806-bbs2-0159" title="KyololoOM , StevensB , GastaldoD , GisoreP . Procedural pain in neonatal units in Kenya. Archives of Disease in Childhood. Fetal and Neonatal Edition2014;99(6):F464-7. [DOI: 10.1136/archdischild-2014-306003] [PMID: 24996597]">Kyololo 2014</a>), are equally high. </p> <p>Treatment for prevention or relief of procedural pain in the NICU varies widely in practice and is generally less than optimal (<a href="./references#CD014806-bbs2-0134" title="CarbajalR , RoussetA , DananC , CoqueryS , NolentP , DucrocqS , et al. Epidemiology and treatment of painful procedures in neonates in intensive care units. JAMA2008;300(1):60-70. [DOI: 10.1001/jama.300.1.60] [PMID: 18594041]">Carbajal 2008</a>; <a href="./references#CD014806-bbs2-0157" title="JohnstonCC , BarringtonKJ , TaddioA , CarbajalR , FilionF . Pain in Canadian NICUs: have we improved over the past 12 years?Clinical Journal of Pain2011;27(3):225-32. [DOI: 10.1097/AJP.0b013e3181fe14cf] [PMID: 21178602]">Johnston 2011</a>). An audit of 3508 tissue‐damaging procedures performed on 582 infants across a one‐week period in 14 Canadian NICUs indicated that only about 50% were accompanied by any form of pharmacological, behavioural or physical pain‐relieving intervention (<a href="./references#CD014806-bbs2-0157" title="JohnstonCC , BarringtonKJ , TaddioA , CarbajalR , FilionF . Pain in Canadian NICUs: have we improved over the past 12 years?Clinical Journal of Pain2011;27(3):225-32. [DOI: 10.1097/AJP.0b013e3181fe14cf] [PMID: 21178602]">Johnston 2011</a>). More recently, another Canadian study reported a total of 10,469 painful procedures performed during the entire NICU stay of preterm infants; being pain relief interventions documented for only 58.5% (<a href="./references#CD014806-bbs2-0166" title="OrovecA , DisherT , CaddellK , Campbell-YeoM . Assessment and management of procedural pain during the entire neonatal intensive care unit hospitalization. Pain Management Nursing2019;20(5):503-11. [DOI: 10.1016/j.pmn.2018.11.061] [PMID: 31103509]">Orovec 2019</a>). Although clinical practice guidelines outlining strategies to relieve pain from surgery, medical illness, and major procedures exist (<a href="./references#CD014806-bbs2-0162" title="LeeGY , YamadaJ , KyololoO , ShorkeyA , StevensB . Pediatric pain clinical practice guidelines for acute procedural pain: a systematic review. Pediatrics2014;133(3):500-15. [DOI: 10.1542/peds.2013-2744] [PMID: 24488733]">Lee 2014</a>), their quality is inconsistent. </p> <p>Untreated pain in neonates and, particularly, preterm infants, during a critical time in brain development, has the potential to result in significant immediate and long‐term consequences (<a href="./references#CD014806-bbs2-0139" title="DuerdenEG , GrunauRE , GuoT , FoongJ , PearsonA , Au-YoungS , et al. Early procedural pain Is associated with regionally-specific alterations in thalamic development in preterm neonates. Journal of Neuroscience2018;38(4):878-86. [DOI: 10.1523/JNEUROSCI.0867-17.2017] [PMID: 29255007]">Duerden 2018</a>; <a href="./references#CD014806-bbs2-0145" title="GrunauRE . Long-term effects of pain in children. In: McGrathP , StevensB , WalkerS , ZempskyW , editors(s). Oxford Textbook of Paediatric Pain. Oxford, UK: Oxford University Press, 2013:30-8.">Grunau 2013</a>; <a href="./references#CD014806-bbs2-0175" title="SchwallerF , FitzgeraldM . The consequences of pain in early life: injury-induced plasticity in developing pain pathways. European Journal of Neuroscience2014;39(3):344-52. [DOI: 10.1111/ejn.12414] [PMID: 24494675]">Schwaller 2014</a>; <a href="./references#CD014806-bbs2-0194" title="WalkerSM . Neuropathic pain in children. In: McGrathP , StevensB , WalkerS , ZempskyW , editors(s). Oxford Textbook of Paediatric Pain. Oxford University Press, 2013:205-14.">Walker 2013</a>). These consequences include: (a) changes in somatosensory processing and altered sensitivity to future painful stimuli; (b) impaired neuro‐anatomical development (e.g. to thalamus – <a href="./references#CD014806-bbs2-0139" title="DuerdenEG , GrunauRE , GuoT , FoongJ , PearsonA , Au-YoungS , et al. Early procedural pain Is associated with regionally-specific alterations in thalamic development in preterm neonates. Journal of Neuroscience2018;38(4):878-86. [DOI: 10.1523/JNEUROSCI.0867-17.2017] [PMID: 29255007]">Duerden 2018</a>); and, (c) behavioural, emotional and learning disabilities (<a href="./references#CD014806-bbs2-0122" title="BartocciM , BergqvistLL , LagercrantzH , AnandKJ . Pain activates cortical areas in preterm newborn brain. Pain2006;122(1-2):109-17. [DOI: 10.1016/j.pain.2006.01.015] [PMID: 16530965]">Bartocci 2006</a>; <a href="./references#CD014806-bbs2-0127" title="BrummelteS , GrunauRE , ChauV , PoskittKJ , BrantR , VinallJ , et al. Procedural pain and brain development in premature newborns. Annals of Neurology2012;71(3):385-96. [DOI: 10.1002/ana.22267] [PMID: 22374882]">Brummelte 2012</a>; <a href="./references#CD014806-bbs2-0145" title="GrunauRE . Long-term effects of pain in children. In: McGrathP , StevensB , WalkerS , ZempskyW , editors(s). Oxford Textbook of Paediatric Pain. Oxford, UK: Oxford University Press, 2013:30-8.">Grunau 2013</a>; <a href="./references#CD014806-bbs2-0153" title="HolstiL , GrunauRE , OberlanderTF , WhitfieldMF . Prior pain induces heightened motor responses during clustered care in preterm infants in the NICU. Early Human Development2005;81(3):293-302. [DOI: 10.1016/j.earlhumdev.2004.08.002] [PMID: 15814212]">Holsti 2005</a>; <a href="./references#CD014806-bbs2-0180" title="SlaterR , CantarellaA , GallellaS , WorleyA , BoydS , MeekJ , et al. Cortical pain responses in human infants. Journal of Neuroscience2006;26(14):3662-6. [DOI: 10.1523/JNEUROSCI.0348-06.2006] [PMID: 16597720]">Slater 2006</a>; <a href="./references#CD014806-bbs2-0189" title="TuMT , GrunauRE , Petrie-ThomasJ , HaleyDW , WeinbergJ , WhitfieldMF . Maternal stress and behavior modulate relationships between neonatal stress, attention, and basal cortisol at 8 months in preterm infants. Developmental Psychobiology2007;49(2):150-64. [DOI: 10.1002/dev.20204] [PMID: 17299787]">Tu 2007</a>; <a href="./references#CD014806-bbs2-0191" title="VinallJ , MillerSP , BjornsonBH , FitzpatrickKP , PoskittKJ , BrantR , et al. Invasive procedures in preterm children: brain and cognitive development at school age. Pediatrics2014;133(3):412-21. [DOI: 10.1542/peds.2013-1863] [PMID: 24534406]">Vinall 2014a</a>; <a href="./references#CD014806-bbs2-0192" title="VinallJ , GrunauRE . Impact of repeated procedural pain-related stress in infants born very preterm. Pediatric Research2014;75(5):584-7. [DOI: 10.1038/pr.2014.16] [PMID: 24500615]">Vinall 2014b</a>; <a href="./references#CD014806-bbs2-0194" title="WalkerSM . Neuropathic pain in children. In: McGrathP , StevensB , WalkerS , ZempskyW , editors(s). Oxford Textbook of Paediatric Pain. Oxford University Press, 2013:205-14.">Walker 2013</a>; <a href="./references#CD014806-bbs2-0195" title="ZwickerJG , GrunauRE , AdamsE , ChauV , BrantR , PoskittKJ , et al. Score for neonatal acute physiology-II and neonatal pain predict corticospinal tract development in premature newborns. Pediatric Neurology2013;48(2):123-9. [DOI: 10.1016/j.pediatrneurol.2012.10.016] [PMID: 23337005]">Zwicker 2013</a>). </p> </section> <section id="CD014806-sec-0011"> <h3 class="title" id="CD014806-sec-0011">Description of the intervention</h3> <p>Administration of oral sucrose with or without non‐nutritive sucking (NNS) (e.g. pacifiers) and other sweet solutions (e.g. glucose) prior to and during heel lance have been the most frequently studied interventions for relief of procedural pain in neonate infants (<a href="./references#CD014806-bbs2-0129" title="BuenoM , YamadaJ , HarrisonD , KhanS , OhlssonA , Adams-WebberT , et al. A systematic review and meta-analyses of non-sucrose sweet solutions for pain relief in neonates. Pain Research and Management2013;18(3):153-61. [DOI: 10.1155/2013/956549] [PMID: 23748256]">Bueno 2013</a>; <a href="./references#CD014806-bbs2-0150" title="HarrisonD , LarocqueC , BuenoM , StokesY , TurnerL , HuttonB , et al. Sweet solutions to reduce procedural pain in neonates: a meta-analysis. Pediatrics2017;139(1):e20160955. [DOI: 10.1542/peds.2016-0955] [PMID: 27986905]">Harrison 2017</a>; <a href="./references#CD014806-bbs2-0201" title="StevensB , YamadaJ , OhlssonA , HaliburtonS , ShorkeyA . Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database of Systematic Reviews2016, Issue 7. Art. No: CD001069. [DOI: 10.1002/14651858.CD001069.pub5]">Stevens 2016</a>). Analgesic effects persist up to approximately one year of age, although the robustness of the effect may decline in older infants compared to neonates (<a href="./references#CD014806-bbs2-0149" title="HarrisonD , AnseloniVCZ , YamadaJ , BuenoM . Sucrose and sweet taste. In: McGrathP , StevensB , WalkerS , ZempskyW , editors(s). Oxford Textbook of Paediatric Pain. Oxford, UK: Oxford University Press, 2013:508-16.">Harrison 2013</a>). </p> </section> <section id="CD014806-sec-0012"> <h3 class="title" id="CD014806-sec-0012">How the intervention might work</h3> <p>Analgesic, calming and stress‐reducing effects of sucrose were first reported in infant rats (<a href="./references#CD014806-bbs2-0125" title="BlassEM , ShideDJ , WellerA . Stress-reducing effects of ingesting milk, sugars, and fats. A developmental perspective. Annals of the New York Academy of Sciences1989;575:292-305. [DOI: 10.1111/j.1749-6632.1989.tb53251.x] [PMID: 2699193]">Blass 1989</a>; <a href="./references#CD014806-bbs2-0172" title="RenK , BlassEM , ZhouQ , DubnerR . Suckling and sucrose ingestion suppress persistent hyperalgesia and spinal Fos expression after forepaw inflammation in infant rats. Proceedings of the National Academy of Sciences of the United States of America1997;94(4):1471-75. [DOI: 10.1073/pnas.94.4.1471] [PMID: 9037077]">Ren 1997</a>; <a href="./references#CD014806-bbs2-0179" title="ShideDJ , BlassEM . Opioidlike effects of intraoral infusions of corn oil and polycose on stress reactions in 10-day-old rats. Behavioral Neuroscience1989;103(6):1168-75. [DOI: 10.1037//0735-7044.103.6.1168] [PMID: 2558674]">Shide 1989</a>). These effects occurred rapidly, persisted for several minutes and were blocked by systemic opioid receptor antagonists. They were age‐dependent and had differential maturational effects consistent with changes in the endogenous analgesic mechanisms and the development of the gustatory and pain pathways (<a href="./references#CD014806-bbs2-0120" title="AnseloniVC , WengHR , TerayamaR , LetiziaD , DavisBJ , RenK , et al. Age-dependency of analgesia elicited by intraoral sucrose in acute and persistent pain models. Pain2002;97(1):93-103. [DOI: 10.1016/s0304-3959(02)00010-6] [PMID: 12031783]">Anseloni 2002</a>). Researchers contend that sucrose may act at, or be mediated at, the level of the brainstem (<a href="./references#CD014806-bbs2-0120" title="AnseloniVC , WengHR , TerayamaR , LetiziaD , DavisBJ , RenK , et al. Age-dependency of analgesia elicited by intraoral sucrose in acute and persistent pain models. Pain2002;97(1):93-103. [DOI: 10.1016/s0304-3959(02)00010-6] [PMID: 12031783]">Anseloni 2002</a>; <a href="./references#CD014806-bbs2-0121" title="AnseloniVC , RenK , DubnerR , EnnisM . A brainstem substrate for analgesia elicited by intraoral sucrose. Neuroscience2005;133(1):231-43. [DOI: 10.1016/j.neuroscience.2005.01.055] [PMID: 15893646]">Anseloni 2005</a>; <a href="./references#CD014806-bbs2-0141" title="FitzgeraldM . What do we really know about newborn infant pain?Experimental Physiology2015;100(12):1451-7. [DOI: 10.1113/EP085134] [PMID: 26446174]">Fitzgerald 2015</a>), which has been shown to be a primary relay in the ascending gustatory pathway in animals (<a href="./references#CD014806-bbs2-0121" title="AnseloniVC , RenK , DubnerR , EnnisM . A brainstem substrate for analgesia elicited by intraoral sucrose. Neuroscience2005;133(1):231-43. [DOI: 10.1016/j.neuroscience.2005.01.055] [PMID: 15893646]">Anseloni 2005</a>). </p> <p>In human infants, the analgesic and calming effects of sweet‐tasting solutions are speculated to influence endogenous opioid pathways activated by the sweet taste (<a href="./references#CD014806-bbs2-0126" title="BlassE , CiaramitaroV . A new look at some old mechanisms in human newborns: taste and tactile determinants of state, affect and action. Monographs of the Society for Research in Child Development1994;59(1):1-80. [PMID: 8047076]">Blass 1994</a>). However, the underlying mechanisms for calming and pain may differ. These mechanisms may be additive or synergistic, but most likely depend on normal functioning of central mechanisms. The effects are associated with the potency of sweet taste (i.e. sweeter, more concentrated solutions), rather than volume of solution administered; with sucrose being more analgesic than glucose and fructose, and lactose not demonstrating any analgesic effects (<a href="./references#CD014806-bbs2-0126" title="BlassE , CiaramitaroV . A new look at some old mechanisms in human newborns: taste and tactile determinants of state, affect and action. Monographs of the Society for Research in Child Development1994;59(1):1-80. [PMID: 8047076]">Blass 1994</a>). In a systematic review/meta‐analysis of the efficacy of sucrose for procedural pain management in 13 trials and 982 neonates, <a href="./references#CD014806-bbs2-0183" title="StevensB , TaddioA , OhlssonA , EinarsonT . The efficacy of sucrose for relieving procedural pain in neonates - a systematic review and meta-analysis. Acta Paediatrica1997;86(8):837-42. [DOI: 10.1111/j.1651-2227.1997.tb08607.x] [PMID: 9307163]">Stevens 1997a</a> found that the proportion of time crying decreased with 240 mg to 480 mg sucrose (i.e. 2 mL of a 12% to 24% solution) administered orally two minutes prior to a painful procedure (e.g. heel lance or venipuncture). </p> <p>Despite advances on the potential mechanisms of sucrose analgesia, further research is required to enhance our understanding of the opioid pathways involved in the developing infant, the effectiveness of sucrose when administered with concomitant opioids or other pain‐relieving interventions, or both, and with repeated use over time (<a href="./references#CD014806-bbs2-0148" title="HarrisonD , BeggsS , StevensB . Sucrose for procedural pain management in infants. Pediatrics2012;130(5):918-25. [DOI: 10.1542/peds.2011-3848] [PMID: 23045554]">Harrison 2012</a>). </p> </section> <section id="CD014806-sec-0013"> <h3 class="title" id="CD014806-sec-0013">Why it is important to do this review</h3> <p>This systematic review builds on the findings of previously published Cochrane reviews (<a href="./references#CD014806-bbs2-0196" title="StevensB , OhlssonA . Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database of Systematic Reviews1998, Issue 1. Art. No: CD001069. [DOI: 10.1002/14651858.CD001069.pub2]">Stevens 1998</a>; <a href="./references#CD014806-bbs2-0197" title="StevensB , YamadaJ , OhlssonA . Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database of Systematic Reviews2001, Issue 1. Art. No: CD001069. [DOI: 10.1002/14651858.CD001069.pub2]">Stevens 2001</a>; <a href="./references#CD014806-bbs2-0198" title="StevensB , YamadaJ , OhlssonA . Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database of Systematic Reviews2004, Issue 3. Art. No: CD001069. [DOI: 10.1002/14651858.CD001069.pub2]">Stevens 2004</a>; <a href="./references#CD014806-bbs2-0199" title="StevensB , YamadaJ , Ohlsson, A. Sucrose for analgesia in newborns infants undergoing painful procedures. Cochrane Database of Systematic Reviews2010, Issue 1. Art. No: CD001069. [DOI: 10.1002/14651858.CD001069.pub3]">Stevens 2010</a>; <a href="./references#CD014806-bbs2-0200" title="StevensB , YamadaJ , LeeGY , OhlssonA . Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database of Systematic Reviews2013, Issue 1. Art. No: CD001069. [DOI: 10.1002/14651858.CD001069.pub4]">Stevens 2013</a>; <a href="./references#CD014806-bbs2-0201" title="StevensB , YamadaJ , OhlssonA , HaliburtonS , ShorkeyA . Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database of Systematic Reviews2016, Issue 7. Art. No: CD001069. [DOI: 10.1002/14651858.CD001069.pub5]">Stevens 2016</a>). In the 2016 review, 74 studies were included, with 7049 term and preterm infants, and results demonstrated that sucrose reduces different neonatal pain indicators alone and in composite scores of neonatal pain intensity during heel lance, venipuncture, and intramuscular injection (<a href="./references#CD014806-bbs2-0201" title="StevensB , YamadaJ , OhlssonA , HaliburtonS , ShorkeyA . Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database of Systematic Reviews2016, Issue 7. Art. No: CD001069. [DOI: 10.1002/14651858.CD001069.pub5]">Stevens 2016</a>). Tissue‐damaging procedures included heel lance, venipuncture, arterial puncture, intramuscular injections, echocardiography, peripheral venous catheter insertion, suctioning, eye examinations, circumcision, subcutaneous injections, bladder catheterisation, and nasogastric tube insertion. Since heel lance is the most commonly performed painful procedure in neonates as well as the most frequently investigated procedure in randomised controlled trials (RCTs), the authors decided to focus specifically on the effects of sucrose on heel lance for this current 2022 review (see <a href="#CD014806-sec-0169">Differences between protocol and review</a>). </p> <p>Repeated use, or use in extremely preterm and sick infants, has rarely been addressed (<a href="./references#CD014806-bbs2-0147" title="HarrisonD , LoughnanP , ManiaE , GordonI , JohnstonL . Repeated doses of sucrose in infants continue to reduce procedural pain during prolonged hospitalizations. Nursing Research2009;58(6):427-34. [DOI: 10.1097/NNR.0b013e3181b4b5e4] [PMID: 19918153]">Harrison 2009</a>). Johnston reported that preterm infants of less than 31 weeks' gestational age who were exposed to more than 10 repeated doses of sucrose per day were more prone to poorer attention and motor development in early life (<a href="./references#CD014806-bbs2-0023" title="BoyerK , JohnstonC , WalkerCD , FilionF , SherrardA . Does sucrose analgesia promote physiological stability in preterm neonates?Biology of the Neonate2004;85(1):26-31. [DOI: 10.1159/000074954] [PMID: 14631163]JohnstonCC , FilionF , SniderL , MajnemerA , LimperopolousC , WalkerCD , et al. Routine sucrose analgesia during the first week of life in neonates younger than 31 weeks' postconceptional age. Pediatrics2002;110(3):523-8. [DOI: 10.1542/peds.110.3.523] [PMID: 12205254]">Johnston 2002</a>; <a href="./references#CD014806-bbs2-0156" title="JohnstonCC , FilionF , SniderL , LimperopoulosC , MajnemerA , PelausaE , et al. How much sucrose is too much sucrose?Pediatrics2007;119(1):226. [DOI: 10.1542/peds.2006-3001] [PMID: 17200300]">Johnston 2007</a>). Other studies have not reported differences between sucrose and non‐sucrose groups (<a href="./references#CD014806-bbs2-0063" title="BangaS , DattaV , RehanHS , BhakhriBK . Effects of sucrose analgesia, for repeated painful procedures, on short-term neurobehavioral outcome of preterm neonates: a randomized controlled trial. Journal of Tropical Pediatrics2016;62(2):101-6. [DOI: 10.1093/tropej/fmv079] [PMID: 26615181]">Banga 2016</a>; <a href="./references#CD014806-bbs2-0013" title="GaspardoCM , MiyaseCI , ChimelloJT , MartinezFE , Martins LinharesMB . Is pain relief equally efficacious and free of side effects with repeated doses of oral sucrose in preterm neonates?Pain2008;137(1):16-25. [DOI: 10.1016/j.pain.2007.07.032] [PMID: 17854995]">Gaspardo 2008</a>; <a href="./references#CD014806-bbs2-0184" title="StevensB , YamadaJ , BeyeneJ , GibbinsS , PetryshenP , StinsonJ , et al. Consistent management of repeated procedural pain with sucrose in preterm neonates: is it effective and safe for repeated use over time?Clinical Journal of Pain2005;12(6):543-48. [DOI: 10.1097/01.ajp.0000149802.46864.e2] [PMID: 16215340]">Stevens 2005b</a>; <a href="./references#CD014806-bbs2-0188" title="TaddioA , YiuA , SmithRW , KatzJ , McNairC , ShahV . Variability in clinical practice guidelines for sweetening agents in newborn infants undergoing painful procedures. Clinical Journal of Pain2009;25(2):153-5. [DOI: 10.1097/AJP.0b013e3181847a09] [PMID: 19333162]">Taddio 2009a</a>). However, comprehensive studies evaluating repeated dosing of sucrose for all painful procedures during hospitalisations of the neonate have not been undertaken. </p> <p>Concerns regarding the repeated use of sucrose and cumulative volumes administered during painful procedures in the developing brains of preterm infants have been raised (<a href="./references#CD014806-bbs2-0165" title="McPhersonC , MillerSP , El-DibM , MassaroAN , InderTE . The influence of pain, agitation, and their management on the immature brain. Pediatric Research2020;88(2):168-75. [DOI: 10.1038/s41390-019-0744-6] [PMID: 31896130]">McPherson 2020</a>). </p> <p>Although 24% or 25% sucrose solutions are the most widely used concentrations for the treatment of procedural pain in clinical practice, there is considerable variation in the volumes of sucrose reported to be effective in diminishing pain, and a more than 20‐fold variation in doses used in clinical practice (<a href="./references#CD014806-bbs2-0188" title="TaddioA , YiuA , SmithRW , KatzJ , McNairC , ShahV . Variability in clinical practice guidelines for sweetening agents in newborn infants undergoing painful procedures. Clinical Journal of Pain2009;25(2):153-5. [DOI: 10.1097/AJP.0b013e3181847a09] [PMID: 19333162]">Taddio 2009a</a>). There is currently no clear recommendation regarding the optimal volume of sucrose for analgesia in infants, or for the use of sucrose in the presence of opioid analgesia, despite administration of opioids to infants during their NICU stay (<a href="./references#CD014806-bbs2-0147" title="HarrisonD , LoughnanP , ManiaE , GordonI , JohnstonL . Repeated doses of sucrose in infants continue to reduce procedural pain during prolonged hospitalizations. Nursing Research2009;58(6):427-34. [DOI: 10.1097/NNR.0b013e3181b4b5e4] [PMID: 19918153]">Harrison 2009</a>; <a href="./references#CD014806-bbs2-0157" title="JohnstonCC , BarringtonKJ , TaddioA , CarbajalR , FilionF . Pain in Canadian NICUs: have we improved over the past 12 years?Clinical Journal of Pain2011;27(3):225-32. [DOI: 10.1097/AJP.0b013e3181fe14cf] [PMID: 21178602]">Johnston 2011</a>). Ideally, the amount of sucrose (mg/kg body weight) administered should be reported. A critical evaluation of guidelines for incorporating sucrose as an intervention for preventing or ameliorating procedural pain in infants indicates that recommendations for practitioners are not clear (<a href="./references#CD014806-bbs2-0162" title="LeeGY , YamadaJ , KyololoO , ShorkeyA , StevensB . Pediatric pain clinical practice guidelines for acute procedural pain: a systematic review. Pediatrics2014;133(3):500-15. [DOI: 10.1542/peds.2013-2744] [PMID: 24488733]">Lee 2014</a>). These knowledge gaps and lack of consistent strategies for effective application of knowledge most likely contribute to the current suboptimal or non‐standardised utilisation of sucrose in NICUs. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD014806-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD014806-sec-0014"></div> <p>To assess the effectiveness of sucrose for relieving the pain of heel lance in neonate infants in terms of immediate (i.e. validated pain scores, neurophysiological and behavioural pain indicators) and long‐term (neurodevelopmental) outcomes </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD014806-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD014806-sec-0015"></div> <section id="CD014806-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD014806-sec-0017"> <h4 class="title">Types of studies</h4> <p>We considered RCTs that evaluated the effect of sucrose analgesia in neonate infants undergoing single or repeated heel lances. We did not include quasi‐randomised trials. Conference abstracts were not included as we have identified discrepancies in numbers of infants enrolled between abstracts and final publications (<a href="./references#CD014806-bbs2-0193" title="WaliaR , OhlssonA . Clinical trials in neonatal medicine. In: 7th Annual Cochrane Colloquium, Abstracts; October 1999; Rome, Italy. 1999.">Walia 1999</a>). We did not impose language restrictions. </p> </section> <section id="CD014806-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included studies that assessed term, preterm, or both term and preterm neonate infants, with maximum postnatal age (PNA) of 28 days after reaching 40 weeks' postmenstrual age (PMA). </p> </section> <section id="CD014806-sec-0019"> <h4 class="title">Types of interventions</h4> <p>Interventions:</p> <p> <ul id="CD014806-list-0001"> <li> <p>Oral sucrose in any concentration or dose, administered via any method.</p> </li> <li> <p>Oral sucrose in any concentration or dose, administered via any method with non‐nutritive sucking (NNS), e.g. pacifier. </p> </li> </ul> </p> <p>Comparisons:</p> <p>a. water, placebo or no intervention;</p> <p>b. analgesia;</p> <p>c. NNS with or without water;</p> <p>d. glucose (any concentration, any dose);</p> <p>e. breastfeeding;</p> <p>f. breast milk or milk formula;</p> <p>g. recorded music;</p> <p>h. laser acupuncture;</p> <p>i. facilitated tucking;</p> <p>j. skin‐to‐skin care.</p> </section> <section id="CD014806-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>The outcomes are organised as follows.</p> <section id="CD014806-sec-0021"> <h5 class="title">Primary outcomes</h5> <p>Pain intensity scores measured by validated instruments such as:</p> <p> <ul id="CD014806-list-0002"> <li> <p>Premature Infant Pain Profile (PIPP; <a href="./references#CD014806-bbs2-0182" title="StevensB , JohnstonC , PetryshenP , TaddioA . Premature infant pain profile; development and initial validation. Clinical Journal of Pain1996;12(1):13-22. [DOI: 10.1097/00002508-199603000-00004] [PMID: 8722730]">Stevens 1996</a>); </p> </li> <li> <p>Premature Infant Pain Profile‐Revised (PIPP‐R; <a href="./references#CD014806-bbs2-0185" title="StevensB , GibbinsS , YamadaY , DionneK , LeeG , TaddioA . The premature infant pain profile - revised: initial validation and feasibility. Clinical Journal of Pain2014;30(3):238-43. [DOI: 10.1097/AJP.0b013e3182906aed] [PMID: 24503979]">Stevens 2014a</a>); </p> </li> <li> <p>Douleur Aiguë du Nouveau‐né Scale (DAN; <a href="./references#CD014806-bbs2-0133" title="CarbajalR , PaupeA , HoennE , LenclenR , Olivier MartinM . APN: evaluation behavioral scale of acute pain in newborn infants [DAN: une échelle comportementale d’évaluation de la douleur aiguë du nouveau-né]. Archives Pediatrie1997;4(7):623-8. [DOI: 10.1016/s0929-693x(97)83360-x] [PMID: 9295899]">Carbajal 1997</a>); </p> </li> <li> <p>Neonatal Infant Pain Scale (NIPS; <a href="./references#CD014806-bbs2-0161" title="LawrenceJ , AlcockD , McGrathP , KayJ , MacMurraySB , DulbergC . The development of a tool to assess neonatal pain. Neonatal Network1993;12(6):59-66. [PMID: 8413140]">Lawrence 1993</a>); </p> </li> <li> <p>Neonatal Facial Coding System (NFCS; <a href="./references#CD014806-bbs2-0144" title="GrunauRE , CraigKD . Pain expression in neonates: facial action and cry. Pain1987;28(3):395-410. [DOI: 10.1016/0304-3959(87)90073-x] [PMID: 3574966]">Grunau 1987</a>); </p> </li> <li> <p>Neonatal Pain Agitation and Sedation Scale (N‐PASS; <a href="./references#CD014806-bbs2-0154" title="HummelP , Lawlor-KleanP , WeissMG . Validity and reliability of the N-PASS assessment tool with acute pain. Journal of Perinatology2010;30(7):474-8. [DOI: 10.1038/jp.2009.185] [PMID: 19924132]">Hummel 2010</a>); </p> </li> <li> <p>Bernese Pain Scale for Neonates (BPSN; <a href="./references#CD014806-bbs2-0136" title="CignaccoE , MuellerR , HamersJP , GesslerP . Pain assessment in the neonate using the Bernese Pain Scale for Neonates. Early Human Development2004;78(2):125-31. [DOI: 10.1016/j.earlhumdev.2004.04.001] [PMID: 15223117]">Cignacco 2004</a>); </p> </li> <li> <p>COMFORTneo Scale (<a href="./references#CD014806-bbs2-0190" title="Van DijkM , RoofthooftDW , AnandKJ , GuldemondF , deGraafJ , SimmonsS , et al. Taking up the challenge of measuring prolonged pain in neonates: the COMFORTneo scale seems promising. Clinical Journal of Pain2009;25(7):607-16. [DOI: 10.1097/AJP.0b013e3181a5b52a] [PMID: 19692803]">Van Dijk 2009</a>); </p> </li> <li> <p>others as reported in trial.</p> </li> </ul> </p> <p>We included pain intensity scores assessed at:</p> <p> <ul id="CD014806-list-0003"> <li> <p>time of the procedure;</p> </li> <li> <p>after the procedure;</p> </li> <li> <p>intervals as reported in the study (e.g. 30 seconds after heel lance, 60 seconds after heel lance, etc.). </p> </li> </ul> </p> </section> <section id="CD014806-sec-0022"> <h5 class="title">Secondary outcomes</h5> <section id="CD014806-sec-0023"> <h6 class="title">Individual behavioural pain indicators</h6> <p> <ul id="CD014806-list-0004"> <li> <p>Cry (duration of first cry in seconds, total duration of cry in seconds, proportion of time crying, etc.); </p> </li> <li> <p>Facial actions (presence or absence of facial actions, time in seconds facial actions were present, etc.). </p> </li> </ul> </p> </section> <section id="CD014806-sec-0024"> <h6 class="title">Individual neurophysiological pain indicators</h6> <p> <ul id="CD014806-list-0005"> <li> <p>Heart rate (in beats per minute (bpm), percentage of change in HR, etc.);</p> </li> <li> <p>Respiratory rate (in respirations per minute (rpm), percentage of change in RR, etc.);</p> </li> <li> <p>Oxygen saturation of the blood (in %, percentage of change in oxygen saturation, etc.);</p> </li> <li> <p>TcpO<sub>2</sub> (in Pascal ‐ Pa, kilopascal ‐ kPa, or millimetres of mercury ‐ mmHg); </p> </li> <li> <p>TcpCO<sub>2</sub> (in Pascal ‐ Pa, kilopascal ‐ kPa, or millimetres of mercury ‐ mmHg); </p> </li> <li> <p>Cortisol level (ug/dL);</p> </li> <li> <p>NIRS;</p> </li> <li> <p>EEG.</p> </li> </ul> </p> <p>Long‐term neurodevelopmental outcomes (assessed by a standardised and validated assessment tool, a child developmental specialist, or both) at 18 to 24 months, or at any later age in childhood. </p> <p>Any adverse effects reported.</p> </section> </section> </section> </section> <section id="CD014806-sec-0025"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD014806-sec-0026"> <h4 class="title">Electronic searches</h4> <p>Searches were run in February 2022 and were conducted without date, language or publication type limits. We acknowledge the date of search is greater than one year old; this resulted from editorial delays related to COVID and staffing issues at the Cochrane Neonatal editorial base. </p> <p>The following databases were searched:</p> <p> <ul id="CD014806-list-0006"> <li> <p>Cochrane Library, Wiley, Issue 2, 2022 (searched February 23, 2022);</p> </li> <li> <p>Ovid MEDLINE® ALL 1946 to February 23, 2022;</p> </li> <li> <p>Embase 1980 to 2022 Week 07 (Ovid);</p> </li> <li> <p>PsycINFO 1806 to February Week 2 2022 (Ovid);</p> </li> <li> <p>CINAHL Complete (EBSCOhost) (searched February 23, 2022);</p> </li> <li> <p>Web of Science Core Collection (Clarivate), (searched 1982‐February 23, 2022).</p> </li> </ul> </p> <p>The search strategies for each database are reported in <a href="./appendices#CD014806-sec-0147">Appendix 1</a>; <a href="./appendices#CD014806-sec-0148">Appendix 2</a>; <a href="./appendices#CD014806-sec-0149">Appendix 3</a>; <a href="./appendices#CD014806-sec-0150">Appendix 4</a>; <a href="./appendices#CD014806-sec-0151">Appendix 5</a>; <a href="./appendices#CD014806-sec-0152">Appendix 6</a>. </p> </section> <section id="CD014806-sec-0027"> <h4 class="title">Searching other resources</h4> <p>The following trials registers resources were searched on February 23, 2022 using their native, web‐based interfaces. </p> <p> <ul id="CD014806-list-0007"> <li> <p>US National Library of Medicine <a href="https://clinicaltrials.gov" target="_blank">https://clinicaltrials.gov</a>; </p> </li> <li> <p>EU Clinical Trials Register (<a href="https://www.clinicaltrialsregister.eu" target="_blank">https://www.clinicaltrialsregister.eu</a>); </p> </li> <li> <p>WHO International Clinical Trials Registers Platform (ICTRP) (<a href="https://trialsearch.who.int" target="_blank">https://trialsearch.who.int</a>). </p> </li> </ul> </p> <p>The search strategies are reported in <a href="./appendices#CD014806-sec-0153">Appendix 7</a>. </p> </section> </section> <section id="CD014806-sec-0028"> <h3 class="title" id="CD014806-sec-0028">Data collection and analysis</h3> <section id="CD014806-sec-0029"> <h4 class="title">Selection of studies</h4> <p>Titles and abstracts were independently screened by two reviewers (MB, LS and MB, SH) and disagreements were resolved by discussion or a third reviewer (JY). </p> </section> <section id="CD014806-sec-0030"> <h4 class="title">Data extraction and management</h4> <p>Two reviewers (LS, MB) extracted data separately using predesigned forms. We compared the data and resolved differences using a third reviewer (JY). We had additional data provided by investigators for three studies (<a href="./references#CD014806-bbs2-0019" title="HarrisonD , JohnstonL , LoughnanP . Oral sucrose for procedural pain in sick hospitalized infants: a randomized-controlled trial. Journal of Paediatric and Child Health2003;39(8):591-7. [DOI: 10.1046/j.1440-1754.2003.00242.x] [PMID: 14629524]">Harrison 2003</a>; <a href="./references#CD014806-bbs2-0022" title="JohnstonCC , StremlerR , HortonL , FriedmanA . Effect of repeated doses of sucrose during heel stick procedure in preterm neonates. Biology of the Neonate1999;75(3):160-6. [DOI: 10.1159/000014092] [PMID: 9925903]">Johnston 1999</a>; <a href="./references#CD014806-bbs2-0046" title="JohnstonCC , SherrardA , StevensB , FranckL , StremlerR , JackA . Do cry features reflect pain intensity in preterm neonates?Biology of the Neonate1999;76(2):120-4. [DOI: 10.1159/000014150] [PMID: 10393997]StevensB , JohnstonC , FranckP , PetryshenP , JackA , FosterG . The efficacy of developmentally sensitive interventions and sucrose for relieving pain in very low birth weight infants. Nursing Research1999;48(1):35-43. [DOI: 10.1097/00006199-199901000-00006] [PMID: 10029400]">Stevens 1999</a>) that were previously included in another review (<a href="./references#CD014806-bbs2-0201" title="StevensB , YamadaJ , OhlssonA , HaliburtonS , ShorkeyA . Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database of Systematic Reviews2016, Issue 7. Art. No: CD001069. [DOI: 10.1002/14651858.CD001069.pub5]">Stevens 2016</a>). </p> </section> <section id="CD014806-sec-0031"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two reviewers (LS, MB), independently assessed the risk of bias (low, high, or unclear) of all included trials using the Cochrane Risk of bias tool (<a href="./references#CD014806-bbs2-0152" title="HigginsJP , AltmanDG , SterneJA , editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from training.cochrane.org/handbook/archive/v5.2.">Higgins 2017</a>), for the following domains: </p> <p>• random sequence generation (selection bias);</p> <p>• allocation concealment (selection bias);</p> <p>• blinding of participants and personnel (performance bias and detection bias);</p> <p>• blinding of outcome assessment (detection bias);</p> <p>• incomplete outcome data (attrition bias);</p> <p>• selective reporting (reporting bias);</p> <p>• any other bias.</p> <p>We resolved any disagreements by discussion or by a third assessor (JY). See <a href="./appendices#CD014806-sec-0154">Appendix 8</a> for a more detailed description of risk of bias for each domain.  </p> </section> <section id="CD014806-sec-0032"> <h4 class="title">Measures of treatment effect</h4> <p>We performed statistical analyses using Review Manager 5 (RevMan 5) (<a href="./references#CD014806-bbs2-0173" title="Review Manager Web (RevMan Web 5). Version 5.5. The Cochrane Collaboration, 2023. Available at revman.cochrane.org.">RevMan Web 2020</a>). We analysed categorical data using risk ratio (RR), risk difference (RD) and the number needed to treat for an additional beneficial outcome (NNTB), or the number needed to treat for an additional harmful outcome (NNTH) if the RD was statistically significant. We analysed continuous data using mean difference (MD). We reported the 95% confidence interval (CI) on all estimates. Following advice from Dr Michael Bracken (statistician of Cochrane Neonatal) we decided not to convert medians and interquartile or full ranges to means and SDs. </p> </section> <section id="CD014806-sec-0033"> <h4 class="title">Unit of analysis issues</h4> <p>We did not identify any cluster‐randomised trials and so did not encounter any unit of analysis issues. </p> </section> <section id="CD014806-sec-0034"> <h4 class="title">Dealing with missing data</h4> <p>Many authors did not report means and SDs for the outcomes. We transformed 95% CIs to SDs using the techniques described under <a href="#CD014806-sec-0032">Measures of treatment effect</a>. Many studies reported the results in graph form only, and we could not incorporate the findings in RevMan analyses. </p> </section> <section id="CD014806-sec-0035"> <h4 class="title">Assessment of heterogeneity</h4> <p>We report the I<sup>2</sup> statistic for all analyses in which more than one trial was included. We categorised the heterogeneity using the following labels and cutoffs for the results of the I<sup>2</sup> test; less than 25%, no heterogeneity present; 25% to 49%, low heterogeneity; 50% to 74%, moderate heterogeneity; and 75% or more, high heterogeneity. If we detected statistical heterogeneity (I<sup>2</sup> = 50%), we explored the possible causes (e.g. differences in study quality, participants (term or preterm infants), intervention regimens or outcome assessments) using post hoc subgroup analyses. </p> </section> <section id="CD014806-sec-0036"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to construct forest plots if there were at least 10 studies included in one meta‐analysis that assessed the same outcome in comparable trials of the same intervention in the same population; however, no single meta‐analysis fulfilled this criterion. </p> </section> <section id="CD014806-sec-0037"> <h4 class="title">Data synthesis</h4> <p>We used the statistical package Review Manager 5 (RevMan 5) provided by Cochrane (<a href="./references#CD014806-bbs2-0173" title="Review Manager Web (RevMan Web 5). Version 5.5. The Cochrane Collaboration, 2023. Available at revman.cochrane.org.">RevMan Web 2020</a>). For meta‐analyses, we reported an MD with 95% CI using a fixed‐effect model for continuous outcome measures. For categorical outcomes, we reported the typical RR, RD and, if the RD was statistically significant, we planned to report the NNTB or NNTH. All values were reported with their 95% CIs. </p> </section> <section id="CD014806-sec-0038"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We did not make separate subgroup comparisons.</p> </section> <section id="CD014806-sec-0039"> <h4 class="title">Sensitivity analysis</h4> <p>Under each comparison for the outcomes, we reported the results in the term and the preterm populations separately and combined these whenever data were available. </p> </section> <section id="CD014806-sec-0040"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We used the GRADE approach, as outlined in the GRADE Handbook (<a href="./references#CD014806-bbs2-0176" title="SchünemannH , BrożekJ , GuyattG , Oxman A (editors). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.">Schünemann 2013</a>), to assess the certainty of evidence of the following (clinically relevant) outcome: </p> <p> <ul id="CD014806-list-0008"> <li> <p>validated pain score</p> </li> </ul> </p> <p>Two review authors (SH, MB) independently assessed the certainty of the evidence for the outcome above. We considered evidence from RCTs as high certainty but downgraded the evidence one level for serious (or two levels for very serious) limitations based upon the following: design (risk of bias), consistency across studies, directness of the evidence, precision of estimates, and presence of publication bias. We used the <a href="./references#CD014806-bbs2-0143" title="GRADEpro GDT. Version accessed 8 December 2022. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a> to create nine Summary of findings tables to report the certainty of the evidence. </p> <p>The GRADE approach results in an assessment of the certainty of a body of evidence as one of four grades. </p> <p> <ul id="CD014806-list-0009"> <li> <p>High certainty: further research is very unlikely to change our confidence in the estimate of effect. </p> </li> <li> <p>Moderate certainty: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> </li> <li> <p>Low certainty: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> </li> <li> <p>Very low certainty: we are very uncertain about the estimate.</p> </li> </ul> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD014806-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD014806-sec-0041"></div> <section id="CD014806-sec-0042"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD014806-sec-0171" title="">Characteristics of included studies</a>; <a href="./references#CD014806-sec-0172" title="">Characteristics of excluded studies</a>; <a href="./references#CD014806-sec-0173" title="">Characteristics of studies awaiting classification</a>; <a href="./references#CD014806-sec-0174" title="">Characteristics of ongoing studies</a> </p> <section id="CD014806-sec-0043"> <h4 class="title">Results of the search</h4> <p>Searches of databases and trial registries identified 16,896 references; after removing 9721 duplicates, 7175 records were available for screening. We excluded 7057 based on title/abstract and reviewed 118 full‐texts or trial registry records. We included 55 studies; excluded 57 studies; allocated two studies to awaiting classification; and identified four ongoing trials. Details are available in <a href="#CD014806-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD014806-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram: review update" data-id="CD014806-fig-0001" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram: review update</p> </div> </div> </div> </section> <section id="CD014806-sec-0044"> <h4 class="title">Included studies</h4> <p>We included a total of 55 studies (enrolling 6273 infants) in this systematic review.</p> <p>Of the 55 included studies, 42 were included in our previous, broader review of multiple painful procedures, Sucrose for analgesia in newborn infants undergoing painful procedures (<a href="./references#CD014806-bbs2-0201" title="StevensB , YamadaJ , OhlssonA , HaliburtonS , ShorkeyA . Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database of Systematic Reviews2016, Issue 7. Art. No: CD001069. [DOI: 10.1002/14651858.CD001069.pub5]">Stevens 2016</a>); and 13 are newly identified studies (<a href="./references#CD014806-bbs2-0004" title="BenoitB , NewmanA , Martin-MisenerR , LatimerM , Campbell-YeoM . The influence of breastfeeding on cortical and bio-behavioural indicators of procedural pain in newborns: findings of a randomized controlled trial. Early Human Development2021;154:105308. [DOI: 10.1016/j.earlhumdev.2021.105308] [PMID: 33513546]">Benoit 2021</a>; <a href="./references#CD014806-bbs2-0008" title="Campbell-YeoM , JohnstonCC , BenoitB , DisherT , CaddellK , VincerM , et al. Sustained efficacy of kangaroo care for repeated painful procedures over neonatal intensive care unit hospitalization: a single-blind randomized controlled trial. Pain2019;160(11):2580-8. [DOI: 10.1097/j.pain.0000000000001646] [PMID: 31356452]">Campbell‐Yeo 2019</a><a href="./references#CD014806-bbs2-0009" title="ChangJ , FiloteoL , NasrAS . Comparing the analgesic effects of 4 nonpharmacologic interventions on term newborns undergoing heel lance: a randomized controlled trial. Journal of Perinatal &amp; Neonatal Nursing2020;34(4):338-45. [DOI: 10.1097/JPN.0000000000000495] [PMID: 32804876]">Chang 2020</a>; <a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a>; <a href="./references#CD014806-bbs2-0024" title="KumariS , DattaV , RehanH . Comparison of the efficacy of oral 25% glucose with oral 24% sucrose for pain relief during heel lance in preterm neonates: a double blind randomized controlled trial. Journal of Tropical Pediatrics2017;63(1):30-5. [DOI: 10.1093/tropej/fmw045] [PMID: 27435886]">Kumari 2017</a>; <a href="./references#CD014806-bbs2-0025" title="LagoP , CavicchioloME , MionT , Dal CengioV , AllegroA , DaverioM , et al. Repeating a dose of sucrose for heel prick procedure in preterms is not effective in reducing pain: a randomised controlled trial. European Journal of Pediatrics2020;179(2):293-301. [DOI: 10.1007/s00431-019-03509-2] [PMID: 31728675]">Lago 2020</a>; <a href="./references#CD014806-bbs2-0031" title="McGinnisK , MurrayE , ChervenB , McCrackenC , TraversC . Effect of vibration on pain response to heel lance: a pilot randomized control trial. Advances in Neonatal Care2016;16(6):439-48. [DOI: 10.1097/ANC.0000000000000315] [PMID: 27533335]">McGinnis 2016</a>; <a href="./references#CD014806-bbs2-0032" title="MitchellAJ , HallRW , GolianuB , YatesC , WilliamsDK , ChangJ , et al. Does noninvasive electrical stimulation of acupuncture points reduce heelstick pain in neonates?Acta Paediatrica2016;105(12):1434-9. [DOI: 10.1111/apa.13581] [PMID: 27607517]">Mitchell 2016</a>; <a href="./references#CD014806-bbs2-0033" title="NimbalkarS , ShuklaVV , ChauhanV , PhatakA , PatelD , ChaplaA , et al. Blinded randomized crossover trial: skin-to-skin care vs. sucrose for preterm neonatal pain. Journal of Perinatology2020;40(6):896-901. [DOI: 10.1038/s41372-020-0638-9] [PMID: 32152488]">Nimbalkar 2020</a>; <a href="./references#CD014806-bbs2-0042" title="SenE , ManavG . Effect of kangaroo care and oral sucrose on pain in premature infants: a randomized controlled trial. Pain Management Nursing2020;21(6):556-64. [DOI: 10.1016/j.pmn.2020.05.003] [PMID: 32768272]">Sen 2020</a>; <a href="./references#CD014806-bbs2-0043" title="ShahSR , KadageS , SinnJ . Trial of music, sucrose, and combination therapy for pain relief during heel prick procedures in neonates. Journal of Pediatrics2017;190:153-8. [DOI: 10.1016/j.jpeds.2017.08.003] [PMID: 29144240]">Shah 2017</a>; <a href="./references#CD014806-bbs2-0048" title="StevensB , YamadaJ , Campbell-YeoM , GibbinsS , HarrisonD , DionneK , et al. The minimally effective dose of sucrose for procedural pain relief in neonates: a randomized controlled trial. BMC Pediatrics2018;18(1):85. [DOI: 10.1186/s12887-018-1026-x] [DOI: 10.1186/s12887-018-1026-x] [PMID: 29475433]">Stevens 2018</a>; <a href="./references#CD014806-bbs2-0054" title="VelumulaPK , ElbakoushF , Tabb C 2nd, FarooqiA , Lulic-BoticaM , JaniS , et al. Breast milk vs 24% sucrose for procedural pain relief in preterm neonates: a non-inferiority randomized controlled trial. Journal of Perinatology2022;42(7):914-9. [DOI: 10.1038/s41372-022-01352-2] [PMID: 35197549]">Velumula 2020</a>). The largest study included in this review reported results on 671 infants (<a href="./references#CD014806-bbs2-0027" title="LengHY , ZhengXL , ZhangXH , HeHY , TuGF , FuQ . Combined non-pharmacological interventions for newborn pain relief in two degrees of pain procedures: a randomized clinical trial. European Journal of Pain2016;20(6):989-97. [DOI: 10.1002/ejp.824] [PMID: 26685099]">Leng 2015</a>). </p> <p>Twenty‐nine of the 55 included studies focused on term infants only (<a href="./references#CD014806-bbs2-0001" title="AbbasogluA , CabiogluMT , TugcuAU , YapakciE , TekindalMA , TarcanA . Laser acupuncture before heel lancing for pain management in healthy term newborns: a randomised controlled trial. Acupuncture in Medicine2015;33(6):445-50. [DOI: 10.1136/acupmed-2015-010765] [PMID: 26438556]">Abbasoglu 2015</a>; <a href="./references#CD014806-bbs2-0002" title="Altun-KöroğluO , ÖzekE , BilgenH , CebeciD . Hindmilk for procedural pain in term neonates. Turkish Journal of Pediatrics2010;52(6):623-9. [PMID: 21428195]">Altun‐Köroğlu 2010</a>; <a href="./references#CD014806-bbs2-0004" title="BenoitB , NewmanA , Martin-MisenerR , LatimerM , Campbell-YeoM . The influence of breastfeeding on cortical and bio-behavioural indicators of procedural pain in newborns: findings of a randomized controlled trial. Early Human Development2021;154:105308. [DOI: 10.1016/j.earlhumdev.2021.105308] [PMID: 33513546]">Benoit 2021</a>; <a href="./references#CD014806-bbs2-0005" title="BlassEM . Milk-induced hypoalgesia in human newborns. Pediatrics1997;99(6):825-9. [DOI: 10.1542/peds.99.6.825] [PMID: 9164777]">Blass 1997</a>; <a href="./references#CD014806-bbs2-0006" title="BlassEM , WattLB . Suckling- and sucrose-induced analgesia in human newborns. Pain1999;83(3):611-23. [DOI: 10.1016/s0304-3959(99)00166-9] [PMID: 10568870]">Blass 1999</a>; <a href="./references#CD014806-bbs2-0009" title="ChangJ , FiloteoL , NasrAS . Comparing the analgesic effects of 4 nonpharmacologic interventions on term newborns undergoing heel lance: a randomized controlled trial. Journal of Perinatal &amp; Neonatal Nursing2020;34(4):338-45. [DOI: 10.1097/JPN.0000000000000495] [PMID: 32804876]">Chang 2020</a>; <a href="./references#CD014806-bbs2-0011" title="CodipietroL , CeccarelliM , PonzoneA . Breastfeeding or oral sucrose solution in term neonates receiving heel lance: a randomized controlled trial. Pediatrics2008;122(3):e716-21. [DOI: 10.1542/peds.2008-0221] [PMID: 18762508]">Codipietro 2008</a>; <a href="./references#CD014806-bbs2-0015" title="GormallyS , BarrRG , WertheimL , AlkawafR , CalinoiuN , YoungSN . Contact and nutrient caregiving effects on newborn infant pain responses. Developmental Medicine and Child Neurology2001;43(1):28-38. [DOI: 10.1017/s0012162201000056] [PMID: 11201419]">Gormally 2001</a>; <a href="./references#CD014806-bbs2-0016" title="GreenbergCS . A sugar-coated pacifier reduces procedural pain in newborns. Pediatric Nursing2002;28(3):271-7. [PMID: 12087649]">Greenberg 2002</a>; <a href="./references#CD014806-bbs2-0017" title="GualaA , PastoreG , LiveraniME , GirolettiG , GulinoF , MeriggiAI , et al. Glucose or sucrose as an analgesic for newborns: a randomised controlled blind trial. Minerva Pediatrica2001;53(4):271-4. [PMID: 11573063]">Guala 2001</a>; <a href="./references#CD014806-bbs2-0018" title="HaouariN , WoodC , GriffithsG , LeveneM . The analgesic effect of sucrose in full term infants: a randomised controlled trial. BMJ1995;310(6993):1498-500. [DOI: 10.1136/bmj.310.6993.1498] [PMID: 7787595]">Haouari 1995</a>; <a href="./references#CD014806-bbs2-0020" title="IsikU , OzekE , BilgenH , CebeciD . Comparison of oral glucose and sucrose solutions on pain response in neonates. Journal of Pain2000;1(4):275-8. [DOI: 10.1054/jpai.2000.8919] [PMID: 14622610]">Isik 2000a</a>; <a href="./references#CD014806-bbs2-0026" title="LengHY , ZhengXL , YanL , ZhangXH , HeHY , XiangM . [Effects of different types and concentration of oral sweet solution on reducing neonatal pain during heel lance procedures]. Zhonghua Er Ke Za Zhi. Chinese Journal of Pediatrics2013;51(9):654-8. [PMID: 24330983]">Leng 2013</a>; <a href="./references#CD014806-bbs2-0027" title="LengHY , ZhengXL , ZhangXH , HeHY , TuGF , FuQ . Combined non-pharmacological interventions for newborn pain relief in two degrees of pain procedures: a randomized clinical trial. European Journal of Pain2016;20(6):989-97. [DOI: 10.1002/ejp.824] [PMID: 26685099]">Leng 2015</a>; <a href="./references#CD014806-bbs2-0029" title="Marin GabrielMA , delRey Hurtado de MendozaB , Jimenez FigueroaL , MedinaV , Iglesias FernandezB , Vazquez RodriguezM , et al. Analgesia with breastfeeding in addition to skin-to-skin contact during heel prick. Archives of Disease in Childhood. Fetal and neonatal edition2013;98(6):F499-503. [DOI: 10.1136/archdischild-2012-302921] [PMID: 23839984]">Marin Gabriel 2013</a>; <a href="./references#CD014806-bbs2-0030" title="MathaiS , NatrajanN , RajalakshmiNR . A comparative study of non-pharmacological methods to reduce pain in neonates. Indian Pediatrics2006;43(12):1070-5. [PMID: 17202604]">Mathai 2006</a>; <a href="./references#CD014806-bbs2-0031" title="McGinnisK , MurrayE , ChervenB , McCrackenC , TraversC . Effect of vibration on pain response to heel lance: a pilot randomized control trial. Advances in Neonatal Care2016;16(6):439-48. [DOI: 10.1097/ANC.0000000000000315] [PMID: 27533335]">McGinnis 2016</a>; <a href="./references#CD014806-bbs2-0032" title="MitchellAJ , HallRW , GolianuB , YatesC , WilliamsDK , ChangJ , et al. Does noninvasive electrical stimulation of acupuncture points reduce heelstick pain in neonates?Acta Paediatrica2016;105(12):1434-9. [DOI: 10.1111/apa.13581] [PMID: 27607517]">Mitchell 2016</a>; <a href="./references#CD014806-bbs2-0034" title="OgawaS , OgiharaT , FujiwaraE , ItoK , NakanoM , NakayamaS , et al. Venepuncture is preferable to heel lance for blood sampling in term neonates. Archives of Disease in Childhood. Fetal and Neonatal Edition2005;90(5):F432-6. [DOI: 10.1136/adc.2004.069328] [PMID: 15871991]">Ogawa 2005</a>; <a href="./references#CD014806-bbs2-0036" title="OrsR , OzekE , BaysoyG , CebeciD , BilgenH , TürkünerM , et al. Comparison of sucrose and human milk on pain response in newborns. European Journal of Pediatrics1999;158(1):63-6. [DOI: 10.1007/s004310051011] [PMID: 9950311]">Ors 1999</a>; <a href="./references#CD014806-bbs2-0037" title="OvergaardC , KnudesenA . Pain-relieving effect of sucrose in newborns during heel prick. Biology of the Neonate1999;75(5):279-84. [DOI: 10.1159/000014105] [PMID: 10095141]">Overgaard 1999</a>; <a href="./references#CD014806-bbs2-0038" title="RamenghiLA , GriffithGC , WoodCM , LeveneMI . Effect of non-sucrose sweet tasting solution on neonatal heel prick responses. Archives of Disease in Childhood. Fetal and Neonatal Edition1996;74(2):F129-31. [DOI: 10.1136/fn.74.2.f129] [PMID: 8777661]">Ramenghi 1996a</a>; <a href="./references#CD014806-bbs2-0041" title="RushforthJA , LeveneMI . Effect of sucrose on crying in response to heel stab. Archives of Disease in Childhood1993;69(3):388-9. [DOI: 10.1136/adc.69.3.388] [PMID: 8215552]">Rushforth 1993</a>; <a href="./references#CD014806-bbs2-0045" title="SlaterR , CornelissenL , FabriziL , PattenD , YoxenJ , WorleyA , et al. Oral sucrose as an analgesic drug for procedural pain in newborn infants: a randomised controlled trial. Lancet2010;376(9748):1225-32. [DOI: 10.1016/S0140-6736(10)61303-7] [PMID: 20817247]">Slater 2010</a>; <a href="./references#CD014806-bbs2-0050" title="TaddioA , ShahV , HancockR , SmithRW , StephensD , AtenafuE , et al. Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures. Canadian Medical Association Journal2008;179(1):37-43. [DOI: 10.1503/cmaj.071734] [PMID: 18591525]">Taddio 2008</a>; <a href="./references#CD014806-bbs2-0051" title="ThakkarP , AroraK , GoyalK , DasRR , JavadekarB , AiyerS , et al. To evaluate and compare the efficacy of combined sucrose and non-nutritive sucking for analgesia in newborns undergoing minor painful procedure: a randomized controlled trial. Journal of Perinatology2016;36(1):67-70. [DOI: 10.1038/jp.2015.122] [PMID: 26583940]">Thakkar 2016</a>; <a href="./references#CD014806-bbs2-0052" title="Tutag LehrV , CortezJ , GreverW , CepedaE , ThomasR , ArandaJV . Randomized placebo controlled trial of sucrose analgesia on neonatal skin blood flow and pain response during heel lance. Clinical Journal of Pain2015;31(5):451-8. [DOI: 10.1097/AJP.0000000000000126] [PMID: 24918475]">Tutag Lehr 2015</a>; <a href="./references#CD014806-bbs2-0053" title="Unceta-BarrenecheaA , Saitua IturriagaG , Sainz de Rozas AparicioI , Riveira FernándezD . Analgesia when taking heel lance blood in the newborn [Analgesia en la toma sanguínea de talónen los recién nacidos]. Anales de Pediatria (Barcelona)2008;69(6):544-7. [DOI: 10.1016/s1695-4033(08)75237-8] [PMID: 19128767]">Unceta‐Barranechea 2008</a>; <a href="./references#CD014806-bbs2-0055" title="YilmazF , ArikanD . The effects of various interventions to newborns on pain and duration of crying. Journal of Clinical Nursing2010;20(7-8):1008-17. [DOI: 10.1111/j.1365-2702.2010.03356.x] [PMID: 21054600]">Yilmaz 2010</a>), while 22 included preterm infants only (<a href="./references#CD014806-bbs2-0003" title="AsmeromY , SlaterL , BoskovicDS , BahjriK , HoldenMS , PhillipsR , et al. Oral sucrose for heel lance increases adenosine triphosphate use and oxidative stress in preterm neonates. Journal of Pediatrics2013;163(1):29-35.e1. [DOI: 10.1016/j.jpeds.2012.12.088] [PMID: 23415615]">Asmerom 2013</a>; <a href="./references#CD014806-bbs2-0007" title="BucherHU , MoserT , vonSiebenthalK , KeelM , WolfM , DucG . Sucrose reduces pain reaction to heel lancing in preterm infants: a placebo-controlled, randomized and masked study. Pediatric Research1995;38(3):332-5. [DOI: 10.1203/00006450-199509000-00010] [PMID: 7494655]">Bucher 1995</a>; <a href="./references#CD014806-bbs2-0008" title="Campbell-YeoM , JohnstonCC , BenoitB , DisherT , CaddellK , VincerM , et al. Sustained efficacy of kangaroo care for repeated painful procedures over neonatal intensive care unit hospitalization: a single-blind randomized controlled trial. Pain2019;160(11):2580-8. [DOI: 10.1097/j.pain.0000000000001646] [PMID: 31356452]">Campbell‐Yeo 2019</a>; <a href="./references#CD014806-bbs2-0010" title='CignaccoEL , SellamG , StoffelL , GerullR , NelleM , AnandKJ , et al. Oral sucrose and "facilitated tucking" for repeated pain relief in preterms: a randomized controlled trial. Pediatrics2012;129(2):299-308. [DOI: 10.1542/peds.2011-1879] [PMID: 22232305]GerullR , CignaccoE , StoffelL , SellamG , NelleM . Physiological parameters after nonpharmacological analgesia in preterm infants: a randomized trial. Acta Paediatrica2013;102(8):e368-73. [DOI: 10.1111/apa.12288] [PMID: 23651076]'>Cignacco 2012</a>; <a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a>; <a href="./references#CD014806-bbs2-0013" title="GaspardoCM , MiyaseCI , ChimelloJT , MartinezFE , Martins LinharesMB . Is pain relief equally efficacious and free of side effects with repeated doses of oral sucrose in preterm neonates?Pain2008;137(1):16-25. [DOI: 10.1016/j.pain.2007.07.032] [PMID: 17854995]">Gaspardo 2008</a>; <a href="./references#CD014806-bbs2-0019" title="HarrisonD , JohnstonL , LoughnanP . Oral sucrose for procedural pain in sick hospitalized infants: a randomized-controlled trial. Journal of Paediatric and Child Health2003;39(8):591-7. [DOI: 10.1046/j.1440-1754.2003.00242.x] [PMID: 14629524]">Harrison 2003</a>; <a href="./references#CD014806-bbs2-0021" title="JohnstonCC , StremlerRL , StevensBJ , HortonLJ . Effectiveness of oral sucrose and simulated rocking on pain response in preterm neonates. Pain1997;72(1-2):193-9. [DOI: 10.1016/s0304-3959(97)00033-x] [PMID: 9272803]">Johnston 1997</a>; <a href="./references#CD014806-bbs2-0022" title="JohnstonCC , StremlerR , HortonL , FriedmanA . Effect of repeated doses of sucrose during heel stick procedure in preterm neonates. Biology of the Neonate1999;75(3):160-6. [DOI: 10.1159/000014092] [PMID: 9925903]">Johnston 1999</a>; <a href="./references#CD014806-bbs2-0023" title="BoyerK , JohnstonC , WalkerCD , FilionF , SherrardA . Does sucrose analgesia promote physiological stability in preterm neonates?Biology of the Neonate2004;85(1):26-31. [DOI: 10.1159/000074954] [PMID: 14631163]JohnstonCC , FilionF , SniderL , MajnemerA , LimperopolousC , WalkerCD , et al. Routine sucrose analgesia during the first week of life in neonates younger than 31 weeks' postconceptional age. Pediatrics2002;110(3):523-8. [DOI: 10.1542/peds.110.3.523] [PMID: 12205254]">Johnston 2002</a>; <a href="./references#CD014806-bbs2-0024" title="KumariS , DattaV , RehanH . Comparison of the efficacy of oral 25% glucose with oral 24% sucrose for pain relief during heel lance in preterm neonates: a double blind randomized controlled trial. Journal of Tropical Pediatrics2017;63(1):30-5. [DOI: 10.1093/tropej/fmw045] [PMID: 27435886]">Kumari 2017</a>; <a href="./references#CD014806-bbs2-0025" title="LagoP , CavicchioloME , MionT , Dal CengioV , AllegroA , DaverioM , et al. Repeating a dose of sucrose for heel prick procedure in preterms is not effective in reducing pain: a randomised controlled trial. European Journal of Pediatrics2020;179(2):293-301. [DOI: 10.1007/s00431-019-03509-2] [PMID: 31728675]">Lago 2020</a>; <a href="./references#CD014806-bbs2-0033" title="NimbalkarS , ShuklaVV , ChauhanV , PhatakA , PatelD , ChaplaA , et al. Blinded randomized crossover trial: skin-to-skin care vs. sucrose for preterm neonatal pain. Journal of Perinatology2020;40(6):896-901. [DOI: 10.1038/s41372-020-0638-9] [PMID: 32152488]">Nimbalkar 2020</a>; <a href="./references#CD014806-bbs2-0035" title="OkanF , CobanA , InceZ , YapiciZ , CanG . Analgesia in preterm newborns: the comparative effects of sucrose and glucose. European Journal of Pediatrics2007;166(10):1017-24. [DOI: 10.1007/s00431-006-0373-z] [PMID: 17203281]OzdoganT , AkmanI , CebeciD , BilgenH , OzekE . Comparison of two doses of breast milk and sucrose during neonatal heel prick. Pediatrics International2010;52(2):175-9. [DOI: 10.1111/j.1442-200X.2009.02921.x] [PMID: 19627552]">Okan 2007</a>; <a href="./references#CD014806-bbs2-0039" title="RamenghiLA , WoodCM , GriffithGC , LeveneMI . Reduction of pain response in premature infants using intraoral sucrose. Archives of Disease in Childhood. Fetal and Neonatal Edition1996;74(2):F126-8. [DOI: 10.1136/fn.74.2.f126] [PMID: 8777660]">Ramenghi 1996b</a>; <a href="./references#CD014806-bbs2-0040" title='RamenghiLA , EvansDJ , LeveneMI . "Sucrose analgesia": absorptive mechanism or taste perception?Archives of Disease in Childhood. Fetal and Neonatal Edition1999;80(2):F146-7. [DOI: 10.1136/fn.80.2.f146] [PMID: 10325795]'>Ramenghi 1999</a>; <a href="./references#CD014806-bbs2-0042" title="SenE , ManavG . Effect of kangaroo care and oral sucrose on pain in premature infants: a randomized controlled trial. Pain Management Nursing2020;21(6):556-64. [DOI: 10.1016/j.pmn.2020.05.003] [PMID: 32768272]">Sen 2020</a>; <a href="./references#CD014806-bbs2-0044" title="SimonseE , MulderPG , vanBeekRH . Analgesic effect of breast milk versus sucrose for analgesia during heel lance in late preterm infants. Pediatrics2012;129(4):657-63. [DOI: 10.1542/peds.2011-2173] [PMID: 22392168]">Simonse 2012</a>; <a href="./references#CD014806-bbs2-0046" title="JohnstonCC , SherrardA , StevensB , FranckL , StremlerR , JackA . Do cry features reflect pain intensity in preterm neonates?Biology of the Neonate1999;76(2):120-4. [DOI: 10.1159/000014150] [PMID: 10393997]StevensB , JohnstonC , FranckP , PetryshenP , JackA , FosterG . The efficacy of developmentally sensitive interventions and sucrose for relieving pain in very low birth weight infants. Nursing Research1999;48(1):35-43. [DOI: 10.1097/00006199-199901000-00006] [PMID: 10029400]">Stevens 1999</a>; <a href="./references#CD014806-bbs2-0047" title="StevensB , YamadaJ , BeyeneJ , GibbinsS , PetryshenP , StinsonJ , et al. Consistent management of repeated procedural pain with sucrose in preterm neonates: is it effective and safe for repeated use over time?Clinical Journal of Pain2005;21(6):543-8. [DOI: 10.1097/01.ajp.0000149802.46864.e2] [PMID: 16215340]">Stevens 2005a</a>; <a href="./references#CD014806-bbs2-0049" title="StormH , FremmingA . Food intake and oral sucrose in preterms prior to heel prick. Acta Paediatrica2002;91(5):555-60. [DOI: 10.1080/080352502753711687] [PMID: 12113325]">Storm 2002</a>; <a href="./references#CD014806-bbs2-0054" title="VelumulaPK , ElbakoushF , Tabb C 2nd, FarooqiA , Lulic-BoticaM , JaniS , et al. Breast milk vs 24% sucrose for procedural pain relief in preterm neonates: a non-inferiority randomized controlled trial. Journal of Perinatology2022;42(7):914-9. [DOI: 10.1038/s41372-022-01352-2] [PMID: 35197549]">Velumula 2020</a>), and four included both preterm and term infants (<a href="./references#CD014806-bbs2-0014" title="GibbinsS , StevensB , HodnettE , PinelliJ , OhlssonA , DarlingtonG . Efficacy and safety of sucrose for procedural pain relief in preterm and term neonates. Nursing Research2002;51(6):375-82. [DOI: 10.1097/00006199-200211000-00005] [PMID: 12464757]GibbinsS , StevensB . The influence of gestational age on the efficacy and short-term safety of sucrose for procedural pain relief. Advances in Neonatal Care2003;3(5):241-9. [PMID: 14648521]GibbinsS . Efficacy and Safety of Sucrose for Procedural Pain Relief in Preterm and Term Neonates [PhD Thesis]. Toronto: University of Toronto, 2001. ">Gibbins 2002</a>; <a href="./references#CD014806-bbs2-0028" title="LiawJJ , YangL , LeeCM , FanHC , ChangYC , ChengLP . Effects of combined use of non-nutritive sucking, oral sucrose, and facilitated tucking on infant behavioural states across heel-stick procedures: a prospective, randomised controlled trial. International Journal of Nursing Studies2013;50(7):883-94. [DOI: 10.1016/j.ijnurstu.2012.08.021] [PMID: 23068310]YinT , YangL , LeeTY , LiCC , HuaYM , LiawJJ . Development of atraumatic heel-stick procedures by combined treatment with non-nutritive sucking, oral sucrose, and facilitated tucking: a randomised, controlled trial. International Journal of Nursing Studies2015;52(8):1288-99. [DOI: 10.1016/j.ijnurstu.2015.04.012] [PMID: 25939641]">Liaw 2013</a>; <a href="./references#CD014806-bbs2-0043" title="ShahSR , KadageS , SinnJ . Trial of music, sucrose, and combination therapy for pain relief during heel prick procedures in neonates. Journal of Pediatrics2017;190:153-8. [DOI: 10.1016/j.jpeds.2017.08.003] [PMID: 29144240]">Shah 2017</a>; <a href="./references#CD014806-bbs2-0048" title="StevensB , YamadaJ , Campbell-YeoM , GibbinsS , HarrisonD , DionneK , et al. The minimally effective dose of sucrose for procedural pain relief in neonates: a randomized controlled trial. BMC Pediatrics2018;18(1):85. [DOI: 10.1186/s12887-018-1026-x] [DOI: 10.1186/s12887-018-1026-x] [PMID: 29475433]">Stevens 2018</a>). Details of each study are outlined in <a href="#CD014806-tbl-0010">Table 1</a>; <a href="#CD014806-tbl-0011">Table 2</a>; <a href="#CD014806-tbl-0012">Table 3</a>. </p> <div class="table" id="CD014806-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of included studies assessing pain during heel lances</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Procedure</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Metrics used</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Results</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Funding sources and declaration of interest</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0001" title="AbbasogluA , CabiogluMT , TugcuAU , YapakciE , TekindalMA , TarcanA . Laser acupuncture before heel lancing for pain management in healthy term newborns: a randomised controlled trial. Acupuncture in Medicine2015;33(6):445-50. [DOI: 10.1136/acupmed-2015-010765] [PMID: 26438556]">Abbasoglu 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42 term newborns, undergoing heel lancing between postnatal days 3 and 8 as part of neonatal screening </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0010"> <li> <p>Laser acupuncture: 0.3 J of energy was applied to the Yintang point using a Laser PREMIO‐30 unit for 30 s </p> </li> <li> <p>Sucrose: 0.5 mL 24% solution was given orally via syringe 2 min before heel lancing</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0011"> <li> <p>NIPS</p> </li> <li> <p>Crying time</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean and SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The NIPS score was lower in the sucrose group than in the laser group (3.66 ± 1.01 vs 4.52 ± 0.87; P = 0.006). </p> <p>The crying time was lower in the sucrose group than in the laser group (46.66 s ± 37.82 s vs 97.95 s ± 34.23 s; P = 0.000). </p> <p>No infant developed any clinically visible changes on the skin, and no side effects were observed in their comparison of laser acupuncture with oral sucrose. </p> <p>Data are included in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: none declared</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0002" title="Altun-KöroğluO , ÖzekE , BilgenH , CebeciD . Hindmilk for procedural pain in term neonates. Turkish Journal of Pediatrics2010;52(6):623-9. [PMID: 21428195]">Altun‐Köroğlu 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75 full‐term infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0012"> <li> <p>3 mL hindmilk (n = 25)</p> </li> <li> <p>3 mL 12.5% sucrose solution (n = 25)</p> </li> <li> <p>3 mL distilled water (n = 25)</p> </li> </ul> </p> <p>The volume of 3 mL was provided in 3 doses (1 mL prior to, 1 mL immediately before, and 1 mL after the procedure) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0013"> <li> <p>NFCS</p> </li> <li> <p>Crying time</p> </li> <li> <p>Duration of crying</p> </li> <li> <p>HR</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median and IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median crying time, duration of first cry and tachycardia, and time needed to return to baseline were longest in the distilled water group and shorter in the hindmilk group when compared to distilled water group (P = 0.022, P = 0.008, P = 0.009 and P = 0.038, respectively). </p> <p>No differences were observed between the hindmilk and sucrose group for all measures.</p> <p>Maximum HR in hindmilk group was lower than in distilled water group (184 beats/min vs 196 beats/min, P = 0.031). </p> <p>Reduction in average NFCS score. First‐minute NFCS score and fifth‐minute NFCS scores were lower in the hindmilk group compared to the distilled water group (P = 0.006, P = 0.017 and P = 0.021, respectively). </p> <p>No data were included in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0003" title="AsmeromY , SlaterL , BoskovicDS , BahjriK , HoldenMS , PhillipsR , et al. Oral sucrose for heel lance increases adenosine triphosphate use and oxidative stress in preterm neonates. Journal of Pediatrics2013;163(1):29-35.e1. [DOI: 10.1016/j.jpeds.2012.12.088] [PMID: 23415615]">Asmerom 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>131 preterm infants ≤ 36.5 weeks' gestation who:</p> <p> <ul id="CD014806-list-0014"> <li> <p>weighed ≥ 800 g;</p> </li> <li> <p>had a central catheter in place; and</p> </li> <li> <p>required a heel lance</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0015"> <li> <p>Sucrose (24%) with NNS (n = 44): 2 mL for neonates &gt; 2 kg, 1.5 mL for neonates 1.5 kg to 2 kg, and 0.5 mL for neonates &lt; 1.5 kg </p> </li> <li> <p>Placebo + NNS (n = 45)</p> </li> <li> <p>42 infants received no heel lance, no sucrose, or placebo.</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0016"> <li> <p>PIPP after 2 min</p> </li> <li> <p>Plasma hypoxanthine</p> </li> <li> <p>Uric acid</p> </li> <li> <p>Xanthine</p> </li> <li> <p>Allantoin</p> </li> <li> <p>HR</p> </li> <li> <p>SpO<sub>2</sub> </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean and lowest and highest values</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oral sucrose given before a single heel lance decreased behavioural markers of pain.<br/>Sucrose increased markers of ATP use, as evidenced by increases over time in plasma hypoxanthine and uric acid concentrations.<br/>We received the PIPP scores as means and SD from Dr D Angeles, and the data were included in RevMan analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: National Institutes of Health (RO1</p> <p>NR011209)</p> <p>Declaration of interest: none.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0004" title="BenoitB , NewmanA , Martin-MisenerR , LatimerM , Campbell-YeoM . The influence of breastfeeding on cortical and bio-behavioural indicators of procedural pain in newborns: findings of a randomized controlled trial. Early Human Development2021;154:105308. [DOI: 10.1016/j.earlhumdev.2021.105308] [PMID: 33513546]">Benoit 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39 healthy full‐term (born ≥ 37 0/7 weeks' gestation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0017"> <li> <p>BF (n = 20)</p> </li> <li> <p>24% sucrose (0.24 mL) + NNS + containment in a blanket while in an infant cot 2 min prior to heel lance (n = 19) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0018"> <li> <p>Pain‐related potential was recorded on electroencephalogram</p> </li> <li> <p>PIPP‐R at 30 s, 90 s, 120 s after heel lance</p> </li> <li> <p>Physiologic recovery</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PIPP‐R scores: t‐tests were reported; no means or SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Infants in BF group had a smaller, but not different (F[1,15.9] = 0.58, P = 0.64, SE = 11.79), amplitude pain‐related potential (peak amplitude 0.29 μV) following heel lance compared to infants who received oral sucrose (peak amplitude 8.97 μV). Mean PIPP‐R scores were not different between groups following heel lance, however, but represented low pain across groups. Mean time in seconds to physiologic recovery was faster in BF group (M = 17.5, SD = 31.1) compared to oral sucrose group (M = 70.8, SD = 144.3). </p> <p>There were no adverse events or safety concerns in either group.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: IWK Health Centre Category A Operating Grant and the Dalhousie University School of Nursing Research Fund </p> <p>Declaration of interest: none</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0005" title="BlassEM . Milk-induced hypoalgesia in human newborns. Pediatrics1997;99(6):825-9. [DOI: 10.1542/peds.99.6.825] [PMID: 9164777]">Blass 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72 term infants, 22 h to 40 h old</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 mL of one of the following solutions:</p> <p> <ul id="CD014806-list-0019"> <li> <p>water;</p> </li> <li> <p>12% sucrose;</p> </li> <li> <p>protein mixture;</p> </li> <li> <p>7% lactose;</p> </li> <li> <p>dilute fat (coconut and soy oil);</p> </li> <li> <p>concentrated fat;</p> </li> <li> <p>fat and lactose mixture RSF (water, protein, lactose, fat); and</p> </li> <li> <p>milk</p> </li> </ul> </p> <p>n = 8 for all groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0020"> <li> <p>Crying time (%) during blood collection and 1 min, 2 min and 3 min after heel lance</p> </li> <li> <p>Mean percentage of crying time per minute at 1 min, 2 min and 3 min after heel lance (recovery period) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0021"> <li> <p>Mean proportions</p> </li> <li> <p>Graphically reported</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Less crying time during blood collection in the sucrose group (47%) compared to the water group (92%, P = 0.015) </p> <p>No data could be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Grant in Aid of Research MH</p> <p>51705 and by Research Scientist Award MH 00524 from the National Institutes of Mental Health </p> <p>Declaration of interest: none</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0006" title="BlassEM , WattLB . Suckling- and sucrose-induced analgesia in human newborns. Pain1999;83(3):611-23. [DOI: 10.1016/s0304-3959(99)00166-9] [PMID: 10568870]">Blass 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40 term newborn infants, 34 h to 55 h old</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prior to heel lance:</p> <p> <ul id="CD014806-list-0022"> <li> <p>2 mL 12% sucrose over 2 min via syringe (n = 10);</p> </li> <li> <p>2 mL water via syringe over 2 min (n = 10);</p> </li> <li> <p>pacifier dipped every 30 s in 12% sucrose solution for 2 min (n = 10); and</p> </li> <li> <p>pacifier dipped in water every 30 s for 2 min (n = 10)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0023"> <li> <p>Percentage of time crying 3 min after heel lance</p> </li> <li> <p>Mean change in HR</p> </li> <li> <p>Percentage of time grimacing</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0024"> <li> <p>Mean percentage</p> </li> <li> <p>Mean change (beats/min)</p> </li> <li> <p>Graphically reported</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 mL 12% (0.24 g) sucrose alone diminished cry duration from heel lance compared to water (8% vs 50%, P = 0.003) and water with pacifier (8% vs 35%, P = 0.002). Pacifier with 12% sucrose was more effective in reducing cry duration compared to water with pacifier (5% vs 35%, P = 0.001) or water alone (50%, P = 0.002). </p> <p>Mean HR increased from treatment to heel lance in infants receiving water alone (mean increase of 17 beats/min, P = 0.002) and water with pacifier (mean increase of 20 beats/min, P = 0.005). Mean increase in HR also increased for the 12% sucrose and pacifier group (mean difference of 7.4 beats/min, P = 0.05) but not for infants receiving 12% sucrose alone (mean difference of 5.9 beats/min, P = 0.142). </p> <p>12% sucrose reduced grimacing compared to water (P = 0.0003). 12% sucrose with pacifier reduced grimacing compared to water (P = 0.001) and pacifier alone (P = 0.04). </p> <p>No data could be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Grant RO‐1</p> <p>MH51705‐04A1 and Research Scientist Award KO‐5,</p> <p>MH5 00524, from the National Institutes of Mental Health to EMB</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0007" title="BucherHU , MoserT , vonSiebenthalK , KeelM , WolfM , DucG . Sucrose reduces pain reaction to heel lancing in preterm infants: a placebo-controlled, randomized and masked study. Pediatric Research1995;38(3):332-5. [DOI: 10.1203/00006450-199509000-00010] [PMID: 7494655]">Bucher 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 preterm infants, 27 weeks' to 34 weeks' GA, PNA approximately 42 d</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0025"> <li> <p>2 mL 50% sucrose via syringe into the mouth 2 min before heel lance</p> </li> <li> <p>2 mL distilled water via syringe into the mouth 2 min before heel lance (n = 16, cross‐over design) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0026"> <li> <p>Percentage of time crying</p> </li> <li> <p>Recovery time until crying stopped</p> </li> <li> <p>Increase in HR</p> </li> <li> <p>Recovery time for HR;</p> </li> <li> <p>TcPO<sub>2</sub> (maximum increase, measured in kPa; maximum decrease, in kPa; difference between baseline and 10 min after end of intervention ‐ kPa); </p> </li> <li> <p>TcPCO<sub>2</sub> (maximum decrease, in kPa; difference between baseline and 10 min after the end of intervention) </p> </li> <li> <p>Recovery time for respirations</p> </li> <li> <p>Cerebral near‐infrared spectroscopy (cerebral oxyhaemoglobin, deoxyhaemoglobin, total blood volume) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median, IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cry duration (percentage of total duration of intervention) was reduced in 2 mL 50% (1.0 g) sucrose group (71.5%) compared to control group (93.5%, P = 0.002). </p> <p>Median increase in HR (beats/min) after heel lance was reduced in the 2 mL 50% (1.0 g) sucrose group (35 beats/min) compared to water (51 beats/min) (P = 0.005). </p> <p>No differences between groups with respect to measures for TcPO<sub>2</sub> (P = 0.05) and TcPCO<sub>2</sub> (P = 0.21) </p> <p>There was no decrease in cerebral blood volume between sucrose and placebo groups.</p> <p>Data were not presented for effects of sucrose or water prior to cross over. No data could be used in RevMan analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0008" title="Campbell-YeoM , JohnstonCC , BenoitB , DisherT , CaddellK , VincerM , et al. Sustained efficacy of kangaroo care for repeated painful procedures over neonatal intensive care unit hospitalization: a single-blind randomized controlled trial. Pain2019;160(11):2580-8. [DOI: 10.1097/j.pain.0000000000001646] [PMID: 31356452]">Campbell‐Yeo 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>242 preterm infants, ≤ 36 6/7 weeks' GA (mean GA 32 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention provided for every painful procedure during hospitalisation; outcomes measured for heel lances </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0027"> <li> <p>KC (n = 81)</p> </li> <li> <p>24% sucrose, 0.4 mL to 1 mL (n = 81)</p> </li> <li> <p>KC + 24% sucrose, 0.4 mL to 1 mL (n = 80)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0028"> <li> <p>PIPP at 3 medically indicated heel lances (at 30 s, 60 s, 90 s post‐heel lance)</p> </li> <li> <p>Neurobehavioral assessment using NAPI at 32 weeks, 36 weeks and 40 weeks</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No differences in mean PIPP scores between groups for the 3 time points<br/>No differences in neurobehavioural assessment and adverse events for both groups </p> <p>No differences reported for adverse events (bradycardia, oxygen desaturation) between groups </p> <p>No data could be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Canadian Institutes of Health</p> <p>Research (CIHR) [244640/2011‐7517]; Nova Scotia Health Research Foundation [MED‐MAT‐2011‐7517] and Mayday Fund </p> <p>Declaration of interest: The authors had no conflict of interest to declare.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0009" title="ChangJ , FiloteoL , NasrAS . Comparing the analgesic effects of 4 nonpharmacologic interventions on term newborns undergoing heel lance: a randomized controlled trial. Journal of Perinatal &amp; Neonatal Nursing2020;34(4):338-45. [DOI: 10.1097/JPN.0000000000000495] [PMID: 32804876]">Chang 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>226 term infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance at &gt; 24 h old when receiving the heel lance procedure as a newborn<br/>screen test </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0029"> <li> <p>BF group (n = 45), initiated before heel lance and during heel lance procedure</p> </li> <li> <p>Oral sucrose group (n = 42), 24% oral sucrose‐5 drops (0.33 mL) before heel lance and again during procedure if cues of pain, up to 15 drops (1 mL) </p> </li> <li> <p>NNS group (n = 51), pacifier given before and during heel lance</p> </li> <li> <p>SSC group (n = 38), newborns wore only diapers, positioned on mother's bare chest immediately before heel lance procedure </p> </li> <li> <p>Control group (n = 50), newborns were placed in a crib in supine position and covered with blankets </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N‐PASS scores (duration of the heel lance was calculated from the point of lancet puncture until blood collection completion); N‐PASS scores were collected at these same procedure time points </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All intervention groups showed decreased pain levels compared with the control group (P &lt; 0.01). The oral sucrose group experienced a superior analgesic effect compared to the SSC group (P &lt; 0.01), but there was no difference when compared with the BF group<br/>(P &gt; 0.05) or the NNS group (P &gt; 0.05). </p> <p>All intervention groups had shortened crying times (P &lt; 0.01) and reduced procedural duration (P &lt; 0.01) compared with the control group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: the Lucile Packard Foundation Children’s<br/>Health Fund and the Stanford NIH CTSA (UL1RR025744) </p> <p>Declaration of interest: The authors disclosed that they had no significant relationships with, or financial interest in, any commercial companies pertaining to this article. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0010" title='CignaccoEL , SellamG , StoffelL , GerullR , NelleM , AnandKJ , et al. Oral sucrose and "facilitated tucking" for repeated pain relief in preterms: a randomized controlled trial. Pediatrics2012;129(2):299-308. [DOI: 10.1542/peds.2011-1879] [PMID: 22232305]GerullR , CignaccoE , StoffelL , SellamG , NelleM . Physiological parameters after nonpharmacological analgesia in preterm infants: a randomized trial. Acta Paediatrica2013;102(8):e368-73. [DOI: 10.1111/apa.12288] [PMID: 23651076]'>Cignacco 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71 preterm infants between 24 0/7 weeks' and 32 0/7 weeks' PMA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Repeated heel lances</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0030"> <li> <p>Sucrose group (n = 24): 20% oral sucrose (0.2 mL/kg), ∼2 min before the heel lance. If the infant seemed to be in pain during the heel lance phase, up to 2 additional doses of sucrose were administered and noted in the study chart. </p> </li> <li> <p>Sucrose + FT group (n = 23): FT was started at the beginning of the baseline phase, and sucrose was given 2 min before the heel lance. </p> </li> <li> <p>FT group (n = 24): FT was started at the beginning of the baseline phase, and the infant was 'tucked' through all 3 phases. </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>BPSN. Data collection occurred during:</p> <p> <ul id="CD014806-list-0031"> <li> <p>baseline (before any manipulation);</p> </li> <li> <p>heel lance (skin preparation, heel stick and haemostasis after blood was drawn); and</p> </li> <li> <p>recovery (3 min after the heel lance).</p> </li> </ul> </p> <p>The BPSN contains 9 items: 3 physiologic (HR, RR and SpO<sub>2</sub>) and 6 behavioural (grimacing, body movements, crying, skin colour, sleeping patterns, consolation) items. </p> <p>3 phases (baseline, heel stick, recovery) of 5 heel stick procedures were videotaped for each infant. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sucrose with and without FT had pain‐relieving effects even in preterm infants of GA ≤ 32 weeks having repeated pain exposures. These interventions remained effective during repeated heel sticks across time. FT was not as effective. </p> <p>Data were included in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Swiss National Science Foundation and the following private</p> <p>foundations: Botnar Foundation, Basel;</p> <p>the Foundation of Nursing Science, Basel; the Foundation for Research in</p> <p>Neonatology, Zürich; the Marie Anna Foundation, Basel; and the Foundation</p> <p>for Sick Children, Basel</p> <p>Declaration of interest: The authors indicated they had no financial relationships relevant to this article to disclose. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0011" title="CodipietroL , CeccarelliM , PonzoneA . Breastfeeding or oral sucrose solution in term neonates receiving heel lance: a randomized controlled trial. Pediatrics2008;122(3):e716-21. [DOI: 10.1542/peds.2008-0221] [PMID: 18762508]">Codipietro 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101 term infants</p> <p>Mean PMA:</p> <p> <ul id="CD014806-list-0032"> <li> <p>sucrose group: 39.3 weeks; and</p> </li> <li> <p>BF group: 39.4 weeks</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0033"> <li> <p>1 mL 25% sucrose via syringe (n = 50)</p> </li> <li> <p>BF prior to heel lance (n = 51)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0034"> <li> <p>Duration of first cry (s), percentage of crying time in first 2 min, and percentage of crying time during blood sampling </p> </li> <li> <p>HR (beats/min) increase from baselines at 30 s following commencement of procedure</p> </li> <li> <p>SpO<sub>2</sub> decrease </p> </li> <li> <p>PIPP during blood sampling, 2 min after heel lance</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median, range</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median duration of first cry: BF group, 3 s (range 0 s to 120 s) compared to sucrose group, 21 s (range 0 s to 120 s) (P = 0.004) </p> <p>Percentage of crying during first 2 min: BF group, 4% (range 0% to 100%) compared to sucrose, 45% (range 0% to 100%) (P &lt; 0.0001) </p> <p>Percentage of crying during sampling: BF group, 8% (range 0% to 100%) compared to sucrose, 56.5% (range 0% to 100%) (P = 0.0003) </p> <p>Median increase in HR from baseline to 30 s after start of heel lance was lower in BF group (13 beats/min; range 12 beats/min to 54 beats/min) compared to sucrose group (22 beats/min; range 32 to 65) (P = 0.005) </p> <p>Median decrease in SpO<sub>2</sub> from baseline to 30 s after start of heel lance was greater in sucrose group (−3%; range 30% to 1%) compared to BF group (−1%; range −14% to 2%) (P = 0.001) </p> <p>Median PIPP scores lower in BF group (3.0) compared to sucrose group (8.5) (P &lt; 0.0001)</p> <p>No adverse effects were noted in any infant.</p> <p>Data could not be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: The authors indicated they had no financial relationships relevant to this article to disclose. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86 preterm infants born before 37 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0035"> <li> <p>Routine care (routine comfort through gentle touch when infants cried; n = 21)</p> </li> <li> <p>NNS (n = 22) 2 min before and during recovery of heel lance</p> </li> <li> <p>1 mL sucrose (0.2 mL/kg of 20%; n = 21) 2 min before heel lance</p> </li> <li> <p>1 mL sucrose (0.2 mL/kg of 20%) + NNS (n = 22) 2 min before heel lance</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0036"> <li> <p>PIPP score (during heel lance, 1 min after heel lance)</p> </li> <li> <p>HR (baseline = 2 min before, during, 1 min after heel lance)</p> </li> <li> <p>SpO<sub>2</sub> (baseline = 2 min before, during, 1 min after heel lance) </p> </li> <li> <p>Crying time (baseline = 2 min before, during, 1 min after heel lance)</p> </li> <li> <p>Incidence of adverse events</p> <ul id="CD014806-list-0037"> <li> <p>Choking, coughing, vomiting, abdominal distension, oral infection, necrotising enterocolitis</p> </li> <li> <p>Sustained tachycardia (HR &gt; 200 beats/min), bradycardia (HR &lt; 80 beats/min), tachypnoea (RR &gt; 80 beats/min), dyspnoea (RR &lt; 20 beats/min), or oxygen desaturation &lt; 80% for &gt; 15 s </p> </li> <li> <p>hyperglycaemia</p> </li> </ul> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The combination group had lower PIPP scores, HR, and crying time during the heel lance and recovery phase than the sucrose, NNS and routine care groups (P &lt; 0.0001). </p> <p>The combination group had a higher SpO<sub>2</sub> than all other treatment groups (P &lt; 0.035). </p> <p>There were no differences in the HR and SpO<sub>2</sub> between the sucrose, NNS and routine care groups. </p> <p>The sucrose group and NNS group had similar duration of crying, and the routine care group had the longest duration of crying of all treatment groups. </p> <p>3 episodes of vomiting (1 in the routine care group, 1 in the NNS group and 1 in the sucrose + NNS group) and 2 infants who had abdominal distension (1 in the sucrose + NNS group and 1 in the routine care group) were reported. </p> <p>Data were included in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: National Natural</p> <p>Science Foundation of China (81703246), the Preponderant Discipline Project of Universities in Jiangsu Province, Nursing Science Open Fund of Nanjing University of Chinese Medicine (YSHL2016‐018), Top‐notch Academic Programs Project of Jiangsu Higher Education Institutions (PPZY2015C258) and Project of Nursing Science in Nanjing University of Chinese Medicine (NZYHLXPPJG2017‐54) </p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0014" title="GibbinsS , StevensB , HodnettE , PinelliJ , OhlssonA , DarlingtonG . Efficacy and safety of sucrose for procedural pain relief in preterm and term neonates. Nursing Research2002;51(6):375-82. [DOI: 10.1097/00006199-200211000-00005] [PMID: 12464757]GibbinsS , StevensB . The influence of gestational age on the efficacy and short-term safety of sucrose for procedural pain relief. Advances in Neonatal Care2003;3(5):241-9. [PMID: 14648521]GibbinsS . Efficacy and Safety of Sucrose for Procedural Pain Relief in Preterm and Term Neonates [PhD Thesis]. Toronto: University of Toronto, 2001. ">Gibbins 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>190 preterm and term infants, mean GA 33.7 weeks, &lt; 7 d PNA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 min prior to heel lance:</p> <p> <ul id="CD014806-list-0038"> <li> <p>sucrose + NNS group: 0.5 mL 24% sucrose via syringe to the anterior surface of the tongue followed by pacifier (n = 64); </p> </li> <li> <p>sucrose group: 0.5 mL 24% sucrose without pacifier (n = 62); and</p> </li> <li> <p>water + NNS group: 0.5 mL sterile water with pacifier (n = 64)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0039"> <li> <p>PIPP scores at 30 s and 60 s after heel lance</p> </li> <li> <p>Incidence of adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported means, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean PIPP scores at both 30 s (P &lt; 0.001) and 60 s (P &lt; 0.001) after heel lance favoured sucrose group and sucrose + NNS group. Post hoc Tukey tests showed infants who received sucrose + pacifier had lower PIPP scores after heel lance at 30 s (mean 8.16, SD 3.24) compared to infants receiving sucrose alone (mean 9.77, SD 3.04) (P = 0.007) or water + NNS (mean 10.19, SD 2.67 (P &lt; 0.001). At 60 s after heel lance, PIPP scores were lower for sucrose + NNS group (mean 8.78, SD 4.03) compared to the sucrose alone group (mean 11.20, SD 3.25) (P = 0.005) and water + NNS group (mean 11.20, SD 3.47 (P = 0.007). No differences in PIPP scores were found between sucrose alone group or water + NNS group at both follow‐up times. </p> <p>Minor adverse effects were observed in 6 infants, none of which occurred in the sucrose + NNS group. 1 neonate who received water with NNS choked when the water was administered but stabilised within 10 s. 3 infants randomised to the sucrose group and 2 infants randomised to the water with NNS groups experienced oxygen desaturation when the study intervention (sucrose or water) was administered. Each neonate recovered spontaneously with no medical intervention required. </p> <p>Data were used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Hospital for Sick Children, Toronto Ontario, Canada for the Research Training Award </p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0015" title="GormallyS , BarrRG , WertheimL , AlkawafR , CalinoiuN , YoungSN . Contact and nutrient caregiving effects on newborn infant pain responses. Developmental Medicine and Child Neurology2001;43(1):28-38. [DOI: 10.1017/s0012162201000056] [PMID: 11201419]">Gormally 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94 term newborns, mean GA 39.4 weeks, second or third day of life</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0040"> <li> <p>Water group: no holding and sterile water given by pipette (n = 21)</p> </li> <li> <p>Sucrose group: no holding and 0.25 mL 24% sucrose solution given by pipette (n = 22)</p> </li> <li> <p>Holding + water group: holding and sterile water given by pipette (n = 20)</p> </li> <li> <p>Holding + sucrose group: holding and 0.25 mL 24% sucrose solution by pipette (n = 22) </p> </li> </ul> </p> <p>All solutions given 3 times at 30‐second intervals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0041"> <li> <p>Percentage of time crying 1 min, 2 min and 3 min after heel lance</p> </li> <li> <p>Mean HR before intervention and 1 min, 2 min and 3 min after heel lance; mean vagal tone index before intervention and 1 min, 2 min and 3 min after heel lance </p> </li> <li> <p>Pain concentration scores for facial activity before intervention and 1 min, 2 min and 3 min after heel lance </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Crying decreased over time (P &lt; 0.001), but no interaction was noted for time with holding, taste or both. Effect of taste on crying (P &lt; 0.05) favoured sucrose group. No effect of holding (P = 0.09). No interaction between taste and holding to reduce crying (P = 0.37). Effect of combined interventions was additive. </p> <p>Although no change in mean HR due to holding or sucrose as main effects, there was an interaction between holding and taste (P &lt; 0.004), indicating synergistic effect that was also dependent on pre‐intervention HR (P &lt; 0.004). No main effects noted for vagal tone; as with HR, effect of vagal tone was dependent on pre‐intervention vagal tone for both holding and taste interventions (P &lt; 0.03). Pre‐intervention levels interacted to decrease HR and vagal tone in infants who had higher rates before interventions. </p> <p>Pain concatenation scores measuring facial expressions of pain decreased over time (P &lt; 0.001). Only the effect of holding reduced pain scores (P &lt; 0.02). No difference as to whether infant received sucrose (taste main effect P = 0.68) </p> <p>No data could be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Medical Research Council of Canada (MT‐13633), the Allan Ross Fellowship and the Lewis Sessenwein Academic Award </p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0016" title="GreenbergCS . A sugar-coated pacifier reduces procedural pain in newborns. Pediatric Nursing2002;28(3):271-7. [PMID: 12087649]">Greenberg 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84 term newborns, approximately 17 h to 19 h old</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0042"> <li> <p>Sugar‐coated pacifier (n = 21)</p> </li> <li> <p>Water‐moistened pacifier (n = 21)</p> </li> <li> <p>Sucrose group: 2 mL 12% sucrose (n = 21)</p> </li> <li> <p>Control group: routine care (n = 21)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0043"> <li> <p>Duration of cry from procedure phase to 3 min postprocedure</p> </li> <li> <p>Vagal tone and vagal tone index</p> </li> <li> <p>Salivary cortisol levels</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean and SE reported for time crying (s)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decrease in duration of cry for the sugar‐coated pacifier group compared to the control group (P = 0.001) and the water‐moistened pacifier group (P = 0.006) </p> <p>Lower vagal tone during heel lance in the sugar‐coated pacifier group compared to the control group (P = 0.008) and oral sucrose group (P = 0.018). Lower vagal tone index in the sugar‐coated pacifier group compared to control group at heel lance (P = 0.019), and 6 min to 10 min after (P = 0.007) and 11 to 15 min (P = 0.049) after heel lance </p> <p>No differences were found in salivary cortisol levels across groups (no P value reported)</p> <p>Mean duration of cry used in RevMan analyses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: American Cancer Society, California Division Fellowship #3‐3‐95</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0017" title="GualaA , PastoreG , LiveraniME , GirolettiG , GulinoF , MeriggiAI , et al. Glucose or sucrose as an analgesic for newborns: a randomised controlled blind trial. Minerva Pediatrica2001;53(4):271-4. [PMID: 11573063]">Guala 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>140 term, 38 weeks' to 41 weeks' GA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0044"> <li> <p>Nothing (n = 20)</p> </li> <li> <p>Water (n = 20)</p> </li> <li> <p>5% glucose (n = 20)</p> </li> <li> <p>33% glucose (n = 20)</p> </li> <li> <p>50% glucose (n = 20)</p> </li> <li> <p>33% sucrose (n = 20)</p> </li> <li> <p>50% sucrose (n = 20)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0045"> <li> <p>HR before, during and 3 min after heel lance</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No differences were found between groups for differences in HR at each of the 3 phases of the heel lance (P value reported for 3 min after heel lance, P = 0.087; the difference between 3 min after heel lance and during heel lance, P = 0.068) </p> <p>No adverse events were observed.</p> <p>Data were used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0018" title="HaouariN , WoodC , GriffithsG , LeveneM . The analgesic effect of sucrose in full term infants: a randomised controlled trial. BMJ1995;310(6993):1498-500. [DOI: 10.1136/bmj.310.6993.1498] [PMID: 7787595]">Haouari 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 term infants, 37 weeks' to 42 weeks' gestation, 1 d to 6 d of age</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 min prior to heel lance:</p> <p> <ul id="CD014806-list-0046"> <li> <p>2 mL 12.5% sucrose (n = 15);</p> </li> <li> <p>2 mL 25% sucrose (n = 15);</p> </li> <li> <p>2 mL 50% sucrose (n = 15); and</p> </li> <li> <p>2 mL sterile water (n = 15)</p> </li> </ul> </p> <p>All solutions were given by syringe on the tongue over &lt; 1 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0047"> <li> <p>Total time crying over 3 min</p> </li> <li> <p>Time of first cry after lance</p> </li> <li> <p>Percentage of change in HR at 1 min, 3 min and 5 min after heel lance</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0048"> <li> <p>Median, IQR</p> </li> <li> <p>Reported means and SEM</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After heel lance, decreases in total crying time and duration of first cry in 50% sucrose group compared with water (P = 0.02) were observed. Reduction in median time crying at end of first min (P &lt; 0.02) in 50% sucrose group (35 s; range 14 s to 60 s) compared with water (60 s; range 50 s to 60 s). In second minute, duration of cry less in 50% sucrose group (0 s; range 0 s to 25 s) and in 25% sucrose group (18 s; range 0 s to 55 s) compared to water (60 s; range 40 s to 60 s) (P = 0.003 and P = 0.02, respectively) </p> <p>There was a trend towards a reduction in crying time with greater concentrations of sucrose (P = 0.007). There was a similar trend in the reduction of the duration of first cry with increasing concentrations of sucrose (P = 0.004). </p> <p>Decrease in percentage of change in HR 3 min after heel lancing (P = 0.02) in the 50% sucrose group (mean 0.1%, SEM 3.3) compared to water group (mean 17.5%, SEM 6.0) </p> <p>We transcribed SEMs to SDs and included data in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Special Trustees of the Leeds General Infirmary</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0019" title="HarrisonD , JohnstonL , LoughnanP . Oral sucrose for procedural pain in sick hospitalized infants: a randomized-controlled trial. Journal of Paediatric and Child Health2003;39(8):591-7. [DOI: 10.1046/j.1440-1754.2003.00242.x] [PMID: 14629524]">Harrison 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99 sick hospitalised infants</p> <p>Mean GA (SD):</p> <p> <ul id="CD014806-list-0049"> <li> <p>sucrose group: 36.7 weeks (3.3); and</p> </li> <li> <p>control group: 36.8 weeks (3.7)</p> </li> </ul> </p> <p>(Author provided data on a subset of infants from a larger study (n = 128) that fulfilled our inclusion criteria) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0050"> <li> <p>1 mL water (n = 46)</p> </li> <li> <p>1 mL 25% sucrose (n = 53)</p> </li> </ul> </p> <p>For infants weighing ≤ 1500 g, the dose was reduced to 0.5 mL.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0051"> <li> <p>Duration of cry until 5‐second pause; incidence and duration of crying time during the heel lance and squeeze and during the 3‐min recovery period </p> </li> <li> <p>HR at baseline; heel lance; during heel lance; and 1 min, 2 min and 3 min post‐heel lance </p> </li> <li> <p>SpO<sub>2</sub> (%) at baseline; heel lance; during heel lance; and 1 min, 2 min and 3 min post‐heel lance </p> </li> <li> <p>4‐point subset of the NFCS (brow bulge, eye squeeze, nasolabial furrow, stretch mouth) at heel lance; during heel lance; and 1 min, 2 min and 3 min post‐heel lance </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD (collected from authors)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean (SD) length of first cry was higher in the water group (70.5 s (83.6 s)) compared to the sucrose group (46.8 s (63.1 s)). The sucrose group cried 57.1% of the procedure time compared to 58.8% in the water group. The mean (SD) total duration of cry during the heel lance was 84.7 s (68.8 s) in the sucrose group and 87.4 s (87.1 s) in the water group. </p> <p>The mean (SD) HR upon heel lance was 163.0 beats/min (17.9 beats/min) in the sucrose group and 159.5 beats/min (19.2 beats/min) in the water group. HR at 30 s from the beginning of the procedure was 175.4 beats/min (22.2 beats/min) and 172.8 beats/min (23.6 beats/min) in the sucrose and water groups, respectively. The HR in both groups decreased after the procedure to 152.1 beats/min (22.5 beats/min) in the sucrose group and 154.2 beats/min (29.1 beats/min) in the water group 2 min post‐heel lance. </p> <p>Results of SpO<sub>2</sub> (%) were similar between the 2 groups. </p> <p>Mean (SD) facial scores were reduced at heel lance (2.74 (1.8)) in the sucrose group compared to the water group (2.94 (1.6)) (P = 0.02) and at 1 min (P = 0.04) and 2 min (P = 0.046) post‐heel lance. No differences occurred at 3 min post‐heel lance. </p> <p>Data were included in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Murdoch Childrens Research Institute</p> <p>(Trainee Research Scholarship and Minor Grant), Australian</p> <p>Nurses Federation (Elizabeth Hulme Special Interest Group</p> <p>Clinical Research Grant), and Neonatal Unit Charity Group; Tiny Miracles</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0020" title="IsikU , OzekE , BilgenH , CebeciD . Comparison of oral glucose and sucrose solutions on pain response in neonates. Journal of Pain2000;1(4):275-8. [DOI: 10.1054/jpai.2000.8919] [PMID: 14622610]">Isik 2000a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>113 healthy term newborns GA 37 weeks to 42 weeks, median PNA 2 d (range 2 d to 5 d) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Solution syringed into the anterior third of the tongue for 1 min prior to heel lance:</p> <p> <ul id="CD014806-list-0052"> <li> <p>2 mL 30% sucrose (n = 28);</p> </li> <li> <p>2 mL 10% glucose (n = 29);</p> </li> <li> <p>2 mL 30% glucose (n = 28); and</p> </li> <li> <p>2 mL distilled water (n = 28)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0053"> <li> <p>Mean cry time during 3 min after lance</p> </li> <li> <p>Mean maximum HR 3 min from heel lance</p> </li> <li> <p>Mean recovery time for HR</p> </li> <li> <p>Percentage of change in HR at 1 min, 2 min and 3 min after heel lance</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported means and SEM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Infants who received 30% sucrose (mean crying time of 61 s) cried less than those who received 30% glucose (mean crying time of 95 s), 10% glucose (mean crying time of 103 s) or sterile water (mean crying time of 105 s) (P = 0.02). </p> <p>No difference between groups with respect to maximum HR after heel lance (P = 0.71) or mean recovery time (P = 0.09). No difference found in percentage change in HR at 1 min or 3 min after heel lance (P = 0.14, P = 0.53, respectively). At 2 min after heel lance, percentage change in HR favoured group receiving sucrose (P = 0.05) compared to other groups. </p> <p>Data were used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0021" title="JohnstonCC , StremlerRL , StevensBJ , HortonLJ . Effectiveness of oral sucrose and simulated rocking on pain response in preterm neonates. Pain1997;72(1-2):193-9. [DOI: 10.1016/s0304-3959(97)00033-x] [PMID: 9272803]">Johnston 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85 preterm infants, 25 weeks' to 34 weeks' GA, 2 d to 10 d of age</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Solutions via syringe into the mouth just prior to heel lance:</p> <p> <ul id="CD014806-list-0054"> <li> <p>0.05 mL 24% sucrose (n = 27);</p> </li> <li> <p>0.05 mL 24% sucrose and simulated rocking 15 min prior to heel lance (n = 14);</p> </li> <li> <p>0.05 mL sterile water and simulated rocking 15 min prior to heel lance (n = 24); and</p> </li> <li> <p>0.05 mL sterile water</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0055"> <li> <p>HR at baseline and 3 × 30‐second blocks</p> </li> <li> <p>Behavioural facial actions (NFCS) at baseline and 3 × 30‐second blocks</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Means and SD not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Although HR increased across all phases of procedure (P &lt; 0.04), there were no differences noted between groups (P = 0.566). </p> <p>Decrease in percentage of facial action in 24% sucrose alone group and combined 24% sucrose and rocking group compared to water group (P &lt; 0.02) </p> <p>No data could be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0022" title="JohnstonCC , StremlerR , HortonL , FriedmanA . Effect of repeated doses of sucrose during heel stick procedure in preterm neonates. Biology of the Neonate1999;75(3):160-6. [DOI: 10.1159/000014092] [PMID: 9925903]">Johnston 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48 preterm neonates, mean GA 31 weeks (range 25 weeks to 34 weeks), within 10 d of birth </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0056"> <li> <p>0.05 mL 24% sucrose as a single dose, followed by 2 doses of sterile water (n = 15)</p> </li> <li> <p>3 doses 0.05 mL 24% sucrose (n = 17)</p> </li> <li> <p>3 doses 0.05 mL sterile water (n = 16) given by syringe to anterior surface of the tongue at 2 min prior to heel lance, just prior to lancing and 2 min after lancing </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PIPP scores in 5 × 30‐second blocks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported means, SD in graph form</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Difference between groups (P &lt; 0.0001) for mean PIPP scores. Post hoc analysis found lower PIPP scores with repeated doses of 24% sucrose compared to placebo groups across all blocks of time (P &lt; 0.05). PIPP scores for repeated doses of 24% sucrose were lower compared to single doses of 24% sucrose (8.25 vs. 6.25) only at last block of time (P &lt; 0.05). PIPP scores for single doses of 4% sucrose compared to placebo showed trend towards favouring 24% sucrose (P = 0.07) </p> <p>Data obtained from the author on 31 infants that could be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Fonds de la Recherche en Sante du Quebec and Health Canada</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0024" title="KumariS , DattaV , RehanH . Comparison of the efficacy of oral 25% glucose with oral 24% sucrose for pain relief during heel lance in preterm neonates: a double blind randomized controlled trial. Journal of Tropical Pediatrics2017;63(1):30-5. [DOI: 10.1093/tropej/fmw045] [PMID: 27435886]">Kumari 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94 preterm neonates in first 48 h of life</p> <p>GA in mean (SD) for both intervention groups was 35.53 weeks (0.73 weeks) and 35.56 weeks (0.78 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Both interventions given 2 min before heel lance</p> <p> <ul id="CD014806-list-0057"> <li> <p>1 mL 25% glucose (n = 47)</p> </li> <li> <p>1 mL 24% sucrose (n = 47)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0058"> <li> <p>PIPP – 30 s, 1 min, 2 min</p> </li> <li> <p>Duration of crying</p> </li> <li> <p>Immediate adverse events (choking; coughing; vomiting; or sustained tachycardia, bradycardia, tachypnoea, dyspnoea, or oxygen desaturation) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>There were differences between PIPP scores at 30 s (P = 0.7438), 1 min (P = 0.8709) and 2 min after the procedure (P = 0.7134); duration of crying; and rate of adverse events. </p> <p>1 infant developed coughing and another, vomiting, which was present transiently and required no intervention. </p> <p>Data were included in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0025" title="LagoP , CavicchioloME , MionT , Dal CengioV , AllegroA , DaverioM , et al. Repeating a dose of sucrose for heel prick procedure in preterms is not effective in reducing pain: a randomised controlled trial. European Journal of Pediatrics2020;179(2):293-301. [DOI: 10.1007/s00431-019-03509-2] [PMID: 31728675]">Lago 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72 preterm infants admitted to the NICU (23 weeks to 36 + 6 weeks of gestation at birth) with PNA &lt; 28 d or before reaching 40 weeks' corrected PMA </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0059"> <li> <p>Group (A): both syringes 1 and 2 contained <b>sucrose</b> (24%, 0.3 mL,0.07 g of sucrose each) for infant ≤ 1000 g or 0.5 mL for infants &gt; 1000 g (0.12 g of sucrose each) (2 doses of sucrose) (n = 35) </p> </li> <li> <p>Group (B): infants were given a dose of <b>sucrose</b> (24%, 0.3 mL or 0.5 mL) in syringe 1 <b>and the same quantity of sterile water in</b> syringe 2 (1 dose of sucrose) (n = 36) </p> </li> </ul> </p> <p>Infants also received NNS and FT.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0060"> <li> <p>PIPP at 30 s, 60 s and 120 s after heel prick; the heel pricks were also rated using other pain scales more feasible in the clinical practice and indicated in Italy for their use in newborn (FLACC: Faces, Legs, Activity, Cry and Consolability; indirect 10‐cm VAS; NIPS), to compare the performance of these pain scales with the gold standard PIPP </p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median, IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No differences in PIPP scores was found</p> <p>between the groups: median PIPP values 4.0 (IQR 3.0 to 4.0) vs 3.0 (IQR 3.0 to 4.0) at baseline; 6.0 (IQR 5.0 to 10.0) vs 6.0 (IQR 4.0 to 8.5) at 30 s; 6.0 (IQR 4.0 to 7.0) vs 5.0 (IQR 4.0 to 8.5) at 60 s; and 5.0 (IQR 4.0 to 7.0) vs 5.0 (IQR 4.0 to 7.5) at 2 min, in the experimental and standard treatment groups, respectively (P = 0.9020). There was no correlation between PIPP scores and other pain scales. </p> <p>No adverse effects were reported (i.e. no episodes of desaturation or bradycardia or “choking”). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: The authors declared that they had no conflict of interest.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0026" title="LengHY , ZhengXL , YanL , ZhangXH , HeHY , XiangM . [Effects of different types and concentration of oral sweet solution on reducing neonatal pain during heel lance procedures]. Zhonghua Er Ke Za Zhi. Chinese Journal of Pediatrics2013;51(9):654-8. [PMID: 24330983]">Leng 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>560 term neonates, GA 37 weeks to 42 weeks; birthweight 2500 g to 4000 g; age 3 d to 28 d </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0061"> <li> <p>Boiled water</p> </li> <li> <p>10% glucose</p> </li> <li> <p>25% glucose</p> </li> <li> <p>50% glucose</p> </li> <li> <p>12% sucrose</p> </li> <li> <p>24% sucrose</p> </li> <li> <p>30% sucrose</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0062"> <li> <p>Increase in HR (beats/min)</p> </li> <li> <p>Decrease in SpO<sub>2</sub> (%) </p> </li> <li> <p>Pain levels (test not specified)</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported means and full ranges, not IQRs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The average HR increase 3 min, 5 min and 10 min after procedure in the 25% and 50% glucose groups, 12% and 24% and 30% sucrose groups was lower than those in the placebo group (P &lt; 0.01 or 0.05). The average HR increase 3 min after procedure in the sucrose groups was lower than that in the glucose groups (P &lt; 0.01). At 3 min after heel lance, neonates who received 30% sucrose had lower average HR increase than those who received 12% and 24% sucrose (both P &lt; 0.05). The average SpO<sub>2</sub> decrease 3 min, 5 min and 10 min after procedure was lower than that in the placebo group (P &lt; 0.01). The average SpO<sub>2</sub> decrease 3 min after procedure in the sucrose groups was lower than that in the glucose groups (P &lt; 0.01). The average pain score 3 min, 5 min and 10 min after procedure was lower than that in the placebo group (P &lt; 0.01). The average pain score 3 min after procedure in the sucrose groups was lower than that in the glucose groups (P &lt; 0.01).<br/>No adverse events reported </p> <p>We could not include in RevMan analyses data for 30% sucrose vs sterile water for increase in HR and decrease in SpO<sub>2</sub> at 3 min after heel lance, as data were reported as means and full ranges. </p> <p>In addition, results were reported late at 3 min, 5 min and 10 min after heel lance.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Chognqing Health Administration Institution Medical Science Research Grant. </p> <p>Declaration of interest: no conflict of interest.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0027" title="LengHY , ZhengXL , ZhangXH , HeHY , TuGF , FuQ . Combined non-pharmacological interventions for newborn pain relief in two degrees of pain procedures: a randomized clinical trial. European Journal of Pain2016;20(6):989-97. [DOI: 10.1002/ejp.824] [PMID: 26685099]">Leng 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>671 term neonates, GA 37 weeks to 42 weeks at birth; PNA 3 d to 28 d; birthweight 2500 g to 4000 g; Apgar score ≥ 8 at 5 min after birth; resting HR 120 beats/min to 140 beats/min; resting O<sub>2</sub> saturation ≥ 95%; required neonatal congenital metabolism disease screening or blood glucose test </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shallow (blood glucose test) and deep (congenital metabolism disease screening) heel lance </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0063"> <li> <p>Sucrose group: 2 mL 24% sucrose administered to the infant’s mouth by syringe 2 min before the heel lance procedure </p> </li> <li> <p>Sucrose + NNS group: 2 mL 24% sucrose administered as above, then a standard silicone newborn pacifier was placed into the infant’s mouth until the end of the process. </p> </li> <li> <p>Sucrose + swaddling group: infants were swaddled with a cotton blanket, upper but not lower limb movements were restricted by the blanket, and then 2 mL 24% sucrose were administered as above. The lower limbs were swaddled immediately after the heel lance procedure until the end of the process. </p> </li> <li> <p>Sucrose + NNS + swaddling group: infants were swaddled with a cotton blanket, upper but not lower limb movements were restricted by the blanket, then 2 mL 24% sucrose administered as above, then a standard silicone newborn pacifier was placed into the infant’s mouth, the lower limbs were swaddled immediately after the heel lance procedure until the end of the process. </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0064"> <li> <p>Revised NFCS</p> </li> <li> <p>Increase in HR (%)</p> </li> <li> <p>Decrease in SpO<sub>2</sub> (%) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0065"> <li> <p>Factor analysis</p> </li> <li> <p>Mean and SD</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A synergistic analgesic effect was observed between the sucrose + NNS and sucrose + swaddling groups in both the shallow (P = 0.015) and deep heel lance (P = 0.007) procedure. The sucrose + NNS + swaddling group exhibited the lowest pain score. For the deep heel lance procedure, the sucrose + NNS group had a lower increase in HR percentage and decrease in SpO<sub>2</sub> (%) than the sucrose group (P = 0.000, P = 0.001), while this difference was not observed in the shallow heel lance procedure. No difference was found between the sucrose and sucrose + swaddling groups, in terms of different physiological parameters; </p> <p>NNS and swaddling had synergistic effects on pain relief when used with oral sucrose. For the deep heel lance procedure, oral sucrose combined with NNS and swaddling provided the best pain relief effect. </p> <p>For the shallow heel lance procedure, addition of NNS and swaddling did not improve the effects. </p> <p>Data could not be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: National Key Clinical Specialist Construction Program</p> <p>of China, No [2013]544 and Medical Research Funding of Health Bureau of Chongqing, No [2011‐1‐071] </p> <p>Declaration of interest:</p> <p>none declared</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0028" title="LiawJJ , YangL , LeeCM , FanHC , ChangYC , ChengLP . Effects of combined use of non-nutritive sucking, oral sucrose, and facilitated tucking on infant behavioural states across heel-stick procedures: a prospective, randomised controlled trial. International Journal of Nursing Studies2013;50(7):883-94. [DOI: 10.1016/j.ijnurstu.2012.08.021] [PMID: 23068310]YinT , YangL , LeeTY , LiCC , HuaYM , LiawJJ . Development of atraumatic heel-stick procedures by combined treatment with non-nutritive sucking, oral sucrose, and facilitated tucking: a randomised, controlled trial. International Journal of Nursing Studies2015;52(8):1288-99. [DOI: 10.1016/j.ijnurstu.2015.04.012] [PMID: 25939641]">Liaw 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110 infants (PMA 26.4 weeks to 37 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0066"> <li> <p>Sucrose intervention: 0.2 mL to 2.0 mL 20% sucrose fed through a syringe 2 min before the heel‐lance procedures depending on the infant’s PMA (PMA 26 weeks to 28 weeks: 0.2 mL; PMA 28.1 weeks to 30 weeks: 0.5 mL; PMA 30.1 weeks to 32 weeks: 1 mL; PMA 32.1 weeks to 37 weeks: 1.5 mL; PMA &gt; 37 weeks: 2.0 mL) </p> </li> <li> <p>NNS intervention: NNS via a standard silicone newborn pacifier to stimulate sucking 1 min before touching the foot to initiate heel‐lance procedures </p> </li> <li> <p>FT intervention: infants were in a flexed posture and gently held by the intervener’s warm hands without strongly restraining the infant’s head and body, one hand on the infant’s head, and the other on the trunk. </p> </li> </ul> </p> <p>The 3 interventions outlined above were used in different combinations:</p> <p> <ul id="CD014806-list-0067"> <li> <p>NNS + FT (n = 22);</p> </li> <li> <p>FT + sucrose (n = 21);</p> </li> <li> <p>NNS + sucrose (n = 21);</p> </li> <li> <p>NNS + sucrose + FT (n = 23); amd</p> </li> <li> <p>control: routine care (n = 23).</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Infants’ behavioural states (quiet sleep, active sleep, transition state, active awake, quiet awake, fussing or crying) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Graph form, CI, rate ratio and SE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Infants receiving NNS + sucrose + FT or NNS + sucrose experienced<br/>52.8% (P = 0.023) and 42.6% (P = 0.063) more quiet‐sleep occurrences than those receiving routine care after adjusting for phase, baseline states, nontreatment sucking during baseline and recovery, positioning, and infants’ characteristics. Infants receiving FT + sucrose, NNS + sucrose, NNS + sucrose + FT and NNS + FT experienced 77.3% (P &lt; 0.001), 72.1% (P = 0.008), 51.5% (P = 0.017) and 33.0% (P = 0.105) fewer occurrences of fussing or crying, respectively, than those receiving routine care after adjusting for related factors </p> <p>No data could be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: National</p> <p>Science Council of Taiwan, ROC (NSC 95‐2314‐B‐016‐057</p> <p>and NSC 96‐2314‐B‐016‐004)</p> <p>Declaration of interest:</p> <p>none declared</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0029" title="Marin GabrielMA , delRey Hurtado de MendozaB , Jimenez FigueroaL , MedinaV , Iglesias FernandezB , Vazquez RodriguezM , et al. Analgesia with breastfeeding in addition to skin-to-skin contact during heel prick. Archives of Disease in Childhood. Fetal and neonatal edition2013;98(6):F499-503. [DOI: 10.1136/archdischild-2012-302921] [PMID: 23839984]">Marin Gabriel 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>136 healthy, term neonates; GA 37 weeks to 41 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0068"> <li> <p>Sucrose group (n = 32 analysed): 2 mL 24% sucrose (given with a sterile syringe into the mouth) 2 min before heel lance </p> </li> <li> <p>Sucrose + SSC group (n = 35 analysed): sucrose as above, SSC as below</p> </li> <li> <p>SSC group (n = 31? Written to authors, as could be 32): infants were held prone between mothers’ breast at least 5 min before heel lance. </p> </li> <li> <p>BF + SSC (n = 29 analysed): infants started BF 5 min before heel lance.</p> </li> </ul> </p> <p>These interventions were used in different combinations (BF + SSC; sucrose + SSC; SSC; sucrose). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0069"> <li> <p>NIPS</p> </li> <li> <p>HR</p> </li> <li> <p>Crying time (s)</p> </li> <li> <p>Crying in blood sampling</p> </li> <li> <p>Number of heel lances (%)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median and IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The BF + SSC group achieved a lower median NIPS score (value = 1) compared with other groups (value = 2, 4 and 4, respectively). The percentage of neonates with moderate‐to‐severe pain was lower in the BF + SSC group. Both the BF + SSC group and the sucrose + SSC group experienced a lower percentage of crying compared with the SSC group. </p> <p>No adverse events were reported.</p> <p>No data were used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: none</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0030" title="MathaiS , NatrajanN , RajalakshmiNR . A comparative study of non-pharmacological methods to reduce pain in neonates. Indian Pediatrics2006;43(12):1070-5. [PMID: 17202604]">Mathai 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104 term neonates, PNA &gt; 24 h</p> <p>Mean PNA:</p> <p> <ul id="CD014806-list-0070"> <li> <p>sucrose group: 48 h; and</p> </li> <li> <p>distilled water group: 44 h</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0071"> <li> <p>2 mL 20% sucrose inserted in mouth via a dropper (n = 17)</p> </li> <li> <p>2 mL distilled water inserted in mouth via a dropper (n = 15)</p> </li> <li> <p>Rocking (n = 17)</p> </li> <li> <p>Massage (n = 17)</p> </li> <li> <p>2 mL expressed breast milk (n = 18)</p> </li> <li> <p>NNS (n = 20)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0072"> <li> <p>Time of first cry (s), total cry (s)</p> </li> <li> <p>HR before heel lance, 2 min after heel lance and 4 min after heel lance</p> </li> <li> <p>SpO<sub>2</sub> (%) before heel lance, 2 min after heel lance and 4 min after heel lance </p> </li> <li> <p>DAN score before the heel lance and 30 s, 1 min, 2 min and 4 min after heel lance</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No difference between sucrose group and any other group for time of first cry</p> <p>NNS or rocking reduced total duration of cry (P &lt; 0.05).</p> <p>No difference in HR between the groups at any time point</p> <p>No difference in SpO<sub>2</sub> (%) between the groups at any time point </p> <p>Reduced DAN scores at 30 s after the heel lance for the sucrose group (mean 7.6, SD 14, P &lt; 0.05); however, this was not sustained at 1 min, 2 min and 4 min </p> <p>NNS or rocking decreased the DAN scores at 2 and 4 min post‐heel lance (P &lt; 0.05).</p> <p>Reported data that could be used in RevMan analyses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: none</p> <p>Declaration of interest: none</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0031" title="McGinnisK , MurrayE , ChervenB , McCrackenC , TraversC . Effect of vibration on pain response to heel lance: a pilot randomized control trial. Advances in Neonatal Care2016;16(6):439-48. [DOI: 10.1097/ANC.0000000000000315] [PMID: 27533335]">McGinnis 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56 infants, GA median (IQR) of 38 weeks (30 weeks to 39 weeks) and 36 weeks (20 weeks to 38 weeks) for both intervention groups </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0073"> <li> <p>Control: swaddling (1 leg exposed on heel warmer for 3 min to 5 min before heel lance) + 0.1 mL to 0.2 mL 24% sucrose with pacifier 2 min before heel lance (n = 30) </p> </li> <li> <p>Control + vibration for heel lance analgesia (92 Hz, 0.6 mm amplitude) 30 s before heel lance (n = 26) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0074"> <li> <p>N‐PASS scores</p> </li> <li> <p>Change in HR from baseline</p> </li> <li> <p>Change in SpO<sub>2</sub> from baseline (immediately after heel stick, 2 min after, 5 min after) </p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, CI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The change in N‐PASS scores was lower in the vibration group vs the nonvibration group during (P = 0.006) and 2 min after heel stick (P = 0.037). HR elevation was also lower in the vibration group during (P = 0.002) and 2 min after heel stick (P = 0.016). There were no differences in SpO<sub>2</sub> between the two treatment groups. </p> <p>No adverse events were reported.<br/>Data could not be used in RevMan analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Dudley L. Moore Nursing and Allied</p> <p>Health Fund</p> <p>Declaration of interest: The authors declared no conflicts of interest.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0032" title="MitchellAJ , HallRW , GolianuB , YatesC , WilliamsDK , ChangJ , et al. Does noninvasive electrical stimulation of acupuncture points reduce heelstick pain in neonates?Acta Paediatrica2016;105(12):1434-9. [DOI: 10.1111/apa.13581] [PMID: 27607517]">Mitchell 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>162 infants with a GA between 37 weeks and 42 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NESAP given 10 min ± 1 min prior until 2 min after, and sucrose/water given 2 min ± 0.5 min prior: </p> <p> <ul id="CD014806-list-0075"> <li> <p>sham NESAP with (1 mL ± 0.1 mL) 24% oral sucrose (n = 37);</p> </li> <li> <p>NESAP (3.5 mA, 10 Hz) with (1 mL ± 0.1 mL) water (n = 37)</p> </li> <li> <p>NESAP (3.5 mA, 10 Hz) with (1 mL ± 0.1 mL) 24% oral sucrose (n = 40); and</p> </li> <li> <p>sham NESAP with (1 mL ± 0.1 mL) water (n = 39)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0076"> <li> <p>PIPP score (during heel lance and then every 30 s for 120 s after heel stick)</p> </li> <li> <p>Change in HRV</p> </li> <li> <p>Salivary cortisol (5 min after heel lance)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PIPP scores increased during heel stick (F (9,119) = 1.95, P = 0.05) for all 4 treatment groups. PIPP scores increased the least for the groups receiving sucrose (P &lt; 0.01). There were no differences in HRV from baseline to heel stick (P = 0.6315) and salivary cortisol levels between treatment groups.<br/>Data could not be used in RevMan analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source‐Mayday Fund and NIGMS IDeA Program award P30 GM 110702</p> <p>Declaration of interest: The authors declared no conflict of interest.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0033" title="NimbalkarS , ShuklaVV , ChauhanV , PhatakA , PatelD , ChaplaA , et al. Blinded randomized crossover trial: skin-to-skin care vs. sucrose for preterm neonatal pain. Journal of Perinatology2020;40(6):896-901. [DOI: 10.1038/s41372-020-0638-9] [PMID: 32152488]">Nimbalkar 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 preterm neonates (28 0/7 weeks' to 36 6/7 weeks' GA)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0077"> <li> <p>Group A (n = 50): skin‐to‐skin care was provided 15 min before the first heel stick and was continued post‐procedure as per the protocol of the study institute. Subsequently, during their next heel stick (3/6h after the first heel stick as clinically indicated), participants were given 24% oral sucrose 0.5 mL to those at &lt; 32 weeks' gestation and 1 mL to those at 32 weeks' to 36 weeks' gestation, 2 min before heel stick. </p> </li> <li> <p>Group B (n = 50): participants were given 24% sucrose 2‐min before heel‐stick (dosage same as previous) and SSC (3/6 h after the first heel‐stick as clinically indicated, duration same as previous) before their next heel stick. </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PIPP at 0 min, 1 min and 5 min after heel stick</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The behaviour state component was lower in the sucrose group at all assessment points. There was no difference between 1 min and 0 min (just before heel stick) (SSC 3.58 (3.16) vs sucrose 4.09 (3.82), P = 0.24) between groups. </p> <p>The mean (SD) PIPP score was similar across groups at 1 min after the heel stick (sucrose 6.84 (3.58) vs SSC 6.98 (3.34), P = 0.78). The mean (SD) PIPP score at 0 min (just before the heel stick – i.e. 2 min after sucrose administration and 15 min after SSC started, as applicable) and at 5 min after the heel stick were marginally lower in the sucrose group as compared with SSC group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: The authors declared that they had no conflict of interest.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0035" title="OkanF , CobanA , InceZ , YapiciZ , CanG . Analgesia in preterm newborns: the comparative effects of sucrose and glucose. European Journal of Pediatrics2007;166(10):1017-24. [DOI: 10.1007/s00431-006-0373-z] [PMID: 17203281]OzdoganT , AkmanI , CebeciD , BilgenH , OzekE . Comparison of two doses of breast milk and sucrose during neonatal heel prick. Pediatrics International2010;52(2):175-9. [DOI: 10.1111/j.1442-200X.2009.02921.x] [PMID: 19627552]">Okan 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31 healthy, preterm newborns; mean GA 30.5 weeks; mean PMA 32.3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0078"> <li> <p>2 mL 20% sucrose</p> </li> <li> <p>2 mL 20% glucose</p> </li> <li> <p>2 mL water</p> </li> </ul> </p> <p>The solutions were administered via syringe onto the anterior portion of the tongue.</p> <p>Cross‐over study – infants received all 3 interventions at different times.</p> <p>Data from the first treatment in each infant could not be derived.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0079"> <li> <p>Duration of first cry</p> </li> <li> <p>Total crying time</p> </li> <li> <p>HR, SpO<sub>2</sub> (%) </p> </li> <li> <p>RR (breaths/min)</p> </li> <li> <p>NFCS scores (baseline; during heel lance; and 1 min, 2 min, 3 min, 4 min and 5 min post‐heel lance) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increased duration of first cry and total crying time in the water group compared to the sucrose and glucose groups (P = 0.005 and P = 0.007, respectively) </p> <p>No differences in cry characteristics were observed between the sucrose and glucose groups. </p> <p>Higher HR in the water group (mean 175 beats/min, SD 20.8 beats/min) compared to the sucrose (mean 166 beats/min, SD 17.6 beats/min) and glucose groups (mean 165 beats/min, SD 17.5 beats/min) at 1 min following heel lance (P = 0.007). No differences between the sucrose and glucose groups </p> <p>The study found no differences for RR or SpO<sub>2</sub> between groups. </p> <p>Higher NFCS score in the placebo group in the fourth minute following heel lance (mean 1.3, SD 2.0) and fifth min following heel lance (mean 1.0, SD 1.0) compared to the sucrose (mean 0.5, SD 1.7; mean 0.3, SD 1.3, respectively) and glucose groups (mean 0.2, SD 0.5; mean 0.1, SD 0.3, respectively) (P = 0.009 at fourth minute and P = 0.046 at fifth minute). There were no differences between the sucrose and glucose groups. </p> <p>Data could not be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0036" title="OrsR , OzekE , BaysoyG , CebeciD , BilgenH , TürkünerM , et al. Comparison of sucrose and human milk on pain response in newborns. European Journal of Pediatrics1999;158(1):63-6. [DOI: 10.1007/s004310051011] [PMID: 9950311]">Ors 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102 healthy, term infants; GA 37 weeks to 42 weeks; median PNA 1.6 d (range 1 d to 15 d) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0080"> <li> <p>2 mL 25% sucrose (n = 35)</p> </li> <li> <p>2 mL human milk (n = 33)</p> </li> <li> <p>2 mL sterile water (n = 34)</p> </li> </ul> </p> <p>All solutions syringed onto anterior part of tongue for 1 min; heel prick performed 2 min after intervention </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0081"> <li> <p>Median cry time (in seconds) during 3 min after lance</p> </li> <li> <p>Percentage of change in HR 1 min, 2 min and 3 min after heel lance</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median, IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decrease in crying time (in seconds) for 25% sucrose group (median 36, IQR 18 to 43) compared to human milk (median 62, IQR 29 to 107) and sterile water (median 52, IQR 32 to 158) (P = 0.0009). Recovery time for crying was reduced in 25% sucrose group (median 72, IQR 48 to 116) compared to human milk (median 112, IQR 72 to 180) and sterile water (median 124, IQR 82 to 180) (P = 0.004) </p> <p>Percentage of change in HR after heel lance was lower in the group receiving 25% sucrose compared to groups receiving human milk and sterile water at 1 min, 2 min and 3 min (P = 0.008, P = 0.01, P = 0.002, respectively) </p> <p>No data were used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0037" title="OvergaardC , KnudesenA . Pain-relieving effect of sucrose in newborns during heel prick. Biology of the Neonate1999;75(5):279-84. [DOI: 10.1159/000014105] [PMID: 10095141]">Overgaard 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 newborn term infants, mean PNA 6 d (range 4 d to 9 d)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0082"> <li> <p>2 mL 50% sucrose solution via syringe into the mouth over 30 s 2 min prior to heel lance (n = 49) </p> </li> <li> <p>2 mL sterile water via syringe into the mouth over 30 s 2 min prior to heel lance (n = 47) </p> </li> </ul> </p> <p>In addition to the intervention to which the infants were assigned, parents were instructed to comfort the infant as much as possible. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0083"> <li> <p>Median crying time during heel lance, fraction of crying during sampling, crying time during first minute after end of sampling, total crying time </p> </li> <li> <p>Change in HR at 0 min and 1 min</p> </li> <li> <p>SpO<sub>2</sub> (%) at 0 min and 1 min </p> </li> <li> <p>NIPS scores 1 min after heel lance and 1 min after blood sampling</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median, 5th and 95th percentiles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median duration of first cry in group receiving 50% sucrose was lower (18 s (2 s to 75 s)) compared to placebo group (22 s (11 s to 143 s)) (P = 0.03). Median crying time during heel lance in the sucrose group was lower (26 s (2 s to 183 s)) compared to placebo group (40 s (12 s to 157 s)) (P = 0.07). Median fraction of crying during sampling in 50% sucrose group was lower (43% (4% to 100%)) compared to placebo group (83% (20% to 100%)) (P = 0.004). Median crying time during first min after end of sampling in 50% sucrose group was lower (3 s (0 s to 58 s)) compared to placebo group (16 s (0 s to 59 s)) (P = 0.004). Median total time crying in 50% sucrose group was lower (30 s (2 s to 217 s)) compared to placebo group (71 s (13 s to 176 s)) (P = 0.007). </p> <p>No differences between groups with respect to HR (P = 0.6)</p> <p>No differences between groups with respect to changes in SpO<sub>2</sub> (%) (P = 0.9) </p> <p>Median NIPS scores 1 min after heel lance were lower in 50% sucrose group compared to placebo group (3 (0 to 7) and 6 (0 to 7), respectively; P = 0.04). Median NIPS scores 1 min after end of blood sampling were lower in 50% sucrose group (0 (0 to 7)) compared to placebo group (2 (0 to 7)) (P = 0.05). </p> <p>As means were not reported, we could not include the results in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Source of funding: Det Obelske family Foundation and Danico’s Foundation</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0039" title="RamenghiLA , WoodCM , GriffithGC , LeveneMI . Reduction of pain response in premature infants using intraoral sucrose. Archives of Disease in Childhood. Fetal and Neonatal Edition1996;74(2):F126-8. [DOI: 10.1136/fn.74.2.f126] [PMID: 8777660]">Ramenghi 1996b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 preterm infants, GA 32 weeks to 34 weeks, &gt; 24 h of age</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0084"> <li> <p>1 mL 25% sucrose</p> </li> <li> <p>1 mL sterile water</p> </li> </ul> </p> <p>The solutions were administered via syringe into the baby’s mouth for 1 min.</p> <p>Cross‐over study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0085"> <li> <p>Duration of first cry and percentage of time crying 5 min after lance</p> </li> <li> <p>HR at −2 min, 0 min, 1 min, 3 min and 5 min from heel lance</p> </li> <li> <p>Behavioural scores (4 facial expressions and the presence of crying) at −2 min, −1 min, 0 min, 1 min, 2 min, 3 min and 5 min </p> </li> <li> <p>Quality and intensity of sucking</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median, IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No adverse events were reported.</p> <p>No data could be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0038" title="RamenghiLA , GriffithGC , WoodCM , LeveneMI . Effect of non-sucrose sweet tasting solution on neonatal heel prick responses. Archives of Disease in Childhood. Fetal and Neonatal Edition1996;74(2):F129-31. [DOI: 10.1136/fn.74.2.f129] [PMID: 8777661]">Ramenghi 1996a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 term infants, GA 37 weeks to 42 weeks, 2 d to 5 d old</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0086"> <li> <p>2 mL 25% (0.5 g) sucrose (n = 15)</p> </li> <li> <p>2 mL 50% (1.0 g) sucrose (n = 15)</p> </li> <li> <p>Calpol (n = 15)</p> </li> <li> <p>Single‐dose sterile water (n = 15)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0087"> <li> <p>Duration of first cry after lance</p> </li> <li> <p>Percentage of time crying over 3 min after heel lance</p> </li> <li> <p>Percentage of change in HR over 5 min (at −2 min, 0 min, 1 min, 3 min and 5 min from heel lance) </p> </li> <li> <p>Behavioural scores (4 facial expressions and the presence of crying) at −2 min, −1 min, 0 min, 1 min, 2 min, 3 min and 5 min </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median, IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decrease in duration of first cry and percentage of time crying during 3 min after heel lance in the 25% sucrose, 50% sucrose and Calpol groups (P = 0.02) (data in graph form only) </p> <p>Increase in HR for 3 min after heel lance in water group compared with 50% sucrose group and Calpol group (P = 0.009) </p> <p>Pain score (0 to 5) was higher in water group (score = 2, range 1 to 5) than in other 3 groups: 50% sucrose group (score = 0, range 0 to 3); 25% sucrose group (score = 0, range 0 to 2); Calpol group (score = 0, range 0 to 1) (P = 0.05). </p> <p>No data were used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0040" title='RamenghiLA , EvansDJ , LeveneMI . "Sucrose analgesia": absorptive mechanism or taste perception?Archives of Disease in Childhood. Fetal and Neonatal Edition1999;80(2):F146-7. [DOI: 10.1136/fn.80.2.f146] [PMID: 10325795]'>Ramenghi 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 preterm infants, GA 32 weeks to 36 weeks, PNA &gt; 24 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0088"> <li> <p>25% sucrose solution (volume not reported) given via syringe into the mouth or via NG tube 2 min prior to first heel lance (n = 15), and via the alternate route for the second heel lance within 48 h </p> </li> <li> <p>Sterile water given via syringe into the mouth or via NG tube 2 min prior to first heel lance and for the second heel lance the alternate route within 48 h (cross‐over design, n = 15) </p> </li> </ul> </p> <p>The cross‐over concerned mode of delivery of the solution: intraorally or via NG tube.</p> <p>Infants stayed in their original group assigned to receive either sucrose or sterile water. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0089"> <li> <p>Percentage of time crying over 5 min after sampling</p> </li> <li> <p>Behavioural scores (4 facial expressions and the presence of cry) at 1 min, 3 min and 5 min after the lance for a total behavioural score </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median, IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median percentage of time crying in intra‐oral water group was 22% (IQR 10.6% to 40%) and 27% (IQR 11.6% to 47%) for infants in NG tube water group. Median percentage of time crying in intra‐oral 25% sucrose group was 6% (IQR 0.6% to 15%) and 18.3% (IQR 11.6% to 41.6%) in NG tube 25% sucrose group. </p> <p>Reduction in crying time (P = 0.006) was noted in the 25% sucrose group compared with water group when infants received 25% sucrose intra‐orally, not via NG‐tube route. For infants in 25% sucrose group, a reduction in crying time was noted (P = 0.008) when solution was given intra‐orally compared to NG tube route. </p> <p>Behavioural scores for the intra‐oral water group were 9 (IQR 6 to 12) and 10 (IQR 6 to 14) for NG tube water group. Behavioural scores for intra‐oral 25% sucrose group were 5 (IQR 3 to 6) and 9 (IQR 8 to 10) for NG tube sucrose group. Reduction in behavioural scores was noted in 25% sucrose group (P = 0.002) compared with water group when infants received 25% sucrose intra‐orally but not via NG route. For infants in 25% sucrose group, there was a reduction in behavioural score (P = 0.001) when solution was given intra‐orally compared to via NG tube. </p> <p>Cross‐over design: data from the first assignment prior to cross‐over were presented. These data were not used in RevMan analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0041" title="RushforthJA , LeveneMI . Effect of sucrose on crying in response to heel stab. Archives of Disease in Childhood1993;69(3):388-9. [DOI: 10.1136/adc.69.3.388] [PMID: 8215552]">Rushforth 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52 term infants, GA 37 weeks to 42 weeks, 2 d to 7 d of age</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0090"> <li> <p>2 mL 7.5% sucrose administered by a dropper into the mouth over a 1‐minute period prior to heel lance (n = 26) </p> </li> <li> <p>2 mL sterile water administered by dropper into the mouth over a 1‐minute period prior to heel lance (n = 26) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage of crying during sampling and 3 min after sampling</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Medians only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No differences in median percentage of time crying between group receiving 7.5% sucrose (74.3%) compared to group receiving water (73.2%). No differences between groups in duration of cry after 1 min (P = 0.65), 2 min (P = 0.52) and 3 min (P = 0.72). No difference in time to cessation of crying (P = 0.16) </p> <p>No data could be used in RevMan analyses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0042" title="SenE , ManavG . Effect of kangaroo care and oral sucrose on pain in premature infants: a randomized controlled trial. Pain Management Nursing2020;21(6):556-64. [DOI: 10.1016/j.pmn.2020.05.003] [PMID: 32768272]">Sen 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64 preterm neonates (infants born between 32 and 37 gestational weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0091"> <li> <p>Sucrose group (n = 32) given 0.5 mL, 24% oral sucrose without pacifier by the researcher 2 min before heel lance </p> </li> <li> <p>KC group (n = 32) – KC started 15 min before heel lance</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HR, SpO<sub>2</sub> and PIPP score during and 2 min after heel lance </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0092"> <li> <p>Median, IQR: PIPP scores</p> </li> <li> <p>Mean, SD: HR and SpO<sub>2</sub> </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PIPP scores were lower in the KC group compared to the sucrose group 2 min after heel lancing (P &lt; 0.001). </p> <p>There was a difference between groups in<br/>the change in PIPP values during and after heel lancing (P = 0.002) favouring the KC group.<br/>There was a difference between the groups in<br/>changes observed in HR values after and before heel<br/>lance (P &lt; 0.001); the change observed in the oral sucrose group<br/>was greater than that in the KC group. </p> <p>There was no<br/>difference between the groups in <br/>changes in SpO<sub>2</sub> values after and during heel lance (P &gt; 0.05). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: No conflict of interest has been declared by the authors.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0043" title="ShahSR , KadageS , SinnJ . Trial of music, sucrose, and combination therapy for pain relief during heel prick procedures in neonates. Journal of Pediatrics2017;190:153-8. [DOI: 10.1016/j.jpeds.2017.08.003] [PMID: 29144240]">Shah 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35 neonates, PMA 35 weeks (SD 2.3 weeks), average weight 2210 g (SD 710 g)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0093"> <li> <p>Recorded music (sounds up to 60 A‐weighted decibels, 20 min prior to heel prick until 7 min after procedure) (n = 35) </p> </li> <li> <p>Oral sucrose therapy (0.5 mL oral sucrose (24%) 2 min before heel prick) (n = 35)</p> </li> <li> <p>Combination therapy (n = 35)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0094"> <li> <p>PIPP‐R score at 1‐minute intervals for a total of 6 min after heel prick</p> </li> <li> <p>Mean HR and SpO<sub>2</sub> at 1‐minute intervals for 20 min before heel prick to 7 min after </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0095"> <li> <p>Median, IQR: PIPP‐R</p> </li> <li> <p>Mean, SD: SpO<sub>2</sub> and average HR </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>There was no difference in overall PIPP scores between the music (median 4, IQR 0 to 6) and sucrose groups (median 3, IQR 0 to 6). The PIPP scores were lower for the combination group (median 1, IQR 0 to 3). There was lower trend in SpO<sub>2</sub> for the combination group compared with the sucrose group (P &lt; 0.001).<br/>Data were included in RevMan analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: The authors declared no conflict of interest.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0044" title="SimonseE , MulderPG , vanBeekRH . Analgesic effect of breast milk versus sucrose for analgesia during heel lance in late preterm infants. Pediatrics2012;129(4):657-63. [DOI: 10.1542/peds.2011-2173] [PMID: 22392168]">Simonse 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71 preterm infants, GA 32 weeks to 36 + 6/7 weeks at birth, undergoing heel lance with an automated piercing device </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0096"> <li> <p>1 mL to 2 mL 24% sucrose orally before heel lance (n = 24 were analysed), combined with NNS </p> </li> <li> <p>Breastfed in mother's arms (n = 23)</p> </li> <li> <p>Bottle‐fed breast milk and held in the arms of an experienced nurse (n = 23)</p> </li> </ul> </p> <p>All 46 infants (in groups 2 and 3) were analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0097"> <li> <p>PIPP score</p> </li> <li> <p>COMFORTneo score</p> </li> <li> <p>HR</p> </li> <li> <p>SpO<sub>2</sub> (%) </p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean and 95% CI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>There was no difference in mean PIPP score between neonates receiving breast milk (6.1) and those receiving sucrose (5.5), with a mean difference of 0.6 (95% CI −1.6 to 2.8; P = 0.58). </p> <p>No data were provided for HR and SpO<sub>2</sub>. </p> <p>No adverse events were reported.</p> <p>95% CIs were transformed to SDs and used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: no external funding</p> <p>Declaration of interest: The authors indicated they had</p> <p>no financial relationships relevant to this article to disclose.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0045" title="SlaterR , CornelissenL , FabriziL , PattenD , YoxenJ , WorleyA , et al. Oral sucrose as an analgesic drug for procedural pain in newborn infants: a randomised controlled trial. Lancet2010;376(9748):1225-32. [DOI: 10.1016/S0140-6736(10)61303-7] [PMID: 20817247]">Slater 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44 term infants, GA 37 weeks to 43 weeks, &lt; 8 d old</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0098"> <li> <p>0.5 mL 24% sucrose given via syringe (n = 20)</p> </li> <li> <p>0.5 mL sterile water (n = 24)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0099"> <li> <p>HR change</p> </li> <li> <p>PIPP score</p> </li> <li> <p>Nociceptive‐specific brain activity</p> </li> <li> <p>Latency to change in facial expression (s)</p> </li> <li> <p>Facial nonresponders</p> </li> <li> <p>Nociceptive reflex withdrawal activity</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, 95% CI, mean weight</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only mean baseline HR given: 24% sucrose 132.6 beats/min (124.3 beats/min to 140.9 beats/min); sterile water 131.8 beats/min (122.2 beats/min to 141.5 beats/min) (P = 0.90) </p> <p>Only mean baseline SpO<sub>2</sub> given: 24% sucrose 99.4% (98.8% to 100.1%); sterile water 97.4% (95.0% to 99.8%) (P = 0.13) </p> <p>PIPP score during insertion: baseline PIPP score: 24% sucrose 1.3 (0.8 to 1.7), sterile water 1.3 (0.8 to 1.8) (P = 0.91); PIPP during procedure: 24% sucrose 5.8 (3.7 to 7.8), sterile water 8.5 (7.3 to 9.8) (P = 0.02) </p> <p>No differences in nociceptive‐specific brain activity (P = 0.46), latency to change in facial expression (P = 0.86), mean nociceptive reflex withdrawal activity (P = 0.49) or mean latency to nociceptive reflex withdrawal activity (P = 0.56); difference in facial nonresponders for 24% sucrose 35%, for sterile water 0% (P &lt; 0.0001) </p> <p>Results presented as mean and 95% CIs</p> <p>Data used in RevMan analyses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Medical Research Council</p> <p>Declaration of interest: Authors declared that they had no conflicts of interest.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0046" title="JohnstonCC , SherrardA , StevensB , FranckL , StremlerR , JackA . Do cry features reflect pain intensity in preterm neonates?Biology of the Neonate1999;76(2):120-4. [DOI: 10.1159/000014150] [PMID: 10393997]StevensB , JohnstonC , FranckP , PetryshenP , JackA , FosterG . The efficacy of developmentally sensitive interventions and sucrose for relieving pain in very low birth weight infants. Nursing Research1999;48(1):35-43. [DOI: 10.1097/00006199-199901000-00006] [PMID: 10029400]">Stevens 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>122 preterm neonates, GA 27 weeks to 31 weeks, ≤ 28 d of age</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0100"> <li> <p>Prone positioning 30 min prior to heel lance</p> </li> <li> <p>Pacifier dipped in sterile water and placed into the mouth 2 min prior to heel lance</p> </li> <li> <p>Pacifier dipped in 24% sucrose and placed into the mouth 2 min prior to heel lance</p> </li> <li> <p>Control: containment in SnuggleUp device (n = 122)</p> </li> </ul> </p> <p>All infants were contained in SnuggleUp device for all interventions.</p> <p>Each infant received all 4 interventions in random order (serving as his or her own control); there was 1 control group and 3 intervention groups. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0101"> <li> <p>PIPP scores at 30 s and 60 s</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported means, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Main effect of treatment for mean PIPP scores (P &lt; 0.0001). Post hoc analysis revealed a reduction in PIPP scores 30 s after heel lance in sucrose group (pacifier dipped in 24% sucrose estimated at 0.02 g) (mean 7.87, SD 3.35) compared to control group (mean 9.80, SD 3.55) (P &lt; 0.0001). Reduction in PIPP scores in pacifier and water group (mean 8.44, SD 3.55) compared to control group (mean 9.80, SD 3.55) (P = 0.003). Trend towards lower PIPP scores with sucrose and pacifier group compared to water and pacifier group (P &lt; 0.05) </p> <p>No adverse effects were observed when administering 24% sucrose orally via a pacifier.</p> <p>The first author provided data for 61 infants for PIPP at 30 s after heel lance and for 45 infants at 60 s after heel lance for infants before cross‐over. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: National Institutes of Health, National Institute of Nursing Research</p> <p>(grant NR 03916 R01) and a National Institutes of Health Pediatric Clinical Research Center grant at the University of California San Francisco and Children's Hospital, Oakland research sites (M01 ‐ RR012771) </p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0047" title="StevensB , YamadaJ , BeyeneJ , GibbinsS , PetryshenP , StinsonJ , et al. Consistent management of repeated procedural pain with sucrose in preterm neonates: is it effective and safe for repeated use over time?Clinical Journal of Pain2005;21(6):543-8. [DOI: 10.1097/01.ajp.0000149802.46864.e2] [PMID: 16215340]">Stevens 2005a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66 preterm infants, GA 26 weeks to 30 weeks, PNA &lt; 72 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0102"> <li> <p>Standard care (i.e. positioning and swaddling) (n = 21)</p> </li> <li> <p>Standard care as above + 0.1 mL sterile water via syringe into the mouth immediately followed by a pacifier 2 min prior to painful procedure (n = 23) </p> </li> <li> <p>Standard care as above + 0.1 mL 24% sucrose via syringe into the mouth immediately followed by a pacifier 2 min prior to painful procedure (n = 22) </p> </li> </ul> </p> <p>These interventions were given every time there was a painful procedure during the first 28 d of life. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0103"> <li> <p>PIPP at days 7, 14, 21 and 28 at routine heel lance</p> </li> <li> <p>Adverse events</p> </li> <li> <p>Neurobiological risk status</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Main effect of group (there was a difference in a particular group) (P = 0.03) with differences occurring between the sucrose + pacifier group and the standard care group (at 60 s P = 0.01). Mean PIPP scores were generally higher in the standard care group. </p> <p>Adverse effects: no group differences for adverse events, clinical outcomes or neurobiological risk status </p> <p>No data used in RevMan analyses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0048" title="StevensB , YamadaJ , Campbell-YeoM , GibbinsS , HarrisonD , DionneK , et al. The minimally effective dose of sucrose for procedural pain relief in neonates: a randomized controlled trial. BMC Pediatrics2018;18(1):85. [DOI: 10.1186/s12887-018-1026-x] [DOI: 10.1186/s12887-018-1026-x] [PMID: 29475433]">Stevens 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>245 neonates, 24 weeks' to 42 weeks' GA at birth and &lt; 30 d of life or &lt; 44 weeks' GA </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All interventions given 2 min before heel lance</p> <p> <ul id="CD014806-list-0104"> <li> <p>0.1 mL 24% sucrose (n = 81)</p> </li> <li> <p>0.5 mL 24% sucrose (n = 81)</p> </li> <li> <p>1.0 mL 24% sucrose (n = 83)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0105"> <li> <p>PIPP‐R at 30 s and 60 s</p> </li> <li> <p>Incidence of adverse events (HR &gt; 240 beats/min or HR &lt; 80 beats/min for &gt; 20 s; SpO<sub>2</sub> &lt; 80% for &gt; 20 s; no spontaneous respirations for &gt; 20 s; and choking/gagging) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean (SD) PIPP‐R scores at 30 s were 6.9 (3.5), 6.8 (3.2) and 6.7 (3.4) for 0.1 mL, 0.5 mL and 1.0 mL, respectively. There were no differences in PIPP‐R score between treatment groups at 30 s (P = 0.97) and at 60 s (P = 0.93). </p> <p>There were 5 adverse events reported: 3 infants experienced gagging, 1 had an HR &lt; 80 beats/min and another developed 80% SpO<sub>2</sub> following sucrose administration. There were no differences in proportion of adverse events between the intervention groups (P = 0.62), and all resolved spontaneously.<br/>No data could be used in RevMan analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: The Canadian Institutes of Health Research (MOP‐126167)</p> <p>Declaration of interest:</p> <p>the authors declared that they had no competing interests.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0049" title="StormH , FremmingA . Food intake and oral sucrose in preterms prior to heel prick. Acta Paediatrica2002;91(5):555-60. [DOI: 10.1080/080352502753711687] [PMID: 12113325]">Storm 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48 preterm infants, median GA of 32 weeks, median PNA of 14 d</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0106"> <li> <p>2 mL 15% sucrose (n = 12)</p> </li> <li> <p>1 mL 25% sucrose (n = 12)</p> </li> <li> <p>Milk via NG tube (n = 12)</p> </li> <li> <p>Milk via NG tube + 1 mL 25% sucrose (n = 12)</p> </li> </ul> </p> <p>All infants were given water prior to a second heel lance.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0107"> <li> <p>Differences in crying time for pre‐heel lance to heel lance procedure</p> </li> <li> <p>Changes in HR from pre‐heel lance to heel lance procedure</p> </li> <li> <p>Difference in skin conductance from pre‐heel lance to heel lance procedure</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Less crying in infants receiving 25% sucrose (P &lt; 0.05) and food (milk) + 25% sucrose (P &lt; 0.05) </p> <p>No differences between groups in changes in HR from before heel lance to heel lance procedure (P value not reported) </p> <p>Smaller increase in skin conductance variables compared to their water control session (P value not reported) </p> <p>No data could be included in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: SIDS Society, Oslo, Norway</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0051" title="ThakkarP , AroraK , GoyalK , DasRR , JavadekarB , AiyerS , et al. To evaluate and compare the efficacy of combined sucrose and non-nutritive sucking for analgesia in newborns undergoing minor painful procedure: a randomized controlled trial. Journal of Perinatology2016;36(1):67-70. [DOI: 10.1038/jp.2015.122] [PMID: 26583940]">Thakkar 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>180 full‐term neonates, birthweight &gt; 2000 g and age &gt; 24 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0108"> <li> <p>2 mL 30% sucrose (n = 45)</p> </li> <li> <p>2 mL 30% sucrose + NNS (n = 45)</p> </li> <li> <p>NNS (n = 45)</p> </li> <li> <p>No intervention (n = 45)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0109"> <li> <p>PIPP</p> </li> <li> <p>Total crying time</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median, IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR) PIPP score was 3 (2 to 4) in the sucrose + NNS group compared with 7 (6.5 to 8) in the sucrose only group, 9 (7 to 11) in the NNS group and 13 (10.5 to 15) in the no intervention group. The sucrose + NNS group had a decrease in the median PIPP score compared with other groups (P = 0.000). Median PIPP score decreased with any intervention compared with no intervention (P = 0.000). </p> <p>A total of 5 episodes of adverse events were reported: 1 neonate each in the sucrose group, the NNS group and the sucrose + NNS group desaturated, and 2 neonates desaturated in the no intervention group. </p> <p>No data were used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest:</p> <p>the authors declared no conflict of interest.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0052" title="Tutag LehrV , CortezJ , GreverW , CepedaE , ThomasR , ArandaJV . Randomized placebo controlled trial of sucrose analgesia on neonatal skin blood flow and pain response during heel lance. Clinical Journal of Pain2015;31(5):451-8. [DOI: 10.1097/AJP.0000000000000126] [PMID: 24918475]">Tutag Lehr 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56 term infants ≤ 7 d old: appropriate for GA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0110"> <li> <p>2.0 mL 24% sucrose orally (n = 29)</p> </li> <li> <p>Sterile water orally (n = 27)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0111"> <li> <p>NIPS</p> </li> <li> <p>Mean SBF</p> </li> <li> <p>SBF</p> </li> <li> <p>PU measured by LDI during heel lance</p> </li> <li> <p>HR</p> </li> <li> <p>RR</p> </li> <li> <p>SpO<sub>2</sub> (%) </p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SE, median, IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean SBF and median NIPS scores immediately post‐heel lance were lower in sucrose‐treated infants (SBF: 167.9 PU ± 15.5 PU vs 205.4 PU ± 16.0 PU, P = 0.09; NIPS: 1 (IQR 0 to 4) vs 3 (IQR 0 to 6), P = 0.02), although there was no difference in mean SBF. During heel lance, NIPS score was predictive of SBF. An increase of 1 in NIPS score was associated with 11‐PU increase in SBF (R = 0.21; P = 0.09) for sucrose and 16‐PU increase for placebo‐treated infants (R = 0.20; P = 0.014). </p> <p>Increased SBF assessed by LDI is a pain response among term neonates following routine heel lance that was not completely attenuated by oral sucrose administration. Increased SBF is associated with NIPS scores. Sucrose analgesic efficacy evidenced by decreased NIPS scores for the sucrose group. Association of SBF with NIPS scores suggests LDI is potentially useful for assessing newborn procedural pain. </p> <p>SEs were transformed to SDs and were used in RevMan analyses for SBF.</p> <p>For HR, RR and SpO<sub>2,</sub> results were presented as means and SDs and were used in RevMan analyses. </p> <p>Assessed adverse events including</p> <p>gagging, choking and vomiting, and only 1 infant in the sucrose group was noted to experience a mild episode of 'spitting up'. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: The Gerber Foundation, Fremont, Michigan</p> <p>Declaration of interest: The authors</p> <p>declared no conflict of interest.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0053" title="Unceta-BarrenecheaA , Saitua IturriagaG , Sainz de Rozas AparicioI , Riveira FernándezD . Analgesia when taking heel lance blood in the newborn [Analgesia en la toma sanguínea de talónen los recién nacidos]. Anales de Pediatria (Barcelona)2008;69(6):544-7. [DOI: 10.1016/s1695-4033(08)75237-8] [PMID: 19128767]">Unceta‐Barranechea 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150 term infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0112"> <li> <p>FT</p> </li> <li> <p>NNS + water</p> </li> <li> <p>NNS + 2 mL 24% sucrose</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0113"> <li> <p>Mean crying time between groups</p> </li> <li> <p>Modified NFCS</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Differences in crying time between FT and 2 intervention groups (P &lt; 0.001). No difference between NNS + water and NNS + sucrose groups (P = 0.735) </p> <p>Differences in pain score between control group and 2 intervention groups (P &lt; 0.001). No difference between sucking with placebo and sucking with sucrose groups (P = 0.105) </p> <p>Data used in RevMan analyses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0054" title="VelumulaPK , ElbakoushF , Tabb C 2nd, FarooqiA , Lulic-BoticaM , JaniS , et al. Breast milk vs 24% sucrose for procedural pain relief in preterm neonates: a non-inferiority randomized controlled trial. Journal of Perinatology2022;42(7):914-9. [DOI: 10.1038/s41372-022-01352-2] [PMID: 35197549]">Velumula 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94 neonates born between 30 1/7 weeks' and 36 6/7 weeks' GA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0114"> <li> <p>0.5 mL 24% sucrose (n = 47)</p> </li> <li> <p>2 mL expressed breast milk via syringe (n = 47)</p> </li> </ul> </p> <p>Infants in both groups also received swaddling 2 min prior to scheduled heel lance.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0115"> <li> <p>PIPP‐R scores at baseline; during the procedure; and at 30 s, 60 s, 90 s and 120 s postprocedure, assessed in real time by two investigators. Final pain score was determined by calculating the average of the two assessors' scores. </p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0116"> <li> <p>Mean, SD</p> </li> <li> <p>Median, IQR</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PIPP‐R scores during procedure ranged from 5 to 12 in the two groups, with a mean (SD) score of 8.3 (1.3). PIPP‐R scores at 30 s and 60 s post‐procedure ranged from 0 to 6 and 0 to 5 with mean (SD) of 4.14 (0.98) and 1.27 (1.88) at 30 s and 60 s, respectively. All infants reached their baseline score of 0 by 90 s post‐procedure. PIPP‐R scores at 60 s were lower in the breast milk group compared to sucrose group. No differences were noted in PIPP‐R scores during the procedure (P = 0.17) and at 30 s post‐procedure (P = 0.39). PIPP‐R scores at 60 s post‐procedure were higher in the sucrose group compared to breast milk group (P &lt; 0.01). </p> <p>No adverse events were noted in any infant in both groups.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Institutional grant from Sarnaik Endowment Grant, Detroit Medical Center </p> <p>Declaration of interest: the authors declared no competing interests.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0055" title="YilmazF , ArikanD . The effects of various interventions to newborns on pain and duration of crying. Journal of Clinical Nursing2010;20(7-8):1008-17. [DOI: 10.1111/j.1365-2702.2010.03356.x] [PMID: 21054600]">Yilmaz 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>120 infants, GA 37 weeks to 42 weeks</p> <p>Mean GA (SD):</p> <p> <ul id="CD014806-list-0117"> <li> <p>control group (n = 30): 39.67 weeks (0.80 weeks);</p> </li> <li> <p>mother’s milk group (n = 30): 39.10 weeks (1.03 weeks);</p> </li> <li> <p>sucrose group (n = 30): 39.10 weeks (0.71 weeks); and</p> </li> <li> <p>pacifier group (n = 30): 39.20 weeks (0.93 weeks)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0118"> <li> <p>Control group: infants lay in their mothers’ lap; no interventions were made before the painful procedure </p> </li> <li> <p>Mother's milk group: 2 mL mother’s milk administered 2 min before the procedure by using an oral syringe and avoiding contact of the syringe with the mouth and lips </p> </li> <li> <p>Sucrose group: 2 mL 20% sucrose via a syringe as above, 2 min before the procedure</p> </li> <li> <p>Pacifier group: given a pacifier</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0119"> <li> <p>NIPS score</p> </li> <li> <p>HR</p> </li> <li> <p>RR</p> </li> <li> <p>Crying time</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No differences in HR and SpO<sub>2</sub> between groups </p> <p>After the procedure, the mean crying time of the sucrose group was shorter than those of the other groups. Comparing the crying times of the control and experimental groups according to the procedure time showed no differences between the values before and during the procedure (F = 1.50, P &gt; 0.05); (F = 2.43, P &gt; 0.05). </p> <p>Before the procedure, the lowest NIPS mean was in the sucrose group, and the highest NIPS mean was in the pacifier group. During the procedure, no differences were found between the groups for NIPS means (P &gt; 0.05). After the procedure, the sucrose group showed the lowest response to pain, while the mother's milk group had the highest response. Comparing the NIPS means of the control and experimental groups according to the procedure times, differences were found between the groups for values obtained before and after the procedure (F = 3.49, P &lt; 0.05); (F = 6.71, P &lt; 0.05). </p> <p>Outcome data were presented according to different procedure times, and no data could be included in RevMan analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: none</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ATP: adenosine triphosphate; BF: breastfeeeding; BPSN: Bernese Pain Scale for Neonates; CI: confidence interval; DAN: Douleur Aiguë du Nouveau‐né Scale; FT: facilitated tucking; GA: gestational age; HR: heart rate; HRV: heart rate variability; IQR: interquartile range; KC: kangaroo care; LDI: laser Doppler imager; NAPI: Neurobehavioral Assessment of the Preterm Infant; NESAP: noninvasive electrical stimulation of acupuncture points; NFCS: Neonatal Facial Coding System; NG: nasogastric; NICU: Neonatal Infant Care Unit ; NIPS: Neonatal Infant Pain Scale; NNS: nonnutritive sucking; N‐PASS: Neonatal Pain Agitation and Sedation Scale; O<sub>2</sub>: oxygen; PIPP: Premature Infant Pain Profile; PIPP‐R: Premature Infant Pain Profile – Revised; PMA: postmenstrual age; PNA: postnatal age; PU: perfusion unit; RR: respiratory rate; RSF: Ross Special Formula; SBF: skin blood flow; SD: standard deviation; SE: standard error; SEM: standard error of the mean; SpO<sub>2</sub>: oxygen saturation; SSC: skin‐to‐skin contact; TcPO<sub>2</sub>: transcutaneous oxygen pressure; VAS: visual analogue scale </p> </div> </div> <div class="table" id="CD014806-tbl-0011"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Characteristics of included studies assessing pain during heel lances and venipunctures</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Procedure</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Metrics used</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Results</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Funding sources and declaration of interest</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0034" title="OgawaS , OgiharaT , FujiwaraE , ItoK , NakanoM , NakayamaS , et al. Venepuncture is preferable to heel lance for blood sampling in term neonates. Archives of Disease in Childhood. Fetal and Neonatal Edition2005;90(5):F432-6. [DOI: 10.1136/adc.2004.069328] [PMID: 15871991]">Ogawa 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 healthy full‐term infants:</p> <p> <ul id="CD014806-list-0120"> <li> <p>Heel lance + water group: GA 40 weeks (range 38 weeks to 42 weeks)</p> </li> <li> <p>Heel lance + sucrose group: GA 39 weeks (range 37 weeks to 41 weeks)</p> </li> <li> <p>Venipuncture + water group: GA 39 weeks (range 37 weeks to 41 weeks)</p> </li> <li> <p>Venipuncture + sucrose group: GA 39 weeks (range 37 weeks to 41 weeks)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance or venipuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 min before procedure:</p> <p> <ul id="CD014806-list-0121"> <li> <p>heel lance + 0.1 mL sterile water on infant's tongue via syringe (n = 25);</p> </li> <li> <p>heel lance + 0.1 mL 50% sucrose on infant's tongue via syringe (n = 25);</p> </li> <li> <p>venipuncture + 0.1 mL sterile water on infant's tongue via syringe (n = 25); and</p> </li> <li> <p>venipuncture + 0.1 mL 50% sucrose on infant's tongue via syringe (n = 25).</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Duration of first cry (s), first crying time/total procedure time (%) and the ratio of crying to no crying </p> <p>NFCS score:</p> <p> <ul id="CD014806-list-0122"> <li> <p>1 min after oral administration of water or sucrose;</p> </li> <li> <p>disinfection of skin before heel lance or venipuncture;</p> </li> <li> <p>during skin puncture;</p> </li> <li> <p>during blood sampling;</p> </li> <li> <p>during compression to stop bleeding;</p> </li> <li> <p>during application of plaster; and</p> </li> <li> <p>1 min after application of plaster.</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported medians, range and mean, SD</p> <p>Reported in graph form, median and IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reduction in duration of first cry in heel lance group given sucrose compared to heel lance alone (P &lt; 0.001) </p> <p>Reduced NFCS scores in sucrose group during heel lance (median 47, IQR 31 to 60) and during compression to stop bleeding (median 32, IQR 8 to 54) compared to the water group (median 58, IQR 54 to 65; median 52, IQR 41 to 61, respectively) (P &lt; 0.001) </p> <p>Sucrose did not reduce NFCS scores during or after venipuncture</p> <p>We included data for sucrose vs water for heel lance and for venipuncture for duration of first cry. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Competing interests: none declared</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>GA: gestational age; IQR: interquartile range; NFCS: Neonatal Facial Coding System; SD: standard deviation </p> </div> </div> <div class="table" id="CD014806-tbl-0012"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Characteristics of included studies assessing pain during multiple procedures</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Procedure</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Metrics used</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Results</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Funding sources and declaration of interest</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0013" title="GaspardoCM , MiyaseCI , ChimelloJT , MartinezFE , Martins LinharesMB . Is pain relief equally efficacious and free of side effects with repeated doses of oral sucrose in preterm neonates?Pain2008;137(1):16-25. [DOI: 10.1016/j.pain.2007.07.032] [PMID: 17854995]">Gaspardo 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33 preterm infants, median PMA 30 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venipuncture, arterial puncture, heel lance, intravenous cannulation, endotracheal tube introduction, endotracheal tube suctioning, gavage insertion for feeding, removal of electrode leads and tape </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>On day 1, no treatment was given to any neonate in order to collect baseline data. After that, on days 2 to 4 before every minor painful procedure, infants received either: </p> <p> <ul id="CD014806-list-0123"> <li> <p>sucrose (n = 17): 0.5 mL/kg 25% sucrose; or</p> </li> <li> <p>water (n = 16): 0.5 mL/kg sterile water.</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain was assessed over 4 d during morning blood collection (heel lance).</p> <p>Incidence of cry (percentage of neonates crying), HR (percentage of neonates with HR ≥ 160 beats/min), </p> <p>NFCS (percentage of neonates with score ≥ 3), Activated Behavioural State (percentage of neonates with score ≥ 4). The assessment was divided into 5 phases: baseline antisepsis, puncture, dressing and recovery. The neonates’<br/>facial activity (NFCS), behavioural state and HR were evaluated. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No means or SDs reported;</p> <p>NFCS results reported in graph form only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The data analysis used cutoff scores for painful and distressful responses. There were fewer sucrose‐group neonates with facial actions signalling pain than water‐group neonates in puncture phase and in antisepsis phase. There were fewer sucrose‐group neonates crying during antisepsis phase, puncture phase and dressing phase. There was no difference between groups for physiological response. The efficacy of sucrose was maintained for pain relief in preterm neonates, with no side effects. </p> <p>Data could not be used in RevMan analyses.</p> <p>No side effects of using sucrose were detected.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: This study was supported by the FAPESP,</p> <p>the CNPq, and the FAEPA</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0023" title="BoyerK , JohnstonC , WalkerCD , FilionF , SherrardA . Does sucrose analgesia promote physiological stability in preterm neonates?Biology of the Neonate2004;85(1):26-31. [DOI: 10.1159/000074954] [PMID: 14631163]JohnstonCC , FilionF , SniderL , MajnemerA , LimperopolousC , WalkerCD , et al. Routine sucrose analgesia during the first week of life in neonates younger than 31 weeks' postconceptional age. Pediatrics2002;110(3):523-8. [DOI: 10.1542/peds.110.3.523] [PMID: 12205254]">Johnston 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103 infants:</p> <p> <ul id="CD014806-list-0124"> <li> <p>sucrose group: mean PMA 28.18 weeks (1.72 weeks); and</p> </li> <li> <p>water group: mean PMA 28.05 weeks (2.06 weeks).</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Every time the infant was to undergo an invasive (e.g. heel lance, intravenous cannulation, arterial puncture, injection) or noninvasive but presumably uncomfortable procedure (e.g. endotracheal tube suctioning, tape or<br/>lead removal, gavage insertion for feeding), the infant received sucrose or water. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0125"> <li> <p>Sucrose group (n = 51): 0.1 mL 24% sucrose in sterile refrigerated syringe</p> </li> <li> <p>Water group (n = 52): 0.1 mL water in sterile refrigerated syringe</p> </li> </ul> </p> <p>The solution was in a syringe and administered into the infant’s mouth at the beginning of the procedure, 2 min into the procedure and another 2 min into the procedure. If the procedure was &gt; 15 min, up to another 3 doses (0.1 mL each) were to be given 2 min apart. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neurobehavioural development was assessed by the subscales of alertness and orientation and motor development and vigour of the NAPI, SNAP and NBRS. </p> <p>SNAP was measured for each 24‐hour period during the study week, and NBRS was measured at 2 weeks’ PNA and at discharge. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Beta, CI (multiple regression)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>On the basis of analysis of covariance with PMA at birth and the number of invasive procedures as covariates, there were no group differences (between sucrose and water) for any of the secondary outcomes of NBRS at 2 weeks' PNA (P = 0.426) or at discharge (P = 0.965). In the sucrose group only, a higher number of sucrose doses predicted lower scores on motor development and vigour and on alertness and orientation at 36 weeks' PNA, lower motor development and vigour at 40 weeks' PNA, and higher NBRS at 2 weeks' PNA. A higher number of invasive procedures was predictive of higher NBRS both times in the water group. </p> <p>No differences were found between the sucrose and water groups for NAPI.</p> <p>Data could not be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Fonds de la Recherche en</p> <p>Sante du Quebec (961297‐104), the IWK Foundation, and Health</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0050" title="TaddioA , ShahV , HancockR , SmithRW , StephensD , AtenafuE , et al. Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures. Canadian Medical Association Journal2008;179(1):37-43. [DOI: 10.1503/cmaj.071734] [PMID: 18591525]">Taddio 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>240 newborn infants born to nondiabetic and diabetic mothers, PMA ≥ 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 heel lances, venipuncture and IM vitamin K injection; multiple painful stimuli</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0126"> <li> <p>2 mL 24% sucrose given to infants of nondiabetic mothers (n = 60)</p> </li> <li> <p>2 mL 24% sucrose given to infants of diabetic mothers (n = 60)</p> </li> <li> <p>2 mL sterile water given to infants of nondiabetic mothers (n = 60)</p> </li> <li> <p>2 mL sterile water given to infants of diabetic mothers (n = 60)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PIPP scores overall, during IM injection, during venipuncture and during all 3 heel lances </p> <p>Safety</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD, 95% CI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall PIPP scores were lower among newborns given sucrose (mean 6.8, SD 2.9) compared to water (mean 8.1, SD 2.5) (MD −1.3, 95% CI −2.0 to −0.6; P &lt; 0.001). </p> <p>PIPP scores during IM injection did not differ between the sucrose and water group for nondiabetic (P = 0.10) or diabetic mothers (P = 0.15). </p> <p>PIPP scores during venipuncture were lower among infants of nondiabetic mothers who received sucrose compared to water (mean score 5.7, 95% CI 4.7 to 6.7 vs mean score 8.9, 95% CI 7.9 to 9.9; P &lt; 0.001). Similar results were found amongst infants of diabetic mothers (sucrose: mean score 6.8, 95% CI 5.7 to 7.9 vs water: mean score 9.2, 95% CI 8.4 to 10.1; P &lt; 0.001). </p> <p>During the first 3 heel lances, newborns from diabetic mothers receiving sucrose or water did not have different PIPP scores. </p> <p>Results for different painful stimuli were reported separately.</p> <p>Data could be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: CIHR grant (MCT 63143) and a Sick Kids Foundation</p> <p>graduate student Research Training Competition Award</p> <p>Competing interests: none declared</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval; CIHR: Canadian Institutes of Health Research; CNPq: National Council of Science and Technology Development; FAEPA: Foundation for Support of Teaching, Research and Assistance of the University Hospital of Clinics; FAPESP: Foundation for Support of Research in the State of São Paulo, Brazil; HR: heart rate; IM: intramuscular; MD: mean difference; NAPI: Neurobehavioral Assessment of the Preterm Infant; NBRS: Neuro‐Biological Risk Score; NFCS: Neonatal Facial Coding System; PIPP: Premature Infant Pain Profile; PMA: postmenstrual age; PNA: postnatal age; SD: standard deviation; SNAP: Score for Neonatal Acute Physiology </p> </div> </div> <p>If authors reported data in such a way that we could not include the results in RevMan analyses, we reported the findings according to the authors in tables (<a href="#CD014806-tbl-0010">Table 1</a>, <a href="#CD014806-tbl-0011">Table 2</a>, <a href="#CD014806-tbl-0012">Table 3</a>). The results of 32 studies could not be included in RevMan analyses (<a href="./references#CD014806-bbs2-0002" title="Altun-KöroğluO , ÖzekE , BilgenH , CebeciD . Hindmilk for procedural pain in term neonates. Turkish Journal of Pediatrics2010;52(6):623-9. [PMID: 21428195]">Altun‐Köroğlu 2010</a>; <a href="./references#CD014806-bbs2-0004" title="BenoitB , NewmanA , Martin-MisenerR , LatimerM , Campbell-YeoM . The influence of breastfeeding on cortical and bio-behavioural indicators of procedural pain in newborns: findings of a randomized controlled trial. Early Human Development2021;154:105308. [DOI: 10.1016/j.earlhumdev.2021.105308] [PMID: 33513546]">Benoit 2021</a>; <a href="./references#CD014806-bbs2-0005" title="BlassEM . Milk-induced hypoalgesia in human newborns. Pediatrics1997;99(6):825-9. [DOI: 10.1542/peds.99.6.825] [PMID: 9164777]">Blass 1997</a>; <a href="./references#CD014806-bbs2-0006" title="BlassEM , WattLB . Suckling- and sucrose-induced analgesia in human newborns. Pain1999;83(3):611-23. [DOI: 10.1016/s0304-3959(99)00166-9] [PMID: 10568870]">Blass 1999</a>; <a href="./references#CD014806-bbs2-0007" title="BucherHU , MoserT , vonSiebenthalK , KeelM , WolfM , DucG . Sucrose reduces pain reaction to heel lancing in preterm infants: a placebo-controlled, randomized and masked study. Pediatric Research1995;38(3):332-5. [DOI: 10.1203/00006450-199509000-00010] [PMID: 7494655]">Bucher 1995</a>; <a href="./references#CD014806-bbs2-0008" title="Campbell-YeoM , JohnstonCC , BenoitB , DisherT , CaddellK , VincerM , et al. Sustained efficacy of kangaroo care for repeated painful procedures over neonatal intensive care unit hospitalization: a single-blind randomized controlled trial. Pain2019;160(11):2580-8. [DOI: 10.1097/j.pain.0000000000001646] [PMID: 31356452]">Campbell‐Yeo 2019</a>; <a href="./references#CD014806-bbs2-0011" title="CodipietroL , CeccarelliM , PonzoneA . Breastfeeding or oral sucrose solution in term neonates receiving heel lance: a randomized controlled trial. Pediatrics2008;122(3):e716-21. [DOI: 10.1542/peds.2008-0221] [PMID: 18762508]">Codipietro 2008</a>; <a href="./references#CD014806-bbs2-0013" title="GaspardoCM , MiyaseCI , ChimelloJT , MartinezFE , Martins LinharesMB . Is pain relief equally efficacious and free of side effects with repeated doses of oral sucrose in preterm neonates?Pain2008;137(1):16-25. [DOI: 10.1016/j.pain.2007.07.032] [PMID: 17854995]">Gaspardo 2008</a>; <a href="./references#CD014806-bbs2-0015" title="GormallyS , BarrRG , WertheimL , AlkawafR , CalinoiuN , YoungSN . Contact and nutrient caregiving effects on newborn infant pain responses. Developmental Medicine and Child Neurology2001;43(1):28-38. [DOI: 10.1017/s0012162201000056] [PMID: 11201419]">Gormally 2001</a>; <a href="./references#CD014806-bbs2-0021" title="JohnstonCC , StremlerRL , StevensBJ , HortonLJ . Effectiveness of oral sucrose and simulated rocking on pain response in preterm neonates. Pain1997;72(1-2):193-9. [DOI: 10.1016/s0304-3959(97)00033-x] [PMID: 9272803]">Johnston 1997</a>; <a href="./references#CD014806-bbs2-0023" title="BoyerK , JohnstonC , WalkerCD , FilionF , SherrardA . Does sucrose analgesia promote physiological stability in preterm neonates?Biology of the Neonate2004;85(1):26-31. [DOI: 10.1159/000074954] [PMID: 14631163]JohnstonCC , FilionF , SniderL , MajnemerA , LimperopolousC , WalkerCD , et al. Routine sucrose analgesia during the first week of life in neonates younger than 31 weeks' postconceptional age. Pediatrics2002;110(3):523-8. [DOI: 10.1542/peds.110.3.523] [PMID: 12205254]">Johnston 2002</a>; <a href="./references#CD014806-bbs2-0025" title="LagoP , CavicchioloME , MionT , Dal CengioV , AllegroA , DaverioM , et al. Repeating a dose of sucrose for heel prick procedure in preterms is not effective in reducing pain: a randomised controlled trial. European Journal of Pediatrics2020;179(2):293-301. [DOI: 10.1007/s00431-019-03509-2] [PMID: 31728675]">Lago 2020</a>; <a href="./references#CD014806-bbs2-0026" title="LengHY , ZhengXL , YanL , ZhangXH , HeHY , XiangM . [Effects of different types and concentration of oral sweet solution on reducing neonatal pain during heel lance procedures]. Zhonghua Er Ke Za Zhi. Chinese Journal of Pediatrics2013;51(9):654-8. [PMID: 24330983]">Leng 2013</a>; <a href="./references#CD014806-bbs2-0027" title="LengHY , ZhengXL , ZhangXH , HeHY , TuGF , FuQ . Combined non-pharmacological interventions for newborn pain relief in two degrees of pain procedures: a randomized clinical trial. European Journal of Pain2016;20(6):989-97. [DOI: 10.1002/ejp.824] [PMID: 26685099]">Leng 2015</a>; <a href="./references#CD014806-bbs2-0028" title="LiawJJ , YangL , LeeCM , FanHC , ChangYC , ChengLP . Effects of combined use of non-nutritive sucking, oral sucrose, and facilitated tucking on infant behavioural states across heel-stick procedures: a prospective, randomised controlled trial. International Journal of Nursing Studies2013;50(7):883-94. [DOI: 10.1016/j.ijnurstu.2012.08.021] [PMID: 23068310]YinT , YangL , LeeTY , LiCC , HuaYM , LiawJJ . Development of atraumatic heel-stick procedures by combined treatment with non-nutritive sucking, oral sucrose, and facilitated tucking: a randomised, controlled trial. International Journal of Nursing Studies2015;52(8):1288-99. [DOI: 10.1016/j.ijnurstu.2015.04.012] [PMID: 25939641]">Liaw 2013</a>; <a href="./references#CD014806-bbs2-0029" title="Marin GabrielMA , delRey Hurtado de MendozaB , Jimenez FigueroaL , MedinaV , Iglesias FernandezB , Vazquez RodriguezM , et al. Analgesia with breastfeeding in addition to skin-to-skin contact during heel prick. Archives of Disease in Childhood. Fetal and neonatal edition2013;98(6):F499-503. [DOI: 10.1136/archdischild-2012-302921] [PMID: 23839984]">Marin Gabriel 2013</a>; <a href="./references#CD014806-bbs2-0031" title="McGinnisK , MurrayE , ChervenB , McCrackenC , TraversC . Effect of vibration on pain response to heel lance: a pilot randomized control trial. Advances in Neonatal Care2016;16(6):439-48. [DOI: 10.1097/ANC.0000000000000315] [PMID: 27533335]">McGinnis 2016</a>; <a href="./references#CD014806-bbs2-0032" title="MitchellAJ , HallRW , GolianuB , YatesC , WilliamsDK , ChangJ , et al. Does noninvasive electrical stimulation of acupuncture points reduce heelstick pain in neonates?Acta Paediatrica2016;105(12):1434-9. [DOI: 10.1111/apa.13581] [PMID: 27607517]">Mitchell 2016</a>; <a href="./references#CD014806-bbs2-0033" title="NimbalkarS , ShuklaVV , ChauhanV , PhatakA , PatelD , ChaplaA , et al. Blinded randomized crossover trial: skin-to-skin care vs. sucrose for preterm neonatal pain. Journal of Perinatology2020;40(6):896-901. [DOI: 10.1038/s41372-020-0638-9] [PMID: 32152488]">Nimbalkar 2020</a>; <a href="./references#CD014806-bbs2-0035" title="OkanF , CobanA , InceZ , YapiciZ , CanG . Analgesia in preterm newborns: the comparative effects of sucrose and glucose. European Journal of Pediatrics2007;166(10):1017-24. [DOI: 10.1007/s00431-006-0373-z] [PMID: 17203281]OzdoganT , AkmanI , CebeciD , BilgenH , OzekE . Comparison of two doses of breast milk and sucrose during neonatal heel prick. Pediatrics International2010;52(2):175-9. [DOI: 10.1111/j.1442-200X.2009.02921.x] [PMID: 19627552]">Okan 2007</a>; <a href="./references#CD014806-bbs2-0036" title="OrsR , OzekE , BaysoyG , CebeciD , BilgenH , TürkünerM , et al. Comparison of sucrose and human milk on pain response in newborns. European Journal of Pediatrics1999;158(1):63-6. [DOI: 10.1007/s004310051011] [PMID: 9950311]">Ors 1999</a>; <a href="./references#CD014806-bbs2-0037" title="OvergaardC , KnudesenA . Pain-relieving effect of sucrose in newborns during heel prick. Biology of the Neonate1999;75(5):279-84. [DOI: 10.1159/000014105] [PMID: 10095141]">Overgaard 1999</a>; <a href="./references#CD014806-bbs2-0039" title="RamenghiLA , WoodCM , GriffithGC , LeveneMI . Reduction of pain response in premature infants using intraoral sucrose. Archives of Disease in Childhood. Fetal and Neonatal Edition1996;74(2):F126-8. [DOI: 10.1136/fn.74.2.f126] [PMID: 8777660]">Ramenghi 1996b</a>; <a href="./references#CD014806-bbs2-0038" title="RamenghiLA , GriffithGC , WoodCM , LeveneMI . Effect of non-sucrose sweet tasting solution on neonatal heel prick responses. Archives of Disease in Childhood. Fetal and Neonatal Edition1996;74(2):F129-31. [DOI: 10.1136/fn.74.2.f129] [PMID: 8777661]">Ramenghi 1996a</a>; <a href="./references#CD014806-bbs2-0040" title='RamenghiLA , EvansDJ , LeveneMI . "Sucrose analgesia": absorptive mechanism or taste perception?Archives of Disease in Childhood. Fetal and Neonatal Edition1999;80(2):F146-7. [DOI: 10.1136/fn.80.2.f146] [PMID: 10325795]'>Ramenghi 1999</a>; <a href="./references#CD014806-bbs2-0041" title="RushforthJA , LeveneMI . Effect of sucrose on crying in response to heel stab. Archives of Disease in Childhood1993;69(3):388-9. [DOI: 10.1136/adc.69.3.388] [PMID: 8215552]">Rushforth 1993</a>; <a href="./references#CD014806-bbs2-0047" title="StevensB , YamadaJ , BeyeneJ , GibbinsS , PetryshenP , StinsonJ , et al. Consistent management of repeated procedural pain with sucrose in preterm neonates: is it effective and safe for repeated use over time?Clinical Journal of Pain2005;21(6):543-8. [DOI: 10.1097/01.ajp.0000149802.46864.e2] [PMID: 16215340]">Stevens 2005a</a>; <a href="./references#CD014806-bbs2-0048" title="StevensB , YamadaJ , Campbell-YeoM , GibbinsS , HarrisonD , DionneK , et al. The minimally effective dose of sucrose for procedural pain relief in neonates: a randomized controlled trial. BMC Pediatrics2018;18(1):85. [DOI: 10.1186/s12887-018-1026-x] [DOI: 10.1186/s12887-018-1026-x] [PMID: 29475433]">Stevens 2018</a>; <a href="./references#CD014806-bbs2-0049" title="StormH , FremmingA . Food intake and oral sucrose in preterms prior to heel prick. Acta Paediatrica2002;91(5):555-60. [DOI: 10.1080/080352502753711687] [PMID: 12113325]">Storm 2002</a>; <a href="./references#CD014806-bbs2-0051" title="ThakkarP , AroraK , GoyalK , DasRR , JavadekarB , AiyerS , et al. To evaluate and compare the efficacy of combined sucrose and non-nutritive sucking for analgesia in newborns undergoing minor painful procedure: a randomized controlled trial. Journal of Perinatology2016;36(1):67-70. [DOI: 10.1038/jp.2015.122] [PMID: 26583940]">Thakkar 2016</a>; <a href="./references#CD014806-bbs2-0054" title="VelumulaPK , ElbakoushF , Tabb C 2nd, FarooqiA , Lulic-BoticaM , JaniS , et al. Breast milk vs 24% sucrose for procedural pain relief in preterm neonates: a non-inferiority randomized controlled trial. Journal of Perinatology2022;42(7):914-9. [DOI: 10.1038/s41372-022-01352-2] [PMID: 35197549]">Velumula 2020</a>; <a href="./references#CD014806-bbs2-0055" title="YilmazF , ArikanD . The effects of various interventions to newborns on pain and duration of crying. Journal of Clinical Nursing2010;20(7-8):1008-17. [DOI: 10.1111/j.1365-2702.2010.03356.x] [PMID: 21054600]">Yilmaz 2010</a>). The results of those studies are summarised after the analyses for each comparison. </p> <p>No studies assessing long‐term neurodevelopmental outcomes were identified.</p> <p>The studies were conducted in 16 different countries; Canada (11), US (9), Turkey (7), UK (6), India (4), Italy (3) China (3). Two studies were conducted in Australia, Spain, and Switzerland, and one study was conducted in Brazil, Denmark, Japan, Netherlands, Norway, and Taiwan. </p> <section id="CD014806-sec-0045"> <h5 class="title">Painful procedures</h5> <p>Heel lance was exclusively studied in 50 trials (<a href="./references#CD014806-bbs2-0001" title="AbbasogluA , CabiogluMT , TugcuAU , YapakciE , TekindalMA , TarcanA . Laser acupuncture before heel lancing for pain management in healthy term newborns: a randomised controlled trial. Acupuncture in Medicine2015;33(6):445-50. [DOI: 10.1136/acupmed-2015-010765] [PMID: 26438556]">Abbasoglu 2015</a>; <a href="./references#CD014806-bbs2-0002" title="Altun-KöroğluO , ÖzekE , BilgenH , CebeciD . Hindmilk for procedural pain in term neonates. Turkish Journal of Pediatrics2010;52(6):623-9. [PMID: 21428195]">Altun‐Köroğlu 2010</a>; <a href="./references#CD014806-bbs2-0003" title="AsmeromY , SlaterL , BoskovicDS , BahjriK , HoldenMS , PhillipsR , et al. Oral sucrose for heel lance increases adenosine triphosphate use and oxidative stress in preterm neonates. Journal of Pediatrics2013;163(1):29-35.e1. [DOI: 10.1016/j.jpeds.2012.12.088] [PMID: 23415615]">Asmerom 2013</a>; <a href="./references#CD014806-bbs2-0004" title="BenoitB , NewmanA , Martin-MisenerR , LatimerM , Campbell-YeoM . The influence of breastfeeding on cortical and bio-behavioural indicators of procedural pain in newborns: findings of a randomized controlled trial. Early Human Development2021;154:105308. [DOI: 10.1016/j.earlhumdev.2021.105308] [PMID: 33513546]">Benoit 2021</a>; <a href="./references#CD014806-bbs2-0005" title="BlassEM . Milk-induced hypoalgesia in human newborns. Pediatrics1997;99(6):825-9. [DOI: 10.1542/peds.99.6.825] [PMID: 9164777]">Blass 1997</a>; <a href="./references#CD014806-bbs2-0006" title="BlassEM , WattLB . Suckling- and sucrose-induced analgesia in human newborns. Pain1999;83(3):611-23. [DOI: 10.1016/s0304-3959(99)00166-9] [PMID: 10568870]">Blass 1999</a>; <a href="./references#CD014806-bbs2-0007" title="BucherHU , MoserT , vonSiebenthalK , KeelM , WolfM , DucG . Sucrose reduces pain reaction to heel lancing in preterm infants: a placebo-controlled, randomized and masked study. Pediatric Research1995;38(3):332-5. [DOI: 10.1203/00006450-199509000-00010] [PMID: 7494655]">Bucher 1995</a>; <a href="./references#CD014806-bbs2-0009" title="ChangJ , FiloteoL , NasrAS . Comparing the analgesic effects of 4 nonpharmacologic interventions on term newborns undergoing heel lance: a randomized controlled trial. Journal of Perinatal &amp; Neonatal Nursing2020;34(4):338-45. [DOI: 10.1097/JPN.0000000000000495] [PMID: 32804876]">Chang 2020</a>; <a href="./references#CD014806-bbs2-0010" title='CignaccoEL , SellamG , StoffelL , GerullR , NelleM , AnandKJ , et al. Oral sucrose and "facilitated tucking" for repeated pain relief in preterms: a randomized controlled trial. Pediatrics2012;129(2):299-308. [DOI: 10.1542/peds.2011-1879] [PMID: 22232305]GerullR , CignaccoE , StoffelL , SellamG , NelleM . Physiological parameters after nonpharmacological analgesia in preterm infants: a randomized trial. Acta Paediatrica2013;102(8):e368-73. [DOI: 10.1111/apa.12288] [PMID: 23651076]'>Cignacco 2012</a>; <a href="./references#CD014806-bbs2-0011" title="CodipietroL , CeccarelliM , PonzoneA . Breastfeeding or oral sucrose solution in term neonates receiving heel lance: a randomized controlled trial. Pediatrics2008;122(3):e716-21. [DOI: 10.1542/peds.2008-0221] [PMID: 18762508]">Codipietro 2008</a>; <a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a>; <a href="./references#CD014806-bbs2-0014" title="GibbinsS , StevensB , HodnettE , PinelliJ , OhlssonA , DarlingtonG . Efficacy and safety of sucrose for procedural pain relief in preterm and term neonates. Nursing Research2002;51(6):375-82. [DOI: 10.1097/00006199-200211000-00005] [PMID: 12464757]GibbinsS , StevensB . The influence of gestational age on the efficacy and short-term safety of sucrose for procedural pain relief. Advances in Neonatal Care2003;3(5):241-9. [PMID: 14648521]GibbinsS . Efficacy and Safety of Sucrose for Procedural Pain Relief in Preterm and Term Neonates [PhD Thesis]. Toronto: University of Toronto, 2001. ">Gibbins 2002</a>; <a href="./references#CD014806-bbs2-0015" title="GormallyS , BarrRG , WertheimL , AlkawafR , CalinoiuN , YoungSN . Contact and nutrient caregiving effects on newborn infant pain responses. Developmental Medicine and Child Neurology2001;43(1):28-38. [DOI: 10.1017/s0012162201000056] [PMID: 11201419]">Gormally 2001</a>; <a href="./references#CD014806-bbs2-0016" title="GreenbergCS . A sugar-coated pacifier reduces procedural pain in newborns. Pediatric Nursing2002;28(3):271-7. [PMID: 12087649]">Greenberg 2002</a>; <a href="./references#CD014806-bbs2-0017" title="GualaA , PastoreG , LiveraniME , GirolettiG , GulinoF , MeriggiAI , et al. Glucose or sucrose as an analgesic for newborns: a randomised controlled blind trial. Minerva Pediatrica2001;53(4):271-4. [PMID: 11573063]">Guala 2001</a>; <a href="./references#CD014806-bbs2-0018" title="HaouariN , WoodC , GriffithsG , LeveneM . The analgesic effect of sucrose in full term infants: a randomised controlled trial. BMJ1995;310(6993):1498-500. [DOI: 10.1136/bmj.310.6993.1498] [PMID: 7787595]">Haouari 1995</a>; <a href="./references#CD014806-bbs2-0019" title="HarrisonD , JohnstonL , LoughnanP . Oral sucrose for procedural pain in sick hospitalized infants: a randomized-controlled trial. Journal of Paediatric and Child Health2003;39(8):591-7. [DOI: 10.1046/j.1440-1754.2003.00242.x] [PMID: 14629524]">Harrison 2003</a>; <a href="./references#CD014806-bbs2-0020" title="IsikU , OzekE , BilgenH , CebeciD . Comparison of oral glucose and sucrose solutions on pain response in neonates. Journal of Pain2000;1(4):275-8. [DOI: 10.1054/jpai.2000.8919] [PMID: 14622610]">Isik 2000a</a>; <a href="./references#CD014806-bbs2-0021" title="JohnstonCC , StremlerRL , StevensBJ , HortonLJ . Effectiveness of oral sucrose and simulated rocking on pain response in preterm neonates. Pain1997;72(1-2):193-9. [DOI: 10.1016/s0304-3959(97)00033-x] [PMID: 9272803]">Johnston 1997</a>; <a href="./references#CD014806-bbs2-0022" title="JohnstonCC , StremlerR , HortonL , FriedmanA . Effect of repeated doses of sucrose during heel stick procedure in preterm neonates. Biology of the Neonate1999;75(3):160-6. [DOI: 10.1159/000014092] [PMID: 9925903]">Johnston 1999</a>; <a href="./references#CD014806-bbs2-0024" title="KumariS , DattaV , RehanH . Comparison of the efficacy of oral 25% glucose with oral 24% sucrose for pain relief during heel lance in preterm neonates: a double blind randomized controlled trial. Journal of Tropical Pediatrics2017;63(1):30-5. [DOI: 10.1093/tropej/fmw045] [PMID: 27435886]">Kumari 2017</a>; <a href="./references#CD014806-bbs2-0025" title="LagoP , CavicchioloME , MionT , Dal CengioV , AllegroA , DaverioM , et al. Repeating a dose of sucrose for heel prick procedure in preterms is not effective in reducing pain: a randomised controlled trial. European Journal of Pediatrics2020;179(2):293-301. [DOI: 10.1007/s00431-019-03509-2] [PMID: 31728675]">Lago 2020</a>; <a href="./references#CD014806-bbs2-0026" title="LengHY , ZhengXL , YanL , ZhangXH , HeHY , XiangM . [Effects of different types and concentration of oral sweet solution on reducing neonatal pain during heel lance procedures]. Zhonghua Er Ke Za Zhi. Chinese Journal of Pediatrics2013;51(9):654-8. [PMID: 24330983]">Leng 2013</a>; <a href="./references#CD014806-bbs2-0027" title="LengHY , ZhengXL , ZhangXH , HeHY , TuGF , FuQ . Combined non-pharmacological interventions for newborn pain relief in two degrees of pain procedures: a randomized clinical trial. European Journal of Pain2016;20(6):989-97. [DOI: 10.1002/ejp.824] [PMID: 26685099]">Leng 2015</a>; <a href="./references#CD014806-bbs2-0028" title="LiawJJ , YangL , LeeCM , FanHC , ChangYC , ChengLP . Effects of combined use of non-nutritive sucking, oral sucrose, and facilitated tucking on infant behavioural states across heel-stick procedures: a prospective, randomised controlled trial. International Journal of Nursing Studies2013;50(7):883-94. [DOI: 10.1016/j.ijnurstu.2012.08.021] [PMID: 23068310]YinT , YangL , LeeTY , LiCC , HuaYM , LiawJJ . Development of atraumatic heel-stick procedures by combined treatment with non-nutritive sucking, oral sucrose, and facilitated tucking: a randomised, controlled trial. International Journal of Nursing Studies2015;52(8):1288-99. [DOI: 10.1016/j.ijnurstu.2015.04.012] [PMID: 25939641]">Liaw 2013</a>; <a href="./references#CD014806-bbs2-0029" title="Marin GabrielMA , delRey Hurtado de MendozaB , Jimenez FigueroaL , MedinaV , Iglesias FernandezB , Vazquez RodriguezM , et al. Analgesia with breastfeeding in addition to skin-to-skin contact during heel prick. Archives of Disease in Childhood. Fetal and neonatal edition2013;98(6):F499-503. [DOI: 10.1136/archdischild-2012-302921] [PMID: 23839984]">Marin Gabriel 2013</a>; <a href="./references#CD014806-bbs2-0030" title="MathaiS , NatrajanN , RajalakshmiNR . A comparative study of non-pharmacological methods to reduce pain in neonates. Indian Pediatrics2006;43(12):1070-5. [PMID: 17202604]">Mathai 2006</a>; <a href="./references#CD014806-bbs2-0031" title="McGinnisK , MurrayE , ChervenB , McCrackenC , TraversC . Effect of vibration on pain response to heel lance: a pilot randomized control trial. Advances in Neonatal Care2016;16(6):439-48. [DOI: 10.1097/ANC.0000000000000315] [PMID: 27533335]">McGinnis 2016</a>; <a href="./references#CD014806-bbs2-0032" title="MitchellAJ , HallRW , GolianuB , YatesC , WilliamsDK , ChangJ , et al. Does noninvasive electrical stimulation of acupuncture points reduce heelstick pain in neonates?Acta Paediatrica2016;105(12):1434-9. [DOI: 10.1111/apa.13581] [PMID: 27607517]">Mitchell 2016</a>; <a href="./references#CD014806-bbs2-0033" title="NimbalkarS , ShuklaVV , ChauhanV , PhatakA , PatelD , ChaplaA , et al. Blinded randomized crossover trial: skin-to-skin care vs. sucrose for preterm neonatal pain. Journal of Perinatology2020;40(6):896-901. [DOI: 10.1038/s41372-020-0638-9] [PMID: 32152488]">Nimbalkar 2020</a>; <a href="./references#CD014806-bbs2-0035" title="OkanF , CobanA , InceZ , YapiciZ , CanG . Analgesia in preterm newborns: the comparative effects of sucrose and glucose. European Journal of Pediatrics2007;166(10):1017-24. [DOI: 10.1007/s00431-006-0373-z] [PMID: 17203281]OzdoganT , AkmanI , CebeciD , BilgenH , OzekE . Comparison of two doses of breast milk and sucrose during neonatal heel prick. Pediatrics International2010;52(2):175-9. [DOI: 10.1111/j.1442-200X.2009.02921.x] [PMID: 19627552]">Okan 2007</a>; <a href="./references#CD014806-bbs2-0037" title="OvergaardC , KnudesenA . Pain-relieving effect of sucrose in newborns during heel prick. Biology of the Neonate1999;75(5):279-84. [DOI: 10.1159/000014105] [PMID: 10095141]">Overgaard 1999</a>; <a href="./references#CD014806-bbs2-0039" title="RamenghiLA , WoodCM , GriffithGC , LeveneMI . Reduction of pain response in premature infants using intraoral sucrose. Archives of Disease in Childhood. Fetal and Neonatal Edition1996;74(2):F126-8. [DOI: 10.1136/fn.74.2.f126] [PMID: 8777660]">Ramenghi 1996b</a>; <a href="./references#CD014806-bbs2-0038" title="RamenghiLA , GriffithGC , WoodCM , LeveneMI . Effect of non-sucrose sweet tasting solution on neonatal heel prick responses. Archives of Disease in Childhood. Fetal and Neonatal Edition1996;74(2):F129-31. [DOI: 10.1136/fn.74.2.f129] [PMID: 8777661]">Ramenghi 1996a</a>; <a href="./references#CD014806-bbs2-0040" title='RamenghiLA , EvansDJ , LeveneMI . "Sucrose analgesia": absorptive mechanism or taste perception?Archives of Disease in Childhood. Fetal and Neonatal Edition1999;80(2):F146-7. [DOI: 10.1136/fn.80.2.f146] [PMID: 10325795]'>Ramenghi 1999</a>; <a href="./references#CD014806-bbs2-0041" title="RushforthJA , LeveneMI . Effect of sucrose on crying in response to heel stab. Archives of Disease in Childhood1993;69(3):388-9. [DOI: 10.1136/adc.69.3.388] [PMID: 8215552]">Rushforth 1993</a>; <a href="./references#CD014806-bbs2-0042" title="SenE , ManavG . Effect of kangaroo care and oral sucrose on pain in premature infants: a randomized controlled trial. Pain Management Nursing2020;21(6):556-64. [DOI: 10.1016/j.pmn.2020.05.003] [PMID: 32768272]">Sen 2020</a>; <a href="./references#CD014806-bbs2-0043" title="ShahSR , KadageS , SinnJ . Trial of music, sucrose, and combination therapy for pain relief during heel prick procedures in neonates. Journal of Pediatrics2017;190:153-8. [DOI: 10.1016/j.jpeds.2017.08.003] [PMID: 29144240]">Shah 2017</a>; <a href="./references#CD014806-bbs2-0044" title="SimonseE , MulderPG , vanBeekRH . Analgesic effect of breast milk versus sucrose for analgesia during heel lance in late preterm infants. Pediatrics2012;129(4):657-63. [DOI: 10.1542/peds.2011-2173] [PMID: 22392168]">Simonse 2012</a>; <a href="./references#CD014806-bbs2-0045" title="SlaterR , CornelissenL , FabriziL , PattenD , YoxenJ , WorleyA , et al. Oral sucrose as an analgesic drug for procedural pain in newborn infants: a randomised controlled trial. Lancet2010;376(9748):1225-32. [DOI: 10.1016/S0140-6736(10)61303-7] [PMID: 20817247]">Slater 2010</a>; <a href="./references#CD014806-bbs2-0046" title="JohnstonCC , SherrardA , StevensB , FranckL , StremlerR , JackA . Do cry features reflect pain intensity in preterm neonates?Biology of the Neonate1999;76(2):120-4. [DOI: 10.1159/000014150] [PMID: 10393997]StevensB , JohnstonC , FranckP , PetryshenP , JackA , FosterG . The efficacy of developmentally sensitive interventions and sucrose for relieving pain in very low birth weight infants. Nursing Research1999;48(1):35-43. [DOI: 10.1097/00006199-199901000-00006] [PMID: 10029400]">Stevens 1999</a>; <a href="./references#CD014806-bbs2-0047" title="StevensB , YamadaJ , BeyeneJ , GibbinsS , PetryshenP , StinsonJ , et al. Consistent management of repeated procedural pain with sucrose in preterm neonates: is it effective and safe for repeated use over time?Clinical Journal of Pain2005;21(6):543-8. [DOI: 10.1097/01.ajp.0000149802.46864.e2] [PMID: 16215340]">Stevens 2005a</a>; <a href="./references#CD014806-bbs2-0048" title="StevensB , YamadaJ , Campbell-YeoM , GibbinsS , HarrisonD , DionneK , et al. The minimally effective dose of sucrose for procedural pain relief in neonates: a randomized controlled trial. BMC Pediatrics2018;18(1):85. [DOI: 10.1186/s12887-018-1026-x] [DOI: 10.1186/s12887-018-1026-x] [PMID: 29475433]">Stevens 2018</a>; <a href="./references#CD014806-bbs2-0049" title="StormH , FremmingA . Food intake and oral sucrose in preterms prior to heel prick. Acta Paediatrica2002;91(5):555-60. [DOI: 10.1080/080352502753711687] [PMID: 12113325]">Storm 2002</a>; <a href="./references#CD014806-bbs2-0051" title="ThakkarP , AroraK , GoyalK , DasRR , JavadekarB , AiyerS , et al. To evaluate and compare the efficacy of combined sucrose and non-nutritive sucking for analgesia in newborns undergoing minor painful procedure: a randomized controlled trial. Journal of Perinatology2016;36(1):67-70. [DOI: 10.1038/jp.2015.122] [PMID: 26583940]">Thakkar 2016</a>; <a href="./references#CD014806-bbs2-0052" title="Tutag LehrV , CortezJ , GreverW , CepedaE , ThomasR , ArandaJV . Randomized placebo controlled trial of sucrose analgesia on neonatal skin blood flow and pain response during heel lance. Clinical Journal of Pain2015;31(5):451-8. [DOI: 10.1097/AJP.0000000000000126] [PMID: 24918475]">Tutag Lehr 2015</a>; <a href="./references#CD014806-bbs2-0053" title="Unceta-BarrenecheaA , Saitua IturriagaG , Sainz de Rozas AparicioI , Riveira FernándezD . Analgesia when taking heel lance blood in the newborn [Analgesia en la toma sanguínea de talónen los recién nacidos]. Anales de Pediatria (Barcelona)2008;69(6):544-7. [DOI: 10.1016/s1695-4033(08)75237-8] [PMID: 19128767]">Unceta‐Barranechea 2008</a>; <a href="./references#CD014806-bbs2-0054" title="VelumulaPK , ElbakoushF , Tabb C 2nd, FarooqiA , Lulic-BoticaM , JaniS , et al. Breast milk vs 24% sucrose for procedural pain relief in preterm neonates: a non-inferiority randomized controlled trial. Journal of Perinatology2022;42(7):914-9. [DOI: 10.1038/s41372-022-01352-2] [PMID: 35197549]">Velumula 2020</a>; <a href="./references#CD014806-bbs2-0055" title="YilmazF , ArikanD . The effects of various interventions to newborns on pain and duration of crying. Journal of Clinical Nursing2010;20(7-8):1008-17. [DOI: 10.1111/j.1365-2702.2010.03356.x] [PMID: 21054600]">Yilmaz 2010</a>; <a href="./references#CD014806-bbs2-0036" title="OrsR , OzekE , BaysoyG , CebeciD , BilgenH , TürkünerM , et al. Comparison of sucrose and human milk on pain response in newborns. European Journal of Pediatrics1999;158(1):63-6. [DOI: 10.1007/s004310051011] [PMID: 9950311]">Ors 1999</a>) (<a href="#CD014806-tbl-0010">Table 1</a>). One study assessed both heel lance and venipuncture (<a href="./references#CD014806-bbs2-0034" title="OgawaS , OgiharaT , FujiwaraE , ItoK , NakanoM , NakayamaS , et al. Venepuncture is preferable to heel lance for blood sampling in term neonates. Archives of Disease in Childhood. Fetal and Neonatal Edition2005;90(5):F432-6. [DOI: 10.1136/adc.2004.069328] [PMID: 15871991]">Ogawa 2005</a>) (<a href="#CD014806-tbl-0011">Table 2</a>). Three studies assessed multiple painful procedures (<a href="./references#CD014806-bbs2-0013" title="GaspardoCM , MiyaseCI , ChimelloJT , MartinezFE , Martins LinharesMB . Is pain relief equally efficacious and free of side effects with repeated doses of oral sucrose in preterm neonates?Pain2008;137(1):16-25. [DOI: 10.1016/j.pain.2007.07.032] [PMID: 17854995]">Gaspardo 2008</a>; <a href="./references#CD014806-bbs2-0023" title="BoyerK , JohnstonC , WalkerCD , FilionF , SherrardA . Does sucrose analgesia promote physiological stability in preterm neonates?Biology of the Neonate2004;85(1):26-31. [DOI: 10.1159/000074954] [PMID: 14631163]JohnstonCC , FilionF , SniderL , MajnemerA , LimperopolousC , WalkerCD , et al. Routine sucrose analgesia during the first week of life in neonates younger than 31 weeks' postconceptional age. Pediatrics2002;110(3):523-8. [DOI: 10.1542/peds.110.3.523] [PMID: 12205254]">Johnston 2002</a>; <a href="./references#CD014806-bbs2-0050" title="TaddioA , ShahV , HancockR , SmithRW , StephensD , AtenafuE , et al. Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures. Canadian Medical Association Journal2008;179(1):37-43. [DOI: 10.1503/cmaj.071734] [PMID: 18591525]">Taddio 2008</a>) (<a href="#CD014806-tbl-0012">Table 3</a>). One study provided the interventions for all painful procedures during the entire hospital stay of infants; however, outcomes were assessed during three medically indicated heel lances (<a href="./references#CD014806-bbs2-0008" title="Campbell-YeoM , JohnstonCC , BenoitB , DisherT , CaddellK , VincerM , et al. Sustained efficacy of kangaroo care for repeated painful procedures over neonatal intensive care unit hospitalization: a single-blind randomized controlled trial. Pain2019;160(11):2580-8. [DOI: 10.1097/j.pain.0000000000001646] [PMID: 31356452]">Campbell‐Yeo 2019</a>). </p> <p>Twenty‐two studies evaluated adverse effects.</p> </section> <section id="CD014806-sec-0046"> <h5 class="title">Ongoing studies</h5> <p>We identified four ongoing studies (three studies focusing on preterm infants and one focusing on term infants) in clinical trial registry platforms. (<a href="./references#CD014806-bbs2-0115" title="CTRI/2012/06/002730. Effectiveness of human breast milk, table sugar vs sterile water for pain relief in premature infants undergoing a heel prick procedure in nursery of Christian Medical College and Hospital, Vellor [Effectiveness of expressed human breast milk, 24% oral sucrose vs placebo (sterile water) for pain relief in preterm infants undergoing a heel prick procedure in the nursery of Christian Medical College and Hospital, Vellore]. ctri.nic.in/Clinicaltrials/pdf_generate.php?trialid=4739&amp;EncHid=&amp;modid=&amp;compid=%27,%274739det%27 (first received 15 June 2012). ">CTRI/2012/06/002730</a>; <a href="./references#CD014806-bbs2-0116" title="NCT01742520. Neurodevelopmental outcomes of preterm infants treated for pain management with repeated doses of sucrose 24% [Its an interventional study that will evaluate the effect of different doses of sucrose 24% on neurodevelopmental outcome of preterm infants]. clinicaltrials.gov/ct2/show/NCT01742520 (first received 5 December 2012). ">NCT01742520</a>; <a href="./references#CD014806-bbs2-0117" title="NCT01894659. Oral sucrose versus glucose for procedural pain in premature neonates. clinicaltrials.gov/ct2/show/NCT01894659 (first received 10 July 2013). ">NCT01894659</a>; <a href="./references#CD014806-bbs2-0118" title="NCT02109263. Prevention of the procedural pain in the newborn (ACTISUCROSE) [Breastfeeding versus saccharose for prevention of the procedural pain in the newborn]. clinicaltrials.gov/ct2/show/NCT02109263 (first received 9 April 2014). ">NCT02109263</a>); two studies will compare breast milk to sucrose; one study will compare sucrose to breastfeeding; and one study will compare sucrose to glucose (See <a href="./references#CD014806-sec-0174" title="">Characteristics of ongoing studies</a>). </p> </section> <section id="CD014806-sec-0047"> <h5 class="title">Studies awaiting classification</h5> <p>We listed two studies as awaiting classification as we have not been able to locate full‐text copies in libraries in either Canada or the USA (<a href="./references#CD014806-bbs2-0113" title="AldásY , CevallosJ , CoronadoX , LeónL , Estrell. Sucrose effective dose for analgesia in newborn infants undergoing painful procedures. Revista Ecuatoriana de Pediatría2007;8(2):5-13. ">Aldás 2007</a>; <a href="./references#CD014806-bbs2-0114" title="SinghM . The need for analgesia and sedation in newborn babies. Perinatology2001;3:240-2. ">Singh 2001</a>) (See <a href="./references#CD014806-sec-0173" title="">Characteristics of studies awaiting classification</a>). </p> </section> </section> <section id="CD014806-sec-0048"> <h4 class="title">Excluded studies</h4> <p>We excluded 57 studies after full‐text review. Reasons for exclusion are described for each study in the <a href="./references#CD014806-sec-0172" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD014806-sec-0049"> <h3 class="title">Risk of bias in included studies</h3> <p>The included studies enrolled between 15 (<a href="./references#CD014806-bbs2-0039" title="RamenghiLA , WoodCM , GriffithGC , LeveneMI . Reduction of pain response in premature infants using intraoral sucrose. Archives of Disease in Childhood. Fetal and Neonatal Edition1996;74(2):F126-8. [DOI: 10.1136/fn.74.2.f126] [PMID: 8777660]">Ramenghi 1996b</a>), and 671 infants (<a href="./references#CD014806-bbs2-0027" title="LengHY , ZhengXL , ZhangXH , HeHY , TuGF , FuQ . Combined non-pharmacological interventions for newborn pain relief in two degrees of pain procedures: a randomized clinical trial. European Journal of Pain2016;20(6):989-97. [DOI: 10.1002/ejp.824] [PMID: 26685099]">Leng 2015</a>). Thirty‐one (56.3%) enrolled more than 100 infants. The largest study enrolled 671 term infants, who were randomised into four groups (<a href="./references#CD014806-bbs2-0027" title="LengHY , ZhengXL , ZhangXH , HeHY , TuGF , FuQ . Combined non-pharmacological interventions for newborn pain relief in two degrees of pain procedures: a randomized clinical trial. European Journal of Pain2016;20(6):989-97. [DOI: 10.1002/ejp.824] [PMID: 26685099]">Leng 2015</a>); sucrose, sucrose + NNS, sucrose + swaddling, and sucrose + NNS + swaddling. The second‐largest study enrolled 560 infants (<a href="./references#CD014806-bbs2-0026" title="LengHY , ZhengXL , YanL , ZhangXH , HeHY , XiangM . [Effects of different types and concentration of oral sweet solution on reducing neonatal pain during heel lance procedures]. Zhonghua Er Ke Za Zhi. Chinese Journal of Pediatrics2013;51(9):654-8. [PMID: 24330983]">Leng 2013</a>), but we could not include data for sucrose versus sterile water for increase in heart rate and decrease in oxygen saturation at three minutes after heel lance in RevMan analyses, as they were reported as means and full ranges. </p> <p>Few researchers provided a definition of pain or how it was conceptualised in relation to the outcomes. There were differences in study methods. Heel lance was studied as the pain stimulus, however, little detail about this procedure (e.g. manual versus automated lance) was provided. Therefore, it is impossible to know if the painful stimuli were comparable in intensity, duration or frequency across studies. The length of infant observation following the heel lance was infrequently reported, and may have implications for the incidence of reported adverse effects. </p> <p>The delivery method of sucrose differed between studies (syringe, dropper, sucrose‐dipped pacifier), as did the concentrations of sucrose and the volume administered. Outcomes were reported inconsistently; as means with SDs, standard errors (SE) or 95% CIs, or medians with ranges and often in graphic form without reporting of numerical data. </p> <p>The risk of bias is reported in the Risk of bias graph (<a href="#CD014806-fig-0002">Figure 2</a>), and the Risk of bias summary (<a href="#CD014806-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD014806-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD014806-fig-0002" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> </div> <div class="figure" id="CD014806-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD014806-fig-0003" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <section id="CD014806-sec-0050"> <h4 class="title">Allocation</h4> <p>Thirty‐five studies (63.6%) reported an adequate random sequence generation (selection bias), however, in 20 studies (36.3%), it was unclear how the random sequence was generated. No study had a high risk of bias. </p> <p>In 24 studies (43.6%), allocation concealment (selection bias) was adequate. There was a high risk of bias for allocation concealment in 13 studies (23.6%), and an unclear risk of bias in 18 studies (32.7%). </p> </section> <section id="CD014806-sec-0051"> <h4 class="title">Blinding</h4> <p>There was a low risk of bias in the blinding of participants and personnel (performance and detection bias) in 25 studies (45.4%), and a high risk detected in 20 studies (36.3%). There was an unclear risk of bias in 10 studies (18.2%). </p> <p>There was a low risk of bias in the blinding of outcome assessments (detection bias) in 34 studies (61.8%), high risk in 12 studies (21.8%), and an unclear risk in nine studies (16.3%). </p> </section> <section id="CD014806-sec-0052"> <h4 class="title">Incomplete outcome data</h4> <p>There was a low risk of attrition bias in 44 studies (80%), a high risk in four studies (7.3%), and an unclear risk in seven studies (12.7%). </p> </section> <section id="CD014806-sec-0053"> <h4 class="title">Selective reporting</h4> <p>Thirteen studies (23.6%) had a low risk of reporting bias. One study (1.8%) had a high risk of reporting bias and the risk of reporting bias was unclear for 41 studies (74.5%). </p> </section> <section id="CD014806-sec-0054"> <h4 class="title">Other potential sources of bias</h4> <p>The risk of bias was unclear in two studies (3.7%), and we did not detect other sources of bias in 53 studies (96.3%). </p> </section> </section> <section id="CD014806-sec-0055"> <h3 class="title" id="CD014806-sec-0055">Effects of interventions</h3> <p>See: <a href="./full#CD014806-tbl-0001"><b>Summary of findings 1</b> Summary of findings table ‐ Sucrose (any concentration, any dose, with or without NNS) compared to control (water, placebo, or no intervention) for analgesia for heel lancing in neonates</a>; <a href="./full#CD014806-tbl-0002"><b>Summary of findings 2</b> Summary of findings table ‐ Sucrose (any concentration, any dose) compared to NNS for analgesia for heel lancing in neonates</a>; <a href="./full#CD014806-tbl-0003"><b>Summary of findings 3</b> Summary of findings table ‐ Sucrose (any concentration, any dose) + NNS compared to NNS (with or without water) for analgesia for heel lancing in neonates</a>; <a href="./full#CD014806-tbl-0004"><b>Summary of findings 4</b> Summary of findings table ‐ Sucrose (any concentration, any dose) compared to glucose (any concentration, any dose) for heel lancing in neonates</a>; <a href="./full#CD014806-tbl-0005"><b>Summary of findings 5</b> Summary of findings table ‐ Sucrose (any concentration, any dose) compared to breastfeeding for analgesia for heel lancing in neonates</a>; <a href="./full#CD014806-tbl-0006"><b>Summary of findings 6</b> Summary of findings table ‐ Sucrose (any concentration, any dose) compared to expressed breast milk for analgesia for heel lancing in neonates</a>; <a href="./full#CD014806-tbl-0007"><b>Summary of findings 7</b> Summary of findings table ‐ Sucrose (any concentration, any dose) compared to laser acupuncture for analgesia for heel lancing in neonates</a>; <a href="./full#CD014806-tbl-0008"><b>Summary of findings 8</b> Summary of findings table ‐ Sucrose (any concentration, any dose) compared to facilitated tucking for analgesia during repeated heel lancing in neonates</a>; <a href="./full#CD014806-tbl-0009"><b>Summary of findings 9</b> Summary of findings table ‐ Sucrose (any concentration, any dose) compared to skin to skin care + water for analgesia during repeated heel lancing in neonates</a> </p> <section id="CD014806-sec-0056"> <h4 class="title">Comparison 1. Sucrose (any concentration, any dose, with or without NNS) compared to control (water, placebo, or no intervention) for analgesia for heel lancing in neonates </h4> <p><a href="./full#CD014806-tbl-0001">summary of findings Table 1</a> </p> <section id="CD014806-sec-0057"> <h5 class="title">Primary outcome</h5> <section id="CD014806-sec-0058"> <h6 class="title">PIPP scores at 30 seconds after heel lancing (term and preterm infants)</h6> <p>Seven studies reported this outcome for a total of 547 term and preterm infants (<a href="./references#CD014806-bbs2-0003" title="AsmeromY , SlaterL , BoskovicDS , BahjriK , HoldenMS , PhillipsR , et al. Oral sucrose for heel lance increases adenosine triphosphate use and oxidative stress in preterm neonates. Journal of Pediatrics2013;163(1):29-35.e1. [DOI: 10.1016/j.jpeds.2012.12.088] [PMID: 23415615]">Asmerom 2013</a>; <a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a>; <a href="./references#CD014806-bbs2-0014" title="GibbinsS , StevensB , HodnettE , PinelliJ , OhlssonA , DarlingtonG . Efficacy and safety of sucrose for procedural pain relief in preterm and term neonates. Nursing Research2002;51(6):375-82. [DOI: 10.1097/00006199-200211000-00005] [PMID: 12464757]GibbinsS , StevensB . The influence of gestational age on the efficacy and short-term safety of sucrose for procedural pain relief. Advances in Neonatal Care2003;3(5):241-9. [PMID: 14648521]GibbinsS . Efficacy and Safety of Sucrose for Procedural Pain Relief in Preterm and Term Neonates [PhD Thesis]. Toronto: University of Toronto, 2001. ">Gibbins 2002</a>; <a href="./references#CD014806-bbs2-0032" title="MitchellAJ , HallRW , GolianuB , YatesC , WilliamsDK , ChangJ , et al. Does noninvasive electrical stimulation of acupuncture points reduce heelstick pain in neonates?Acta Paediatrica2016;105(12):1434-9. [DOI: 10.1111/apa.13581] [PMID: 27607517]">Mitchell 2016</a>; <a href="./references#CD014806-bbs2-0045" title="SlaterR , CornelissenL , FabriziL , PattenD , YoxenJ , WorleyA , et al. Oral sucrose as an analgesic drug for procedural pain in newborn infants: a randomised controlled trial. Lancet2010;376(9748):1225-32. [DOI: 10.1016/S0140-6736(10)61303-7] [PMID: 20817247]">Slater 2010</a>; <a href="./references#CD014806-bbs2-0046" title="JohnstonCC , SherrardA , StevensB , FranckL , StremlerR , JackA . Do cry features reflect pain intensity in preterm neonates?Biology of the Neonate1999;76(2):120-4. [DOI: 10.1159/000014150] [PMID: 10393997]StevensB , JohnstonC , FranckP , PetryshenP , JackA , FosterG . The efficacy of developmentally sensitive interventions and sucrose for relieving pain in very low birth weight infants. Nursing Research1999;48(1):35-43. [DOI: 10.1097/00006199-199901000-00006] [PMID: 10029400]">Stevens 1999</a>; <a href="./references#CD014806-bbs2-0050" title="TaddioA , ShahV , HancockR , SmithRW , StephensD , AtenafuE , et al. Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures. Canadian Medical Association Journal2008;179(1):37-43. [DOI: 10.1503/cmaj.071734] [PMID: 18591525]">Taddio 2008</a>). The study with the smallest sample size reported on 42 preterm infants (<a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a>), and the largest study reported on 128 term and preterm infants (<a href="./references#CD014806-bbs2-0014" title="GibbinsS , StevensB , HodnettE , PinelliJ , OhlssonA , DarlingtonG . Efficacy and safety of sucrose for procedural pain relief in preterm and term neonates. Nursing Research2002;51(6):375-82. [DOI: 10.1097/00006199-200211000-00005] [PMID: 12464757]GibbinsS , StevensB . The influence of gestational age on the efficacy and short-term safety of sucrose for procedural pain relief. Advances in Neonatal Care2003;3(5):241-9. [PMID: 14648521]GibbinsS . Efficacy and Safety of Sucrose for Procedural Pain Relief in Preterm and Term Neonates [PhD Thesis]. Toronto: University of Toronto, 2001. ">Gibbins 2002</a>). The evidence suggests that sucrose (20‐30%, 0.1‐2 mL), with or without NNS, probably results in a reduction in PIPP scores compared to the control group at 30 seconds after lancing (MD ‐1.74 (95% CI ‐2.11 to ‐1.37); 7 studies, 547 infants; I<sup>2</sup> = 62%; moderate‐certainty evidence: <a href="./references#CD014806-fig-0004" title="">Analysis 1.1</a>; Figure 4). </p> <p>Three (<a href="./references#CD014806-bbs2-0032" title="MitchellAJ , HallRW , GolianuB , YatesC , WilliamsDK , ChangJ , et al. Does noninvasive electrical stimulation of acupuncture points reduce heelstick pain in neonates?Acta Paediatrica2016;105(12):1434-9. [DOI: 10.1111/apa.13581] [PMID: 27607517]">Mitchell 2016</a>; <a href="./references#CD014806-bbs2-0045" title="SlaterR , CornelissenL , FabriziL , PattenD , YoxenJ , WorleyA , et al. Oral sucrose as an analgesic drug for procedural pain in newborn infants: a randomised controlled trial. Lancet2010;376(9748):1225-32. [DOI: 10.1016/S0140-6736(10)61303-7] [PMID: 20817247]">Slater 2010</a>; <a href="./references#CD014806-bbs2-0050" title="TaddioA , ShahV , HancockR , SmithRW , StephensD , AtenafuE , et al. Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures. Canadian Medical Association Journal2008;179(1):37-43. [DOI: 10.1503/cmaj.071734] [PMID: 18591525]">Taddio 2008</a>) of the seven studies reported this outcome for a total of 277 term infants. The evidence suggests that sucrose results in little to no difference in PIPP scores compared to control at 30 seconds after heel lancing (MD ‐0.87 (95% CI ‐1.80 to 0.06); 3 studies, 277 infants; I<sup>2</sup> = 47%; low‐certainty evidence: <a href="./references#CD014806-fig-0005" title="">Analysis 1.2</a>; Figure 4). </p> <p>Three (<a href="./references#CD014806-bbs2-0003" title="AsmeromY , SlaterL , BoskovicDS , BahjriK , HoldenMS , PhillipsR , et al. Oral sucrose for heel lance increases adenosine triphosphate use and oxidative stress in preterm neonates. Journal of Pediatrics2013;163(1):29-35.e1. [DOI: 10.1016/j.jpeds.2012.12.088] [PMID: 23415615]">Asmerom 2013</a>; <a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a>; <a href="./references#CD014806-bbs2-0046" title="JohnstonCC , SherrardA , StevensB , FranckL , StremlerR , JackA . Do cry features reflect pain intensity in preterm neonates?Biology of the Neonate1999;76(2):120-4. [DOI: 10.1159/000014150] [PMID: 10393997]StevensB , JohnstonC , FranckP , PetryshenP , JackA , FosterG . The efficacy of developmentally sensitive interventions and sucrose for relieving pain in very low birth weight infants. Nursing Research1999;48(1):35-43. [DOI: 10.1097/00006199-199901000-00006] [PMID: 10029400]">Stevens 1999</a>) of the seven studies reported this outcome for a total of 192 preterm infants. The evidence suggests that sucrose results in little to no difference in PIPP scores compared to control at 30 seconds after heel lancing (MD ‐1.88 (95% CI ‐2.32 to ‐1.44); 3 studies, 192 infants; I<sup>2</sup> = 75%; low‐certainty evidence: <a href="./references#CD014806-fig-0006" title="">Analysis 1.3</a>; Figure 4). </p> </section> <section id="CD014806-sec-0059"> <h6 class="title">PIPP scores at 60 seconds after heel lancing (term and preterm infants)</h6> <p>Two studies reported this outcome for a total of 164 infants. One study reported this outcome for 119 term and preterm infants (<a href="./references#CD014806-bbs2-0014" title="GibbinsS , StevensB , HodnettE , PinelliJ , OhlssonA , DarlingtonG . Efficacy and safety of sucrose for procedural pain relief in preterm and term neonates. Nursing Research2002;51(6):375-82. [DOI: 10.1097/00006199-200211000-00005] [PMID: 12464757]GibbinsS , StevensB . The influence of gestational age on the efficacy and short-term safety of sucrose for procedural pain relief. Advances in Neonatal Care2003;3(5):241-9. [PMID: 14648521]GibbinsS . Efficacy and Safety of Sucrose for Procedural Pain Relief in Preterm and Term Neonates [PhD Thesis]. Toronto: University of Toronto, 2001. ">Gibbins 2002</a>). Another study reported on 45 preterm infants, who received either pacifier dipped in sucrose or pacifier dipped in water (<a href="./references#CD014806-bbs2-0046" title="JohnstonCC , SherrardA , StevensB , FranckL , StremlerR , JackA . Do cry features reflect pain intensity in preterm neonates?Biology of the Neonate1999;76(2):120-4. [DOI: 10.1159/000014150] [PMID: 10393997]StevensB , JohnstonC , FranckP , PetryshenP , JackA , FosterG . The efficacy of developmentally sensitive interventions and sucrose for relieving pain in very low birth weight infants. Nursing Research1999;48(1):35-43. [DOI: 10.1097/00006199-199901000-00006] [PMID: 10029400]">Stevens 1999</a>). The evidence suggests that sucrose probably results in a reduction in PIPP scores compared with water at 60 seconds after heel lancing (MD ‐2.14 (95% CI ‐3.34 to ‐0.94); 2 studies, 164 infants; I<sup>2</sup> = 0%; moderate‐certainty evidence: <a href="./references#CD014806-fig-0007" title="">Analysis 1.4</a>; Figure 4). </p> </section> <section id="CD014806-sec-0060"> <h6 class="title">DAN scores at 30 seconds after heel lancing (term infants)</h6> <p>One study reported this outcome for 32 term neonates (<a href="./references#CD014806-bbs2-0030" title="MathaiS , NatrajanN , RajalakshmiNR . A comparative study of non-pharmacological methods to reduce pain in neonates. Indian Pediatrics2006;43(12):1070-5. [PMID: 17202604]">Mathai 2006</a>). The evidence is very uncertain about the effects of 20% sucrose on DAN scores at 30 seconds after heel lancing compared to water (MD ‐1.90 (95% CI ‐8.58 to 4.78); 1 study, 32 infants; heterogeneity not applicable; very low‐certainty evidence; <a href="./references#CD014806-fig-0008" title="">Analysis 1.5</a>). </p> </section> <section id="CD014806-sec-0061"> <h6 class="title">NIPS scores immediately after heel lancing (term infants)</h6> <p>One study reported this outcome for 56 term infants (<a href="./references#CD014806-bbs2-0052" title="Tutag LehrV , CortezJ , GreverW , CepedaE , ThomasR , ArandaJV . Randomized placebo controlled trial of sucrose analgesia on neonatal skin blood flow and pain response during heel lance. Clinical Journal of Pain2015;31(5):451-8. [DOI: 10.1097/AJP.0000000000000126] [PMID: 24918475]">Tutag Lehr 2015</a>). The evidence suggests that sucrose (24%) probably results in a reduction in NIPS scores immediately after heel lancing compared to the water group (MD ‐2.00 (95% CI ‐2.42 to ‐1.58); 1 study, 56 infants; heterogeneity not applicable; moderate‐certainty evidence; <a href="./references#CD014806-fig-0009" title="">Analysis 1.6</a>). </p> </section> </section> <section id="CD014806-sec-0062"> <h5 class="title">Secondary outcomes</h5> <section id="CD014806-sec-0063"> <h6 class="title">Total crying time (in seconds) after lancing</h6> <p>Four studies reported this outcome for a total of 222 term infants (<a href="./references#CD014806-bbs2-0009" title="ChangJ , FiloteoL , NasrAS . Comparing the analgesic effects of 4 nonpharmacologic interventions on term newborns undergoing heel lance: a randomized controlled trial. Journal of Perinatal &amp; Neonatal Nursing2020;34(4):338-45. [DOI: 10.1097/JPN.0000000000000495] [PMID: 32804876]">Chang 2020</a>; <a href="./references#CD014806-bbs2-0016" title="GreenbergCS . A sugar-coated pacifier reduces procedural pain in newborns. Pediatric Nursing2002;28(3):271-7. [PMID: 12087649]">Greenberg 2002</a>; <a href="./references#CD014806-bbs2-0020" title="IsikU , OzekE , BilgenH , CebeciD . Comparison of oral glucose and sucrose solutions on pain response in neonates. Journal of Pain2000;1(4):275-8. [DOI: 10.1054/jpai.2000.8919] [PMID: 14622610]">Isik 2000a</a>; <a href="./references#CD014806-bbs2-0030" title="MathaiS , NatrajanN , RajalakshmiNR . A comparative study of non-pharmacological methods to reduce pain in neonates. Indian Pediatrics2006;43(12):1070-5. [PMID: 17202604]">Mathai 2006</a>). The evidence is very uncertain about the effect of sucrose on total crying time (in seconds) in the sucrose group (12‐30%, 0.33‐2 mL) compared to the control group after lancing (MD ‐30.74 (95% CI ‐40.73 to ‐20.74); 4 studies, 222 infants; I<sup>2</sup> = 96%; <a href="./references#CD014806-fig-0010" title="">Analysis 1.7</a>). </p> </section> <section id="CD014806-sec-0064"> <h6 class="title">Duration of first cry (in seconds) after lancing</h6> <p>Three studies (<a href="./references#CD014806-bbs2-0018" title="HaouariN , WoodC , GriffithsG , LeveneM . The analgesic effect of sucrose in full term infants: a randomised controlled trial. BMJ1995;310(6993):1498-500. [DOI: 10.1136/bmj.310.6993.1498] [PMID: 7787595]">Haouari 1995</a>; <a href="./references#CD014806-bbs2-0019" title="HarrisonD , JohnstonL , LoughnanP . Oral sucrose for procedural pain in sick hospitalized infants: a randomized-controlled trial. Journal of Paediatric and Child Health2003;39(8):591-7. [DOI: 10.1046/j.1440-1754.2003.00242.x] [PMID: 14629524]">Harrison 2003</a>; <a href="./references#CD014806-bbs2-0034" title="OgawaS , OgiharaT , FujiwaraE , ItoK , NakanoM , NakayamaS , et al. Venepuncture is preferable to heel lance for blood sampling in term neonates. Archives of Disease in Childhood. Fetal and Neonatal Edition2005;90(5):F432-6. [DOI: 10.1136/adc.2004.069328] [PMID: 15871991]">Ogawa 2005</a>) reported this outcome for 190 infants. The evidence suggests that sucrose may result in a reduction in the duration of the first cry (measured from the start of the vocalisation until a quiet interval of 5 seconds) after heel lancing compared to the control group (MD ‐53.18 (95% CI ‐76.90 to ‐39.46); 3 studies, 190 infants; I<sup>2</sup> = 69%; <a href="./references#CD014806-fig-0011" title="">Analysis 1.8</a>). One study (<a href="./references#CD014806-bbs2-0030" title="MathaiS , NatrajanN , RajalakshmiNR . A comparative study of non-pharmacological methods to reduce pain in neonates. Indian Pediatrics2006;43(12):1070-5. [PMID: 17202604]">Mathai 2006</a>) reported on 32 infants; the evidence is very uncertain about the effect of sucrose compared to the control group (MD ‐5.00 (95% CI ‐17.40 to ‐7.40); 1 study, 32 infants, heterogeneity not applicable) for the duration of first cry (measured from the start of the vocalisation until before first inspiration). </p> </section> <section id="CD014806-sec-0065"> <h6 class="title">Heart rate (bpm) during heel lancing</h6> <p>Two studies reporting this outcome with term infants were included (<a href="./references#CD014806-bbs2-0017" title="GualaA , PastoreG , LiveraniME , GirolettiG , GulinoF , MeriggiAI , et al. Glucose or sucrose as an analgesic for newborns: a randomised controlled blind trial. Minerva Pediatrica2001;53(4):271-4. [PMID: 11573063]">Guala 2001</a>;<a href="./references#CD014806-bbs2-0052" title="Tutag LehrV , CortezJ , GreverW , CepedaE , ThomasR , ArandaJV . Randomized placebo controlled trial of sucrose analgesia on neonatal skin blood flow and pain response during heel lance. Clinical Journal of Pain2015;31(5):451-8. [DOI: 10.1097/AJP.0000000000000126] [PMID: 24918475]">Tutag Lehr 2015</a>). For one study, data from four different groups were included in the analyses (<a href="./references#CD014806-bbs2-0017" title="GualaA , PastoreG , LiveraniME , GirolettiG , GulinoF , MeriggiAI , et al. Glucose or sucrose as an analgesic for newborns: a randomised controlled blind trial. Minerva Pediatrica2001;53(4):271-4. [PMID: 11573063]">Guala 2001</a>). The evidence suggests that sucrose results in little to no difference in heart rate during heel lance compared to control groups (MD 2.21 (95% CI ‐3.95 to 8.37); 2 studies, 136 infants; I<sup>2</sup> = 0; <a href="./references#CD014806-fig-0012" title="">Analysis 1.9</a>). </p> </section> <section id="CD014806-sec-0066"> <h6 class="title">Percentage change in heart rate after heel lancing</h6> <p>Two studies reported this outcome for 86 term infants (<a href="./references#CD014806-bbs2-0018" title="HaouariN , WoodC , GriffithsG , LeveneM . The analgesic effect of sucrose in full term infants: a randomised controlled trial. BMJ1995;310(6993):1498-500. [DOI: 10.1136/bmj.310.6993.1498] [PMID: 7787595]">Haouari 1995</a>; <a href="./references#CD014806-bbs2-0020" title="IsikU , OzekE , BilgenH , CebeciD . Comparison of oral glucose and sucrose solutions on pain response in neonates. Journal of Pain2000;1(4):275-8. [DOI: 10.1054/jpai.2000.8919] [PMID: 14622610]">Isik 2000a</a>). The evidence is very uncertain about the effect of sucrose on the percentage of change in heart rate one minute after heel lance compared with the control group (MD 0.90 (95% CI ‐5.81 to 7.61); 2 studies, 86 infants; I<sup>2</sup> = 86%; <a href="./references#CD014806-fig-0013" title="">Analysis 1.10</a>). </p> </section> <section id="CD014806-sec-0067"> <h6 class="title">Respiratory rate (rpm) during heel lancing</h6> <p>One study reported this outcome for 56 term infants (<a href="./references#CD014806-bbs2-0052" title="Tutag LehrV , CortezJ , GreverW , CepedaE , ThomasR , ArandaJV . Randomized placebo controlled trial of sucrose analgesia on neonatal skin blood flow and pain response during heel lance. Clinical Journal of Pain2015;31(5):451-8. [DOI: 10.1097/AJP.0000000000000126] [PMID: 24918475]">Tutag Lehr 2015</a>). The evidence suggests that sucrose results in little to no difference in the respiratory rate (breaths/minute) during heel lancing compared to the control group (MD ‐1.00 (95% CI ‐7.64 to 5.64); 1 study, 56 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0014" title="">Analysis 1.11</a>). </p> </section> <section id="CD014806-sec-0068"> <h6 class="title">Oxygen saturation (%) during heel lancing</h6> <p>One study reported this outcome for 56 term infants (<a href="./references#CD014806-bbs2-0052" title="Tutag LehrV , CortezJ , GreverW , CepedaE , ThomasR , ArandaJV . Randomized placebo controlled trial of sucrose analgesia on neonatal skin blood flow and pain response during heel lance. Clinical Journal of Pain2015;31(5):451-8. [DOI: 10.1097/AJP.0000000000000126] [PMID: 24918475]">Tutag Lehr 2015</a>). The evidence suggests that sucrose results in little to no difference in the oxygen saturation (%) during heel lancing compared to the control group (MD ‐5.00 (95% CI ‐12.79 to 2.79); 1 study, 56 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0015" title="">Analysis 1.12</a>). </p> </section> <section id="CD014806-sec-0069"> <h6 class="title">Skin blood flow (PU) during heel lancing</h6> <p>One study reported this outcome for 56 term infants (<a href="./references#CD014806-bbs2-0052" title="Tutag LehrV , CortezJ , GreverW , CepedaE , ThomasR , ArandaJV . Randomized placebo controlled trial of sucrose analgesia on neonatal skin blood flow and pain response during heel lance. Clinical Journal of Pain2015;31(5):451-8. [DOI: 10.1097/AJP.0000000000000126] [PMID: 24918475]">Tutag Lehr 2015</a>). The evidence suggests that sucrose results in little to no difference in skin blood flow (PU) during heel lance compared to the control group (MD ‐32.00 (95% CI ‐68.87 to 4.87); 1 study, 56 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0016" title="">Analysis 1.13</a>). </p> </section> <section id="CD014806-sec-0070"> <h6 class="title">Nociceptive‐specific brain activity</h6> <p>One study reported this outcome for 44 term infants (<a href="./references#CD014806-bbs2-0045" title="SlaterR , CornelissenL , FabriziL , PattenD , YoxenJ , WorleyA , et al. Oral sucrose as an analgesic drug for procedural pain in newborn infants: a randomised controlled trial. Lancet2010;376(9748):1225-32. [DOI: 10.1016/S0140-6736(10)61303-7] [PMID: 20817247]">Slater 2010</a>). The evidence suggests that sucrose results in little to no difference in the nociceptive‐specific brain activity (mean weight by EEG) compared to the water group (MD 0.02 (95% CI ‐0.05 to 0.09); 1 study, 44 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0017" title="">Analysis 1.14</a>). </p> </section> </section> </section> <section id="CD014806-sec-0071"> <h4 class="title">Comparison 2. Sucrose (any concentration, any dose) compared to NNS for analgesia for heel lancing in neonates </h4> <p><a href="./full#CD014806-tbl-0002">summary of findings Table 2</a> </p> <section id="CD014806-sec-0072"> <h5 class="title">Primary outcome</h5> <section id="CD014806-sec-0073"> <h6 class="title">PIPP scores during recovery after heel lancing (preterm infants)</h6> <p>One study reported this outcome for 43 preterm infants (<a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a>). The evidence is very uncertain about the effect of 20% sucrose compared to NNS on PIPP scores during the recovery period after heel lancing (MD 0.60 (95% CI ‐0.30 to 1.50); 1 study, 43 infants; heterogeneity not applicable; very low‐certainty evidence; <a href="./references#CD014806-fig-0018" title="">Analysis 2.1</a>). </p> </section> <section id="CD014806-sec-0074"> <h6 class="title">DAN scores at 30 seconds after heel lancing (term infants)</h6> <p>One study reported this outcome for 37 term infants (<a href="./references#CD014806-bbs2-0030" title="MathaiS , NatrajanN , RajalakshmiNR . A comparative study of non-pharmacological methods to reduce pain in neonates. Indian Pediatrics2006;43(12):1070-5. [PMID: 17202604]">Mathai 2006</a>). The evidence is very uncertain about the effect of 20% sucrose compared to NNS on DAN scores at 30 seconds after heel lancing (MD ‐1.20 (95% CI ‐7.87 to 5.47); 1 study, 37 infants; heterogeneity not applicable; very low‐certainty evidence; <a href="./references#CD014806-fig-0019" title="">Analysis 2.2</a>). </p> </section> </section> <section id="CD014806-sec-0075"> <h5 class="title">Secondary outcomes</h5> <section id="CD014806-sec-0076"> <h6 class="title">Percentage of crying time during heel lancing</h6> <p>One study reported this outcome for 43 preterm infants (<a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a>). The evidence is very uncertain about the effect of sucrose on the percentage of crying time during the heel lance compared to the NNS group (MD 9.60 (95% CI 1.41 to 17.79); 1 study, 43 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0020" title="">Analysis 2.3</a>). </p> </section> <section id="CD014806-sec-0077"> <h6 class="title">Total crying time (in seconds) after lancing</h6> <p>One study reported on 37 term infants (<a href="./references#CD014806-bbs2-0030" title="MathaiS , NatrajanN , RajalakshmiNR . A comparative study of non-pharmacological methods to reduce pain in neonates. Indian Pediatrics2006;43(12):1070-5. [PMID: 17202604]">Mathai 2006</a>). The evidence is very uncertain about the effect of sucrose on total crying time after lancing compared to the NNS group (MD 36.00 (95% CI 27.00 to 45.00); 1 study, 37 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0021" title="">Analysis 2.4</a>). </p> </section> <section id="CD014806-sec-0078"> <h6 class="title">Duration of first cry (in seconds) after lancing</h6> <p>One study reported this outcome for 37 term infants (<a href="./references#CD014806-bbs2-0030" title="MathaiS , NatrajanN , RajalakshmiNR . A comparative study of non-pharmacological methods to reduce pain in neonates. Indian Pediatrics2006;43(12):1070-5. [PMID: 17202604]">Mathai 2006</a>). The evidence is very uncertain about the effect of sucrose on the duration of first cry compared to the NNS group (MD ‐2.00 (95% CI ‐8.78 to 4.78); 1 study, 37 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0022" title="">Analysis 2.5</a>). </p> </section> <section id="CD014806-sec-0079"> <h6 class="title">Heart rate (bpm) during heel lancing</h6> <p>One study reported this outcome for 43 preterm infants (<a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a>). The evidence is very uncertain about the effect of sucrose on heart rate (beats/min) during the heel lance compared to the NNS group (MD ‐2.60 (95% CI ‐8.17 to 2.97); 1 study, 43 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0023" title="">Analysis 2.6</a>). </p> </section> <section id="CD014806-sec-0080"> <h6 class="title">Oxygen saturation (%) during heel lancing</h6> <p>One study reported this outcome for 43 preterm infants (<a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a>). The evidence is very uncertain about the effect of sucrose on oxygen saturation (%) during the heel lance compared to NNS group (MD 0.60 (95% CI ‐0.64 to 1.84); 1 study, 43 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0024" title="">Analysis 2.7</a>). </p> </section> </section> </section> <section id="CD014806-sec-0081"> <h4 class="title">Comparison 3. Sucrose (any concentration, any dose) + NNS compared to NNS (with or without water) for analgesia for heel lancing in neonates </h4> <p><a href="./full#CD014806-tbl-0003">summary of findings Table 3</a> </p> <section id="CD014806-sec-0082"> <h5 class="title">Primary outcome</h5> <section id="CD014806-sec-0083"> <h6 class="title">PIPP scores during heel lancing (preterm infants)</h6> <p>One study reported this outcome for 44 preterm infants (<a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a>). The evidence is very uncertain about the effect of 20% sucrose + NNS on PIPP scores during heel lance in infants compared to the NNS group (MD ‐4.90 (95% CI ‐5.73 to ‐4.07); 1 study, 44 infants; heterogeneity not applicable; very low‐certainty evidence; <a href="./references#CD014806-fig-0025" title="">Analysis 3.1</a>). </p> </section> <section id="CD014806-sec-0084"> <h6 class="title">PIPP scores during recovery after heel lancing (preterm infants)</h6> <p>One study reported this outcome for 44 preterm infants (<a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a>). The evidence is very uncertain about the effect of 20% sucrose + NNS on PIPP scores during recovery after heel lancing compared to the NNS group (MD ‐3.80 (95% CI ‐4.47 to ‐3.13); 1 study, 44 infants; heterogeneity not applicable; very low‐certainty evidence; <a href="./references#CD014806-fig-0026" title="">Analysis 3.2</a>). </p> </section> <section id="CD014806-sec-0085"> <h6 class="title">NFCS during heel lancing (term infants)</h6> <p>One study reported this outcome for 100 term infants (<a href="./references#CD014806-bbs2-0053" title="Unceta-BarrenecheaA , Saitua IturriagaG , Sainz de Rozas AparicioI , Riveira FernándezD . Analgesia when taking heel lance blood in the newborn [Analgesia en la toma sanguínea de talónen los recién nacidos]. Anales de Pediatria (Barcelona)2008;69(6):544-7. [DOI: 10.1016/s1695-4033(08)75237-8] [PMID: 19128767]">Unceta‐Barranechea 2008</a>). The evidence is very uncertain about the effects of 24% sucrose + NNS on NFCS scores during heel lancing compared to NNS + water (MD ‐0.60 (95% CI ‐1.47 to 0.27); 1 study, 100 infants; heterogeneity not applicable; very low‐certainty evidence; <a href="./references#CD014806-fig-0027" title="">Analysis 3.3</a>). </p> </section> </section> <section id="CD014806-sec-0086"> <h5 class="title">Secondary outcomes</h5> <section id="CD014806-sec-0087"> <h6 class="title">Crying time (%) during heel lancing</h6> <p>One study reported this outcome for 44 preterm infants (<a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a>). The evidence is very uncertain about the effect of sucrose + NNS lower crying time (%) during the heel lance compared to the NNS group (MD ‐32.70 (95% CI ‐38.37 to ‐27.03); 1 study, 44 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0028" title="">Analysis 3.4</a>). </p> </section> <section id="CD014806-sec-0088"> <h6 class="title">Percentage of crying time (in seconds) after heel lancing</h6> <p>One study reported this outcome for 100 term infants and compared sucrose + NNS with water + NNS (<a href="./references#CD014806-bbs2-0053" title="Unceta-BarrenecheaA , Saitua IturriagaG , Sainz de Rozas AparicioI , Riveira FernándezD . Analgesia when taking heel lance blood in the newborn [Analgesia en la toma sanguínea de talónen los recién nacidos]. Anales de Pediatria (Barcelona)2008;69(6):544-7. [DOI: 10.1016/s1695-4033(08)75237-8] [PMID: 19128767]">Unceta‐Barranechea 2008</a>). Another study reported on 42 term infants and compared a sucrose‐coated pacifier with a water‐moistened pacifier (<a href="./references#CD014806-bbs2-0016" title="GreenbergCS . A sugar-coated pacifier reduces procedural pain in newborns. Pediatric Nursing2002;28(3):271-7. [PMID: 12087649]">Greenberg 2002</a>). The evidence is very uncertain about the effect of sucrose + NNS on crying time (in seconds) compared to the water + NNS group (MD ‐1.41 s (95% CI ‐9.87 to 7.04); 2 studies, 142 infants; I<sup>2</sup> = 83%; <a href="./references#CD014806-fig-0029" title="">Analysis 3.5</a>). </p> </section> <section id="CD014806-sec-0089"> <h6 class="title">Heart rate (bpm) during heel lancing</h6> <p>One study reported this outcome for 44 preterm infants (<a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a>). The evidence is very uncertain about the effect of sucrose + NNS on heart rate (beats/min) during the heel lance compared to the NNS group (MD ‐15.60 (95% CI ‐20.60 to 18.27; 1 study, 44 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0030" title="">Analysis 3.6</a>). </p> </section> <section id="CD014806-sec-0090"> <h6 class="title">Oxygen saturation (%) during heel lancing</h6> <p>One study reported this outcome for 44 preterm infants (<a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a>). The evidence is very uncertain about the effect of sucrose + NNS on oxygen saturation (%) during the heel lance compared to the NNS group (MD 2.30 (95% CI 1.09 to 3.51); 1 study, 44 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0031" title="">Analysis 3.7</a>). </p> </section> </section> </section> <section id="CD014806-sec-0091"> <h4 class="title">Comparison 4. Sucrose (any concentration, any dose) compared to glucose (any concentration, any dose) for heel lancing in neonates </h4> <p><a href="./full#CD014806-tbl-0004">summary of findings Table 4</a> </p> <section id="CD014806-sec-0092"> <h5 class="title">Primary outcome</h5> <section id="CD014806-sec-0093"> <h6 class="title">PIPP scores at 30 seconds after heel lancing (preterm infants)</h6> <p>One study reported this outcome for 94 preterm infants (<a href="./references#CD014806-bbs2-0024" title="KumariS , DattaV , RehanH . Comparison of the efficacy of oral 25% glucose with oral 24% sucrose for pain relief during heel lance in preterm neonates: a double blind randomized controlled trial. Journal of Tropical Pediatrics2017;63(1):30-5. [DOI: 10.1093/tropej/fmw045] [PMID: 27435886]">Kumari 2017</a>). The evidence suggests that 24% sucrose results in little to no difference in PIPP scores 30 seconds after heel lancing compared to 25% glucose (MD 0.26 (95% CI ‐0.70 to 1.22); 1 study, 94 infants; heterogeneity not applicable; low‐certainty evidence; <a href="./references#CD014806-fig-0032" title="">Analysis 4.1</a>). </p> </section> <section id="CD014806-sec-0094"> <h6 class="title">PIPP scores at 60 seconds after heel lancing (preterm infants)</h6> <p>One study reported this outcome for 94 preterm infants (<a href="./references#CD014806-bbs2-0024" title="KumariS , DattaV , RehanH . Comparison of the efficacy of oral 25% glucose with oral 24% sucrose for pain relief during heel lance in preterm neonates: a double blind randomized controlled trial. Journal of Tropical Pediatrics2017;63(1):30-5. [DOI: 10.1093/tropej/fmw045] [PMID: 27435886]">Kumari 2017</a>). The evidence suggests that 24% sucrose results in little to no difference in PIPP scores 60 seconds after heel lancing compared to 25% glucose (MD ‐0.02 (95% CI ‐0.79 to 0.75); 1 study, 94 infants; heterogeneity not applicable; low‐certainty evidence; <a href="./references#CD014806-fig-0033" title="">Analysis 4.2</a>). </p> </section> </section> <section id="CD014806-sec-0095"> <h5 class="title">Secondary outcomes</h5> <section id="CD014806-sec-0096"> <h6 class="title">Heart rate (bpm) during heel lancing</h6> <p>One study reported this outcome for four different groups comparing sucrose 33%, sucrose 50%, glucose 33%, and glucose 50% (<a href="./references#CD014806-bbs2-0017" title="GualaA , PastoreG , LiveraniME , GirolettiG , GulinoF , MeriggiAI , et al. Glucose or sucrose as an analgesic for newborns: a randomised controlled blind trial. Minerva Pediatrica2001;53(4):271-4. [PMID: 11573063]">Guala 2001</a>). The evidence suggests glucose results in a slight reduction in the heart rate (beats/minute) during heel lance compared with the sucrose group (MD 10.51 (95% CI 1.12 to 19.89); 1 study, 80 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0034" title="">Analysis 4.3</a>). </p> </section> <section id="CD014806-sec-0097"> <h6 class="title">Percentage change in heart rate 60 seconds after heel lancing</h6> <p>One study reported this outcome for 56 term infants (<a href="./references#CD014806-bbs2-0020" title="IsikU , OzekE , BilgenH , CebeciD . Comparison of oral glucose and sucrose solutions on pain response in neonates. Journal of Pain2000;1(4):275-8. [DOI: 10.1054/jpai.2000.8919] [PMID: 14622610]">Isik 2000a</a>). The evidence is very uncertain about the effect of sucrose in the percentage change in heart rate one minute after heel lance compared to the glucose group (MD ‐6.58 (95% CI ‐14.85 to 1.69); 1 study, 56 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0035" title="">Analysis 4.4</a>). </p> </section> <section id="CD014806-sec-0098"> <h6 class="title">Total crying time (in seconds) after heel lancing</h6> <p>One study reported this outcome for 56 term infants (<a href="./references#CD014806-bbs2-0020" title="IsikU , OzekE , BilgenH , CebeciD . Comparison of oral glucose and sucrose solutions on pain response in neonates. Journal of Pain2000;1(4):275-8. [DOI: 10.1054/jpai.2000.8919] [PMID: 14622610]">Isik 2000a</a>). The evidence is very uncertain about the effect of sucrose in total crying time (in seconds) after heel lance compared to the glucose group (MD ‐34.89 (95% CI ‐61.67 to ‐8.11); 1 study, 56 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0036" title="">Analysis 4.5</a>). </p> </section> </section> </section> <section id="CD014806-sec-0099"> <h4 class="title">Comparison 5. Sucrose (any concentration, any dose) compared to breastfeeding for analgesia for heel lancing in neonates </h4> <p><a href="./full#CD014806-tbl-0005">summary of findings Table 5</a> </p> <section id="CD014806-sec-0100"> <h5 class="title">Primary outcome</h5> <section id="CD014806-sec-0101"> <h6 class="title">PIPP scores at 30 seconds after heel lancing (term and preterm infants)</h6> <p>Two studies reported this outcome for a total of 148 term and preterm infants (<a href="./references#CD014806-bbs2-0011" title="CodipietroL , CeccarelliM , PonzoneA . Breastfeeding or oral sucrose solution in term neonates receiving heel lance: a randomized controlled trial. Pediatrics2008;122(3):e716-21. [DOI: 10.1542/peds.2008-0221] [PMID: 18762508]">Codipietro 2008</a>; <a href="./references#CD014806-bbs2-0044" title="SimonseE , MulderPG , vanBeekRH . Analgesic effect of breast milk versus sucrose for analgesia during heel lance in late preterm infants. Pediatrics2012;129(4):657-63. [DOI: 10.1542/peds.2011-2173] [PMID: 22392168]">Simonse 2012</a>). The evidence is very uncertain about the effect of 24‐25% sucrose (1‐2 mL), with or without NNS, compared to breastfeeding, on PIPP scores at 30 seconds after heel lancing (MD ‐0.70 (95% CI ‐0.49 to 1.88); 2 studies, 148 infants; I<sup>2</sup> = 94 %; very low‐certainty evidence; <a href="./references#CD014806-fig-0037" title="">Analysis 5.1</a>; Figure 8). </p> </section> <section id="CD014806-sec-0102"> <h6 class="title">COMFORTneo scores after heel lancing (preterm infants)</h6> <p>One study reported this outcome for 47 preterm infants (<a href="./references#CD014806-bbs2-0044" title="SimonseE , MulderPG , vanBeekRH . Analgesic effect of breast milk versus sucrose for analgesia during heel lance in late preterm infants. Pediatrics2012;129(4):657-63. [DOI: 10.1542/peds.2011-2173] [PMID: 22392168]">Simonse 2012</a>). The evidence is very uncertain about the effect of 24% sucrose on COMFORTneo scores after heel lancing compared to breastfeeding (MD ‐2.60 (95% CI ‐3.06 to ‐2.14); 1 study, 47 infants; heterogeneity not applicable; very low‐certainty evidence; <a href="./references#CD014806-fig-0038" title="">Analysis 5.2</a>). </p> </section> </section> </section> <section id="CD014806-sec-0103"> <h4 class="title">Comparison 6. Sucrose (any concentration, any dose) compared to expressed breast milk for analgesia for heel lancing in neonates </h4> <p><a href="./full#CD014806-tbl-0006">summary of findings Table 6</a> </p> <section id="CD014806-sec-0104"> <h5 class="title">Primary outcome</h5> <section id="CD014806-sec-0105"> <h6 class="title">PIPP‐R scores during heel lancing (preterm infants)</h6> <p>One study reported this outcome for 88 preterm infants (<a href="./references#CD014806-bbs2-0054" title="VelumulaPK , ElbakoushF , Tabb C 2nd, FarooqiA , Lulic-BoticaM , JaniS , et al. Breast milk vs 24% sucrose for procedural pain relief in preterm neonates: a non-inferiority randomized controlled trial. Journal of Perinatology2022;42(7):914-9. [DOI: 10.1038/s41372-022-01352-2] [PMID: 35197549]">Velumula 2020</a>). The evidence suggests that 24% sucrose may result in little to no difference in PIPP‐R scores during heel lancing compared to expressed breast milk (MD 0.3 (95% CI ‐0.24 to 0.84); 1 study, 88 infants; heterogeneity not applicable; low‐certainty evidence; <a href="./references#CD014806-fig-0039" title="">Analysis 6.1</a>). </p> </section> <section id="CD014806-sec-0106"> <h6 class="title">PIPP‐R scores at 30 seconds after heel lancing (preterm infants)</h6> <p>One study reported this outcome for 94 preterm infants (<a href="./references#CD014806-bbs2-0054" title="VelumulaPK , ElbakoushF , Tabb C 2nd, FarooqiA , Lulic-BoticaM , JaniS , et al. Breast milk vs 24% sucrose for procedural pain relief in preterm neonates: a non-inferiority randomized controlled trial. Journal of Perinatology2022;42(7):914-9. [DOI: 10.1038/s41372-022-01352-2] [PMID: 35197549]">Velumula 2020</a>). The evidence suggests that 24% sucrose may result in little to no difference in PIPP‐R scores at 30 seconds after heel lancing compared to expressed breast milk (MD 0.30 (95% CI ‐0.11 to 0.71); 1 study, 88 infants; heterogeneity not applicable; low‐certainty evidence; <a href="./references#CD014806-fig-0040" title="">Analysis 6.2</a>). </p> </section> <section id="CD014806-sec-0107"> <h6 class="title">PIPP‐R scores at 60 seconds after heel lancing (preterm infants)</h6> <p>One study reported this outcome for 94 preterm infants (<a href="./references#CD014806-bbs2-0054" title="VelumulaPK , ElbakoushF , Tabb C 2nd, FarooqiA , Lulic-BoticaM , JaniS , et al. Breast milk vs 24% sucrose for procedural pain relief in preterm neonates: a non-inferiority randomized controlled trial. Journal of Perinatology2022;42(7):914-9. [DOI: 10.1038/s41372-022-01352-2] [PMID: 35197549]">Velumula 2020</a>). The evidence suggests that 24% sucrose probably may result in slightly increased PIPP‐R scores at 60 seconds after heel lancing compared to expressed breast milk (MD 1.10 (95% CI 0.34 to 1.86); 1 study, 88 infants; heterogeneity not applicable; low‐certainty evidence; <a href="./references#CD014806-fig-0041" title="">Analysis 6.3</a>). </p> </section> <section id="CD014806-sec-0108"> <h6 class="title">DAN scores at 30 seconds after heel lancing (term infants)</h6> <p>One study reported this outcome for 35 term infants (<a href="./references#CD014806-bbs2-0030" title="MathaiS , NatrajanN , RajalakshmiNR . A comparative study of non-pharmacological methods to reduce pain in neonates. Indian Pediatrics2006;43(12):1070-5. [PMID: 17202604]">Mathai 2006</a>). The evidence is very uncertain about the effect of 20% sucrose on DAN scores at 30 seconds after lancing compared to expressed breast milk (MD ‐1.80 (95% CI ‐8.47 to 4.87); 1 study, 35 infants; heterogeneity not applicable; very low‐certainty evidence; <a href="./references#CD014806-fig-0042" title="">Analysis 6.4</a>). </p> </section> </section> <section id="CD014806-sec-0109"> <h5 class="title">Secondary outcomes</h5> <section id="CD014806-sec-0110"> <h6 class="title">Total crying time (in seconds) after heel lancing</h6> <p>One study reported this outcome for 35 term infants (<a href="./references#CD014806-bbs2-0030" title="MathaiS , NatrajanN , RajalakshmiNR . A comparative study of non-pharmacological methods to reduce pain in neonates. Indian Pediatrics2006;43(12):1070-5. [PMID: 17202604]">Mathai 2006</a>). The evidence is very uncertain about the effect of sucrose on crying time after heel lancing compared to the human milk group in this study (MD ‐8.00 s (95% CI ‐21.07 to 5.07); 1 study, 35 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0043" title="">Analysis 6.5</a>). </p> </section> </section> </section> <section id="CD014806-sec-0111"> <h4 class="title">Comparison 7. Sucrose (any concentration, any dose) compared to recorded music for analgesia for heel lancing in neonates </h4> <section id="CD014806-sec-0112"> <h5 class="title">Primary outcome</h5> <section id="CD014806-sec-0113"> <h6 class="title">PIPP‐R scores at 1 minute after heel lancing (preterm infants)</h6> <p>One study reported this outcome for 75 preterm infants (<a href="./references#CD014806-bbs2-0043" title="ShahSR , KadageS , SinnJ . Trial of music, sucrose, and combination therapy for pain relief during heel prick procedures in neonates. Journal of Pediatrics2017;190:153-8. [DOI: 10.1016/j.jpeds.2017.08.003] [PMID: 29144240]">Shah 2017</a>). There was no difference in PIPP‐R scores between the 24% sucrose and music groups; however, the data were reported as median and interquartile range and were not included in the analysis. </p> </section> </section> <section id="CD014806-sec-0114"> <h5 class="title">Secondary outcomes</h5> <section id="CD014806-sec-0115"> <h6 class="title">Heart rate (bpm) during heel lancing</h6> <p>One study reported this outcome for 35 preterm and term infants (<a href="./references#CD014806-bbs2-0043" title="ShahSR , KadageS , SinnJ . Trial of music, sucrose, and combination therapy for pain relief during heel prick procedures in neonates. Journal of Pediatrics2017;190:153-8. [DOI: 10.1016/j.jpeds.2017.08.003] [PMID: 29144240]">Shah 2017</a>). The evidence is very uncertain about the effect of sucrose on heart rate (beats/min) during heel lancing compared to the recorded music group (MD 8.00 (95% CI ‐0.43 to 16.43); 1 study, 35 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0044" title="">Analysis 7.1</a>). </p> </section> <section id="CD014806-sec-0116"> <h6 class="title">Oxygen saturation (%) during heel lancing</h6> <p>One study reported this outcome for 35 preterm and term infants (<a href="./references#CD014806-bbs2-0043" title="ShahSR , KadageS , SinnJ . Trial of music, sucrose, and combination therapy for pain relief during heel prick procedures in neonates. Journal of Pediatrics2017;190:153-8. [DOI: 10.1016/j.jpeds.2017.08.003] [PMID: 29144240]">Shah 2017</a>). The evidence is very uncertain about the effect of sucrose on oxygen saturation (%) during heel lancing compared to the recorded music group (MD ‐0.20 (95% CI ‐1.36 to 0.96); 1 study, 35 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0045" title="">Analysis 7.2</a>). </p> </section> </section> </section> <section id="CD014806-sec-0117"> <h4 class="title">Comparison 8. Sucrose (any concentration, any dose) compared to laser acupuncture for analgesia for heel lancing in neonates </h4> <p><a href="./full#CD014806-tbl-0007">summary of findings Table 7</a> </p> <section id="CD014806-sec-0118"> <h5 class="title">Primary outcome</h5> <section id="CD014806-sec-0119"> <h6 class="title">NIPS scores during heel lancing (term infants)</h6> <p>One study reported this outcome for 42 term infants (<a href="./references#CD014806-bbs2-0001" title="AbbasogluA , CabiogluMT , TugcuAU , YapakciE , TekindalMA , TarcanA . Laser acupuncture before heel lancing for pain management in healthy term newborns: a randomised controlled trial. Acupuncture in Medicine2015;33(6):445-50. [DOI: 10.1136/acupmed-2015-010765] [PMID: 26438556]">Abbasoglu 2015</a>). The evidence is very uncertain about the effect of 24% sucrose compared to laser acupuncture on NIPS scores during heel lance (MD ‐0.86 (95% CI ‐1.43 to ‐0.29); 1 study, 42 infants; heterogeneity not applicable; very low‐certainty evidence; <a href="./references#CD014806-fig-0046" title="">Analysis 8.1</a>). </p> </section> </section> <section id="CD014806-sec-0120"> <h5 class="title">Secondary outcomes</h5> <section id="CD014806-sec-0121"> <h6 class="title">Total crying time (in seconds) after heel lancing</h6> <p>One study reported this outcome for 42 term infants (<a href="./references#CD014806-bbs2-0001" title="AbbasogluA , CabiogluMT , TugcuAU , YapakciE , TekindalMA , TarcanA . Laser acupuncture before heel lancing for pain management in healthy term newborns: a randomised controlled trial. Acupuncture in Medicine2015;33(6):445-50. [DOI: 10.1136/acupmed-2015-010765] [PMID: 26438556]">Abbasoglu 2015</a>). The evidence is very uncertain about the effect of sucrose on total crying time after heel lancing compared to the laser acupuncture group (MD ‐51.29 (95% CI ‐73.11 to ‐29.47); 1 study, 42 infants; heterogeneity not applicable; <a href="./references#CD014806-fig-0047" title="">Analysis 8.2</a>). </p> </section> </section> </section> <section id="CD014806-sec-0122"> <h4 class="title">Comparison 9. Sucrose (any concentration, any dose) compared to facilitated tucking for analgesia during repeated heel lancing in neonates </h4> <p><a href="./full#CD014806-tbl-0008">summary of findings Table 8</a> </p> <section id="CD014806-sec-0123"> <h5 class="title">Primary outcome</h5> <section id="CD014806-sec-0124"> <h6 class="title">BPSN scores during heel lancing (preterm infants)</h6> <p>One study reported this outcome for 48 preterm infants (<a href="./references#CD014806-bbs2-0010" title='CignaccoEL , SellamG , StoffelL , GerullR , NelleM , AnandKJ , et al. Oral sucrose and "facilitated tucking" for repeated pain relief in preterms: a randomized controlled trial. Pediatrics2012;129(2):299-308. [DOI: 10.1542/peds.2011-1879] [PMID: 22232305]GerullR , CignaccoE , StoffelL , SellamG , NelleM . Physiological parameters after nonpharmacological analgesia in preterm infants: a randomized trial. Acta Paediatrica2013;102(8):e368-73. [DOI: 10.1111/apa.12288] [PMID: 23651076]'>Cignacco 2012</a>). The evidence is very uncertain about the effect of 20% sucrose in total BPSN scores during heel lancing compared to facilitated tucking (MD ‐2.27 (95% CI ‐4.66 to 0.12); heterogeneity not applicable; 1 study, 48 infants; very low‐certainty evidence; <a href="./references#CD014806-fig-0048" title="">Analysis 9.1</a>). </p> </section> <section id="CD014806-sec-0125"> <h6 class="title">BPSN scores during recovery after heel lancing (preterm infants)</h6> <p>One study reported this outcome for 48 preterm infants (<a href="./references#CD014806-bbs2-0010" title='CignaccoEL , SellamG , StoffelL , GerullR , NelleM , AnandKJ , et al. Oral sucrose and "facilitated tucking" for repeated pain relief in preterms: a randomized controlled trial. Pediatrics2012;129(2):299-308. [DOI: 10.1542/peds.2011-1879] [PMID: 22232305]GerullR , CignaccoE , StoffelL , SellamG , NelleM . Physiological parameters after nonpharmacological analgesia in preterm infants: a randomized trial. Acta Paediatrica2013;102(8):e368-73. [DOI: 10.1111/apa.12288] [PMID: 23651076]'>Cignacco 2012</a>). The evidence is very uncertain about the effect of 20% sucrose in total BPSN scores during recovery after heel lancing compared to facilitated tucking (MD ‐0.31 (95% CI ‐1.72 to 1.10); 1 study, 48 infants; heterogeneity not applicable; very low‐certainty evidence; <a href="./references#CD014806-fig-0049" title="">Analysis 9.2</a>). </p> </section> </section> </section> <section id="CD014806-sec-0126"> <h4 class="title">Comparison 10. Sucrose (any concentration, any dose) compared to skin‐to‐skin care + water for analgesia during repeated heel lancing in neonates </h4> <p><a href="./full#CD014806-tbl-0009">summary of findings Table 9</a> </p> <section id="CD014806-sec-0127"> <h5 class="title">Primary outcome</h5> <section id="CD014806-sec-0128"> <h6 class="title">PIPP scores at 30 seconds after heel lancing (preterm infants)</h6> <p>One study compared this outcome on the effects of 24% sucrose compared to skin‐to‐skin care on PIPP scores after repeated heel lances (<a href="./references#CD014806-bbs2-0008" title="Campbell-YeoM , JohnstonCC , BenoitB , DisherT , CaddellK , VincerM , et al. Sustained efficacy of kangaroo care for repeated painful procedures over neonatal intensive care unit hospitalization: a single-blind randomized controlled trial. Pain2019;160(11):2580-8. [DOI: 10.1097/j.pain.0000000000001646] [PMID: 31356452]">Campbell‐Yeo 2019</a>). The evidence suggests that sucrose compared to skin‐to‐skin plus water results in little to no difference in PIPP scores at 30 seconds after heel lancing #1 (MD 0.13 (95% CI ‐0.70 to 0.96); 1 study, 151 infants; heterogeneity not applicable; low‐certainty evidence), heel lancing #2 (MD ‐0.56 (95% CI ‐1.57 to 0.45); 1 study, 144 infants; heterogeneity not applicable; low‐certainty evidence), or heel lancing #3 (MD‐0.15 (95% CI ‐1.26 to 0.96); 1 study, 111 infants; heterogeneity not applicable; low‐certainty evidence; <a href="./references#CD014806-fig-0050" title="">Analysis 10.1</a>). </p> </section> <section id="CD014806-sec-0129"> <h6 class="title">PIPP scores at 60 seconds after heel lancing (preterm infants)</h6> <p>One study compared this outcome on the effects of 24% sucrose compared to skin‐to‐skin care on PIPP scores after repeated heel lances (<a href="./references#CD014806-bbs2-0008" title="Campbell-YeoM , JohnstonCC , BenoitB , DisherT , CaddellK , VincerM , et al. Sustained efficacy of kangaroo care for repeated painful procedures over neonatal intensive care unit hospitalization: a single-blind randomized controlled trial. Pain2019;160(11):2580-8. [DOI: 10.1097/j.pain.0000000000001646] [PMID: 31356452]">Campbell‐Yeo 2019</a>). The evidence suggests that sucrose compared to skin‐to‐skin plus water results in little to no difference in PIPP scores at 60 seconds after heel lancing #1 (MD –0.61 (95% CI ‐1.55 to 0.33); 1 study, 154 infants; heterogeneity not applicable; low‐certainty evidence), heel lancing #2 (MD ‐0.12 (95% CI ‐0.99 to 0.75); 1 study, 143 infants; heterogeneity not applicable; low‐certainty evidence), or heel lancing #3 (MD‐0.40 (95% CI ‐1.48 to 0.68); 1 study, 111 infants; heterogeneity not applicable; low‐certainty evidence); <a href="./references#CD014806-fig-0051" title="">Analysis 10.2</a>). </p> <p>Data from 30 studies could not be included in analyses in RevMan (<a href="./references#CD014806-bbs2-0002" title="Altun-KöroğluO , ÖzekE , BilgenH , CebeciD . Hindmilk for procedural pain in term neonates. Turkish Journal of Pediatrics2010;52(6):623-9. [PMID: 21428195]">Altun‐Köroğlu 2010</a>; <a href="./references#CD014806-bbs2-0004" title="BenoitB , NewmanA , Martin-MisenerR , LatimerM , Campbell-YeoM . The influence of breastfeeding on cortical and bio-behavioural indicators of procedural pain in newborns: findings of a randomized controlled trial. Early Human Development2021;154:105308. [DOI: 10.1016/j.earlhumdev.2021.105308] [PMID: 33513546]">Benoit 2021</a>; <a href="./references#CD014806-bbs2-0005" title="BlassEM . Milk-induced hypoalgesia in human newborns. Pediatrics1997;99(6):825-9. [DOI: 10.1542/peds.99.6.825] [PMID: 9164777]">Blass 1997</a>; <a href="./references#CD014806-bbs2-0006" title="BlassEM , WattLB . Suckling- and sucrose-induced analgesia in human newborns. Pain1999;83(3):611-23. [DOI: 10.1016/s0304-3959(99)00166-9] [PMID: 10568870]">Blass 1999</a>; <a href="./references#CD014806-bbs2-0007" title="BucherHU , MoserT , vonSiebenthalK , KeelM , WolfM , DucG . Sucrose reduces pain reaction to heel lancing in preterm infants: a placebo-controlled, randomized and masked study. Pediatric Research1995;38(3):332-5. [DOI: 10.1203/00006450-199509000-00010] [PMID: 7494655]">Bucher 1995</a>; <a href="./references#CD014806-bbs2-0013" title="GaspardoCM , MiyaseCI , ChimelloJT , MartinezFE , Martins LinharesMB . Is pain relief equally efficacious and free of side effects with repeated doses of oral sucrose in preterm neonates?Pain2008;137(1):16-25. [DOI: 10.1016/j.pain.2007.07.032] [PMID: 17854995]">Gaspardo 2008</a>; <a href="./references#CD014806-bbs2-0015" title="GormallyS , BarrRG , WertheimL , AlkawafR , CalinoiuN , YoungSN . Contact and nutrient caregiving effects on newborn infant pain responses. Developmental Medicine and Child Neurology2001;43(1):28-38. [DOI: 10.1017/s0012162201000056] [PMID: 11201419]">Gormally 2001</a>; <a href="./references#CD014806-bbs2-0021" title="JohnstonCC , StremlerRL , StevensBJ , HortonLJ . Effectiveness of oral sucrose and simulated rocking on pain response in preterm neonates. Pain1997;72(1-2):193-9. [DOI: 10.1016/s0304-3959(97)00033-x] [PMID: 9272803]">Johnston 1997</a>; <a href="./references#CD014806-bbs2-0022" title="JohnstonCC , StremlerR , HortonL , FriedmanA . Effect of repeated doses of sucrose during heel stick procedure in preterm neonates. Biology of the Neonate1999;75(3):160-6. [DOI: 10.1159/000014092] [PMID: 9925903]">Johnston 1999</a>; <a href="./references#CD014806-bbs2-0023" title="BoyerK , JohnstonC , WalkerCD , FilionF , SherrardA . Does sucrose analgesia promote physiological stability in preterm neonates?Biology of the Neonate2004;85(1):26-31. [DOI: 10.1159/000074954] [PMID: 14631163]JohnstonCC , FilionF , SniderL , MajnemerA , LimperopolousC , WalkerCD , et al. Routine sucrose analgesia during the first week of life in neonates younger than 31 weeks' postconceptional age. Pediatrics2002;110(3):523-8. [DOI: 10.1542/peds.110.3.523] [PMID: 12205254]">Johnston 2002</a>; <a href="./references#CD014806-bbs2-0025" title="LagoP , CavicchioloME , MionT , Dal CengioV , AllegroA , DaverioM , et al. Repeating a dose of sucrose for heel prick procedure in preterms is not effective in reducing pain: a randomised controlled trial. European Journal of Pediatrics2020;179(2):293-301. [DOI: 10.1007/s00431-019-03509-2] [PMID: 31728675]">Lago 2020</a>; <a href="./references#CD014806-bbs2-0026" title="LengHY , ZhengXL , YanL , ZhangXH , HeHY , XiangM . [Effects of different types and concentration of oral sweet solution on reducing neonatal pain during heel lance procedures]. Zhonghua Er Ke Za Zhi. Chinese Journal of Pediatrics2013;51(9):654-8. [PMID: 24330983]">Leng 2013</a>; <a href="./references#CD014806-bbs2-0027" title="LengHY , ZhengXL , ZhangXH , HeHY , TuGF , FuQ . Combined non-pharmacological interventions for newborn pain relief in two degrees of pain procedures: a randomized clinical trial. European Journal of Pain2016;20(6):989-97. [DOI: 10.1002/ejp.824] [PMID: 26685099]">Leng 2015</a>; <a href="./references#CD014806-bbs2-0028" title="LiawJJ , YangL , LeeCM , FanHC , ChangYC , ChengLP . Effects of combined use of non-nutritive sucking, oral sucrose, and facilitated tucking on infant behavioural states across heel-stick procedures: a prospective, randomised controlled trial. International Journal of Nursing Studies2013;50(7):883-94. [DOI: 10.1016/j.ijnurstu.2012.08.021] [PMID: 23068310]YinT , YangL , LeeTY , LiCC , HuaYM , LiawJJ . Development of atraumatic heel-stick procedures by combined treatment with non-nutritive sucking, oral sucrose, and facilitated tucking: a randomised, controlled trial. International Journal of Nursing Studies2015;52(8):1288-99. [DOI: 10.1016/j.ijnurstu.2015.04.012] [PMID: 25939641]">Liaw 2013</a>; <a href="./references#CD014806-bbs2-0029" title="Marin GabrielMA , delRey Hurtado de MendozaB , Jimenez FigueroaL , MedinaV , Iglesias FernandezB , Vazquez RodriguezM , et al. Analgesia with breastfeeding in addition to skin-to-skin contact during heel prick. Archives of Disease in Childhood. Fetal and neonatal edition2013;98(6):F499-503. [DOI: 10.1136/archdischild-2012-302921] [PMID: 23839984]">Marin Gabriel 2013</a>; <a href="./references#CD014806-bbs2-0031" title="McGinnisK , MurrayE , ChervenB , McCrackenC , TraversC . Effect of vibration on pain response to heel lance: a pilot randomized control trial. Advances in Neonatal Care2016;16(6):439-48. [DOI: 10.1097/ANC.0000000000000315] [PMID: 27533335]">McGinnis 2016</a>; <a href="./references#CD014806-bbs2-0033" title="NimbalkarS , ShuklaVV , ChauhanV , PhatakA , PatelD , ChaplaA , et al. Blinded randomized crossover trial: skin-to-skin care vs. sucrose for preterm neonatal pain. Journal of Perinatology2020;40(6):896-901. [DOI: 10.1038/s41372-020-0638-9] [PMID: 32152488]">Nimbalkar 2020</a>; <a href="./references#CD014806-bbs2-0035" title="OkanF , CobanA , InceZ , YapiciZ , CanG . Analgesia in preterm newborns: the comparative effects of sucrose and glucose. European Journal of Pediatrics2007;166(10):1017-24. [DOI: 10.1007/s00431-006-0373-z] [PMID: 17203281]OzdoganT , AkmanI , CebeciD , BilgenH , OzekE . Comparison of two doses of breast milk and sucrose during neonatal heel prick. Pediatrics International2010;52(2):175-9. [DOI: 10.1111/j.1442-200X.2009.02921.x] [PMID: 19627552]">Okan 2007</a>; <a href="./references#CD014806-bbs2-0036" title="OrsR , OzekE , BaysoyG , CebeciD , BilgenH , TürkünerM , et al. Comparison of sucrose and human milk on pain response in newborns. European Journal of Pediatrics1999;158(1):63-6. [DOI: 10.1007/s004310051011] [PMID: 9950311]">Ors 1999</a>; <a href="./references#CD014806-bbs2-0037" title="OvergaardC , KnudesenA . Pain-relieving effect of sucrose in newborns during heel prick. Biology of the Neonate1999;75(5):279-84. [DOI: 10.1159/000014105] [PMID: 10095141]">Overgaard 1999</a>; <a href="./references#CD014806-bbs2-0039" title="RamenghiLA , WoodCM , GriffithGC , LeveneMI . Reduction of pain response in premature infants using intraoral sucrose. Archives of Disease in Childhood. Fetal and Neonatal Edition1996;74(2):F126-8. [DOI: 10.1136/fn.74.2.f126] [PMID: 8777660]">Ramenghi 1996b</a>; <a href="./references#CD014806-bbs2-0038" title="RamenghiLA , GriffithGC , WoodCM , LeveneMI . Effect of non-sucrose sweet tasting solution on neonatal heel prick responses. Archives of Disease in Childhood. Fetal and Neonatal Edition1996;74(2):F129-31. [DOI: 10.1136/fn.74.2.f129] [PMID: 8777661]">Ramenghi 1996a</a>; <a href="./references#CD014806-bbs2-0040" title='RamenghiLA , EvansDJ , LeveneMI . "Sucrose analgesia": absorptive mechanism or taste perception?Archives of Disease in Childhood. Fetal and Neonatal Edition1999;80(2):F146-7. [DOI: 10.1136/fn.80.2.f146] [PMID: 10325795]'>Ramenghi 1999</a>; <a href="./references#CD014806-bbs2-0041" title="RushforthJA , LeveneMI . Effect of sucrose on crying in response to heel stab. Archives of Disease in Childhood1993;69(3):388-9. [DOI: 10.1136/adc.69.3.388] [PMID: 8215552]">Rushforth 1993</a>; <a href="./references#CD014806-bbs2-0042" title="SenE , ManavG . Effect of kangaroo care and oral sucrose on pain in premature infants: a randomized controlled trial. Pain Management Nursing2020;21(6):556-64. [DOI: 10.1016/j.pmn.2020.05.003] [PMID: 32768272]">Sen 2020</a>; <a href="./references#CD014806-bbs2-0047" title="StevensB , YamadaJ , BeyeneJ , GibbinsS , PetryshenP , StinsonJ , et al. Consistent management of repeated procedural pain with sucrose in preterm neonates: is it effective and safe for repeated use over time?Clinical Journal of Pain2005;21(6):543-8. [DOI: 10.1097/01.ajp.0000149802.46864.e2] [PMID: 16215340]">Stevens 2005a</a>; <a href="./references#CD014806-bbs2-0048" title="StevensB , YamadaJ , Campbell-YeoM , GibbinsS , HarrisonD , DionneK , et al. The minimally effective dose of sucrose for procedural pain relief in neonates: a randomized controlled trial. BMC Pediatrics2018;18(1):85. [DOI: 10.1186/s12887-018-1026-x] [DOI: 10.1186/s12887-018-1026-x] [PMID: 29475433]">Stevens 2018</a>; <a href="./references#CD014806-bbs2-0049" title="StormH , FremmingA . Food intake and oral sucrose in preterms prior to heel prick. Acta Paediatrica2002;91(5):555-60. [DOI: 10.1080/080352502753711687] [PMID: 12113325]">Storm 2002</a>; <a href="./references#CD014806-bbs2-0051" title="ThakkarP , AroraK , GoyalK , DasRR , JavadekarB , AiyerS , et al. To evaluate and compare the efficacy of combined sucrose and non-nutritive sucking for analgesia in newborns undergoing minor painful procedure: a randomized controlled trial. Journal of Perinatology2016;36(1):67-70. [DOI: 10.1038/jp.2015.122] [PMID: 26583940]">Thakkar 2016</a>; <a href="./references#CD014806-bbs2-0055" title="YilmazF , ArikanD . The effects of various interventions to newborns on pain and duration of crying. Journal of Clinical Nursing2010;20(7-8):1008-17. [DOI: 10.1111/j.1365-2702.2010.03356.x] [PMID: 21054600]">Yilmaz 2010</a>); for details see <a href="#CD014806-tbl-0010">Table 1</a>, though a brief summary is provided below. </p> <p>In the <a href="./references#CD014806-bbs2-0002" title="Altun-KöroğluO , ÖzekE , BilgenH , CebeciD . Hindmilk for procedural pain in term neonates. Turkish Journal of Pediatrics2010;52(6):623-9. [PMID: 21428195]">Altun‐Köroğlu 2010</a> study, there were no differences observed between the hind milk group and the sucrose group for all measures. In a study comparing the influence of breastfeeding or oral sucrose on pain related electrophysiologic activity, pain scores, and physiologic recovery (<a href="./references#CD014806-bbs2-0004" title="BenoitB , NewmanA , Martin-MisenerR , LatimerM , Campbell-YeoM . The influence of breastfeeding on cortical and bio-behavioural indicators of procedural pain in newborns: findings of a randomized controlled trial. Early Human Development2021;154:105308. [DOI: 10.1016/j.earlhumdev.2021.105308] [PMID: 33513546]">Benoit 2021</a>), both interventions reduced bio‐behavioural responses to pain; however, the interventions may differentially modulate pain response in the infant brain. In <a href="./references#CD014806-bbs2-0005" title="BlassEM . Milk-induced hypoalgesia in human newborns. Pediatrics1997;99(6):825-9. [DOI: 10.1542/peds.99.6.825] [PMID: 9164777]">Blass 1997</a>, there was less crying time during blood collection in the sucrose group than in the water group and, in the later <a href="./references#CD014806-bbs2-0006" title="BlassEM , WattLB . Suckling- and sucrose-induced analgesia in human newborns. Pain1999;83(3):611-23. [DOI: 10.1016/s0304-3959(99)00166-9] [PMID: 10568870]">Blass 1999</a> study, sucrose diminished cry duration compared to water. In <a href="./references#CD014806-bbs2-0007" title="BucherHU , MoserT , vonSiebenthalK , KeelM , WolfM , DucG . Sucrose reduces pain reaction to heel lancing in preterm infants: a placebo-controlled, randomized and masked study. Pediatric Research1995;38(3):332-5. [DOI: 10.1203/00006450-199509000-00010] [PMID: 7494655]">Bucher 1995</a>, cry duration was reduced by sucrose compared to water. <a href="./references#CD014806-bbs2-0015" title="GormallyS , BarrRG , WertheimL , AlkawafR , CalinoiuN , YoungSN . Contact and nutrient caregiving effects on newborn infant pain responses. Developmental Medicine and Child Neurology2001;43(1):28-38. [DOI: 10.1017/s0012162201000056] [PMID: 11201419]">Gormally 2001</a> reported no difference in facial activity related to pain between infants who received sucrose and those who did not. <a href="./references#CD014806-bbs2-0021" title="JohnstonCC , StremlerRL , StevensBJ , HortonLJ . Effectiveness of oral sucrose and simulated rocking on pain response in preterm neonates. Pain1997;72(1-2):193-9. [DOI: 10.1016/s0304-3959(97)00033-x] [PMID: 9272803]">Johnston 1997</a> found a decrease in percentage facial action in the sucrose alone group and the sucrose plus rocking group compared to the water group. <a href="./references#CD014806-bbs2-0025" title="LagoP , CavicchioloME , MionT , Dal CengioV , AllegroA , DaverioM , et al. Repeating a dose of sucrose for heel prick procedure in preterms is not effective in reducing pain: a randomised controlled trial. European Journal of Pediatrics2020;179(2):293-301. [DOI: 10.1007/s00431-019-03509-2] [PMID: 31728675]">Lago 2020</a> investigated whether a repeated dose of 24% sucrose associated with NNS and facilitated tucking was more effective than a single dose of 24% (with volumes varying from 0.3 to 0.5 mL according to infant's weight). There were no differences in pain scores between the two groups. In the large study, <a href="./references#CD014806-bbs2-0026" title="LengHY , ZhengXL , YanL , ZhangXH , HeHY , XiangM . [Effects of different types and concentration of oral sweet solution on reducing neonatal pain during heel lance procedures]. Zhonghua Er Ke Za Zhi. Chinese Journal of Pediatrics2013;51(9):654-8. [PMID: 24330983]">Leng 2013</a>, the average pain score three minutes after the procedure was lower in the sucrose groups compared to the glucose groups. <a href="./references#CD014806-bbs2-0028" title="LiawJJ , YangL , LeeCM , FanHC , ChangYC , ChengLP . Effects of combined use of non-nutritive sucking, oral sucrose, and facilitated tucking on infant behavioural states across heel-stick procedures: a prospective, randomised controlled trial. International Journal of Nursing Studies2013;50(7):883-94. [DOI: 10.1016/j.ijnurstu.2012.08.021] [PMID: 23068310]YinT , YangL , LeeTY , LiCC , HuaYM , LiawJJ . Development of atraumatic heel-stick procedures by combined treatment with non-nutritive sucking, oral sucrose, and facilitated tucking: a randomised, controlled trial. International Journal of Nursing Studies2015;52(8):1288-99. [DOI: 10.1016/j.ijnurstu.2015.04.012] [PMID: 25939641]">Liaw 2013</a> found that infants receiving NNS + oral sucrose + tucking or NNS + oral sucrose experienced more quiet sleep occurrences than those receiving routine care. <a href="./references#CD014806-bbs2-0029" title="Marin GabrielMA , delRey Hurtado de MendozaB , Jimenez FigueroaL , MedinaV , Iglesias FernandezB , Vazquez RodriguezM , et al. Analgesia with breastfeeding in addition to skin-to-skin contact during heel prick. Archives of Disease in Childhood. Fetal and neonatal edition2013;98(6):F499-503. [DOI: 10.1136/archdischild-2012-302921] [PMID: 23839984]">Marin Gabriel 2013</a> reported lower percentage of crying with both the breastfed combined with skin‐to‐skin contact group and also the sucrose plus skin‐to‐skin contact group compared with the skin‐to‐skin contact group. <a href="./references#CD014806-bbs2-0031" title="McGinnisK , MurrayE , ChervenB , McCrackenC , TraversC . Effect of vibration on pain response to heel lance: a pilot randomized control trial. Advances in Neonatal Care2016;16(6):439-48. [DOI: 10.1097/ANC.0000000000000315] [PMID: 27533335]">McGinnis 2016</a> described lower NPASS scores over time measured at baseline, immediately after the heel lance, and two and five minutes after heel lance for the 24% sucrose (0.1 to 0.2 mL) + NNS + swaddling + vibration group compared to the 24% sucrose (0.1 to 0.2 mL) + NNS + swaddling group. The effects of 0.5 mL of 24% sucrose compared to skin‐to‐skin care on PIPP scores during heel lances in a cross‐over study by <a href="./references#CD014806-bbs2-0033" title="NimbalkarS , ShuklaVV , ChauhanV , PhatakA , PatelD , ChaplaA , et al. Blinded randomized crossover trial: skin-to-skin care vs. sucrose for preterm neonatal pain. Journal of Perinatology2020;40(6):896-901. [DOI: 10.1038/s41372-020-0638-9] [PMID: 32152488]">Nimbalkar 2020</a> indicated no differences between the groups. In <a href="./references#CD014806-bbs2-0035" title="OkanF , CobanA , InceZ , YapiciZ , CanG . Analgesia in preterm newborns: the comparative effects of sucrose and glucose. European Journal of Pediatrics2007;166(10):1017-24. [DOI: 10.1007/s00431-006-0373-z] [PMID: 17203281]OzdoganT , AkmanI , CebeciD , BilgenH , OzekE . Comparison of two doses of breast milk and sucrose during neonatal heel prick. Pediatrics International2010;52(2):175-9. [DOI: 10.1111/j.1442-200X.2009.02921.x] [PMID: 19627552]">Okan 2007</a>, the sucrose and glucose groups showed a shorter time for the duration of first cry and total crying time than the water group. <a href="./references#CD014806-bbs2-0036" title="OrsR , OzekE , BaysoyG , CebeciD , BilgenH , TürkünerM , et al. Comparison of sucrose and human milk on pain response in newborns. European Journal of Pediatrics1999;158(1):63-6. [DOI: 10.1007/s004310051011] [PMID: 9950311]">Ors 1999</a> noted a decrease in crying time for the sucrose group compared to the human milk or sterile water groups, and recovery time from crying was shorter in the sucrose group, as was the percentage change in heart rate after heel lance. In <a href="./references#CD014806-bbs2-0037" title="OvergaardC , KnudesenA . Pain-relieving effect of sucrose in newborns during heel prick. Biology of the Neonate1999;75(5):279-84. [DOI: 10.1159/000014105] [PMID: 10095141]">Overgaard 1999</a>, the NIPS scores one minute after heel lance and one minute after blood sampling were lower in the sucrose group than the water group. <a href="./references#CD014806-bbs2-0039" title="RamenghiLA , WoodCM , GriffithGC , LeveneMI . Reduction of pain response in premature infants using intraoral sucrose. Archives of Disease in Childhood. Fetal and Neonatal Edition1996;74(2):F126-8. [DOI: 10.1136/fn.74.2.f126] [PMID: 8777660]">Ramenghi 1996b</a> noted lower mean pain scores in the group receiving sucrose at one and two minutes after heel lance compared to the water group. In <a href="./references#CD014806-bbs2-0038" title="RamenghiLA , GriffithGC , WoodCM , LeveneMI . Effect of non-sucrose sweet tasting solution on neonatal heel prick responses. Archives of Disease in Childhood. Fetal and Neonatal Edition1996;74(2):F129-31. [DOI: 10.1136/fn.74.2.f129] [PMID: 8777661]">Ramenghi 1996a</a>, the pain scores were lower in the sucrose (25% and 50%) groups and the Calpol group compared to the water group. In the third study by <a href="./references#CD014806-bbs2-0040" title='RamenghiLA , EvansDJ , LeveneMI . "Sucrose analgesia": absorptive mechanism or taste perception?Archives of Disease in Childhood. Fetal and Neonatal Edition1999;80(2):F146-7. [DOI: 10.1136/fn.80.2.f146] [PMID: 10325795]'>Ramenghi 1999</a>, which was a cross‐over design (sucrose and water were given by nasogastric tube or intra‐orally, but the infant received either sucrose or water both times), reductions in behavioural scores were noted in the sucrose group compared with the water group. Infants in the 25% sucrose group displayed a reduction in behavioural score (P = 0.001) when sucrose was given intra‐orally compared to via a nasogastric tube. <a href="./references#CD014806-bbs2-0041" title="RushforthJA , LeveneMI . Effect of sucrose on crying in response to heel stab. Archives of Disease in Childhood1993;69(3):388-9. [DOI: 10.1136/adc.69.3.388] [PMID: 8215552]">Rushforth 1993</a> used a low concentration of sucrose (7.5%) and found no difference in median percentage crying time between the sucrose group and the group that received water. In <a href="./references#CD014806-bbs2-0047" title="StevensB , YamadaJ , BeyeneJ , GibbinsS , PetryshenP , StinsonJ , et al. Consistent management of repeated procedural pain with sucrose in preterm neonates: is it effective and safe for repeated use over time?Clinical Journal of Pain2005;21(6):543-8. [DOI: 10.1097/01.ajp.0000149802.46864.e2] [PMID: 16215340]">Stevens 2005a</a>, 66 preterm infants were randomised to (i) standard of care (positioning + swaddling), (ii) sterile water plus pacifier, or (iii) 24% sucrose plus pacifier two minutes prior to all painful procedures during the first 28 days of life. PIPP scores were recorded on day 7, 14, 21, and 28 following heel lance. There was a main effect of group (P = 0.03) with differences occurring between the sucrose plus pacifier group and standard care group at 60 s (P = 0.01). Mean PIPP scores were generally higher in the standard care group. In <a href="./references#CD014806-bbs2-0048" title="StevensB , YamadaJ , Campbell-YeoM , GibbinsS , HarrisonD , DionneK , et al. The minimally effective dose of sucrose for procedural pain relief in neonates: a randomized controlled trial. BMC Pediatrics2018;18(1):85. [DOI: 10.1186/s12887-018-1026-x] [DOI: 10.1186/s12887-018-1026-x] [PMID: 29475433]">Stevens 2018</a>, there was no difference between PIPP‐Revised (PIPP‐R) scores in infants randomised to receive 0.1 mL, 0.5 mL, and 1.0 mL of 24% sucrose. <a href="./references#CD014806-bbs2-0049" title="StormH , FremmingA . Food intake and oral sucrose in preterms prior to heel prick. Acta Paediatrica2002;91(5):555-60. [DOI: 10.1080/080352502753711687] [PMID: 12113325]">Storm 2002</a> reported less crying in infants in the groups that received sucrose (25%) or sucrose (25%) plus milk compared to the groups that received a lower concentration of sucrose (15%) or milk. <a href="./references#CD014806-bbs2-0051" title="ThakkarP , AroraK , GoyalK , DasRR , JavadekarB , AiyerS , et al. To evaluate and compare the efficacy of combined sucrose and non-nutritive sucking for analgesia in newborns undergoing minor painful procedure: a randomized controlled trial. Journal of Perinatology2016;36(1):67-70. [DOI: 10.1038/jp.2015.122] [PMID: 26583940]">Thakkar 2016</a> reported lower median PIPP scores in the sucrose combined with the NNS group compared to the sucrose only, NNS only, or no intervention groups. <a href="./references#CD014806-bbs2-0055" title="YilmazF , ArikanD . The effects of various interventions to newborns on pain and duration of crying. Journal of Clinical Nursing2010;20(7-8):1008-17. [DOI: 10.1111/j.1365-2702.2010.03356.x] [PMID: 21054600]">Yilmaz 2010</a> reported that the mean crying time in the sucrose group was lower than in the groups where the infant was sitting on the mother's lap, received mother's milk by syringe, or was given a pacifier. </p> </section> </section> </section> <section id="CD014806-sec-0130"> <h4 class="title">Effects of sucrose on long‐term neurodevelopmental outcomes</h4> <p>None of the included studies reported on long‐term neurodevelopmental outcomes (assessed by a standardised and validated assessment tool, a child developmental specialist, or both) at 18 to 24 months or at any later age in childhood. </p> </section> <section id="CD014806-sec-0131"> <h4 class="title">Adverse effects</h4> <p><a href="./references#CD014806-bbs2-0200" title="StevensB , YamadaJ , LeeGY , OhlssonA . Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database of Systematic Reviews2013, Issue 1. Art. No: CD001069. [DOI: 10.1002/14651858.CD001069.pub4]">Stevens 2013</a> reported seven studies that evaluated the adverse effects of sucrose compared to placebo (<a href="./references#CD014806-bbs2-0011" title="CodipietroL , CeccarelliM , PonzoneA . Breastfeeding or oral sucrose solution in term neonates receiving heel lance: a randomized controlled trial. Pediatrics2008;122(3):e716-21. [DOI: 10.1542/peds.2008-0221] [PMID: 18762508]">Codipietro 2008</a>; <a href="./references#CD014806-bbs2-0014" title="GibbinsS , StevensB , HodnettE , PinelliJ , OhlssonA , DarlingtonG . Efficacy and safety of sucrose for procedural pain relief in preterm and term neonates. Nursing Research2002;51(6):375-82. [DOI: 10.1097/00006199-200211000-00005] [PMID: 12464757]GibbinsS , StevensB . The influence of gestational age on the efficacy and short-term safety of sucrose for procedural pain relief. Advances in Neonatal Care2003;3(5):241-9. [PMID: 14648521]GibbinsS . Efficacy and Safety of Sucrose for Procedural Pain Relief in Preterm and Term Neonates [PhD Thesis]. Toronto: University of Toronto, 2001. ">Gibbins 2002</a>; <a href="./references#CD014806-bbs2-0017" title="GualaA , PastoreG , LiveraniME , GirolettiG , GulinoF , MeriggiAI , et al. Glucose or sucrose as an analgesic for newborns: a randomised controlled blind trial. Minerva Pediatrica2001;53(4):271-4. [PMID: 11573063]">Guala 2001</a>; <a href="./references#CD014806-bbs2-0039" title="RamenghiLA , WoodCM , GriffithGC , LeveneMI . Reduction of pain response in premature infants using intraoral sucrose. Archives of Disease in Childhood. Fetal and Neonatal Edition1996;74(2):F126-8. [DOI: 10.1136/fn.74.2.f126] [PMID: 8777660]">Ramenghi 1996b</a>; <a href="./references#CD014806-bbs2-0046" title="JohnstonCC , SherrardA , StevensB , FranckL , StremlerR , JackA . Do cry features reflect pain intensity in preterm neonates?Biology of the Neonate1999;76(2):120-4. [DOI: 10.1159/000014150] [PMID: 10393997]StevensB , JohnstonC , FranckP , PetryshenP , JackA , FosterG . The efficacy of developmentally sensitive interventions and sucrose for relieving pain in very low birth weight infants. Nursing Research1999;48(1):35-43. [DOI: 10.1097/00006199-199901000-00006] [PMID: 10029400]">Stevens 1999</a>; <a href="./references#CD014806-bbs2-0047" title="StevensB , YamadaJ , BeyeneJ , GibbinsS , PetryshenP , StinsonJ , et al. Consistent management of repeated procedural pain with sucrose in preterm neonates: is it effective and safe for repeated use over time?Clinical Journal of Pain2005;21(6):543-8. [DOI: 10.1097/01.ajp.0000149802.46864.e2] [PMID: 16215340]">Stevens 2005a</a>; <a href="./references#CD014806-bbs2-0050" title="TaddioA , ShahV , HancockR , SmithRW , StephensD , AtenafuE , et al. Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures. Canadian Medical Association Journal2008;179(1):37-43. [DOI: 10.1503/cmaj.071734] [PMID: 18591525]">Taddio 2008</a>). Three of these studies observed minor immediate adverse effects in infants (<a href="./references#CD014806-bbs2-0014" title="GibbinsS , StevensB , HodnettE , PinelliJ , OhlssonA , DarlingtonG . Efficacy and safety of sucrose for procedural pain relief in preterm and term neonates. Nursing Research2002;51(6):375-82. [DOI: 10.1097/00006199-200211000-00005] [PMID: 12464757]GibbinsS , StevensB . The influence of gestational age on the efficacy and short-term safety of sucrose for procedural pain relief. Advances in Neonatal Care2003;3(5):241-9. [PMID: 14648521]GibbinsS . Efficacy and Safety of Sucrose for Procedural Pain Relief in Preterm and Term Neonates [PhD Thesis]. Toronto: University of Toronto, 2001. ">Gibbins 2002</a>; <a href="./references#CD014806-bbs2-0047" title="StevensB , YamadaJ , BeyeneJ , GibbinsS , PetryshenP , StinsonJ , et al. Consistent management of repeated procedural pain with sucrose in preterm neonates: is it effective and safe for repeated use over time?Clinical Journal of Pain2005;21(6):543-8. [DOI: 10.1097/01.ajp.0000149802.46864.e2] [PMID: 16215340]">Stevens 2005a</a>; <a href="./references#CD014806-bbs2-0050" title="TaddioA , ShahV , HancockR , SmithRW , StephensD , AtenafuE , et al. Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures. Canadian Medical Association Journal2008;179(1):37-43. [DOI: 10.1503/cmaj.071734] [PMID: 18591525]">Taddio 2008</a>). <a href="./references#CD014806-bbs2-0014" title="GibbinsS , StevensB , HodnettE , PinelliJ , OhlssonA , DarlingtonG . Efficacy and safety of sucrose for procedural pain relief in preterm and term neonates. Nursing Research2002;51(6):375-82. [DOI: 10.1097/00006199-200211000-00005] [PMID: 12464757]GibbinsS , StevensB . The influence of gestational age on the efficacy and short-term safety of sucrose for procedural pain relief. Advances in Neonatal Care2003;3(5):241-9. [PMID: 14648521]GibbinsS . Efficacy and Safety of Sucrose for Procedural Pain Relief in Preterm and Term Neonates [PhD Thesis]. Toronto: University of Toronto, 2001. ">Gibbins 2002</a> described minor adverse effects in six infants, none of which occurred in the sucrose + pacifier group. One neonate who received water + pacifier choked when the water was administered but stabilised within 10 s. Three infants randomised to the sucrose group and two infants randomised to the water + pacifier groups experienced oxygen desaturation when the study intervention (sucrose or water) was administered. Each neonate recovered spontaneously with no medical intervention required. <a href="./references#CD014806-bbs2-0047" title="StevensB , YamadaJ , BeyeneJ , GibbinsS , PetryshenP , StinsonJ , et al. Consistent management of repeated procedural pain with sucrose in preterm neonates: is it effective and safe for repeated use over time?Clinical Journal of Pain2005;21(6):543-8. [DOI: 10.1097/01.ajp.0000149802.46864.e2] [PMID: 16215340]">Stevens 2005a</a> reported that the frequency of adverse events related to repeated use of sucrose over the first 28 days of life was 'low' and all immediate adverse events resolved spontaneously. <a href="./references#CD014806-bbs2-0050" title="TaddioA , ShahV , HancockR , SmithRW , StephensD , AtenafuE , et al. Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures. Canadian Medical Association Journal2008;179(1):37-43. [DOI: 10.1503/cmaj.071734] [PMID: 18591525]">Taddio 2008</a> reported no differences between groups in blood glucose levels monitored during the study, or between the incidence of spitting up the sucrose solution. </p> <p><a href="./references#CD014806-bbs2-0052" title="Tutag LehrV , CortezJ , GreverW , CepedaE , ThomasR , ArandaJV . Randomized placebo controlled trial of sucrose analgesia on neonatal skin blood flow and pain response during heel lance. Clinical Journal of Pain2015;31(5):451-8. [DOI: 10.1097/AJP.0000000000000126] [PMID: 24918475]">Tutag Lehr 2015</a> assessed adverse events including gagging, choking, and vomiting and noted that only one infant in the sucrose group experienced a mild episode of 'spitting up'. <a href="./references#CD014806-bbs2-0051" title="ThakkarP , AroraK , GoyalK , DasRR , JavadekarB , AiyerS , et al. To evaluate and compare the efficacy of combined sucrose and non-nutritive sucking for analgesia in newborns undergoing minor painful procedure: a randomized controlled trial. Journal of Perinatology2016;36(1):67-70. [DOI: 10.1038/jp.2015.122] [PMID: 26583940]">Thakkar 2016</a> reported on a total of five episodes of adverse effects in all four groups: one neonate each in the sucrose group, the NNS group and the sucrose + NNS group desaturated, with two neonates desaturated in the no intervention group. Three studies (<a href="./references#CD014806-bbs2-0027" title="LengHY , ZhengXL , ZhangXH , HeHY , TuGF , FuQ . Combined non-pharmacological interventions for newborn pain relief in two degrees of pain procedures: a randomized clinical trial. European Journal of Pain2016;20(6):989-97. [DOI: 10.1002/ejp.824] [PMID: 26685099]">Leng 2015</a>; <a href="./references#CD014806-bbs2-0029" title="Marin GabrielMA , delRey Hurtado de MendozaB , Jimenez FigueroaL , MedinaV , Iglesias FernandezB , Vazquez RodriguezM , et al. Analgesia with breastfeeding in addition to skin-to-skin contact during heel prick. Archives of Disease in Childhood. Fetal and neonatal edition2013;98(6):F499-503. [DOI: 10.1136/archdischild-2012-302921] [PMID: 23839984]">Marin Gabriel 2013</a>; <a href="./references#CD014806-bbs2-0044" title="SimonseE , MulderPG , vanBeekRH . Analgesic effect of breast milk versus sucrose for analgesia during heel lance in late preterm infants. Pediatrics2012;129(4):657-63. [DOI: 10.1542/peds.2011-2173] [PMID: 22392168]">Simonse 2012</a>), noted no adverse effects in any infant. <a href="./references#CD014806-bbs2-0001" title="AbbasogluA , CabiogluMT , TugcuAU , YapakciE , TekindalMA , TarcanA . Laser acupuncture before heel lancing for pain management in healthy term newborns: a randomised controlled trial. Acupuncture in Medicine2015;33(6):445-50. [DOI: 10.1136/acupmed-2015-010765] [PMID: 26438556]">Abbasoglu 2015</a> stated that no child developed any clinically visible changes on the skin, and that no adverse effects were observed in their comparison of laser acupuncture with oral sucrose. </p> <p>For the newly identified studies, adverse effects were reported in eight studies (<a href="./references#CD014806-bbs2-0008" title="Campbell-YeoM , JohnstonCC , BenoitB , DisherT , CaddellK , VincerM , et al. Sustained efficacy of kangaroo care for repeated painful procedures over neonatal intensive care unit hospitalization: a single-blind randomized controlled trial. Pain2019;160(11):2580-8. [DOI: 10.1097/j.pain.0000000000001646] [PMID: 31356452]">Campbell‐Yeo 2019</a>; <a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a>; <a href="./references#CD014806-bbs2-0024" title="KumariS , DattaV , RehanH . Comparison of the efficacy of oral 25% glucose with oral 24% sucrose for pain relief during heel lance in preterm neonates: a double blind randomized controlled trial. Journal of Tropical Pediatrics2017;63(1):30-5. [DOI: 10.1093/tropej/fmw045] [PMID: 27435886]">Kumari 2017</a>; <a href="./references#CD014806-bbs2-0031" title="McGinnisK , MurrayE , ChervenB , McCrackenC , TraversC . Effect of vibration on pain response to heel lance: a pilot randomized control trial. Advances in Neonatal Care2016;16(6):439-48. [DOI: 10.1097/ANC.0000000000000315] [PMID: 27533335]">McGinnis 2016</a>; <a href="./references#CD014806-bbs2-0048" title="StevensB , YamadaJ , Campbell-YeoM , GibbinsS , HarrisonD , DionneK , et al. The minimally effective dose of sucrose for procedural pain relief in neonates: a randomized controlled trial. BMC Pediatrics2018;18(1):85. [DOI: 10.1186/s12887-018-1026-x] [DOI: 10.1186/s12887-018-1026-x] [PMID: 29475433]">Stevens 2018</a>; <a href="./references#CD014806-bbs2-0004" title="BenoitB , NewmanA , Martin-MisenerR , LatimerM , Campbell-YeoM . The influence of breastfeeding on cortical and bio-behavioural indicators of procedural pain in newborns: findings of a randomized controlled trial. Early Human Development2021;154:105308. [DOI: 10.1016/j.earlhumdev.2021.105308] [PMID: 33513546]">Benoit 2021</a>; <a href="./references#CD014806-bbs2-0025" title="LagoP , CavicchioloME , MionT , Dal CengioV , AllegroA , DaverioM , et al. Repeating a dose of sucrose for heel prick procedure in preterms is not effective in reducing pain: a randomised controlled trial. European Journal of Pediatrics2020;179(2):293-301. [DOI: 10.1007/s00431-019-03509-2] [PMID: 31728675]">Lago 2020</a>; <a href="./references#CD014806-bbs2-0054" title="VelumulaPK , ElbakoushF , Tabb C 2nd, FarooqiA , Lulic-BoticaM , JaniS , et al. Breast milk vs 24% sucrose for procedural pain relief in preterm neonates: a non-inferiority randomized controlled trial. Journal of Perinatology2022;42(7):914-9. [DOI: 10.1038/s41372-022-01352-2] [PMID: 35197549]">Velumula 2020</a>). Four studies (<a href="./references#CD014806-bbs2-0004" title="BenoitB , NewmanA , Martin-MisenerR , LatimerM , Campbell-YeoM . The influence of breastfeeding on cortical and bio-behavioural indicators of procedural pain in newborns: findings of a randomized controlled trial. Early Human Development2021;154:105308. [DOI: 10.1016/j.earlhumdev.2021.105308] [PMID: 33513546]">Benoit 2021</a>; <a href="./references#CD014806-bbs2-0025" title="LagoP , CavicchioloME , MionT , Dal CengioV , AllegroA , DaverioM , et al. Repeating a dose of sucrose for heel prick procedure in preterms is not effective in reducing pain: a randomised controlled trial. European Journal of Pediatrics2020;179(2):293-301. [DOI: 10.1007/s00431-019-03509-2] [PMID: 31728675]">Lago 2020</a>; <a href="./references#CD014806-bbs2-0031" title="McGinnisK , MurrayE , ChervenB , McCrackenC , TraversC . Effect of vibration on pain response to heel lance: a pilot randomized control trial. Advances in Neonatal Care2016;16(6):439-48. [DOI: 10.1097/ANC.0000000000000315] [PMID: 27533335]">McGinnis 2016</a>; <a href="./references#CD014806-bbs2-0054" title="VelumulaPK , ElbakoushF , Tabb C 2nd, FarooqiA , Lulic-BoticaM , JaniS , et al. Breast milk vs 24% sucrose for procedural pain relief in preterm neonates: a non-inferiority randomized controlled trial. Journal of Perinatology2022;42(7):914-9. [DOI: 10.1038/s41372-022-01352-2] [PMID: 35197549]">Velumula 2020</a>), observed no adverse effects in any infants. <a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a> reported three episodes of vomiting (one in the routine care group, one in the NNS group, and one in the sucrose + NNS group) and two infants who had abdominal distension (one in the sucrose + NNS group and one in the routine care group). In the 25% glucose group, <a href="./references#CD014806-bbs2-0024" title="KumariS , DattaV , RehanH . Comparison of the efficacy of oral 25% glucose with oral 24% sucrose for pain relief during heel lance in preterm neonates: a double blind randomized controlled trial. Journal of Tropical Pediatrics2017;63(1):30-5. [DOI: 10.1093/tropej/fmw045] [PMID: 27435886]">Kumari 2017</a> observed one infant who developed coughing and another with vomiting which was present transiently and required no intervention. <a href="./references#CD014806-bbs2-0048" title="StevensB , YamadaJ , Campbell-YeoM , GibbinsS , HarrisonD , DionneK , et al. The minimally effective dose of sucrose for procedural pain relief in neonates: a randomized controlled trial. BMC Pediatrics2018;18(1):85. [DOI: 10.1186/s12887-018-1026-x] [DOI: 10.1186/s12887-018-1026-x] [PMID: 29475433]">Stevens 2018</a> reported five adverse events, where three infants experienced gagging, one had a heart rate &lt; 80 bpm, and another developed 80% oxygen saturation following sucrose administration. There were no differences in the proportion of adverse events between the intervention groups, and all resolved spontaneously. No differences were reported for adverse events (bradycardia, oxygen desaturation) between groups in the study by <a href="./references#CD014806-bbs2-0008" title="Campbell-YeoM , JohnstonCC , BenoitB , DisherT , CaddellK , VincerM , et al. Sustained efficacy of kangaroo care for repeated painful procedures over neonatal intensive care unit hospitalization: a single-blind randomized controlled trial. Pain2019;160(11):2580-8. [DOI: 10.1097/j.pain.0000000000001646] [PMID: 31356452]">Campbell‐Yeo 2019</a>. Researchers in more recent studies appear to be much more vigilant in observing and reporting adverse events. The proportion of minor adverse events remains very low with no major adverse events reported. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD014806-sec-0132" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD014806-sec-0132"></div> <section id="CD014806-sec-0133"> <h3 class="title" id="CD014806-sec-0133">Summary of main results</h3> <section id="CD014806-sec-0134"> <h4 class="title">Effectiveness of sucrose for pain associated with heel lance</h4> <p>There were 13 newly identified studies added to this review, including term and preterm infants who received sucrose in doses ranging from 0.1 mL to 1 mL of 20% to 24% sucrose. </p> <p>Evidence from seven studies in 547 term and preterm infants suggests that sucrose (20‐30%, 0.1‐2 mL), with or without NNS, probably results in a reduction in PIPP scores compared to the control group at 30 seconds after lancing; at 60 seconds after heel lancing, sucrose probably results in a reduction in PIPP scores compared with water in two studies (164 infants) (<a href="./full#CD014806-tbl-0001">summary of findings Table 1</a>). Results of individual studies indicate that sucrose (24%) probably results in a reduction in NIPS scores immediately after heel lancing compared to infants receiving water (56 infants) (<a href="./references#CD014806-bbs2-0052" title="Tutag LehrV , CortezJ , GreverW , CepedaE , ThomasR , ArandaJV . Randomized placebo controlled trial of sucrose analgesia on neonatal skin blood flow and pain response during heel lance. Clinical Journal of Pain2015;31(5):451-8. [DOI: 10.1097/AJP.0000000000000126] [PMID: 24918475]">Tutag Lehr 2015</a>) but not in DAN scores for sucrose and water groups (<a href="./references#CD014806-bbs2-0030" title="MathaiS , NatrajanN , RajalakshmiNR . A comparative study of non-pharmacological methods to reduce pain in neonates. Indian Pediatrics2006;43(12):1070-5. [PMID: 17202604]">Mathai 2006</a>). </p> <p>In a single study with 94 preterm infants (<a href="./references#CD014806-bbs2-0024" title="KumariS , DattaV , RehanH . Comparison of the efficacy of oral 25% glucose with oral 24% sucrose for pain relief during heel lance in preterm neonates: a double blind randomized controlled trial. Journal of Tropical Pediatrics2017;63(1):30-5. [DOI: 10.1093/tropej/fmw045] [PMID: 27435886]">Kumari 2017</a>), the evidence suggests that there is little to no difference in PIPP scores when comparing sucrose (24%) to glucose (25%) at 30 seconds and 60 seconds after heel lancing (<a href="./full#CD014806-tbl-0004">summary of findings Table 4</a>). </p> <p>Evidence from two combined studies in 148 term infants is very uncertain about the effect of 24% to 25% sucrose with or without NNS compared to breast milk on PIPP scores at 30 seconds after heel lancing. Similarly, the evidence is very uncertain about the effect of sucrose (24%) compared to breastfeeding in COMFORTneo scores after lancing in a single study involving 47 preterm infants (<a href="./references#CD014806-bbs2-0044" title="SimonseE , MulderPG , vanBeekRH . Analgesic effect of breast milk versus sucrose for analgesia during heel lance in late preterm infants. Pediatrics2012;129(4):657-63. [DOI: 10.1542/peds.2011-2173] [PMID: 22392168]">Simonse 2012</a>) (<a href="./full#CD014806-tbl-0005">summary of findings Table 5</a>). </p> <p>When comparing sucrose and expressed breast milk in a single study with 94 preterm infants (<a href="./references#CD014806-bbs2-0054" title="VelumulaPK , ElbakoushF , Tabb C 2nd, FarooqiA , Lulic-BoticaM , JaniS , et al. Breast milk vs 24% sucrose for procedural pain relief in preterm neonates: a non-inferiority randomized controlled trial. Journal of Perinatology2022;42(7):914-9. [DOI: 10.1038/s41372-022-01352-2] [PMID: 35197549]">Velumula 2020</a>), the evidence suggests that sucrose (24%) may result in little to no difference in PIPP‐R scores compared to expressed breast milk during heel lancing and 30 seconds after heel lancing; however, at 60 seconds after heel lance, sucrose may result in slightly increased PIPP‐R scores compared to expressed breast milk (based on a single study of 94 preterm infants) (<a href="./full#CD014806-tbl-0006">summary of findings Table 6</a>). </p> <p>In terms of secondary outcomes (e.g. crying time, heart rate, oxygen saturation), the evidence is overall very uncertain about the effects of sucrose on individual behavioural and/or neurophysiological pain indicators. </p> <p>In the many studies that could not be included in the RevMan meta‐analyses, or reported on outcomes other than validated pain assessment scores, the evidence is overall very uncertain about the effects of sucrose on individual behavioural and/or neurophysiological pain indicators (see summary in the <a href="./full#CD014806-sec-0041">Results</a> section). </p> </section> <section id="CD014806-sec-0135"> <h4 class="title">Long‐term neurodevelopmental outcomes</h4> <p>Post‐discharge or long‐term neurodevelopmental outcomes were not assessed in any of the included studies on the effectiveness of sucrose for single heel lances. </p> </section> <section id="CD014806-sec-0136"> <h4 class="title">Adverse effects</h4> <p>Adverse effects were evaluated in 22 studies; of these, 14 studies reported no adverse effects. For the remainder, most adverse events were minor and self‐resolved. There were no differences in adverse events between the sucrose groups and control groups. One study that measured blood glucose levels did not find any difference between the sucrose and the water group (<a href="./references#CD014806-bbs2-0050" title="TaddioA , ShahV , HancockR , SmithRW , StephensD , AtenafuE , et al. Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures. Canadian Medical Association Journal2008;179(1):37-43. [DOI: 10.1503/cmaj.071734] [PMID: 18591525]">Taddio 2008</a>). </p> <p>Adverse effects following single event use of sucrose were not a documented issue in these studies. </p> </section> </section> <section id="CD014806-sec-0137"> <h3 class="title" id="CD014806-sec-0137">Overall completeness and applicability of evidence</h3> <p>Although sucrose for pain from heel lance has been studied in 55 trials that included 6273 infants, the large variation in heel lancing procedures, dose of sucrose (concentration and volume), co‐interventions in the comparison groups, assessment tools used to assess effectiveness outcomes, and differences in the infant population (term or preterm born, postnatal age, severity of illness) resulted in a large number of RevMan analyses that included one or few trials. There were few infants included for each comparison and each outcome, which weakens our ability to draw firm conclusions. However, if the effectiveness of sucrose for a specific intervention was measured by a variety of assessment measures, and the results showed a similar reduction, this would strengthen the results and the conclusions. </p> </section> <section id="CD014806-sec-0138"> <h3 class="title" id="CD014806-sec-0138">Quality of the evidence</h3> <p>The certainty of the evidence varied from very low to moderate for the use of sucrose for analgesia for heel lance procedures in term and preterm neonates. Comparisons of the certainty of the evidence are reported in the various Summary of Findings tables. We excluded quasi‐randomised trials and trials reported in abstract form only. We included only a few studies for most comparisons and outcomes. For most outcomes, we included the results of a single study only; therefore, tests for heterogeneity were not applicable. The main reasons for our inability to include study results in RevMan analyses were that the results were not presented as means and SDs or were presented in graph form only. </p> </section> <section id="CD014806-sec-0139"> <h3 class="title" id="CD014806-sec-0139">Potential biases in the review process</h3> <p>We are not aware of any biases in the review process. Two authors (LS, JY) selected the trials from the literature searches and there was 100% agreement. Two authors (MB, LS) abstracted data and filled in predesigned forms for Risk of bias assessments and data abstraction, and one author (JY) checked the data abstraction. Any discrepancies were discussed and resolved by consensus. Three authors (JY, MCY, BS) are co‐authors on some included trials. For these trials, two authors (MB, LS) did the data abstraction and RoB assessments. One author (BS) is the developer of the PIPP and PIPP‐R measure and did not participate in any analyses of the quality of existing trials. </p> </section> <section id="CD014806-sec-0140"> <h3 class="title" id="CD014806-sec-0140">Agreements and disagreements with other studies or reviews</h3> <p>Previous reviews focusing on the analgesic effects of sucrose for different types of skin breaking procedures (<a href="./references#CD014806-bbs2-0197" title="StevensB , YamadaJ , OhlssonA . Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database of Systematic Reviews2001, Issue 1. Art. No: CD001069. [DOI: 10.1002/14651858.CD001069.pub2]">Stevens 2001</a>; <a href="./references#CD014806-bbs2-0198" title="StevensB , YamadaJ , OhlssonA . Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database of Systematic Reviews2004, Issue 3. Art. No: CD001069. [DOI: 10.1002/14651858.CD001069.pub2]">Stevens 2004</a>; <a href="./references#CD014806-bbs2-0199" title="StevensB , YamadaJ , Ohlsson, A. Sucrose for analgesia in newborns infants undergoing painful procedures. Cochrane Database of Systematic Reviews2010, Issue 1. Art. No: CD001069. [DOI: 10.1002/14651858.CD001069.pub3]">Stevens 2010</a>; <a href="./references#CD014806-bbs2-0200" title="StevensB , YamadaJ , LeeGY , OhlssonA . Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database of Systematic Reviews2013, Issue 1. Art. No: CD001069. [DOI: 10.1002/14651858.CD001069.pub4]">Stevens 2013</a>; <a href="./references#CD014806-bbs2-0201" title="StevensB , YamadaJ , OhlssonA , HaliburtonS , ShorkeyA . Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database of Systematic Reviews2016, Issue 7. Art. No: CD001069. [DOI: 10.1002/14651858.CD001069.pub5]">Stevens 2016</a>) reported inconsistency in effective sucrose dosage. <a href="./references#CD014806-bbs2-0021" title="JohnstonCC , StremlerRL , StevensBJ , HortonLJ . Effectiveness of oral sucrose and simulated rocking on pain response in preterm neonates. Pain1997;72(1-2):193-9. [DOI: 10.1016/s0304-3959(97)00033-x] [PMID: 9272803]">Johnston 1997</a> and <a href="./references#CD014806-bbs2-0046" title="JohnstonCC , SherrardA , StevensB , FranckL , StremlerR , JackA . Do cry features reflect pain intensity in preterm neonates?Biology of the Neonate1999;76(2):120-4. [DOI: 10.1159/000014150] [PMID: 10393997]StevensB , JohnstonC , FranckP , PetryshenP , JackA , FosterG . The efficacy of developmentally sensitive interventions and sucrose for relieving pain in very low birth weight infants. Nursing Research1999;48(1):35-43. [DOI: 10.1097/00006199-199901000-00006] [PMID: 10029400]">Stevens 1999</a> identified that very small volumes of 24% sucrose (0.1 mL) reduced procedural pain in infants. However, the meta‐analyses in <a href="./references#CD014806-bbs2-0183" title="StevensB , TaddioA , OhlssonA , EinarsonT . The efficacy of sucrose for relieving procedural pain in neonates - a systematic review and meta-analysis. Acta Paediatrica1997;86(8):837-42. [DOI: 10.1111/j.1651-2227.1997.tb08607.x] [PMID: 9307163]">Stevens 1997a</a> showed 0.18 grams of sucrose were ineffective in reducing crying and did not differ from water. The evidence suggests that sucrose (20‐30%, 0.1‐2 mL), with or without NNS, probably results in a reduction in PIPP scores compared to the control group at 30 seconds after lancing. In these studies, there was a 0.5 to 2.0 point reduction in the PIPP score. <a href="./references#CD014806-bbs2-0177" title="ShahV , IppM , SamJ , EinarsonTR , TaddioA . Eliciting the minimally clinically important difference in the pain response from parents of newborn infants and nurses. In: Canadian Pediatric Society 81st Meeting. Montreal, QC: Pulsus Group, 2004.">Shah 2004</a> reported that clinicians and researchers consider a 20% reduction in pain to be the minimal clinically important difference, although other researchers suggest a 10% reduction may suffice (<a href="./references#CD014806-bbs2-0168" title="PowellCV , KellyAM , WilliamsA . Determining the minimum clinically significant difference in visual analog pain score for children. Annals of Emergency Medicine2001;37(1):28-31. [DOI: 10.1067/mem.2001.111517] [PMID: 11145767]">Powell 2001</a>). Determining the level of clinical improvement is challenging in infants, given their inability to self‐report their pain and their reliance on observers to determine both pain intensity and the level of improvement that could make important contributions to treatment strategies. </p> <p><a href="./references#CD014806-bbs2-0048" title="StevensB , YamadaJ , Campbell-YeoM , GibbinsS , HarrisonD , DionneK , et al. The minimally effective dose of sucrose for procedural pain relief in neonates: a randomized controlled trial. BMC Pediatrics2018;18(1):85. [DOI: 10.1186/s12887-018-1026-x] [DOI: 10.1186/s12887-018-1026-x] [PMID: 29475433]">Stevens 2018</a> addressed the gap in knowledge identified in the 2016 sucrose review where the authors recommended additional research to identify the minimally effective dose of sucrose during a single painful procedure (<a href="./references#CD014806-bbs2-0201" title="StevensB , YamadaJ , OhlssonA , HaliburtonS , ShorkeyA . Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database of Systematic Reviews2016, Issue 7. Art. No: CD001069. [DOI: 10.1002/14651858.CD001069.pub5]">Stevens 2016</a>). No difference in mean pain intensity PIPP‐R scores was found between term and preterm infants who received 0.1 mL, 0.5 mL or 1.0 mL of 24% sucrose for a single heel‐lance procedure. The smallest amount of 24% sucrose (0.1 mL) was equally effective in reducing pain intensity in infants up to 60 seconds after the heel‐lance. The authors concluded that the smallest dose could be used effectively for procedural pain treatment, particularly heel‐lances. </p> <p>The greatest analgesic effect appears to occur when the full dose of sucrose is administered approximately two minutes before the painful stimulus. This interval is thought to coincide with the release of endogenous opioids (<a href="./references#CD014806-bbs2-0126" title="BlassE , CiaramitaroV . A new look at some old mechanisms in human newborns: taste and tactile determinants of state, affect and action. Monographs of the Society for Research in Child Development1994;59(1):1-80. [PMID: 8047076]">Blass 1994</a>). However, <a href="./references#CD014806-bbs2-0022" title="JohnstonCC , StremlerR , HortonL , FriedmanA . Effect of repeated doses of sucrose during heel stick procedure in preterm neonates. Biology of the Neonate1999;75(3):160-6. [DOI: 10.1159/000014092] [PMID: 9925903]">Johnston 1999</a> reported increased analgesia when sucrose solution was repeatedly administered in small aliquots (i.e. 0.05 mL of 24% sucrose) at two‐minute intervals throughout the painful procedure. Future researchers need to further investigate the effectiveness of bolus versus small aliquot delivery of sucrose for single procedures. The peak effect appears to last about five minutes (<a href="./references#CD014806-bbs2-0151" title="HarrisonD , YamadaJ , BuenoM . Sucrose and sweet taste. In: StevensB , HathwayG , ZempskyWT , editors(s). Oxford Textbook of Paediatric Pain. New York: Oxford University Press, In Press.">Harrison 2020</a>); therefore, the analgesic effect may wear off if procedures are prolonged. Because there is a wide variation in the duration of procedures commonly performed in infants, as well as in the extent of tissue damage inflicted by them (<a href="./references#CD014806-bbs2-0160" title="Laudiano-DrayMP , Pillai RiddellR , JonesL , IyerR , WhiteheadK , FitzgeraldM , et al. Quantification of neonatal procedural pain severity: a platform for estimating total pain burden in individual infants. Pain2020;161(6):1270-7. [DOI: 10.1097/j.pain.0000000000001814]">Laudiano‐Dray 2020</a>), other strategies may be considered for prolonged and more invasive procedures. For example, lumbar punctures, endotracheal intubation, injections, and arterial punctures were considered of severe pain intensity (<a href="./references#CD014806-bbs2-0160" title="Laudiano-DrayMP , Pillai RiddellR , JonesL , IyerR , WhiteheadK , FitzgeraldM , et al. Quantification of neonatal procedural pain severity: a platform for estimating total pain burden in individual infants. Pain2020;161(6):1270-7. [DOI: 10.1097/j.pain.0000000000001814]">Laudiano‐Dray 2020</a>) and may require a combination of pain‐relieving strategies, including pharmacological treatment. The infant's postnatal age may influence the effectiveness of sucrose (<a href="./references#CD014806-bbs2-0050" title="TaddioA , ShahV , HancockR , SmithRW , StephensD , AtenafuE , et al. Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures. Canadian Medical Association Journal2008;179(1):37-43. [DOI: 10.1503/cmaj.071734] [PMID: 18591525]">Taddio 2008</a>). </p> <p>Generally, infants in this review were healthy term and preterm neonate infants and very few were under 27 weeks' GA at birth. Although the responses of preterm infants who were greater than 27 weeks GA at birth was generally consistent with that of the term infant, it is often more subtle, less sustained, and affected by the infant's behavioural state and severity of illness (<a href="./references#CD014806-bbs2-0142" title="GibbinsS , StevensB , McGrathPJ , YamadaJ , BeyeneJ , BreauL , et al. Comparison of pain responses in infants of different gestational ages. Neonatology2008;93(1):10-8. [DOI: 10.1159/000105520] [PMID: 17630493]">Gibbins 2008</a>). Given the paucity of knowledge in this age group, more research on preterm infants &lt; 27 weeks' GA is warranted. </p> <p>The evidence was very uncertain about the effects of sucrose on secondary outcomes such as crying in term and preterm infants; however, the incidence of crying following painful stimuli is reported to be 50% less in preterm infants compared to term infants (<a href="./references#CD014806-bbs2-0181" title="StevensB , JohnstonC , HortonL . Factors that influence the behavioral responses of premature infants. Pain1994;59(1):101-9. [DOI: 10.1016/0304-3959(94)90053-1] [PMID: 7854790]">Stevens 1994</a>); therefore, crying alone may not be a valid or reliable indicator of pain in the preterm infant population and is precluded as an indicator in many validated infant pain measures, although it is often used as a unidimensional indicator of pain. </p> <p>Few researchers provided a definition or conceptualisation of pain as an outcome. In a recent revision of the IASP definition of pain (<a href="./references#CD014806-bbs2-0169" title="RajaSN , CarrDB , CohenM , FinnerupNB , FlorH , GibsonS , et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain2020;161(9):1976-82. [DOI: 10.1097/j.pain.0000000000001939] [PMID: 32694387]">Raja 2020</a>), authors acknowledge that all children including very preterm infants can and do experience pain. Having a clear definition of what pain entails in this vulnerable population provides a basis for measuring the quantity and quality of pain, and weighs the risks and benefits of targeted interventions (<a href="./references#CD014806-bbs2-0187" title="StevensB . Revisions to the IASP definition of pain – what does this mean for children?Paediatric &amp; Neonatal Pain2021;3(3):101-5. [DOI: 10.1002/pne2.12047] [PMID: 35547949]">Stevens 2021</a>). We need to make pain more visible, through optimising existing age‐appropriate pain measures, and understanding biological correlates. The use of psychometrically sound pain assessment tools available for neonates as primary outcomes in trials investigating the effectiveness and safety of pain relief interventions for acute pain should be prioritised. The results of a limited number of studies reporting pain intensity scores were combined and provided some evidence on the effectiveness of sucrose analgesia for heel‐lance procedures. However, a large portion of the studies considered behavioural outcomes, such as proportion, percentage or duration of time crying to be the most valid indicator of pain in neonates. Although research on infant crying has delineated certain crying characteristics, such as pitch, intensity, melody and harmonics, as being good indicators of pain, these were not assessed in the sucrose studies reviewed. Cry duration may give some indication of distress. However, cry duration does not necessarily confirm or deny that the infant is in pain. For unstable ventilated infants who often do not cry following painful procedures, any cry characteristic would be an inappropriate outcome. Attempts at cry or a silent cry in ventilated infants may be reasonable to consider. A multivariate approach looking at multiple indicators simultaneously or a reliable and validated composite pain score may be a more comprehensive approach. </p> <p>The majority of researchers provided little detail about the heel lance procedure in their studies (e.g. type of lancet used, number of attempts, number of squeezes, duration of the procedure). Therefore, it was impossible to determine if the painful stimuli were comparable in intensity, duration or frequency both within and between studies. The length of observation in terms of initial response (pain reactivity) and return to baseline (recovery) parameters (e.g. heart rate) of infants following procedures were not reported frequently. </p> <p>The delivery modality of sucrose (by syringe, dropper or dipping pacifier), where it was delivered and whether the full dose was delivered in a bolus or gradually dripped over a specified period, varied amongst studies. The pacifier promotes NNS and calming that may contribute to reducing pain‐elicited distress (<a href="./references#CD014806-bbs2-0132" title="CamposRG . Rocking and pacifier; two comforting interventions for heel stick pain. Research in Nursing and Health1994;17(5):321-31. [DOI: 10.1002/nur.4770170503] [PMID: 8090943]">Campos 1994</a>). <a href="./references#CD014806-bbs2-0126" title="BlassE , CiaramitaroV . A new look at some old mechanisms in human newborns: taste and tactile determinants of state, affect and action. Monographs of the Society for Research in Child Development1994;59(1):1-80. [PMID: 8047076]">Blass 1994</a> suggested that sucking exerts a profound behavioural effect and induces feelings of calm. Other researchers found that NNS reduced heart rate and metabolic rate, promoted self‐soothing, and elevated the pain threshold. NNS has not been shown to affect cortisol response, vagal tone or oxygen saturation of blood (<a href="./references#CD014806-bbs2-0138" title="DiPietroJA , CussonRM , CaughyMO , FoxNA . Behavioral and physiologic effects of nonnutritive sucking during gavage feeding in preterm infants. Pediatric Research1994;36(2):207-14. [DOI: 10.1203/00006450-199408000-00012] [PMID: 7970936]">DiPietro 1994</a>; <a href="./references#CD014806-bbs2-0146" title="GunnarMR . Reactivity of the hypothalamic-pituitary-adrenocortical system to stressors in normal infants and children. Pediatrics1992;90(3 Pt2):491-7. [PMID: 1513614]">Gunnar 1992</a>). The calming effects are not sustained following cessation of the NNS alone. In contrast, the effects of NNS + sucrose administration, persist for several minutes beyond the cessation of contact. Results from this review indicate that the use of sucrose with NNS appears to have a synergistic effect with both single and repeated doses of sucrose. A systematic review on the efficacy and safety of oral sucrose with NNS for procedural pain (including heel lance) reported that sucrose + NNS might be superior in relieving mild pain in neonate infants (<a href="./references#CD014806-bbs2-0163" title="LiQ , TanX , LiX , TangW , MeiL , ChengG , et al. Efficacy and safety of combined oral sucrose and nonnutritive sucking in pain management for infants: a systematic review and meta-analysis. PLOS ONE2022;17(5):e0268033. [DOI: 10.1371/journal.pone.0268033]">Li 2022</a>). </p> <p><a href="./references#CD014806-bbs2-0011" title="CodipietroL , CeccarelliM , PonzoneA . Breastfeeding or oral sucrose solution in term neonates receiving heel lance: a randomized controlled trial. Pediatrics2008;122(3):e716-21. [DOI: 10.1542/peds.2008-0221] [PMID: 18762508]">Codipietro 2008</a> concluded that breastfeeding was more effective than sucrose for reducing pain from heel lance in term infants. <a href="./references#CD014806-bbs2-0178" title="ShahPS , HerbozoC , AliwalasLL , ShahVS . Breastfeeding or breast milk for procedural pain in neonates. Cochrane Database of Systematic Reviews2012, Issue 12. Art. No: CD004950. [DOI: 10.1002/14651858.CD004950.pub3]">Shah 2012</a> recommended that breastfeeding, when available, should be used to reduce procedural pain in neonates who are exposed to single painful procedures; breast milk alone in small volumes was only as effective as water for the relief of procedural pain (much less so than sucrose), and its effectiveness for repeated painful procedures has not yet been established. Based on a recent systematic review, <a href="./references#CD014806-bbs2-0123" title="BenoitB , Martin-MisenerR , LatimerM , Campbell-YeoM . Breast-feeding analgesia in infants: an update on the current state of evidence. Journal of Perinatal &amp; Neonatal Nursing2017;31(2):145-59. [DOI: 10.1097/JPN.0000000000000253] [PMID: 28437305]">Benoit 2017a</a> concluded that breastfeeding was as effective or more effective than sweet‐tasting solutions in full‐term infants, but this has not been demonstrated in preterm infants. Further research on direct comparisons between sucrose and parent‐driven interventions to minimise pain, such as breastfeeding and skin‐to‐skin contact, is warranted. </p> <p><a href="./references#CD014806-bbs2-0167" title="Pillai RiddellRR , RacineNM , GennisHG , TurcotteK , UmanLS , HortonRE , et al. Non-pharmacological management of infant and young child procedural pain. Cochrane Database of Systematic Reviews2015, Issue 12. Art. No: CD006275. [DOI: 10.1002/14651858.CD006275.pub3]">Pillai Riddell 2015</a> in a systematic review of non‐pharmacological interventions (not including sucrose) found that the most established evidence for treating needle‐related procedures in preterm and term neonate infants and older infants was for NNS, swaddling, facilitated tucking, and rocking/holding. More recently, <a href="./references#CD014806-bbs2-0150" title="HarrisonD , LarocqueC , BuenoM , StokesY , TurnerL , HuttonB , et al. Sweet solutions to reduce procedural pain in neonates: a meta-analysis. Pediatrics2017;139(1):e20160955. [DOI: 10.1542/peds.2016-0955] [PMID: 27986905]">Harrison 2017</a> conducted a systematic review and cumulative meta‐analysis (CMA) to evaluate the effects of sweet solutions (sucrose or glucose) for neonatal procedural pain. From the 168 trials included in the review, results of 62 studies were eligible for inclusion in the CMA. Since the first published trials in the early 2000s, there was sufficient evidence to support the effectiveness of sweet solutions for procedural pain relief in neonates compared with placebo or no intervention. </p> <p><a href="./references#CD014806-bbs2-0045" title="SlaterR , CornelissenL , FabriziL , PattenD , YoxenJ , WorleyA , et al. Oral sucrose as an analgesic drug for procedural pain in newborn infants: a randomised controlled trial. Lancet2010;376(9748):1225-32. [DOI: 10.1016/S0140-6736(10)61303-7] [PMID: 20817247]">Slater 2010</a> demonstrated little to no differences in the nociceptive brain activity measured with neonatal EEG or magnitude or latency of the spinal nociceptive reflex withdrawal measured with EMG between infants given sucrose and those given sterile water; however, the PIPP scores were lower in the infants given sucrose. The authors suggested that oral sucrose does not affect activity in the neonatal brain or spinal cord and may not be an effective analgesic. The small sample size, moderate attrition rates and methods used to measure and analyse EEG and EMG recordings limit the generalisation of these findings; thus, further research is warranted. </p> <p>This systematic review evidence on sucrose has been integrated into evidence‐based sucrose consensus protocols and guidelines (<a href="./references#CD014806-bbs2-0119" title="Committee on Fetus and Newborn and Section on Anesthesiology and Pain Medicine. Prevention and management of procedural pain in the neonate: an update. Pediatrics2016;137(2):e20154271. [DOI: 10.1542/peds.2015-4271] [PMID: 26810788]">AAP 2016</a>; <a href="./references#CD014806-bbs2-0174" title="Registered Nurses’ Association of Ontario. Assessment and management of pain. rnao.ca/sites/rnao-ca/files/AssessAndManagementOfPain_15_WEB-_FINAL_DEC_2.pdf accessed 1 January 2023.">RNAO 2013</a>). However, in an evaluation of infant pain guidelines (<a href="./references#CD014806-bbs2-0162" title="LeeGY , YamadaJ , KyololoO , ShorkeyA , StevensB . Pediatric pain clinical practice guidelines for acute procedural pain: a systematic review. Pediatrics2014;133(3):500-15. [DOI: 10.1542/peds.2013-2744] [PMID: 24488733]">Lee 2014</a>), recommendations were not sufficient, clear or consistent enough to guide clinical practice. Furthermore, in a study analysing pain practices during intensive care hospitalisation, pain‐relieving interventions were documented for 58.5% of procedures performed in neonates; sucrose (24%) was used for 34.2% of these procedures (<a href="./references#CD014806-bbs2-0166" title="OrovecA , DisherT , CaddellK , Campbell-YeoM . Assessment and management of procedural pain during the entire neonatal intensive care unit hospitalization. Pain Management Nursing2019;20(5):503-11. [DOI: 10.1016/j.pmn.2018.11.061] [PMID: 31103509]">Orovec 2019</a>). </p> <p>There has been excellent progress in our understanding of the mechanisms underlying nociception and pain, but we still have serious gaps in our understanding of how pain is processed in the developing brain and optimal assessment and treatment approaches (<a href="./references#CD014806-bbs2-0140" title="EcclestonC , FisherE , HowardRF , SlaterR , ForgeronP , PalermoTM , et al. Delivering transformative action in paediatric pain: a Lancet Child &amp; Adolescent Health Commission. Lancet. Child &amp; Adolescent Health2021;5(1):47-87. [DOI: 10.1016/S2352-4642(20)30277-7]">Eccleston 2021</a>; <a href="./references#CD014806-bbs2-0141" title="FitzgeraldM . What do we really know about newborn infant pain?Experimental Physiology2015;100(12):1451-7. [DOI: 10.1113/EP085134] [PMID: 26446174]">Fitzgerald 2015</a>). There are important efforts being directed towards brain‐derived measures (e.g. EEG, near‐infrared spectroscopy) that will aid in distinguishing between noxious and non‐noxious events (<a href="./references#CD014806-bbs2-0140" title="EcclestonC , FisherE , HowardRF , SlaterR , ForgeronP , PalermoTM , et al. Delivering transformative action in paediatric pain: a Lancet Child &amp; Adolescent Health Commission. Lancet. Child &amp; Adolescent Health2021;5(1):47-87. [DOI: 10.1016/S2352-4642(20)30277-7]">Eccleston 2021</a>). Methodological and pain treatment issues need to be addressed, and new evidence generated in light of the existing evidence. A comprehensive approach to validating various measures to evaluate pain in neonates and a standardised approach to measuring outcomes is critical, especially when evaluating pain‐relieving interventions that form the basis for clinical decision‐making (<a href="./references#CD014806-bbs2-0130" title="BuenoM , ErikssonM , StevensB . Neonatal and infant pain assessment. In: StevensB , HathwayG ,  Zempsky WT, editors(s). Oxford Textbook of Paediatric Pain. New York: Oxford University Press, In Press.">Bueno 2020</a>). Although further studies are still required, neurophysiological approaches for pain assessment in infants appear to hold promise as indicators for supplementing existing measures (<a href="./references#CD014806-bbs2-0124" title="BenoitB , Martin-MisenerR , NewmanA , LatimerM , Campbell-YeoM . Neurophysiological assessment of acute pain in infants: a scoping review of research methods. Acta Paediatrica2017;106:1053-66. [DOI: 10.1111/apa.13839] [PMID: 28326623]">Benoit 2017b</a>). </p> <p>Adverse effects following the short‐term use of sucrose with single painful events are currently reported as minimal, minor and self‐resolving. We reported the possible adverse effects in <a href="#CD014806-tbl-0010">Table 1</a>; <a href="#CD014806-tbl-0011">Table 2</a>; and <a href="#CD014806-tbl-0012">Table 3</a>. Adverse effects would be more likely to occur when multiple doses of sucrose are used. <a href="./references#CD014806-bbs2-0047" title="StevensB , YamadaJ , BeyeneJ , GibbinsS , PetryshenP , StinsonJ , et al. Consistent management of repeated procedural pain with sucrose in preterm neonates: is it effective and safe for repeated use over time?Clinical Journal of Pain2005;21(6):543-8. [DOI: 10.1097/01.ajp.0000149802.46864.e2] [PMID: 16215340]">Stevens 2005a</a> found no differences in incidence rates for necrotising enterocolitis between infants who received repeated doses of sucrose over 28 days of life compared to control groups. <a href="./references#CD014806-bbs2-0023" title="BoyerK , JohnstonC , WalkerCD , FilionF , SherrardA . Does sucrose analgesia promote physiological stability in preterm neonates?Biology of the Neonate2004;85(1):26-31. [DOI: 10.1159/000074954] [PMID: 14631163]JohnstonCC , FilionF , SniderL , MajnemerA , LimperopolousC , WalkerCD , et al. Routine sucrose analgesia during the first week of life in neonates younger than 31 weeks' postconceptional age. Pediatrics2002;110(3):523-8. [DOI: 10.1542/peds.110.3.523] [PMID: 12205254]">Johnston 2002</a> studied 107 preterm infants of less than 31 weeks' postmenstrual age who were randomised to receive either 1 mL of 24% sucrose or sterile water up to three times, two minutes apart, for all painful procedures over a seven‐day period. Higher frequency of sucrose doses was predictive of lower awareness, orientation (AO), and motor development and vigour (MDV) on the NAPI scale at 36 weeks, and lower (MDV) at 40 weeks. At two weeks' postnatal age, a higher number of doses of sucrose was predictive of higher Neuro‐Biological Risk Score (NBRS) scores. Proposed explanations were that: (a) low neurodevelopmental scores could be related to infants receiving sucrose during the one‐week study period only, and ongoing exposure to painful procedures might have resulted in heightened sensitivity to pain; or (b) the sample size was inadequate to identify other explanatory variables. Further analysis of these same data five years later revealed that 10 or fewer doses of sucrose over a 24‐hour period were unlikely to be related to poorer neurodevelopmental scores at term equivalence, although no follow‐up testing was conducted to determine if these differences were sustained (<a href="./references#CD014806-bbs2-0156" title="JohnstonCC , FilionF , SniderL , LimperopoulosC , MajnemerA , PelausaE , et al. How much sucrose is too much sucrose?Pediatrics2007;119(1):226. [DOI: 10.1542/peds.2006-3001] [PMID: 17200300]">Johnston 2007</a>). <a href="./references#CD014806-bbs2-0063" title="BangaS , DattaV , RehanHS , BhakhriBK . Effects of sucrose analgesia, for repeated painful procedures, on short-term neurobehavioral outcome of preterm neonates: a randomized controlled trial. Journal of Tropical Pediatrics2016;62(2):101-6. [DOI: 10.1093/tropej/fmv079] [PMID: 26615181]">Banga 2016</a> reported that 93 infants randomised to either repeated doses of sucrose or water for painful procedures for seven consecutive days showed no differences in MDV or AO scores of the NAPI scale or adverse events. <a href="./references#CD014806-bbs2-0047" title="StevensB , YamadaJ , BeyeneJ , GibbinsS , PetryshenP , StinsonJ , et al. Consistent management of repeated procedural pain with sucrose in preterm neonates: is it effective and safe for repeated use over time?Clinical Journal of Pain2005;21(6):543-8. [DOI: 10.1097/01.ajp.0000149802.46864.e2] [PMID: 16215340]">Stevens 2005a</a> reported no differences between sucrose + pacifier, water + pacifier, or the standard care group on neurobiological risk status outcomes. </p> <p>The biochemical effects following sucrose administration are being explored. <a href="./references#CD014806-bbs2-0003" title="AsmeromY , SlaterL , BoskovicDS , BahjriK , HoldenMS , PhillipsR , et al. Oral sucrose for heel lance increases adenosine triphosphate use and oxidative stress in preterm neonates. Journal of Pediatrics2013;163(1):29-35.e1. [DOI: 10.1016/j.jpeds.2012.12.088] [PMID: 23415615]">Asmerom 2013</a> indicated that a single dose of 24% sucrose (0.5‐2 mL, according to infant's weight) administered prior to heel‐lance resulted in increase of adenosine triphosphate (ATP) degradation and oxidative stress in preterm infants. In a subsequent study, <a href="./references#CD014806-bbs2-0060" title="AngelesDM , AsmeromY , BoskovicDS , SlaterL , Bacot-CarterS , BahjriK , et al. Oral sucrose for heel lance enhances adenosine triphosphate use in preterm neonates with respiratory distress. SAGE Open Medicine2015;3:2050312115611431. [PMID: 26770807]">Angeles 2015</a> reported that preterm infants who were intubated and/or receiving ⩾30% FiO<sub>2</sub> displayed increased markers of ATP use following a single dose of oral sucrose given prior to heel lance. These results indicate the need to further investigate the short‐term effects of sucrose administration, on objective markers such as ATP degradation, oxidative stress, and cell injury. </p> <p><a href="./references#CD014806-bbs2-0165" title="McPhersonC , MillerSP , El-DibM , MassaroAN , InderTE . The influence of pain, agitation, and their management on the immature brain. Pediatric Research2020;88(2):168-75. [DOI: 10.1038/s41390-019-0744-6] [PMID: 31896130]">McPherson 2020</a> argues that there is still a limited understanding of the mechanism and efficacy of sucrose administration and therefore caution is required for repeated use in regard to long‐term neurodevelopmental outcomes, especially for preterm infants who are frequently exposed to repeated doses of sucrose in the early stages of brain development. </p> <p>The results of this current review indicate the need for further research on the long‐term effects of repeated doses of sucrose (<a href="./references#CD014806-bbs2-0119" title="Committee on Fetus and Newborn and Section on Anesthesiology and Pain Medicine. Prevention and management of procedural pain in the neonate: an update. Pediatrics2016;137(2):e20154271. [DOI: 10.1542/peds.2015-4271] [PMID: 26810788]">AAP 2016</a>; <a href="./references#CD014806-bbs2-0048" title="StevensB , YamadaJ , Campbell-YeoM , GibbinsS , HarrisonD , DionneK , et al. The minimally effective dose of sucrose for procedural pain relief in neonates: a randomized controlled trial. BMC Pediatrics2018;18(1):85. [DOI: 10.1186/s12887-018-1026-x] [DOI: 10.1186/s12887-018-1026-x] [PMID: 29475433]">Stevens 2018</a>), where total volume administered for procedural pain over time should be tracked, and the proportion of painful events with/without pain‐relieving intervention(s) and characteristics of the infant (e.g. GA, PNA, severity of illness) should be taken into account. Long‐term neurodevelopmental outcomes should be assessed using a standardised and validated assessment tool, a child developmental specialist, or both at 18 to 24 months or at any later age in childhood (<a href="./references#CD014806-bbs2-0119" title="Committee on Fetus and Newborn and Section on Anesthesiology and Pain Medicine. Prevention and management of procedural pain in the neonate: an update. Pediatrics2016;137(2):e20154271. [DOI: 10.1542/peds.2015-4271] [PMID: 26810788]">AAP 2016</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD014806-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram: review update" data-id="CD014806-fig-0001" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram: review update</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD014806-fig-0002" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD014806-fig-0003" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 1: PIPP scores at 30 seconds after lancing (term and preterm infants)" data-id="CD014806-fig-0004" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 1: PIPP scores at 30 seconds after lancing (term and preterm infants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 2: PIPP scores at 30 seconds after heel lancing (term infants)" data-id="CD014806-fig-0005" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 2: PIPP scores at 30 seconds after heel lancing (term infants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 3: PIPP scores at 30 seconds after lancing (preterm infants)" data-id="CD014806-fig-0006" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 3: PIPP scores at 30 seconds after lancing (preterm infants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 4: PIPP scores at 60 seconds after lancing (preterm and term infants)" data-id="CD014806-fig-0007" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 4: PIPP scores at 60 seconds after lancing (preterm and term infants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 5: DAN scores at 30 seconds after heel lancing" data-id="CD014806-fig-0008" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 5: DAN scores at 30 seconds after heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 6: NIPS scores during heel lance" data-id="CD014806-fig-0009" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 6: NIPS scores during heel lance </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 7: Total crying time (in seconds) after lancing" data-id="CD014806-fig-0010" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 7: Total crying time (in seconds) after lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 8: Duration of first cry (in seconds) after lancing" data-id="CD014806-fig-0011" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 8: Duration of first cry (in seconds) after lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 9: Heart rate (beats per minute (bpm)) during heel lancing" data-id="CD014806-fig-0012" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 9: Heart rate (beats per minute (bpm)) during heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 10: Percentage change in heart rate after heel lancing" data-id="CD014806-fig-0013" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 10: Percentage change in heart rate after heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 11: Respiratory rate (breaths per minute) during heel lancing" data-id="CD014806-fig-0014" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 11: Respiratory rate (breaths per minute) during heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 12: Oxygen saturation (%) during heel lancing" data-id="CD014806-fig-0015" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 12: Oxygen saturation (%) during heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 13: Skin blood flow during heel lancing (perfusion units (PU))" data-id="CD014806-fig-0016" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 13: Skin blood flow during heel lancing (perfusion units (PU)) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 14: Nociceptive‐specific brain activity (mean weight)" data-id="CD014806-fig-0017" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: Sucrose (any concentration, any dose) versus placebo, water, or no intervention, Outcome 14: Nociceptive‐specific brain activity (mean weight) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Sucrose (any concentration, any dose) versus NNS, Outcome 1: PIPP scores during recovery" data-id="CD014806-fig-0018" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Sucrose (any concentration, any dose) versus NNS, Outcome 1: PIPP scores during recovery </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Sucrose (any concentration, any dose) versus NNS, Outcome 2: DAN scores at 30 seconds after heel lancing" data-id="CD014806-fig-0019" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Sucrose (any concentration, any dose) versus NNS, Outcome 2: DAN scores at 30 seconds after heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Sucrose (any concentration, any dose) versus NNS, Outcome 3: Crying time (%) during heel lancing" data-id="CD014806-fig-0020" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Sucrose (any concentration, any dose) versus NNS, Outcome 3: Crying time (%) during heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Sucrose (any concentration, any dose) versus NNS, Outcome 4: Total crying time (in seconds)" data-id="CD014806-fig-0021" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Sucrose (any concentration, any dose) versus NNS, Outcome 4: Total crying time (in seconds) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Sucrose (any concentration, any dose) versus NNS, Outcome 5: Duration of first cry (in seconds)" data-id="CD014806-fig-0022" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Sucrose (any concentration, any dose) versus NNS, Outcome 5: Duration of first cry (in seconds) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Sucrose (any concentration, any dose) versus NNS, Outcome 6: Heart rate (bpm) during heel lancing" data-id="CD014806-fig-0023" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Sucrose (any concentration, any dose) versus NNS, Outcome 6: Heart rate (bpm) during heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Sucrose (any concentration, any dose) versus NNS, Outcome 7: Oxygen saturation (%) during heel lancing" data-id="CD014806-fig-0024" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Sucrose (any concentration, any dose) versus NNS, Outcome 7: Oxygen saturation (%) during heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Sucrose + NNS versus NNS (with or without water), Outcome 1: PIPP scores during heel lancing" data-id="CD014806-fig-0025" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Sucrose + NNS versus NNS (with or without water), Outcome 1: PIPP scores during heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Sucrose + NNS versus NNS (with or without water), Outcome 2: PIPP scores during recovery" data-id="CD014806-fig-0026" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Sucrose + NNS versus NNS (with or without water), Outcome 2: PIPP scores during recovery </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Sucrose + NNS versus NNS (with or without water), Outcome 3: NFCS during heel lancing" data-id="CD014806-fig-0027" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Sucrose + NNS versus NNS (with or without water), Outcome 3: NFCS during heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Sucrose + NNS versus NNS (with or without water), Outcome 4: Crying time (%) during heel lancing" data-id="CD014806-fig-0028" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Sucrose + NNS versus NNS (with or without water), Outcome 4: Crying time (%) during heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Sucrose + NNS versus NNS (with or without water), Outcome 5: Crying time (in seconds)" data-id="CD014806-fig-0029" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: Sucrose + NNS versus NNS (with or without water), Outcome 5: Crying time (in seconds) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Sucrose + NNS versus NNS (with or without water), Outcome 6: Heart rate (bpm) during heel lancing" data-id="CD014806-fig-0030" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: Sucrose + NNS versus NNS (with or without water), Outcome 6: Heart rate (bpm) during heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-003.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Sucrose + NNS versus NNS (with or without water), Outcome 7: Oxygen saturation (%) during heel lancing" data-id="CD014806-fig-0031" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-003.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-003.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3: Sucrose + NNS versus NNS (with or without water), Outcome 7: Oxygen saturation (%) during heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-003.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Sucrose (any concentration, any dose) versus glucose (any concentration, any dose), Outcome 1: PIPP scores at 30 seconds after heel lancing" data-id="CD014806-fig-0032" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Sucrose (any concentration, any dose) versus glucose (any concentration, any dose), Outcome 1: PIPP scores at 30 seconds after heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Sucrose (any concentration, any dose) versus glucose (any concentration, any dose), Outcome 2: PIPP scores at 60 seconds after heel lancing" data-id="CD014806-fig-0033" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Sucrose (any concentration, any dose) versus glucose (any concentration, any dose), Outcome 2: PIPP scores at 60 seconds after heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Sucrose (any concentration, any dose) versus glucose (any concentration, any dose), Outcome 3: Heart rate (bpm) during heel lancing" data-id="CD014806-fig-0034" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: Sucrose (any concentration, any dose) versus glucose (any concentration, any dose), Outcome 3: Heart rate (bpm) during heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Sucrose (any concentration, any dose) versus glucose (any concentration, any dose), Outcome 4: Percentage change in heart rate 1 min after heel lancing" data-id="CD014806-fig-0035" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: Sucrose (any concentration, any dose) versus glucose (any concentration, any dose), Outcome 4: Percentage change in heart rate 1 min after heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-004.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Sucrose (any concentration, any dose) versus glucose (any concentration, any dose), Outcome 5: Total crying time (in seconds)" data-id="CD014806-fig-0036" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-004.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-004.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4: Sucrose (any concentration, any dose) versus glucose (any concentration, any dose), Outcome 5: Total crying time (in seconds) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-004.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Sucrose (any concentration, any dose) versus breastfeeding, Outcome 1: PIPP scores at 30 seconds after heel lancing (term and preterm infants)" data-id="CD014806-fig-0037" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Sucrose (any concentration, any dose) versus breastfeeding, Outcome 1: PIPP scores at 30 seconds after heel lancing (term and preterm infants) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Sucrose (any concentration, any dose) versus breastfeeding, Outcome 2: Comfortneo scores after lancing" data-id="CD014806-fig-0038" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Sucrose (any concentration, any dose) versus breastfeeding, Outcome 2: Comfortneo scores after lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Sucrose (any concentration, any dose) versus human milk, Outcome 1: PIPP‐R scores during heel lancing" data-id="CD014806-fig-0039" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Sucrose (any concentration, any dose) versus human milk, Outcome 1: PIPP‐R scores during heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Sucrose (any concentration, any dose) versus human milk, Outcome 2: PIPP‐R scores at 30 seconds after heel lancing" data-id="CD014806-fig-0040" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: Sucrose (any concentration, any dose) versus human milk, Outcome 2: PIPP‐R scores at 30 seconds after heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-006.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Sucrose (any concentration, any dose) versus human milk, Outcome 3: PIPP‐R scores at 60 seconds after heel lancing" data-id="CD014806-fig-0041" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-006.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-006.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6: Sucrose (any concentration, any dose) versus human milk, Outcome 3: PIPP‐R scores at 60 seconds after heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-006.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-006.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Sucrose (any concentration, any dose) versus human milk, Outcome 4: DAN scores at 30 seconds after heel lancing" data-id="CD014806-fig-0042" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-006.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-006.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6: Sucrose (any concentration, any dose) versus human milk, Outcome 4: DAN scores at 30 seconds after heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-006.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-006.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Sucrose (any concentration, any dose) versus human milk, Outcome 5: Crying time (in seconds)" data-id="CD014806-fig-0043" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-006.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-006.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6: Sucrose (any concentration, any dose) versus human milk, Outcome 5: Crying time (in seconds) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-006.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Sucrose versus recorded music, Outcome 1: Heart rate (bpm) during heel lancing" data-id="CD014806-fig-0044" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Sucrose versus recorded music, Outcome 1: Heart rate (bpm) during heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-007.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Sucrose versus recorded music, Outcome 2: Oxygen saturation during heel lancing" data-id="CD014806-fig-0045" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-007.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-007.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7: Sucrose versus recorded music, Outcome 2: Oxygen saturation during heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-007.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Sucrose versus laser acupuncture, Outcome 1: NIPS scores" data-id="CD014806-fig-0046" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: Sucrose versus laser acupuncture, Outcome 1: NIPS scores</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-008.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Sucrose versus laser acupuncture, Outcome 2: Crying time (in seconds)" data-id="CD014806-fig-0047" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-008.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-008.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8: Sucrose versus laser acupuncture, Outcome 2: Crying time (in seconds)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-008.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-009.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Repeated heel lancing: sucrose versus facilitated tucking, Outcome 1: Total Bernese Pain Scale for neonates during heel lancing" data-id="CD014806-fig-0048" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-009.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-009.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9: Repeated heel lancing: sucrose versus facilitated tucking, Outcome 1: Total Bernese Pain Scale for neonates during heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-009.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-009.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Repeated heel lancing: sucrose versus facilitated tucking, Outcome 2: Total Bernese Pain Scale for neonates during recovery" data-id="CD014806-fig-0049" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-009.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-009.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9: Repeated heel lancing: sucrose versus facilitated tucking, Outcome 2: Total Bernese Pain Scale for neonates during recovery </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-009.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-010.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Repeated heel lancing: sucrose versus skin‐to‐skin care, Outcome 1: PIPP scores at 30 seconds after heel lancing" data-id="CD014806-fig-0050" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-010.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-010.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10: Repeated heel lancing: sucrose versus skin‐to‐skin care, Outcome 1: PIPP scores at 30 seconds after heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-010.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD014806-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/urn:x-wiley:14651858:media:CD014806:CD014806-CMP-010.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Repeated heel lancing: sucrose versus skin‐to‐skin care, Outcome 2: PIPP scores at 60 seconds after heel lancing" data-id="CD014806-fig-0051" src="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-010.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_t/tCD014806-CMP-010.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10: Repeated heel lancing: sucrose versus skin‐to‐skin care, Outcome 2: PIPP scores at 60 seconds after heel lancing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD014806/media/CDSR/CD014806/image_n/nCD014806-CMP-010.02.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD014806-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose, with or without NNS) compared to control (water, placebo, or no intervention) for analgesia for heel lancing in neonates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sucrose (any concentration, any dose, with or without NNS) compared to control (water, placebo, or no intervention) for analgesia for heel lancing in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> neonates<br/><b>Setting:</b> neonatal units<br/><b>Intervention:</b> sucrose (any concentration, any dose, with or without NNS)<br/><b>Comparison:</b> control (water, placebo, or no intervention) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with control (water, placebo, or no intervention)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with sucrose (any concentration, any dose, with or without NNS)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 30 seconds after lancing (term and preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 30 seconds<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 30 seconds after lancing (term and preterm infants) ranged from <b>4.9‐13.3</b><sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>1.74 lower</b><br/>(2.11 lower to 1.37 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>547<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose (with or without NNS) compared to control (water, placebo, or no intervention) probably results in a reduction in PIPP scores at 30 seconds after heel lancing in term and preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 30 seconds after heel lancing (term infants)<br/>Scale from: 0 to 21<br/>follow‐up: 30 seconds<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 30 seconds after heel lancing (term infants) ranged from <b>4.9‐8.5</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.87 lower</b><br/>(1.8 lower to 0.06 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>227<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose (with or without NNS) compared to control (water, placebo, or no intervention) results in little to no difference in PIPP scores at 30 seconds after heel lancing in term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 30 seconds after lancing (preterm infants)<br/>Scale from: 0 to 18<br/>follow‐up: 30 seconds<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 30 seconds after lancing (preterm infants) ranged from <b>6.3‐13.3</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>1.88 lower</b><br/>(2.32 lower to 1.44 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>192<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose (with or without NNS) compared to control (water, placebo, or no intervention) results in little to no difference in PIPP scores at 30 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 60 seconds after lancing (preterm and term infants)<br/>Scale from: 0 to 21<br/>follow‐up: 60 seconds<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 60 seconds after lancing (preterm and term infants) ranged from <b>10.54‐11.2</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>2.14 lower</b><br/>(3.34 lower to 0.94 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>164<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose (with or without NNS) compared to control (water, placebo, or no intervention) probably results in a reduction in PIPP scores at 60 seconds after heel lancing in preterm and term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DAN scores at 30 seconds after heel lancing (term infants)<br/>Scale from: 0 to 10<br/>follow‐up: 30 seconds<sup>f</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean DAN scores at 30 seconds after heel lancing (term infants) was <b>9.5</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>1.9 lower</b><br/>(8.58 lower to 4.78 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>g,</sup><sup>h</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose (with or without NNS) compared to control (water, placebo, or no intervention) in DAN scores at 30 seconds after heel lancing in term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NIPS scores immediately after heel lance (term infants)<br/>Scale from: 0 to 7<sup>i,</sup><sup>j</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean NIPS scores immediately after heel lance (term infants) was <b>3</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>2 lower</b><br/>(2.42 lower to 1.58 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose (with or without NNS) compared to control (water, placebo, or no intervention) probably results in a reduction in NIPS scores immediately after heel lancing in term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799338500427522" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799338500427522</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Premature Infant Pain Profile (PIPP).<br/><sup>b</sup> Downgraded one level for serious inconsistency (due to I² = 62%). <br/><sup>c</sup> Downgraded one level for serious inconsistency (due to I² = 47%).<br/><sup>d</sup> Downgraded one level due to wide confidence interval. <br/><sup>e</sup> Downgraded two levels for very serious inconsistency (due to I² = 75%).<br/><sup>f</sup> Douleur Aiguë du Nouveau‐né Scale (DAN).<br/><sup>g</sup> Downgraded two levels due to concerns about performance and detection bias, and unclear risk of bias on allocation, attrition, and reporting bias.<br/><sup>h</sup> Downgraded two levels due to wide confidence interval and small sample size.<br/><sup>i</sup> Neonatal Infant Pain Scale (NIPS). <br/><sup>j</sup> Pain scores were measured immediately after heel lancing according to authors’ description as reported in their study. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose, with or without NNS) compared to control (water, placebo, or no intervention) for analgesia for heel lancing in neonates</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD014806-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to NNS for analgesia for heel lancing in neonates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sucrose (any concentration, any dose) compared to NNS for analgesia for heel lancing in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> neonates<br/><b>Setting:</b> neonatal units <br/><b>Intervention:</b> sucrose (any concentration, any dose)<br/><b>Comparison:</b> NNS </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with NNS</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with sucrose (any concentration, any dose)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores during recovery after heel lancing (preterm infants)<br/>Scale from: 0 to 21<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores during recovery after heel lancing (preterm infants) was <b>6.8</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.6 higher</b><br/>(0.3 lower to 1.5 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose compared to NNS in PIPP scores during recovery after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DAN scores at 30 seconds after heel lancing (term infants)<br/>Scale from: 0 to 10<br/>follow‐up: 30 seconds<sup>e</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean DAN scores at 30 seconds after heel lancing (term infants) was <b>8.8</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>1.2 lower</b><br/>(7.87 lower to 5.47 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>d,</sup><sup>f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose compared to NNS in DAN scores at 30 seconds after heel lancing in term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799490342620980" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799490342620980</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Premature Infant Pain Profile (PIPP).<br/><sup>b</sup> Pain scores were measured during recovery after heel lancing according to authors’ description as reported in their study.<br/><sup>c</sup> Downgraded two levels due to concerns about selection, performance, and detection bias. <br/><sup>d</sup> Downgraded two levels due to wide confidence interval and small sample size. <br/><sup>e</sup> Douleur Aiguë du Nouveau‐né Scale (DAN).<br/><sup>f</sup> Downgraded two levels due to concerns about performance and detection bias, and unclear risk of bias on allocation, attrition, and reporting bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to NNS for analgesia for heel lancing in neonates</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD014806-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) + NNS compared to NNS (with or without water) for analgesia for heel lancing in neonates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sucrose (any concentration, any dose) + NNS compared to NNS (with or without water) for analgesia for heel lancing in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> neonates<br/><b>Setting:</b> neonatal units<br/><b>Intervention:</b> sucrose (any concentration, any dose) + NNS<br/><b>Comparison:</b> NNS (with or without water) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with NNS (with or without water)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with sucrose (any concentration, any dose) + NNS</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores during heel lancing (preterm infants)<br/>Scale from: 0 to 21<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores during heel lancing (preterm infants) was <b>9.3</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>4.9 lower</b><br/>(5.73 lower to 4.07 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose + NNS compared to NNS in PIPP scores during heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores during recovery after heel lancing (preterm infants)<br/>Scale from: 0 to 21<sup>a,</sup><sup>e</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores during recovery after heel lancing (preterm infants) was <b>6.8</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>3.8 lower</b><br/>(4.47 lower to 3.13 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose + NNS compared to NNS in PIPP scores during recovery after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NFCS during heel lancing (term infants)<br/>Scale from: 0 to 9<sup>f,</sup><sup>g</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean NFCS during heel lancing (term infants) was <b>2.1</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.6 lower</b><br/>(1.47 lower to 0.27 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>h,</sup><sup>i</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose + NNS compared to NNS in NFCS scores during heel lancing in term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799652843327471" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799652843327471</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Premature Infant Pain Profile (PIPP).<br/><sup>b</sup> Pain scores were measured during heel lancing according to authors’ description as reported in their study.<br/><sup>c</sup> Downgraded two levels due to concerns about selection, performance, and detection bias. <br/><sup>d</sup> Downgraded two levels due to wide confidence interval and small sample size. <br/><sup>e</sup> Pain scores were measured during recovery after heel lancing according to authors’ description as reported in their study.<br/><sup>f</sup> Neonatal Facial Coding System (NFCS).<br/><sup>g</sup> Pain scores were measured during heel lancing according to authors' description as reported in their study. <br/><sup>h</sup> Downgraded two levels as five items were deemed unclear for the risk of bias assessment. <br/><sup>i</sup> Downgraded one level due to wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) + NNS compared to NNS (with or without water) for analgesia for heel lancing in neonates</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD014806-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to glucose (any concentration, any dose) for heel lancing in neonates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sucrose (any concentration, any dose) compared to glucose (any concentration, any dose) for heel lancing in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> neonates<br/><b>Setting:</b> neonatal units<br/><b>Intervention:</b> sucrose (any concentration, any dose)<br/><b>Comparison:</b> glucose (any concentration, any dose) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with glucose (any concentration, any dose)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with sucrose (any concentration, any dose)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 30 seconds after heel lancing (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 30 seconds<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 30 seconds after heel lancing (preterm infants) was <b>2.74</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.26 higher</b><br/>(0.7 lower to 1.22 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to glucose results in little to no difference in PIPP scores at 30 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 60 seconds after heel lancing (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 60 seconds<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 60 seconds after heel lancing (preterm infants) was <b>1.72</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.02 lower</b><br/>(0.79 lower to 0.75 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to glucose results in little to no difference in PIPP scores at 60 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799782182817780" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799782182817780</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Premature Infant Pain Profile (PIPP). <br/><sup>b</sup> Downgraded one level due to high risk of selective report. <br/><sup>c</sup> Downgraded one level due to wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to glucose (any concentration, any dose) for heel lancing in neonates</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD014806-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to breastfeeding for analgesia for heel lancing in neonates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sucrose (any concentration, any dose) compared to breastfeeding for analgesia for heel lancing in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> neonates<br/><b>Setting:</b> neonatal units<br/><b>Intervention:</b> sucrose (any concentration, any dose, with or without NNS)<br/><b>Comparison:</b> breastfeeding </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with breastfeeding</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with sucrose (any concentration, any dose, with or without NNS)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 30 seconds after heel lancing (term and preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 30 seconds<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 30 seconds after heel lancing (term and preterm infants) ranged from <b>5‐7</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.7 higher</b><br/>(0.49 lower to 1.88 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>148<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,</sup><sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose compared to breastfeeding in PIPP scores at 30 seconds after heel lancing in preterm and term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>COMFORTneo scores after heel lancing (preterm infants)<br/>Scale from: 6 to 30<sup>e</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean cOMFORTneo scores after heel lancing (preterm infants) was <b>18.6</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>2.6 lower</b><br/>(3.06 lower to 2.14 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>f,</sup><sup>g</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose compared to breastfeeding on COMFORTneo scores after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799948390502701" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425799948390502701</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Premature Infant Pain Profile (PIPP).<br/><sup>b</sup> Downgraded one level due to inability to blind outcomes and assessors. <br/><sup>c</sup> Downgraded two levels for very serious inconsistency (due to I²=94%).<br/><sup>d</sup> Downgraded one level due to wide confidence interval. <br/><sup>e</sup> Pain scores were measured after heel lancing according to authors’ description as reported in their study.<br/><sup>f</sup> Downgraded one level due to high risk of performance and detection bias.<br/><sup>g</sup> Downgraded two levels due to wide confidence interval and small sample size. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to breastfeeding for analgesia for heel lancing in neonates</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD014806-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to expressed breast milk for analgesia for heel lancing in neonates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sucrose (any concentration, any dose) compared to expressed breast milk for analgesia for heel lancing in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> neonates<br/><b>Setting:</b> neonatal units<br/><b>Intervention:</b> sucrose(any concentration, any dose)<br/><b>Comparison:</b> expressed breast milk </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with expressed breast milk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with sucrose(any concentration, any dose)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP‐R scores during heel lancing (preterm infants)<br/>Scale from: 0 to 21<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP‐R scores during heel lancing (preterm infants) was <b>0</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.3 higher</b><br/>(0.24 lower to 0.84 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to expressed breast milk may result in little to no difference in PIPP‐R scores during heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP‐R scores at 30 seconds after heel lancing (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 30 seconds<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP‐R scores at 30 seconds after heel lancing (preterm infants) was <b>0</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.3 higher</b><br/>(0.11 lower to 0.71 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to expressed breast milk may result in little to no difference in PIPP‐R scores at 30 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP‐R scores at 60 seconds after heel lancing (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 60 seconds<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP‐R scores at 60 seconds after heel lancing (preterm infants) was <b>0</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>1.1 higher</b><br/>(0.34 higher to 1.86 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to expressed breast milk may result in slightly increased PIPP‐R scores at 60 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DAN scores at 30 seconds after heel lancing (term infants)<br/>Scale from: 0 to 10<br/>follow‐up: 30 seconds<sup>e</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean DAN scores at 30 seconds after heel lancing (term infants) was <b>9.4</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>1.8 lower</b><br/>(8.47 lower to 4.87 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>f,</sup><sup>g</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose compared to expressed breast milk in DAN scores at 30 seconds after heel lancing in term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425800004636643632" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425800004636643632</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Premature Infant Pain Profile ‐ Revised (PIPP‐R). <br/><sup>b</sup> Pain scores were measured during heel lancing according to authors’ description as reported in their study.<br/><sup>c</sup> Velumula 2020, the only study in these analyses, is at unclear risk of performance and detection bias. <br/><sup>d</sup> Downgraded one level due to wide confidence interval. <br/><sup>e</sup> Douleur Aiguë du Nouveau‐né Scale (DAN).<br/><sup>f</sup> Downgraded two levels due to concerns about performance and detection bias, and unclear risk of bias on allocation, attrition, and reporting. <br/><sup>g</sup> Downgraded two levels due to wide confidence interval and small sample size. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to expressed breast milk for analgesia for heel lancing in neonates</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD014806-tbl-0007"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to laser acupuncture for analgesia for heel lancing in neonates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sucrose (any concentration, any dose) compared to laser acupuncture for analgesia for heel lancing in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> neonates<br/><b>Setting:</b> neonatal units<br/><b>Intervention:</b> sucrose (any concentration, any dose)<br/><b>Comparison:</b> laser acupuncture </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with laser acupuncture</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with sucrose (any concentration, any dose)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NIPS scores during heel lancing (term infants)<br/>Scale from: 0 to 7<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean NIPS scores during heel lancing (term infants) was <b>4.52</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.86 lower</b><br/>(1.43 lower to 0.29 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose compared to laser acupuncture in NIPS scores during heel lancing in term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425800210284679704" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425800210284679704</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Neonatal Infant Pain Scale (NIPS). <br/><sup>b</sup> Pain scores were measured during heel lancing according to authors’ description as reported in their study.<br/><sup>c</sup> Downgraded two levels due to concerns about high risk of selection and performance bias and unclear risk of random sequence generation and reporting bias.<br/><sup>d</sup> Downgraded two levels due to wide confidence interval and small sample size. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to laser acupuncture for analgesia for heel lancing in neonates</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD014806-tbl-0008"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to facilitated tucking for analgesia during repeated heel lancing in neonates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sucrose (any concentration, any dose) compared to facilitated tucking for analgesia during repeated heel lancing in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> neonates<br/><b>Setting:</b> Neonatal units<br/><b>Intervention:</b> sucrose (any concentration, any dose)<br/><b>Comparison:</b> facilitated tucking </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with facilitated tucking</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with sucrose (any concentration, any dose)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BPSN scores during heel lancing (preterm infants)<br/>Scale from: 0 to 27<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean BPSN scores during heel lancing (preterm infants) was <b>9.75</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>2.27 lower</b><br/>(4.66 lower to 0.12 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose compared to facilitated tucking on BPSN scores during heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BPSN scores during recovery after heel lancing (preterm infants)<br/>Scale from: 0 to 27<sup>a,</sup><sup>e</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean BPSN scores during recovery after heel lancing (preterm infants) was <b>5.18</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.31 lower</b><br/>(1.72 lower to 1.1 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of sucrose compared to facilitated tucking on BPSN scores after heel lancing in term infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425800249217258038" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425800249217258038</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Bernese Pain Scale for Neonates (BPSN).<br/><sup>b</sup> Pain scores were measured during heel lancing according to authors’ description as reported in their study.<br/><sup>c</sup> Downgraded one level due to concerns about performance and detection bias. <br/><sup>d</sup> Downgraded two levels due to wide confidence interval and small sample size. <br/><sup>e</sup> Pain scores were measured during recovery after heel lancing according to authors’ description as reported in their study. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to facilitated tucking for analgesia during repeated heel lancing in neonates</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD014806-tbl-0009"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to skin to skin care + water for analgesia during repeated heel lancing in neonates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Sucrose (any concentration, any dose) compared to skin to skin care + water for analgesia during repeated heel lancing in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> neonates<br/><b>Setting:</b> Neonatal units<br/><b>Intervention:</b> Sucrose(any concentration, any dose)<br/><b>Comparison:</b> skin to skin care + water </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with skin to skin care + water</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with Sucrose(any concentration, any dose)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 30 seconds after heel lancing ‐ Lancing #1 (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 30 seconds<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 30 seconds after heel lancing ‐ Lancing #1 (preterm infants) was <b>5.76</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.13 higher</b><br/>(0.7 lower to 0.96 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>151<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to skin to skin care results in little to no difference in PIPP scores at 30 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 30 seconds after heel lancing ‐ Lancing #2 (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 30 seconds<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 30 seconds after heel lancing ‐ Lancing #2 (preterm infants) was <b>6.43</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.56 lower</b><br/>(1.57 lower to 0.45 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>144<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to skin to skin care results in little to no difference in PIPP scores at 30 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 30 seconds after heel lancing ‐ Lancing #3 (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 30 seconds<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 30 seconds after heel lancing ‐ Lancing #3 (preterm infants) was <b>6.3</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.15 lower</b><br/>(1.26 lower to 0.96 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>111<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to skin to skin care results in little to no difference in PIPP scores at 30 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 60 seconds after heel lancing ‐ Lancing #1 (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 60 seconds<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 60 seconds after heel lancing ‐ Lancing #1 (preterm infants) was <b>6.39</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.61 lower</b><br/>(1.55 lower to 0.33 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>154<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to skin to skin care results in little to no difference in PIPP scores at 60 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 60 seconds after heel lancing ‐ Lancing #2 (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 60 seconds<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 60 seconds after heel lancing ‐ Lancing #2 (preterm infants) was <b>5.62</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.12 lower</b><br/>(0.99 lower to 0.75 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>143<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to skin to skin care results in little to no difference in PIPP scores at 60 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PIPP scores at 60 seconds after heel lancing ‐ Lancing #3 (preterm infants)<br/>Scale from: 0 to 21<br/>follow‐up: 60 seconds<sup>a,</sup><sup>b</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PIPP scores at 60 seconds after heel lancing ‐ Lancing #3 (preterm infants) was <b>5.95</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.4 lower</b><br/>(1.48 lower to 0.68 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>111<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that sucrose compared to skin to skin care results in little to no difference in PIPP scores at 60 seconds after heel lancing in preterm infants. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425800272531558981" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_425800272531558981</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Medically indicated heel lances at 3 different time points throughout the study period of time were observed. Efforts were made to space data collection periods as soon as possible after enrollment (lancing #1), midway through the infant’s hospital stay (lancing #2), and as close as possible to discharge from the NICU (lancing #3). The three procedures were completed a minimum of 24 hours apart<br/><sup>b</sup> Premature Infant Pain Profile (PIPP).<br/><sup>c</sup> Downgraded one level due to concerns about performance and detection bias. <br/><sup>d</sup> Downgraded one level due to wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Summary of findings table ‐ Sucrose (any concentration, any dose) compared to skin to skin care + water for analgesia during repeated heel lancing in neonates</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD014806-tbl-0010"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of included studies assessing pain during heel lances</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Procedure</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Metrics used</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Results</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Funding sources and declaration of interest</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0001" title="AbbasogluA , CabiogluMT , TugcuAU , YapakciE , TekindalMA , TarcanA . Laser acupuncture before heel lancing for pain management in healthy term newborns: a randomised controlled trial. Acupuncture in Medicine2015;33(6):445-50. [DOI: 10.1136/acupmed-2015-010765] [PMID: 26438556]">Abbasoglu 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42 term newborns, undergoing heel lancing between postnatal days 3 and 8 as part of neonatal screening </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0010"> <li> <p>Laser acupuncture: 0.3 J of energy was applied to the Yintang point using a Laser PREMIO‐30 unit for 30 s </p> </li> <li> <p>Sucrose: 0.5 mL 24% solution was given orally via syringe 2 min before heel lancing</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0011"> <li> <p>NIPS</p> </li> <li> <p>Crying time</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean and SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The NIPS score was lower in the sucrose group than in the laser group (3.66 ± 1.01 vs 4.52 ± 0.87; P = 0.006). </p> <p>The crying time was lower in the sucrose group than in the laser group (46.66 s ± 37.82 s vs 97.95 s ± 34.23 s; P = 0.000). </p> <p>No infant developed any clinically visible changes on the skin, and no side effects were observed in their comparison of laser acupuncture with oral sucrose. </p> <p>Data are included in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: none declared</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0002" title="Altun-KöroğluO , ÖzekE , BilgenH , CebeciD . Hindmilk for procedural pain in term neonates. Turkish Journal of Pediatrics2010;52(6):623-9. [PMID: 21428195]">Altun‐Köroğlu 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75 full‐term infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0012"> <li> <p>3 mL hindmilk (n = 25)</p> </li> <li> <p>3 mL 12.5% sucrose solution (n = 25)</p> </li> <li> <p>3 mL distilled water (n = 25)</p> </li> </ul> </p> <p>The volume of 3 mL was provided in 3 doses (1 mL prior to, 1 mL immediately before, and 1 mL after the procedure) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0013"> <li> <p>NFCS</p> </li> <li> <p>Crying time</p> </li> <li> <p>Duration of crying</p> </li> <li> <p>HR</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median and IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median crying time, duration of first cry and tachycardia, and time needed to return to baseline were longest in the distilled water group and shorter in the hindmilk group when compared to distilled water group (P = 0.022, P = 0.008, P = 0.009 and P = 0.038, respectively). </p> <p>No differences were observed between the hindmilk and sucrose group for all measures.</p> <p>Maximum HR in hindmilk group was lower than in distilled water group (184 beats/min vs 196 beats/min, P = 0.031). </p> <p>Reduction in average NFCS score. First‐minute NFCS score and fifth‐minute NFCS scores were lower in the hindmilk group compared to the distilled water group (P = 0.006, P = 0.017 and P = 0.021, respectively). </p> <p>No data were included in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0003" title="AsmeromY , SlaterL , BoskovicDS , BahjriK , HoldenMS , PhillipsR , et al. Oral sucrose for heel lance increases adenosine triphosphate use and oxidative stress in preterm neonates. Journal of Pediatrics2013;163(1):29-35.e1. [DOI: 10.1016/j.jpeds.2012.12.088] [PMID: 23415615]">Asmerom 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>131 preterm infants ≤ 36.5 weeks' gestation who:</p> <p> <ul id="CD014806-list-0014"> <li> <p>weighed ≥ 800 g;</p> </li> <li> <p>had a central catheter in place; and</p> </li> <li> <p>required a heel lance</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0015"> <li> <p>Sucrose (24%) with NNS (n = 44): 2 mL for neonates &gt; 2 kg, 1.5 mL for neonates 1.5 kg to 2 kg, and 0.5 mL for neonates &lt; 1.5 kg </p> </li> <li> <p>Placebo + NNS (n = 45)</p> </li> <li> <p>42 infants received no heel lance, no sucrose, or placebo.</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0016"> <li> <p>PIPP after 2 min</p> </li> <li> <p>Plasma hypoxanthine</p> </li> <li> <p>Uric acid</p> </li> <li> <p>Xanthine</p> </li> <li> <p>Allantoin</p> </li> <li> <p>HR</p> </li> <li> <p>SpO<sub>2</sub> </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean and lowest and highest values</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oral sucrose given before a single heel lance decreased behavioural markers of pain.<br/>Sucrose increased markers of ATP use, as evidenced by increases over time in plasma hypoxanthine and uric acid concentrations.<br/>We received the PIPP scores as means and SD from Dr D Angeles, and the data were included in RevMan analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: National Institutes of Health (RO1</p> <p>NR011209)</p> <p>Declaration of interest: none.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0004" title="BenoitB , NewmanA , Martin-MisenerR , LatimerM , Campbell-YeoM . The influence of breastfeeding on cortical and bio-behavioural indicators of procedural pain in newborns: findings of a randomized controlled trial. Early Human Development2021;154:105308. [DOI: 10.1016/j.earlhumdev.2021.105308] [PMID: 33513546]">Benoit 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39 healthy full‐term (born ≥ 37 0/7 weeks' gestation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0017"> <li> <p>BF (n = 20)</p> </li> <li> <p>24% sucrose (0.24 mL) + NNS + containment in a blanket while in an infant cot 2 min prior to heel lance (n = 19) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0018"> <li> <p>Pain‐related potential was recorded on electroencephalogram</p> </li> <li> <p>PIPP‐R at 30 s, 90 s, 120 s after heel lance</p> </li> <li> <p>Physiologic recovery</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PIPP‐R scores: t‐tests were reported; no means or SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Infants in BF group had a smaller, but not different (F[1,15.9] = 0.58, P = 0.64, SE = 11.79), amplitude pain‐related potential (peak amplitude 0.29 μV) following heel lance compared to infants who received oral sucrose (peak amplitude 8.97 μV). Mean PIPP‐R scores were not different between groups following heel lance, however, but represented low pain across groups. Mean time in seconds to physiologic recovery was faster in BF group (M = 17.5, SD = 31.1) compared to oral sucrose group (M = 70.8, SD = 144.3). </p> <p>There were no adverse events or safety concerns in either group.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: IWK Health Centre Category A Operating Grant and the Dalhousie University School of Nursing Research Fund </p> <p>Declaration of interest: none</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0005" title="BlassEM . Milk-induced hypoalgesia in human newborns. Pediatrics1997;99(6):825-9. [DOI: 10.1542/peds.99.6.825] [PMID: 9164777]">Blass 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72 term infants, 22 h to 40 h old</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 mL of one of the following solutions:</p> <p> <ul id="CD014806-list-0019"> <li> <p>water;</p> </li> <li> <p>12% sucrose;</p> </li> <li> <p>protein mixture;</p> </li> <li> <p>7% lactose;</p> </li> <li> <p>dilute fat (coconut and soy oil);</p> </li> <li> <p>concentrated fat;</p> </li> <li> <p>fat and lactose mixture RSF (water, protein, lactose, fat); and</p> </li> <li> <p>milk</p> </li> </ul> </p> <p>n = 8 for all groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0020"> <li> <p>Crying time (%) during blood collection and 1 min, 2 min and 3 min after heel lance</p> </li> <li> <p>Mean percentage of crying time per minute at 1 min, 2 min and 3 min after heel lance (recovery period) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0021"> <li> <p>Mean proportions</p> </li> <li> <p>Graphically reported</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Less crying time during blood collection in the sucrose group (47%) compared to the water group (92%, P = 0.015) </p> <p>No data could be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Grant in Aid of Research MH</p> <p>51705 and by Research Scientist Award MH 00524 from the National Institutes of Mental Health </p> <p>Declaration of interest: none</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0006" title="BlassEM , WattLB . Suckling- and sucrose-induced analgesia in human newborns. Pain1999;83(3):611-23. [DOI: 10.1016/s0304-3959(99)00166-9] [PMID: 10568870]">Blass 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40 term newborn infants, 34 h to 55 h old</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prior to heel lance:</p> <p> <ul id="CD014806-list-0022"> <li> <p>2 mL 12% sucrose over 2 min via syringe (n = 10);</p> </li> <li> <p>2 mL water via syringe over 2 min (n = 10);</p> </li> <li> <p>pacifier dipped every 30 s in 12% sucrose solution for 2 min (n = 10); and</p> </li> <li> <p>pacifier dipped in water every 30 s for 2 min (n = 10)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0023"> <li> <p>Percentage of time crying 3 min after heel lance</p> </li> <li> <p>Mean change in HR</p> </li> <li> <p>Percentage of time grimacing</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0024"> <li> <p>Mean percentage</p> </li> <li> <p>Mean change (beats/min)</p> </li> <li> <p>Graphically reported</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 mL 12% (0.24 g) sucrose alone diminished cry duration from heel lance compared to water (8% vs 50%, P = 0.003) and water with pacifier (8% vs 35%, P = 0.002). Pacifier with 12% sucrose was more effective in reducing cry duration compared to water with pacifier (5% vs 35%, P = 0.001) or water alone (50%, P = 0.002). </p> <p>Mean HR increased from treatment to heel lance in infants receiving water alone (mean increase of 17 beats/min, P = 0.002) and water with pacifier (mean increase of 20 beats/min, P = 0.005). Mean increase in HR also increased for the 12% sucrose and pacifier group (mean difference of 7.4 beats/min, P = 0.05) but not for infants receiving 12% sucrose alone (mean difference of 5.9 beats/min, P = 0.142). </p> <p>12% sucrose reduced grimacing compared to water (P = 0.0003). 12% sucrose with pacifier reduced grimacing compared to water (P = 0.001) and pacifier alone (P = 0.04). </p> <p>No data could be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Grant RO‐1</p> <p>MH51705‐04A1 and Research Scientist Award KO‐5,</p> <p>MH5 00524, from the National Institutes of Mental Health to EMB</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0007" title="BucherHU , MoserT , vonSiebenthalK , KeelM , WolfM , DucG . Sucrose reduces pain reaction to heel lancing in preterm infants: a placebo-controlled, randomized and masked study. Pediatric Research1995;38(3):332-5. [DOI: 10.1203/00006450-199509000-00010] [PMID: 7494655]">Bucher 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 preterm infants, 27 weeks' to 34 weeks' GA, PNA approximately 42 d</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0025"> <li> <p>2 mL 50% sucrose via syringe into the mouth 2 min before heel lance</p> </li> <li> <p>2 mL distilled water via syringe into the mouth 2 min before heel lance (n = 16, cross‐over design) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0026"> <li> <p>Percentage of time crying</p> </li> <li> <p>Recovery time until crying stopped</p> </li> <li> <p>Increase in HR</p> </li> <li> <p>Recovery time for HR;</p> </li> <li> <p>TcPO<sub>2</sub> (maximum increase, measured in kPa; maximum decrease, in kPa; difference between baseline and 10 min after end of intervention ‐ kPa); </p> </li> <li> <p>TcPCO<sub>2</sub> (maximum decrease, in kPa; difference between baseline and 10 min after the end of intervention) </p> </li> <li> <p>Recovery time for respirations</p> </li> <li> <p>Cerebral near‐infrared spectroscopy (cerebral oxyhaemoglobin, deoxyhaemoglobin, total blood volume) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median, IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cry duration (percentage of total duration of intervention) was reduced in 2 mL 50% (1.0 g) sucrose group (71.5%) compared to control group (93.5%, P = 0.002). </p> <p>Median increase in HR (beats/min) after heel lance was reduced in the 2 mL 50% (1.0 g) sucrose group (35 beats/min) compared to water (51 beats/min) (P = 0.005). </p> <p>No differences between groups with respect to measures for TcPO<sub>2</sub> (P = 0.05) and TcPCO<sub>2</sub> (P = 0.21) </p> <p>There was no decrease in cerebral blood volume between sucrose and placebo groups.</p> <p>Data were not presented for effects of sucrose or water prior to cross over. No data could be used in RevMan analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0008" title="Campbell-YeoM , JohnstonCC , BenoitB , DisherT , CaddellK , VincerM , et al. Sustained efficacy of kangaroo care for repeated painful procedures over neonatal intensive care unit hospitalization: a single-blind randomized controlled trial. Pain2019;160(11):2580-8. [DOI: 10.1097/j.pain.0000000000001646] [PMID: 31356452]">Campbell‐Yeo 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>242 preterm infants, ≤ 36 6/7 weeks' GA (mean GA 32 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention provided for every painful procedure during hospitalisation; outcomes measured for heel lances </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0027"> <li> <p>KC (n = 81)</p> </li> <li> <p>24% sucrose, 0.4 mL to 1 mL (n = 81)</p> </li> <li> <p>KC + 24% sucrose, 0.4 mL to 1 mL (n = 80)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0028"> <li> <p>PIPP at 3 medically indicated heel lances (at 30 s, 60 s, 90 s post‐heel lance)</p> </li> <li> <p>Neurobehavioral assessment using NAPI at 32 weeks, 36 weeks and 40 weeks</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No differences in mean PIPP scores between groups for the 3 time points<br/>No differences in neurobehavioural assessment and adverse events for both groups </p> <p>No differences reported for adverse events (bradycardia, oxygen desaturation) between groups </p> <p>No data could be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Canadian Institutes of Health</p> <p>Research (CIHR) [244640/2011‐7517]; Nova Scotia Health Research Foundation [MED‐MAT‐2011‐7517] and Mayday Fund </p> <p>Declaration of interest: The authors had no conflict of interest to declare.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0009" title="ChangJ , FiloteoL , NasrAS . Comparing the analgesic effects of 4 nonpharmacologic interventions on term newborns undergoing heel lance: a randomized controlled trial. Journal of Perinatal &amp; Neonatal Nursing2020;34(4):338-45. [DOI: 10.1097/JPN.0000000000000495] [PMID: 32804876]">Chang 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>226 term infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance at &gt; 24 h old when receiving the heel lance procedure as a newborn<br/>screen test </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0029"> <li> <p>BF group (n = 45), initiated before heel lance and during heel lance procedure</p> </li> <li> <p>Oral sucrose group (n = 42), 24% oral sucrose‐5 drops (0.33 mL) before heel lance and again during procedure if cues of pain, up to 15 drops (1 mL) </p> </li> <li> <p>NNS group (n = 51), pacifier given before and during heel lance</p> </li> <li> <p>SSC group (n = 38), newborns wore only diapers, positioned on mother's bare chest immediately before heel lance procedure </p> </li> <li> <p>Control group (n = 50), newborns were placed in a crib in supine position and covered with blankets </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N‐PASS scores (duration of the heel lance was calculated from the point of lancet puncture until blood collection completion); N‐PASS scores were collected at these same procedure time points </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All intervention groups showed decreased pain levels compared with the control group (P &lt; 0.01). The oral sucrose group experienced a superior analgesic effect compared to the SSC group (P &lt; 0.01), but there was no difference when compared with the BF group<br/>(P &gt; 0.05) or the NNS group (P &gt; 0.05). </p> <p>All intervention groups had shortened crying times (P &lt; 0.01) and reduced procedural duration (P &lt; 0.01) compared with the control group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: the Lucile Packard Foundation Children’s<br/>Health Fund and the Stanford NIH CTSA (UL1RR025744) </p> <p>Declaration of interest: The authors disclosed that they had no significant relationships with, or financial interest in, any commercial companies pertaining to this article. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0010" title='CignaccoEL , SellamG , StoffelL , GerullR , NelleM , AnandKJ , et al. Oral sucrose and "facilitated tucking" for repeated pain relief in preterms: a randomized controlled trial. Pediatrics2012;129(2):299-308. [DOI: 10.1542/peds.2011-1879] [PMID: 22232305]GerullR , CignaccoE , StoffelL , SellamG , NelleM . Physiological parameters after nonpharmacological analgesia in preterm infants: a randomized trial. Acta Paediatrica2013;102(8):e368-73. [DOI: 10.1111/apa.12288] [PMID: 23651076]'>Cignacco 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71 preterm infants between 24 0/7 weeks' and 32 0/7 weeks' PMA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Repeated heel lances</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0030"> <li> <p>Sucrose group (n = 24): 20% oral sucrose (0.2 mL/kg), ∼2 min before the heel lance. If the infant seemed to be in pain during the heel lance phase, up to 2 additional doses of sucrose were administered and noted in the study chart. </p> </li> <li> <p>Sucrose + FT group (n = 23): FT was started at the beginning of the baseline phase, and sucrose was given 2 min before the heel lance. </p> </li> <li> <p>FT group (n = 24): FT was started at the beginning of the baseline phase, and the infant was 'tucked' through all 3 phases. </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>BPSN. Data collection occurred during:</p> <p> <ul id="CD014806-list-0031"> <li> <p>baseline (before any manipulation);</p> </li> <li> <p>heel lance (skin preparation, heel stick and haemostasis after blood was drawn); and</p> </li> <li> <p>recovery (3 min after the heel lance).</p> </li> </ul> </p> <p>The BPSN contains 9 items: 3 physiologic (HR, RR and SpO<sub>2</sub>) and 6 behavioural (grimacing, body movements, crying, skin colour, sleeping patterns, consolation) items. </p> <p>3 phases (baseline, heel stick, recovery) of 5 heel stick procedures were videotaped for each infant. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sucrose with and without FT had pain‐relieving effects even in preterm infants of GA ≤ 32 weeks having repeated pain exposures. These interventions remained effective during repeated heel sticks across time. FT was not as effective. </p> <p>Data were included in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Swiss National Science Foundation and the following private</p> <p>foundations: Botnar Foundation, Basel;</p> <p>the Foundation of Nursing Science, Basel; the Foundation for Research in</p> <p>Neonatology, Zürich; the Marie Anna Foundation, Basel; and the Foundation</p> <p>for Sick Children, Basel</p> <p>Declaration of interest: The authors indicated they had no financial relationships relevant to this article to disclose. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0011" title="CodipietroL , CeccarelliM , PonzoneA . Breastfeeding or oral sucrose solution in term neonates receiving heel lance: a randomized controlled trial. Pediatrics2008;122(3):e716-21. [DOI: 10.1542/peds.2008-0221] [PMID: 18762508]">Codipietro 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101 term infants</p> <p>Mean PMA:</p> <p> <ul id="CD014806-list-0032"> <li> <p>sucrose group: 39.3 weeks; and</p> </li> <li> <p>BF group: 39.4 weeks</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0033"> <li> <p>1 mL 25% sucrose via syringe (n = 50)</p> </li> <li> <p>BF prior to heel lance (n = 51)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0034"> <li> <p>Duration of first cry (s), percentage of crying time in first 2 min, and percentage of crying time during blood sampling </p> </li> <li> <p>HR (beats/min) increase from baselines at 30 s following commencement of procedure</p> </li> <li> <p>SpO<sub>2</sub> decrease </p> </li> <li> <p>PIPP during blood sampling, 2 min after heel lance</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median, range</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median duration of first cry: BF group, 3 s (range 0 s to 120 s) compared to sucrose group, 21 s (range 0 s to 120 s) (P = 0.004) </p> <p>Percentage of crying during first 2 min: BF group, 4% (range 0% to 100%) compared to sucrose, 45% (range 0% to 100%) (P &lt; 0.0001) </p> <p>Percentage of crying during sampling: BF group, 8% (range 0% to 100%) compared to sucrose, 56.5% (range 0% to 100%) (P = 0.0003) </p> <p>Median increase in HR from baseline to 30 s after start of heel lance was lower in BF group (13 beats/min; range 12 beats/min to 54 beats/min) compared to sucrose group (22 beats/min; range 32 to 65) (P = 0.005) </p> <p>Median decrease in SpO<sub>2</sub> from baseline to 30 s after start of heel lance was greater in sucrose group (−3%; range 30% to 1%) compared to BF group (−1%; range −14% to 2%) (P = 0.001) </p> <p>Median PIPP scores lower in BF group (3.0) compared to sucrose group (8.5) (P &lt; 0.0001)</p> <p>No adverse effects were noted in any infant.</p> <p>Data could not be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: The authors indicated they had no financial relationships relevant to this article to disclose. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0012" title="GaoH , LiM , GaoH , XuG , LiF , ZhouJ , et al. Effect of non-nutritive sucking and sucrose alone and in combination for repeated procedural pain in preterm infants: a randomized controlled trial. International Journal of Nursing Studies2018;83:25-33. [DOI: 10.1016/j.ijnurstu.2018.04.006] [PMID: 29684832]">Gao 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86 preterm infants born before 37 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0035"> <li> <p>Routine care (routine comfort through gentle touch when infants cried; n = 21)</p> </li> <li> <p>NNS (n = 22) 2 min before and during recovery of heel lance</p> </li> <li> <p>1 mL sucrose (0.2 mL/kg of 20%; n = 21) 2 min before heel lance</p> </li> <li> <p>1 mL sucrose (0.2 mL/kg of 20%) + NNS (n = 22) 2 min before heel lance</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0036"> <li> <p>PIPP score (during heel lance, 1 min after heel lance)</p> </li> <li> <p>HR (baseline = 2 min before, during, 1 min after heel lance)</p> </li> <li> <p>SpO<sub>2</sub> (baseline = 2 min before, during, 1 min after heel lance) </p> </li> <li> <p>Crying time (baseline = 2 min before, during, 1 min after heel lance)</p> </li> <li> <p>Incidence of adverse events</p> <ul id="CD014806-list-0037"> <li> <p>Choking, coughing, vomiting, abdominal distension, oral infection, necrotising enterocolitis</p> </li> <li> <p>Sustained tachycardia (HR &gt; 200 beats/min), bradycardia (HR &lt; 80 beats/min), tachypnoea (RR &gt; 80 beats/min), dyspnoea (RR &lt; 20 beats/min), or oxygen desaturation &lt; 80% for &gt; 15 s </p> </li> <li> <p>hyperglycaemia</p> </li> </ul> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The combination group had lower PIPP scores, HR, and crying time during the heel lance and recovery phase than the sucrose, NNS and routine care groups (P &lt; 0.0001). </p> <p>The combination group had a higher SpO<sub>2</sub> than all other treatment groups (P &lt; 0.035). </p> <p>There were no differences in the HR and SpO<sub>2</sub> between the sucrose, NNS and routine care groups. </p> <p>The sucrose group and NNS group had similar duration of crying, and the routine care group had the longest duration of crying of all treatment groups. </p> <p>3 episodes of vomiting (1 in the routine care group, 1 in the NNS group and 1 in the sucrose + NNS group) and 2 infants who had abdominal distension (1 in the sucrose + NNS group and 1 in the routine care group) were reported. </p> <p>Data were included in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: National Natural</p> <p>Science Foundation of China (81703246), the Preponderant Discipline Project of Universities in Jiangsu Province, Nursing Science Open Fund of Nanjing University of Chinese Medicine (YSHL2016‐018), Top‐notch Academic Programs Project of Jiangsu Higher Education Institutions (PPZY2015C258) and Project of Nursing Science in Nanjing University of Chinese Medicine (NZYHLXPPJG2017‐54) </p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0014" title="GibbinsS , StevensB , HodnettE , PinelliJ , OhlssonA , DarlingtonG . Efficacy and safety of sucrose for procedural pain relief in preterm and term neonates. Nursing Research2002;51(6):375-82. [DOI: 10.1097/00006199-200211000-00005] [PMID: 12464757]GibbinsS , StevensB . The influence of gestational age on the efficacy and short-term safety of sucrose for procedural pain relief. Advances in Neonatal Care2003;3(5):241-9. [PMID: 14648521]GibbinsS . Efficacy and Safety of Sucrose for Procedural Pain Relief in Preterm and Term Neonates [PhD Thesis]. Toronto: University of Toronto, 2001. ">Gibbins 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>190 preterm and term infants, mean GA 33.7 weeks, &lt; 7 d PNA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 min prior to heel lance:</p> <p> <ul id="CD014806-list-0038"> <li> <p>sucrose + NNS group: 0.5 mL 24% sucrose via syringe to the anterior surface of the tongue followed by pacifier (n = 64); </p> </li> <li> <p>sucrose group: 0.5 mL 24% sucrose without pacifier (n = 62); and</p> </li> <li> <p>water + NNS group: 0.5 mL sterile water with pacifier (n = 64)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0039"> <li> <p>PIPP scores at 30 s and 60 s after heel lance</p> </li> <li> <p>Incidence of adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported means, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean PIPP scores at both 30 s (P &lt; 0.001) and 60 s (P &lt; 0.001) after heel lance favoured sucrose group and sucrose + NNS group. Post hoc Tukey tests showed infants who received sucrose + pacifier had lower PIPP scores after heel lance at 30 s (mean 8.16, SD 3.24) compared to infants receiving sucrose alone (mean 9.77, SD 3.04) (P = 0.007) or water + NNS (mean 10.19, SD 2.67 (P &lt; 0.001). At 60 s after heel lance, PIPP scores were lower for sucrose + NNS group (mean 8.78, SD 4.03) compared to the sucrose alone group (mean 11.20, SD 3.25) (P = 0.005) and water + NNS group (mean 11.20, SD 3.47 (P = 0.007). No differences in PIPP scores were found between sucrose alone group or water + NNS group at both follow‐up times. </p> <p>Minor adverse effects were observed in 6 infants, none of which occurred in the sucrose + NNS group. 1 neonate who received water with NNS choked when the water was administered but stabilised within 10 s. 3 infants randomised to the sucrose group and 2 infants randomised to the water with NNS groups experienced oxygen desaturation when the study intervention (sucrose or water) was administered. Each neonate recovered spontaneously with no medical intervention required. </p> <p>Data were used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Hospital for Sick Children, Toronto Ontario, Canada for the Research Training Award </p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0015" title="GormallyS , BarrRG , WertheimL , AlkawafR , CalinoiuN , YoungSN . Contact and nutrient caregiving effects on newborn infant pain responses. Developmental Medicine and Child Neurology2001;43(1):28-38. [DOI: 10.1017/s0012162201000056] [PMID: 11201419]">Gormally 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94 term newborns, mean GA 39.4 weeks, second or third day of life</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0040"> <li> <p>Water group: no holding and sterile water given by pipette (n = 21)</p> </li> <li> <p>Sucrose group: no holding and 0.25 mL 24% sucrose solution given by pipette (n = 22)</p> </li> <li> <p>Holding + water group: holding and sterile water given by pipette (n = 20)</p> </li> <li> <p>Holding + sucrose group: holding and 0.25 mL 24% sucrose solution by pipette (n = 22) </p> </li> </ul> </p> <p>All solutions given 3 times at 30‐second intervals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0041"> <li> <p>Percentage of time crying 1 min, 2 min and 3 min after heel lance</p> </li> <li> <p>Mean HR before intervention and 1 min, 2 min and 3 min after heel lance; mean vagal tone index before intervention and 1 min, 2 min and 3 min after heel lance </p> </li> <li> <p>Pain concentration scores for facial activity before intervention and 1 min, 2 min and 3 min after heel lance </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Crying decreased over time (P &lt; 0.001), but no interaction was noted for time with holding, taste or both. Effect of taste on crying (P &lt; 0.05) favoured sucrose group. No effect of holding (P = 0.09). No interaction between taste and holding to reduce crying (P = 0.37). Effect of combined interventions was additive. </p> <p>Although no change in mean HR due to holding or sucrose as main effects, there was an interaction between holding and taste (P &lt; 0.004), indicating synergistic effect that was also dependent on pre‐intervention HR (P &lt; 0.004). No main effects noted for vagal tone; as with HR, effect of vagal tone was dependent on pre‐intervention vagal tone for both holding and taste interventions (P &lt; 0.03). Pre‐intervention levels interacted to decrease HR and vagal tone in infants who had higher rates before interventions. </p> <p>Pain concatenation scores measuring facial expressions of pain decreased over time (P &lt; 0.001). Only the effect of holding reduced pain scores (P &lt; 0.02). No difference as to whether infant received sucrose (taste main effect P = 0.68) </p> <p>No data could be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Medical Research Council of Canada (MT‐13633), the Allan Ross Fellowship and the Lewis Sessenwein Academic Award </p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0016" title="GreenbergCS . A sugar-coated pacifier reduces procedural pain in newborns. Pediatric Nursing2002;28(3):271-7. [PMID: 12087649]">Greenberg 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84 term newborns, approximately 17 h to 19 h old</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0042"> <li> <p>Sugar‐coated pacifier (n = 21)</p> </li> <li> <p>Water‐moistened pacifier (n = 21)</p> </li> <li> <p>Sucrose group: 2 mL 12% sucrose (n = 21)</p> </li> <li> <p>Control group: routine care (n = 21)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0043"> <li> <p>Duration of cry from procedure phase to 3 min postprocedure</p> </li> <li> <p>Vagal tone and vagal tone index</p> </li> <li> <p>Salivary cortisol levels</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean and SE reported for time crying (s)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decrease in duration of cry for the sugar‐coated pacifier group compared to the control group (P = 0.001) and the water‐moistened pacifier group (P = 0.006) </p> <p>Lower vagal tone during heel lance in the sugar‐coated pacifier group compared to the control group (P = 0.008) and oral sucrose group (P = 0.018). Lower vagal tone index in the sugar‐coated pacifier group compared to control group at heel lance (P = 0.019), and 6 min to 10 min after (P = 0.007) and 11 to 15 min (P = 0.049) after heel lance </p> <p>No differences were found in salivary cortisol levels across groups (no P value reported)</p> <p>Mean duration of cry used in RevMan analyses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: American Cancer Society, California Division Fellowship #3‐3‐95</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0017" title="GualaA , PastoreG , LiveraniME , GirolettiG , GulinoF , MeriggiAI , et al. Glucose or sucrose as an analgesic for newborns: a randomised controlled blind trial. Minerva Pediatrica2001;53(4):271-4. [PMID: 11573063]">Guala 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>140 term, 38 weeks' to 41 weeks' GA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0044"> <li> <p>Nothing (n = 20)</p> </li> <li> <p>Water (n = 20)</p> </li> <li> <p>5% glucose (n = 20)</p> </li> <li> <p>33% glucose (n = 20)</p> </li> <li> <p>50% glucose (n = 20)</p> </li> <li> <p>33% sucrose (n = 20)</p> </li> <li> <p>50% sucrose (n = 20)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0045"> <li> <p>HR before, during and 3 min after heel lance</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No differences were found between groups for differences in HR at each of the 3 phases of the heel lance (P value reported for 3 min after heel lance, P = 0.087; the difference between 3 min after heel lance and during heel lance, P = 0.068) </p> <p>No adverse events were observed.</p> <p>Data were used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0018" title="HaouariN , WoodC , GriffithsG , LeveneM . The analgesic effect of sucrose in full term infants: a randomised controlled trial. BMJ1995;310(6993):1498-500. [DOI: 10.1136/bmj.310.6993.1498] [PMID: 7787595]">Haouari 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 term infants, 37 weeks' to 42 weeks' gestation, 1 d to 6 d of age</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 min prior to heel lance:</p> <p> <ul id="CD014806-list-0046"> <li> <p>2 mL 12.5% sucrose (n = 15);</p> </li> <li> <p>2 mL 25% sucrose (n = 15);</p> </li> <li> <p>2 mL 50% sucrose (n = 15); and</p> </li> <li> <p>2 mL sterile water (n = 15)</p> </li> </ul> </p> <p>All solutions were given by syringe on the tongue over &lt; 1 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0047"> <li> <p>Total time crying over 3 min</p> </li> <li> <p>Time of first cry after lance</p> </li> <li> <p>Percentage of change in HR at 1 min, 3 min and 5 min after heel lance</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0048"> <li> <p>Median, IQR</p> </li> <li> <p>Reported means and SEM</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After heel lance, decreases in total crying time and duration of first cry in 50% sucrose group compared with water (P = 0.02) were observed. Reduction in median time crying at end of first min (P &lt; 0.02) in 50% sucrose group (35 s; range 14 s to 60 s) compared with water (60 s; range 50 s to 60 s). In second minute, duration of cry less in 50% sucrose group (0 s; range 0 s to 25 s) and in 25% sucrose group (18 s; range 0 s to 55 s) compared to water (60 s; range 40 s to 60 s) (P = 0.003 and P = 0.02, respectively) </p> <p>There was a trend towards a reduction in crying time with greater concentrations of sucrose (P = 0.007). There was a similar trend in the reduction of the duration of first cry with increasing concentrations of sucrose (P = 0.004). </p> <p>Decrease in percentage of change in HR 3 min after heel lancing (P = 0.02) in the 50% sucrose group (mean 0.1%, SEM 3.3) compared to water group (mean 17.5%, SEM 6.0) </p> <p>We transcribed SEMs to SDs and included data in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Special Trustees of the Leeds General Infirmary</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0019" title="HarrisonD , JohnstonL , LoughnanP . Oral sucrose for procedural pain in sick hospitalized infants: a randomized-controlled trial. Journal of Paediatric and Child Health2003;39(8):591-7. [DOI: 10.1046/j.1440-1754.2003.00242.x] [PMID: 14629524]">Harrison 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99 sick hospitalised infants</p> <p>Mean GA (SD):</p> <p> <ul id="CD014806-list-0049"> <li> <p>sucrose group: 36.7 weeks (3.3); and</p> </li> <li> <p>control group: 36.8 weeks (3.7)</p> </li> </ul> </p> <p>(Author provided data on a subset of infants from a larger study (n = 128) that fulfilled our inclusion criteria) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0050"> <li> <p>1 mL water (n = 46)</p> </li> <li> <p>1 mL 25% sucrose (n = 53)</p> </li> </ul> </p> <p>For infants weighing ≤ 1500 g, the dose was reduced to 0.5 mL.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0051"> <li> <p>Duration of cry until 5‐second pause; incidence and duration of crying time during the heel lance and squeeze and during the 3‐min recovery period </p> </li> <li> <p>HR at baseline; heel lance; during heel lance; and 1 min, 2 min and 3 min post‐heel lance </p> </li> <li> <p>SpO<sub>2</sub> (%) at baseline; heel lance; during heel lance; and 1 min, 2 min and 3 min post‐heel lance </p> </li> <li> <p>4‐point subset of the NFCS (brow bulge, eye squeeze, nasolabial furrow, stretch mouth) at heel lance; during heel lance; and 1 min, 2 min and 3 min post‐heel lance </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD (collected from authors)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean (SD) length of first cry was higher in the water group (70.5 s (83.6 s)) compared to the sucrose group (46.8 s (63.1 s)). The sucrose group cried 57.1% of the procedure time compared to 58.8% in the water group. The mean (SD) total duration of cry during the heel lance was 84.7 s (68.8 s) in the sucrose group and 87.4 s (87.1 s) in the water group. </p> <p>The mean (SD) HR upon heel lance was 163.0 beats/min (17.9 beats/min) in the sucrose group and 159.5 beats/min (19.2 beats/min) in the water group. HR at 30 s from the beginning of the procedure was 175.4 beats/min (22.2 beats/min) and 172.8 beats/min (23.6 beats/min) in the sucrose and water groups, respectively. The HR in both groups decreased after the procedure to 152.1 beats/min (22.5 beats/min) in the sucrose group and 154.2 beats/min (29.1 beats/min) in the water group 2 min post‐heel lance. </p> <p>Results of SpO<sub>2</sub> (%) were similar between the 2 groups. </p> <p>Mean (SD) facial scores were reduced at heel lance (2.74 (1.8)) in the sucrose group compared to the water group (2.94 (1.6)) (P = 0.02) and at 1 min (P = 0.04) and 2 min (P = 0.046) post‐heel lance. No differences occurred at 3 min post‐heel lance. </p> <p>Data were included in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Murdoch Childrens Research Institute</p> <p>(Trainee Research Scholarship and Minor Grant), Australian</p> <p>Nurses Federation (Elizabeth Hulme Special Interest Group</p> <p>Clinical Research Grant), and Neonatal Unit Charity Group; Tiny Miracles</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0020" title="IsikU , OzekE , BilgenH , CebeciD . Comparison of oral glucose and sucrose solutions on pain response in neonates. Journal of Pain2000;1(4):275-8. [DOI: 10.1054/jpai.2000.8919] [PMID: 14622610]">Isik 2000a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>113 healthy term newborns GA 37 weeks to 42 weeks, median PNA 2 d (range 2 d to 5 d) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Solution syringed into the anterior third of the tongue for 1 min prior to heel lance:</p> <p> <ul id="CD014806-list-0052"> <li> <p>2 mL 30% sucrose (n = 28);</p> </li> <li> <p>2 mL 10% glucose (n = 29);</p> </li> <li> <p>2 mL 30% glucose (n = 28); and</p> </li> <li> <p>2 mL distilled water (n = 28)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0053"> <li> <p>Mean cry time during 3 min after lance</p> </li> <li> <p>Mean maximum HR 3 min from heel lance</p> </li> <li> <p>Mean recovery time for HR</p> </li> <li> <p>Percentage of change in HR at 1 min, 2 min and 3 min after heel lance</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported means and SEM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Infants who received 30% sucrose (mean crying time of 61 s) cried less than those who received 30% glucose (mean crying time of 95 s), 10% glucose (mean crying time of 103 s) or sterile water (mean crying time of 105 s) (P = 0.02). </p> <p>No difference between groups with respect to maximum HR after heel lance (P = 0.71) or mean recovery time (P = 0.09). No difference found in percentage change in HR at 1 min or 3 min after heel lance (P = 0.14, P = 0.53, respectively). At 2 min after heel lance, percentage change in HR favoured group receiving sucrose (P = 0.05) compared to other groups. </p> <p>Data were used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0021" title="JohnstonCC , StremlerRL , StevensBJ , HortonLJ . Effectiveness of oral sucrose and simulated rocking on pain response in preterm neonates. Pain1997;72(1-2):193-9. [DOI: 10.1016/s0304-3959(97)00033-x] [PMID: 9272803]">Johnston 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85 preterm infants, 25 weeks' to 34 weeks' GA, 2 d to 10 d of age</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Solutions via syringe into the mouth just prior to heel lance:</p> <p> <ul id="CD014806-list-0054"> <li> <p>0.05 mL 24% sucrose (n = 27);</p> </li> <li> <p>0.05 mL 24% sucrose and simulated rocking 15 min prior to heel lance (n = 14);</p> </li> <li> <p>0.05 mL sterile water and simulated rocking 15 min prior to heel lance (n = 24); and</p> </li> <li> <p>0.05 mL sterile water</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0055"> <li> <p>HR at baseline and 3 × 30‐second blocks</p> </li> <li> <p>Behavioural facial actions (NFCS) at baseline and 3 × 30‐second blocks</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Means and SD not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Although HR increased across all phases of procedure (P &lt; 0.04), there were no differences noted between groups (P = 0.566). </p> <p>Decrease in percentage of facial action in 24% sucrose alone group and combined 24% sucrose and rocking group compared to water group (P &lt; 0.02) </p> <p>No data could be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0022" title="JohnstonCC , StremlerR , HortonL , FriedmanA . Effect of repeated doses of sucrose during heel stick procedure in preterm neonates. Biology of the Neonate1999;75(3):160-6. [DOI: 10.1159/000014092] [PMID: 9925903]">Johnston 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48 preterm neonates, mean GA 31 weeks (range 25 weeks to 34 weeks), within 10 d of birth </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0056"> <li> <p>0.05 mL 24% sucrose as a single dose, followed by 2 doses of sterile water (n = 15)</p> </li> <li> <p>3 doses 0.05 mL 24% sucrose (n = 17)</p> </li> <li> <p>3 doses 0.05 mL sterile water (n = 16) given by syringe to anterior surface of the tongue at 2 min prior to heel lance, just prior to lancing and 2 min after lancing </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PIPP scores in 5 × 30‐second blocks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported means, SD in graph form</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Difference between groups (P &lt; 0.0001) for mean PIPP scores. Post hoc analysis found lower PIPP scores with repeated doses of 24% sucrose compared to placebo groups across all blocks of time (P &lt; 0.05). PIPP scores for repeated doses of 24% sucrose were lower compared to single doses of 24% sucrose (8.25 vs. 6.25) only at last block of time (P &lt; 0.05). PIPP scores for single doses of 4% sucrose compared to placebo showed trend towards favouring 24% sucrose (P = 0.07) </p> <p>Data obtained from the author on 31 infants that could be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Fonds de la Recherche en Sante du Quebec and Health Canada</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0024" title="KumariS , DattaV , RehanH . Comparison of the efficacy of oral 25% glucose with oral 24% sucrose for pain relief during heel lance in preterm neonates: a double blind randomized controlled trial. Journal of Tropical Pediatrics2017;63(1):30-5. [DOI: 10.1093/tropej/fmw045] [PMID: 27435886]">Kumari 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94 preterm neonates in first 48 h of life</p> <p>GA in mean (SD) for both intervention groups was 35.53 weeks (0.73 weeks) and 35.56 weeks (0.78 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Both interventions given 2 min before heel lance</p> <p> <ul id="CD014806-list-0057"> <li> <p>1 mL 25% glucose (n = 47)</p> </li> <li> <p>1 mL 24% sucrose (n = 47)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0058"> <li> <p>PIPP – 30 s, 1 min, 2 min</p> </li> <li> <p>Duration of crying</p> </li> <li> <p>Immediate adverse events (choking; coughing; vomiting; or sustained tachycardia, bradycardia, tachypnoea, dyspnoea, or oxygen desaturation) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>There were differences between PIPP scores at 30 s (P = 0.7438), 1 min (P = 0.8709) and 2 min after the procedure (P = 0.7134); duration of crying; and rate of adverse events. </p> <p>1 infant developed coughing and another, vomiting, which was present transiently and required no intervention. </p> <p>Data were included in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0025" title="LagoP , CavicchioloME , MionT , Dal CengioV , AllegroA , DaverioM , et al. Repeating a dose of sucrose for heel prick procedure in preterms is not effective in reducing pain: a randomised controlled trial. European Journal of Pediatrics2020;179(2):293-301. [DOI: 10.1007/s00431-019-03509-2] [PMID: 31728675]">Lago 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72 preterm infants admitted to the NICU (23 weeks to 36 + 6 weeks of gestation at birth) with PNA &lt; 28 d or before reaching 40 weeks' corrected PMA </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0059"> <li> <p>Group (A): both syringes 1 and 2 contained <b>sucrose</b> (24%, 0.3 mL,0.07 g of sucrose each) for infant ≤ 1000 g or 0.5 mL for infants &gt; 1000 g (0.12 g of sucrose each) (2 doses of sucrose) (n = 35) </p> </li> <li> <p>Group (B): infants were given a dose of <b>sucrose</b> (24%, 0.3 mL or 0.5 mL) in syringe 1 <b>and the same quantity of sterile water in</b> syringe 2 (1 dose of sucrose) (n = 36) </p> </li> </ul> </p> <p>Infants also received NNS and FT.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0060"> <li> <p>PIPP at 30 s, 60 s and 120 s after heel prick; the heel pricks were also rated using other pain scales more feasible in the clinical practice and indicated in Italy for their use in newborn (FLACC: Faces, Legs, Activity, Cry and Consolability; indirect 10‐cm VAS; NIPS), to compare the performance of these pain scales with the gold standard PIPP </p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median, IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No differences in PIPP scores was found</p> <p>between the groups: median PIPP values 4.0 (IQR 3.0 to 4.0) vs 3.0 (IQR 3.0 to 4.0) at baseline; 6.0 (IQR 5.0 to 10.0) vs 6.0 (IQR 4.0 to 8.5) at 30 s; 6.0 (IQR 4.0 to 7.0) vs 5.0 (IQR 4.0 to 8.5) at 60 s; and 5.0 (IQR 4.0 to 7.0) vs 5.0 (IQR 4.0 to 7.5) at 2 min, in the experimental and standard treatment groups, respectively (P = 0.9020). There was no correlation between PIPP scores and other pain scales. </p> <p>No adverse effects were reported (i.e. no episodes of desaturation or bradycardia or “choking”). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: The authors declared that they had no conflict of interest.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0026" title="LengHY , ZhengXL , YanL , ZhangXH , HeHY , XiangM . [Effects of different types and concentration of oral sweet solution on reducing neonatal pain during heel lance procedures]. Zhonghua Er Ke Za Zhi. Chinese Journal of Pediatrics2013;51(9):654-8. [PMID: 24330983]">Leng 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>560 term neonates, GA 37 weeks to 42 weeks; birthweight 2500 g to 4000 g; age 3 d to 28 d </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0061"> <li> <p>Boiled water</p> </li> <li> <p>10% glucose</p> </li> <li> <p>25% glucose</p> </li> <li> <p>50% glucose</p> </li> <li> <p>12% sucrose</p> </li> <li> <p>24% sucrose</p> </li> <li> <p>30% sucrose</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0062"> <li> <p>Increase in HR (beats/min)</p> </li> <li> <p>Decrease in SpO<sub>2</sub> (%) </p> </li> <li> <p>Pain levels (test not specified)</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported means and full ranges, not IQRs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The average HR increase 3 min, 5 min and 10 min after procedure in the 25% and 50% glucose groups, 12% and 24% and 30% sucrose groups was lower than those in the placebo group (P &lt; 0.01 or 0.05). The average HR increase 3 min after procedure in the sucrose groups was lower than that in the glucose groups (P &lt; 0.01). At 3 min after heel lance, neonates who received 30% sucrose had lower average HR increase than those who received 12% and 24% sucrose (both P &lt; 0.05). The average SpO<sub>2</sub> decrease 3 min, 5 min and 10 min after procedure was lower than that in the placebo group (P &lt; 0.01). The average SpO<sub>2</sub> decrease 3 min after procedure in the sucrose groups was lower than that in the glucose groups (P &lt; 0.01). The average pain score 3 min, 5 min and 10 min after procedure was lower than that in the placebo group (P &lt; 0.01). The average pain score 3 min after procedure in the sucrose groups was lower than that in the glucose groups (P &lt; 0.01).<br/>No adverse events reported </p> <p>We could not include in RevMan analyses data for 30% sucrose vs sterile water for increase in HR and decrease in SpO<sub>2</sub> at 3 min after heel lance, as data were reported as means and full ranges. </p> <p>In addition, results were reported late at 3 min, 5 min and 10 min after heel lance.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Chognqing Health Administration Institution Medical Science Research Grant. </p> <p>Declaration of interest: no conflict of interest.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0027" title="LengHY , ZhengXL , ZhangXH , HeHY , TuGF , FuQ . Combined non-pharmacological interventions for newborn pain relief in two degrees of pain procedures: a randomized clinical trial. European Journal of Pain2016;20(6):989-97. [DOI: 10.1002/ejp.824] [PMID: 26685099]">Leng 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>671 term neonates, GA 37 weeks to 42 weeks at birth; PNA 3 d to 28 d; birthweight 2500 g to 4000 g; Apgar score ≥ 8 at 5 min after birth; resting HR 120 beats/min to 140 beats/min; resting O<sub>2</sub> saturation ≥ 95%; required neonatal congenital metabolism disease screening or blood glucose test </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shallow (blood glucose test) and deep (congenital metabolism disease screening) heel lance </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0063"> <li> <p>Sucrose group: 2 mL 24% sucrose administered to the infant’s mouth by syringe 2 min before the heel lance procedure </p> </li> <li> <p>Sucrose + NNS group: 2 mL 24% sucrose administered as above, then a standard silicone newborn pacifier was placed into the infant’s mouth until the end of the process. </p> </li> <li> <p>Sucrose + swaddling group: infants were swaddled with a cotton blanket, upper but not lower limb movements were restricted by the blanket, and then 2 mL 24% sucrose were administered as above. The lower limbs were swaddled immediately after the heel lance procedure until the end of the process. </p> </li> <li> <p>Sucrose + NNS + swaddling group: infants were swaddled with a cotton blanket, upper but not lower limb movements were restricted by the blanket, then 2 mL 24% sucrose administered as above, then a standard silicone newborn pacifier was placed into the infant’s mouth, the lower limbs were swaddled immediately after the heel lance procedure until the end of the process. </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0064"> <li> <p>Revised NFCS</p> </li> <li> <p>Increase in HR (%)</p> </li> <li> <p>Decrease in SpO<sub>2</sub> (%) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0065"> <li> <p>Factor analysis</p> </li> <li> <p>Mean and SD</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A synergistic analgesic effect was observed between the sucrose + NNS and sucrose + swaddling groups in both the shallow (P = 0.015) and deep heel lance (P = 0.007) procedure. The sucrose + NNS + swaddling group exhibited the lowest pain score. For the deep heel lance procedure, the sucrose + NNS group had a lower increase in HR percentage and decrease in SpO<sub>2</sub> (%) than the sucrose group (P = 0.000, P = 0.001), while this difference was not observed in the shallow heel lance procedure. No difference was found between the sucrose and sucrose + swaddling groups, in terms of different physiological parameters; </p> <p>NNS and swaddling had synergistic effects on pain relief when used with oral sucrose. For the deep heel lance procedure, oral sucrose combined with NNS and swaddling provided the best pain relief effect. </p> <p>For the shallow heel lance procedure, addition of NNS and swaddling did not improve the effects. </p> <p>Data could not be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: National Key Clinical Specialist Construction Program</p> <p>of China, No [2013]544 and Medical Research Funding of Health Bureau of Chongqing, No [2011‐1‐071] </p> <p>Declaration of interest:</p> <p>none declared</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0028" title="LiawJJ , YangL , LeeCM , FanHC , ChangYC , ChengLP . Effects of combined use of non-nutritive sucking, oral sucrose, and facilitated tucking on infant behavioural states across heel-stick procedures: a prospective, randomised controlled trial. International Journal of Nursing Studies2013;50(7):883-94. [DOI: 10.1016/j.ijnurstu.2012.08.021] [PMID: 23068310]YinT , YangL , LeeTY , LiCC , HuaYM , LiawJJ . Development of atraumatic heel-stick procedures by combined treatment with non-nutritive sucking, oral sucrose, and facilitated tucking: a randomised, controlled trial. International Journal of Nursing Studies2015;52(8):1288-99. [DOI: 10.1016/j.ijnurstu.2015.04.012] [PMID: 25939641]">Liaw 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110 infants (PMA 26.4 weeks to 37 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0066"> <li> <p>Sucrose intervention: 0.2 mL to 2.0 mL 20% sucrose fed through a syringe 2 min before the heel‐lance procedures depending on the infant’s PMA (PMA 26 weeks to 28 weeks: 0.2 mL; PMA 28.1 weeks to 30 weeks: 0.5 mL; PMA 30.1 weeks to 32 weeks: 1 mL; PMA 32.1 weeks to 37 weeks: 1.5 mL; PMA &gt; 37 weeks: 2.0 mL) </p> </li> <li> <p>NNS intervention: NNS via a standard silicone newborn pacifier to stimulate sucking 1 min before touching the foot to initiate heel‐lance procedures </p> </li> <li> <p>FT intervention: infants were in a flexed posture and gently held by the intervener’s warm hands without strongly restraining the infant’s head and body, one hand on the infant’s head, and the other on the trunk. </p> </li> </ul> </p> <p>The 3 interventions outlined above were used in different combinations:</p> <p> <ul id="CD014806-list-0067"> <li> <p>NNS + FT (n = 22);</p> </li> <li> <p>FT + sucrose (n = 21);</p> </li> <li> <p>NNS + sucrose (n = 21);</p> </li> <li> <p>NNS + sucrose + FT (n = 23); amd</p> </li> <li> <p>control: routine care (n = 23).</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Infants’ behavioural states (quiet sleep, active sleep, transition state, active awake, quiet awake, fussing or crying) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Graph form, CI, rate ratio and SE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Infants receiving NNS + sucrose + FT or NNS + sucrose experienced<br/>52.8% (P = 0.023) and 42.6% (P = 0.063) more quiet‐sleep occurrences than those receiving routine care after adjusting for phase, baseline states, nontreatment sucking during baseline and recovery, positioning, and infants’ characteristics. Infants receiving FT + sucrose, NNS + sucrose, NNS + sucrose + FT and NNS + FT experienced 77.3% (P &lt; 0.001), 72.1% (P = 0.008), 51.5% (P = 0.017) and 33.0% (P = 0.105) fewer occurrences of fussing or crying, respectively, than those receiving routine care after adjusting for related factors </p> <p>No data could be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: National</p> <p>Science Council of Taiwan, ROC (NSC 95‐2314‐B‐016‐057</p> <p>and NSC 96‐2314‐B‐016‐004)</p> <p>Declaration of interest:</p> <p>none declared</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0029" title="Marin GabrielMA , delRey Hurtado de MendozaB , Jimenez FigueroaL , MedinaV , Iglesias FernandezB , Vazquez RodriguezM , et al. Analgesia with breastfeeding in addition to skin-to-skin contact during heel prick. Archives of Disease in Childhood. Fetal and neonatal edition2013;98(6):F499-503. [DOI: 10.1136/archdischild-2012-302921] [PMID: 23839984]">Marin Gabriel 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>136 healthy, term neonates; GA 37 weeks to 41 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0068"> <li> <p>Sucrose group (n = 32 analysed): 2 mL 24% sucrose (given with a sterile syringe into the mouth) 2 min before heel lance </p> </li> <li> <p>Sucrose + SSC group (n = 35 analysed): sucrose as above, SSC as below</p> </li> <li> <p>SSC group (n = 31? Written to authors, as could be 32): infants were held prone between mothers’ breast at least 5 min before heel lance. </p> </li> <li> <p>BF + SSC (n = 29 analysed): infants started BF 5 min before heel lance.</p> </li> </ul> </p> <p>These interventions were used in different combinations (BF + SSC; sucrose + SSC; SSC; sucrose). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0069"> <li> <p>NIPS</p> </li> <li> <p>HR</p> </li> <li> <p>Crying time (s)</p> </li> <li> <p>Crying in blood sampling</p> </li> <li> <p>Number of heel lances (%)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median and IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The BF + SSC group achieved a lower median NIPS score (value = 1) compared with other groups (value = 2, 4 and 4, respectively). The percentage of neonates with moderate‐to‐severe pain was lower in the BF + SSC group. Both the BF + SSC group and the sucrose + SSC group experienced a lower percentage of crying compared with the SSC group. </p> <p>No adverse events were reported.</p> <p>No data were used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: none</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0030" title="MathaiS , NatrajanN , RajalakshmiNR . A comparative study of non-pharmacological methods to reduce pain in neonates. Indian Pediatrics2006;43(12):1070-5. [PMID: 17202604]">Mathai 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104 term neonates, PNA &gt; 24 h</p> <p>Mean PNA:</p> <p> <ul id="CD014806-list-0070"> <li> <p>sucrose group: 48 h; and</p> </li> <li> <p>distilled water group: 44 h</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0071"> <li> <p>2 mL 20% sucrose inserted in mouth via a dropper (n = 17)</p> </li> <li> <p>2 mL distilled water inserted in mouth via a dropper (n = 15)</p> </li> <li> <p>Rocking (n = 17)</p> </li> <li> <p>Massage (n = 17)</p> </li> <li> <p>2 mL expressed breast milk (n = 18)</p> </li> <li> <p>NNS (n = 20)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0072"> <li> <p>Time of first cry (s), total cry (s)</p> </li> <li> <p>HR before heel lance, 2 min after heel lance and 4 min after heel lance</p> </li> <li> <p>SpO<sub>2</sub> (%) before heel lance, 2 min after heel lance and 4 min after heel lance </p> </li> <li> <p>DAN score before the heel lance and 30 s, 1 min, 2 min and 4 min after heel lance</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No difference between sucrose group and any other group for time of first cry</p> <p>NNS or rocking reduced total duration of cry (P &lt; 0.05).</p> <p>No difference in HR between the groups at any time point</p> <p>No difference in SpO<sub>2</sub> (%) between the groups at any time point </p> <p>Reduced DAN scores at 30 s after the heel lance for the sucrose group (mean 7.6, SD 14, P &lt; 0.05); however, this was not sustained at 1 min, 2 min and 4 min </p> <p>NNS or rocking decreased the DAN scores at 2 and 4 min post‐heel lance (P &lt; 0.05).</p> <p>Reported data that could be used in RevMan analyses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: none</p> <p>Declaration of interest: none</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0031" title="McGinnisK , MurrayE , ChervenB , McCrackenC , TraversC . Effect of vibration on pain response to heel lance: a pilot randomized control trial. Advances in Neonatal Care2016;16(6):439-48. [DOI: 10.1097/ANC.0000000000000315] [PMID: 27533335]">McGinnis 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56 infants, GA median (IQR) of 38 weeks (30 weeks to 39 weeks) and 36 weeks (20 weeks to 38 weeks) for both intervention groups </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0073"> <li> <p>Control: swaddling (1 leg exposed on heel warmer for 3 min to 5 min before heel lance) + 0.1 mL to 0.2 mL 24% sucrose with pacifier 2 min before heel lance (n = 30) </p> </li> <li> <p>Control + vibration for heel lance analgesia (92 Hz, 0.6 mm amplitude) 30 s before heel lance (n = 26) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0074"> <li> <p>N‐PASS scores</p> </li> <li> <p>Change in HR from baseline</p> </li> <li> <p>Change in SpO<sub>2</sub> from baseline (immediately after heel stick, 2 min after, 5 min after) </p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, CI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The change in N‐PASS scores was lower in the vibration group vs the nonvibration group during (P = 0.006) and 2 min after heel stick (P = 0.037). HR elevation was also lower in the vibration group during (P = 0.002) and 2 min after heel stick (P = 0.016). There were no differences in SpO<sub>2</sub> between the two treatment groups. </p> <p>No adverse events were reported.<br/>Data could not be used in RevMan analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Dudley L. Moore Nursing and Allied</p> <p>Health Fund</p> <p>Declaration of interest: The authors declared no conflicts of interest.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0032" title="MitchellAJ , HallRW , GolianuB , YatesC , WilliamsDK , ChangJ , et al. Does noninvasive electrical stimulation of acupuncture points reduce heelstick pain in neonates?Acta Paediatrica2016;105(12):1434-9. [DOI: 10.1111/apa.13581] [PMID: 27607517]">Mitchell 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>162 infants with a GA between 37 weeks and 42 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NESAP given 10 min ± 1 min prior until 2 min after, and sucrose/water given 2 min ± 0.5 min prior: </p> <p> <ul id="CD014806-list-0075"> <li> <p>sham NESAP with (1 mL ± 0.1 mL) 24% oral sucrose (n = 37);</p> </li> <li> <p>NESAP (3.5 mA, 10 Hz) with (1 mL ± 0.1 mL) water (n = 37)</p> </li> <li> <p>NESAP (3.5 mA, 10 Hz) with (1 mL ± 0.1 mL) 24% oral sucrose (n = 40); and</p> </li> <li> <p>sham NESAP with (1 mL ± 0.1 mL) water (n = 39)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0076"> <li> <p>PIPP score (during heel lance and then every 30 s for 120 s after heel stick)</p> </li> <li> <p>Change in HRV</p> </li> <li> <p>Salivary cortisol (5 min after heel lance)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PIPP scores increased during heel stick (F (9,119) = 1.95, P = 0.05) for all 4 treatment groups. PIPP scores increased the least for the groups receiving sucrose (P &lt; 0.01). There were no differences in HRV from baseline to heel stick (P = 0.6315) and salivary cortisol levels between treatment groups.<br/>Data could not be used in RevMan analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source‐Mayday Fund and NIGMS IDeA Program award P30 GM 110702</p> <p>Declaration of interest: The authors declared no conflict of interest.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0033" title="NimbalkarS , ShuklaVV , ChauhanV , PhatakA , PatelD , ChaplaA , et al. Blinded randomized crossover trial: skin-to-skin care vs. sucrose for preterm neonatal pain. Journal of Perinatology2020;40(6):896-901. [DOI: 10.1038/s41372-020-0638-9] [PMID: 32152488]">Nimbalkar 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 preterm neonates (28 0/7 weeks' to 36 6/7 weeks' GA)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0077"> <li> <p>Group A (n = 50): skin‐to‐skin care was provided 15 min before the first heel stick and was continued post‐procedure as per the protocol of the study institute. Subsequently, during their next heel stick (3/6h after the first heel stick as clinically indicated), participants were given 24% oral sucrose 0.5 mL to those at &lt; 32 weeks' gestation and 1 mL to those at 32 weeks' to 36 weeks' gestation, 2 min before heel stick. </p> </li> <li> <p>Group B (n = 50): participants were given 24% sucrose 2‐min before heel‐stick (dosage same as previous) and SSC (3/6 h after the first heel‐stick as clinically indicated, duration same as previous) before their next heel stick. </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PIPP at 0 min, 1 min and 5 min after heel stick</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The behaviour state component was lower in the sucrose group at all assessment points. There was no difference between 1 min and 0 min (just before heel stick) (SSC 3.58 (3.16) vs sucrose 4.09 (3.82), P = 0.24) between groups. </p> <p>The mean (SD) PIPP score was similar across groups at 1 min after the heel stick (sucrose 6.84 (3.58) vs SSC 6.98 (3.34), P = 0.78). The mean (SD) PIPP score at 0 min (just before the heel stick – i.e. 2 min after sucrose administration and 15 min after SSC started, as applicable) and at 5 min after the heel stick were marginally lower in the sucrose group as compared with SSC group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: The authors declared that they had no conflict of interest.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0035" title="OkanF , CobanA , InceZ , YapiciZ , CanG . Analgesia in preterm newborns: the comparative effects of sucrose and glucose. European Journal of Pediatrics2007;166(10):1017-24. [DOI: 10.1007/s00431-006-0373-z] [PMID: 17203281]OzdoganT , AkmanI , CebeciD , BilgenH , OzekE . Comparison of two doses of breast milk and sucrose during neonatal heel prick. Pediatrics International2010;52(2):175-9. [DOI: 10.1111/j.1442-200X.2009.02921.x] [PMID: 19627552]">Okan 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31 healthy, preterm newborns; mean GA 30.5 weeks; mean PMA 32.3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0078"> <li> <p>2 mL 20% sucrose</p> </li> <li> <p>2 mL 20% glucose</p> </li> <li> <p>2 mL water</p> </li> </ul> </p> <p>The solutions were administered via syringe onto the anterior portion of the tongue.</p> <p>Cross‐over study – infants received all 3 interventions at different times.</p> <p>Data from the first treatment in each infant could not be derived.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0079"> <li> <p>Duration of first cry</p> </li> <li> <p>Total crying time</p> </li> <li> <p>HR, SpO<sub>2</sub> (%) </p> </li> <li> <p>RR (breaths/min)</p> </li> <li> <p>NFCS scores (baseline; during heel lance; and 1 min, 2 min, 3 min, 4 min and 5 min post‐heel lance) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increased duration of first cry and total crying time in the water group compared to the sucrose and glucose groups (P = 0.005 and P = 0.007, respectively) </p> <p>No differences in cry characteristics were observed between the sucrose and glucose groups. </p> <p>Higher HR in the water group (mean 175 beats/min, SD 20.8 beats/min) compared to the sucrose (mean 166 beats/min, SD 17.6 beats/min) and glucose groups (mean 165 beats/min, SD 17.5 beats/min) at 1 min following heel lance (P = 0.007). No differences between the sucrose and glucose groups </p> <p>The study found no differences for RR or SpO<sub>2</sub> between groups. </p> <p>Higher NFCS score in the placebo group in the fourth minute following heel lance (mean 1.3, SD 2.0) and fifth min following heel lance (mean 1.0, SD 1.0) compared to the sucrose (mean 0.5, SD 1.7; mean 0.3, SD 1.3, respectively) and glucose groups (mean 0.2, SD 0.5; mean 0.1, SD 0.3, respectively) (P = 0.009 at fourth minute and P = 0.046 at fifth minute). There were no differences between the sucrose and glucose groups. </p> <p>Data could not be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0036" title="OrsR , OzekE , BaysoyG , CebeciD , BilgenH , TürkünerM , et al. Comparison of sucrose and human milk on pain response in newborns. European Journal of Pediatrics1999;158(1):63-6. [DOI: 10.1007/s004310051011] [PMID: 9950311]">Ors 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102 healthy, term infants; GA 37 weeks to 42 weeks; median PNA 1.6 d (range 1 d to 15 d) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0080"> <li> <p>2 mL 25% sucrose (n = 35)</p> </li> <li> <p>2 mL human milk (n = 33)</p> </li> <li> <p>2 mL sterile water (n = 34)</p> </li> </ul> </p> <p>All solutions syringed onto anterior part of tongue for 1 min; heel prick performed 2 min after intervention </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0081"> <li> <p>Median cry time (in seconds) during 3 min after lance</p> </li> <li> <p>Percentage of change in HR 1 min, 2 min and 3 min after heel lance</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median, IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decrease in crying time (in seconds) for 25% sucrose group (median 36, IQR 18 to 43) compared to human milk (median 62, IQR 29 to 107) and sterile water (median 52, IQR 32 to 158) (P = 0.0009). Recovery time for crying was reduced in 25% sucrose group (median 72, IQR 48 to 116) compared to human milk (median 112, IQR 72 to 180) and sterile water (median 124, IQR 82 to 180) (P = 0.004) </p> <p>Percentage of change in HR after heel lance was lower in the group receiving 25% sucrose compared to groups receiving human milk and sterile water at 1 min, 2 min and 3 min (P = 0.008, P = 0.01, P = 0.002, respectively) </p> <p>No data were used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0037" title="OvergaardC , KnudesenA . Pain-relieving effect of sucrose in newborns during heel prick. Biology of the Neonate1999;75(5):279-84. [DOI: 10.1159/000014105] [PMID: 10095141]">Overgaard 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 newborn term infants, mean PNA 6 d (range 4 d to 9 d)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0082"> <li> <p>2 mL 50% sucrose solution via syringe into the mouth over 30 s 2 min prior to heel lance (n = 49) </p> </li> <li> <p>2 mL sterile water via syringe into the mouth over 30 s 2 min prior to heel lance (n = 47) </p> </li> </ul> </p> <p>In addition to the intervention to which the infants were assigned, parents were instructed to comfort the infant as much as possible. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0083"> <li> <p>Median crying time during heel lance, fraction of crying during sampling, crying time during first minute after end of sampling, total crying time </p> </li> <li> <p>Change in HR at 0 min and 1 min</p> </li> <li> <p>SpO<sub>2</sub> (%) at 0 min and 1 min </p> </li> <li> <p>NIPS scores 1 min after heel lance and 1 min after blood sampling</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median, 5th and 95th percentiles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median duration of first cry in group receiving 50% sucrose was lower (18 s (2 s to 75 s)) compared to placebo group (22 s (11 s to 143 s)) (P = 0.03). Median crying time during heel lance in the sucrose group was lower (26 s (2 s to 183 s)) compared to placebo group (40 s (12 s to 157 s)) (P = 0.07). Median fraction of crying during sampling in 50% sucrose group was lower (43% (4% to 100%)) compared to placebo group (83% (20% to 100%)) (P = 0.004). Median crying time during first min after end of sampling in 50% sucrose group was lower (3 s (0 s to 58 s)) compared to placebo group (16 s (0 s to 59 s)) (P = 0.004). Median total time crying in 50% sucrose group was lower (30 s (2 s to 217 s)) compared to placebo group (71 s (13 s to 176 s)) (P = 0.007). </p> <p>No differences between groups with respect to HR (P = 0.6)</p> <p>No differences between groups with respect to changes in SpO<sub>2</sub> (%) (P = 0.9) </p> <p>Median NIPS scores 1 min after heel lance were lower in 50% sucrose group compared to placebo group (3 (0 to 7) and 6 (0 to 7), respectively; P = 0.04). Median NIPS scores 1 min after end of blood sampling were lower in 50% sucrose group (0 (0 to 7)) compared to placebo group (2 (0 to 7)) (P = 0.05). </p> <p>As means were not reported, we could not include the results in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Source of funding: Det Obelske family Foundation and Danico’s Foundation</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0039" title="RamenghiLA , WoodCM , GriffithGC , LeveneMI . Reduction of pain response in premature infants using intraoral sucrose. Archives of Disease in Childhood. Fetal and Neonatal Edition1996;74(2):F126-8. [DOI: 10.1136/fn.74.2.f126] [PMID: 8777660]">Ramenghi 1996b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 preterm infants, GA 32 weeks to 34 weeks, &gt; 24 h of age</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0084"> <li> <p>1 mL 25% sucrose</p> </li> <li> <p>1 mL sterile water</p> </li> </ul> </p> <p>The solutions were administered via syringe into the baby’s mouth for 1 min.</p> <p>Cross‐over study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0085"> <li> <p>Duration of first cry and percentage of time crying 5 min after lance</p> </li> <li> <p>HR at −2 min, 0 min, 1 min, 3 min and 5 min from heel lance</p> </li> <li> <p>Behavioural scores (4 facial expressions and the presence of crying) at −2 min, −1 min, 0 min, 1 min, 2 min, 3 min and 5 min </p> </li> <li> <p>Quality and intensity of sucking</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median, IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No adverse events were reported.</p> <p>No data could be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0038" title="RamenghiLA , GriffithGC , WoodCM , LeveneMI . Effect of non-sucrose sweet tasting solution on neonatal heel prick responses. Archives of Disease in Childhood. Fetal and Neonatal Edition1996;74(2):F129-31. [DOI: 10.1136/fn.74.2.f129] [PMID: 8777661]">Ramenghi 1996a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 term infants, GA 37 weeks to 42 weeks, 2 d to 5 d old</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0086"> <li> <p>2 mL 25% (0.5 g) sucrose (n = 15)</p> </li> <li> <p>2 mL 50% (1.0 g) sucrose (n = 15)</p> </li> <li> <p>Calpol (n = 15)</p> </li> <li> <p>Single‐dose sterile water (n = 15)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0087"> <li> <p>Duration of first cry after lance</p> </li> <li> <p>Percentage of time crying over 3 min after heel lance</p> </li> <li> <p>Percentage of change in HR over 5 min (at −2 min, 0 min, 1 min, 3 min and 5 min from heel lance) </p> </li> <li> <p>Behavioural scores (4 facial expressions and the presence of crying) at −2 min, −1 min, 0 min, 1 min, 2 min, 3 min and 5 min </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median, IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decrease in duration of first cry and percentage of time crying during 3 min after heel lance in the 25% sucrose, 50% sucrose and Calpol groups (P = 0.02) (data in graph form only) </p> <p>Increase in HR for 3 min after heel lance in water group compared with 50% sucrose group and Calpol group (P = 0.009) </p> <p>Pain score (0 to 5) was higher in water group (score = 2, range 1 to 5) than in other 3 groups: 50% sucrose group (score = 0, range 0 to 3); 25% sucrose group (score = 0, range 0 to 2); Calpol group (score = 0, range 0 to 1) (P = 0.05). </p> <p>No data were used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0040" title='RamenghiLA , EvansDJ , LeveneMI . "Sucrose analgesia": absorptive mechanism or taste perception?Archives of Disease in Childhood. Fetal and Neonatal Edition1999;80(2):F146-7. [DOI: 10.1136/fn.80.2.f146] [PMID: 10325795]'>Ramenghi 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 preterm infants, GA 32 weeks to 36 weeks, PNA &gt; 24 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0088"> <li> <p>25% sucrose solution (volume not reported) given via syringe into the mouth or via NG tube 2 min prior to first heel lance (n = 15), and via the alternate route for the second heel lance within 48 h </p> </li> <li> <p>Sterile water given via syringe into the mouth or via NG tube 2 min prior to first heel lance and for the second heel lance the alternate route within 48 h (cross‐over design, n = 15) </p> </li> </ul> </p> <p>The cross‐over concerned mode of delivery of the solution: intraorally or via NG tube.</p> <p>Infants stayed in their original group assigned to receive either sucrose or sterile water. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0089"> <li> <p>Percentage of time crying over 5 min after sampling</p> </li> <li> <p>Behavioural scores (4 facial expressions and the presence of cry) at 1 min, 3 min and 5 min after the lance for a total behavioural score </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median, IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median percentage of time crying in intra‐oral water group was 22% (IQR 10.6% to 40%) and 27% (IQR 11.6% to 47%) for infants in NG tube water group. Median percentage of time crying in intra‐oral 25% sucrose group was 6% (IQR 0.6% to 15%) and 18.3% (IQR 11.6% to 41.6%) in NG tube 25% sucrose group. </p> <p>Reduction in crying time (P = 0.006) was noted in the 25% sucrose group compared with water group when infants received 25% sucrose intra‐orally, not via NG‐tube route. For infants in 25% sucrose group, a reduction in crying time was noted (P = 0.008) when solution was given intra‐orally compared to NG tube route. </p> <p>Behavioural scores for the intra‐oral water group were 9 (IQR 6 to 12) and 10 (IQR 6 to 14) for NG tube water group. Behavioural scores for intra‐oral 25% sucrose group were 5 (IQR 3 to 6) and 9 (IQR 8 to 10) for NG tube sucrose group. Reduction in behavioural scores was noted in 25% sucrose group (P = 0.002) compared with water group when infants received 25% sucrose intra‐orally but not via NG route. For infants in 25% sucrose group, there was a reduction in behavioural score (P = 0.001) when solution was given intra‐orally compared to via NG tube. </p> <p>Cross‐over design: data from the first assignment prior to cross‐over were presented. These data were not used in RevMan analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0041" title="RushforthJA , LeveneMI . Effect of sucrose on crying in response to heel stab. Archives of Disease in Childhood1993;69(3):388-9. [DOI: 10.1136/adc.69.3.388] [PMID: 8215552]">Rushforth 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52 term infants, GA 37 weeks to 42 weeks, 2 d to 7 d of age</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0090"> <li> <p>2 mL 7.5% sucrose administered by a dropper into the mouth over a 1‐minute period prior to heel lance (n = 26) </p> </li> <li> <p>2 mL sterile water administered by dropper into the mouth over a 1‐minute period prior to heel lance (n = 26) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage of crying during sampling and 3 min after sampling</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Medians only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No differences in median percentage of time crying between group receiving 7.5% sucrose (74.3%) compared to group receiving water (73.2%). No differences between groups in duration of cry after 1 min (P = 0.65), 2 min (P = 0.52) and 3 min (P = 0.72). No difference in time to cessation of crying (P = 0.16) </p> <p>No data could be used in RevMan analyses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0042" title="SenE , ManavG . Effect of kangaroo care and oral sucrose on pain in premature infants: a randomized controlled trial. Pain Management Nursing2020;21(6):556-64. [DOI: 10.1016/j.pmn.2020.05.003] [PMID: 32768272]">Sen 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64 preterm neonates (infants born between 32 and 37 gestational weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0091"> <li> <p>Sucrose group (n = 32) given 0.5 mL, 24% oral sucrose without pacifier by the researcher 2 min before heel lance </p> </li> <li> <p>KC group (n = 32) – KC started 15 min before heel lance</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HR, SpO<sub>2</sub> and PIPP score during and 2 min after heel lance </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0092"> <li> <p>Median, IQR: PIPP scores</p> </li> <li> <p>Mean, SD: HR and SpO<sub>2</sub> </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PIPP scores were lower in the KC group compared to the sucrose group 2 min after heel lancing (P &lt; 0.001). </p> <p>There was a difference between groups in<br/>the change in PIPP values during and after heel lancing (P = 0.002) favouring the KC group.<br/>There was a difference between the groups in<br/>changes observed in HR values after and before heel<br/>lance (P &lt; 0.001); the change observed in the oral sucrose group<br/>was greater than that in the KC group. </p> <p>There was no<br/>difference between the groups in <br/>changes in SpO<sub>2</sub> values after and during heel lance (P &gt; 0.05). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: No conflict of interest has been declared by the authors.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0043" title="ShahSR , KadageS , SinnJ . Trial of music, sucrose, and combination therapy for pain relief during heel prick procedures in neonates. Journal of Pediatrics2017;190:153-8. [DOI: 10.1016/j.jpeds.2017.08.003] [PMID: 29144240]">Shah 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35 neonates, PMA 35 weeks (SD 2.3 weeks), average weight 2210 g (SD 710 g)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0093"> <li> <p>Recorded music (sounds up to 60 A‐weighted decibels, 20 min prior to heel prick until 7 min after procedure) (n = 35) </p> </li> <li> <p>Oral sucrose therapy (0.5 mL oral sucrose (24%) 2 min before heel prick) (n = 35)</p> </li> <li> <p>Combination therapy (n = 35)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0094"> <li> <p>PIPP‐R score at 1‐minute intervals for a total of 6 min after heel prick</p> </li> <li> <p>Mean HR and SpO<sub>2</sub> at 1‐minute intervals for 20 min before heel prick to 7 min after </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0095"> <li> <p>Median, IQR: PIPP‐R</p> </li> <li> <p>Mean, SD: SpO<sub>2</sub> and average HR </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>There was no difference in overall PIPP scores between the music (median 4, IQR 0 to 6) and sucrose groups (median 3, IQR 0 to 6). The PIPP scores were lower for the combination group (median 1, IQR 0 to 3). There was lower trend in SpO<sub>2</sub> for the combination group compared with the sucrose group (P &lt; 0.001).<br/>Data were included in RevMan analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: The authors declared no conflict of interest.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0044" title="SimonseE , MulderPG , vanBeekRH . Analgesic effect of breast milk versus sucrose for analgesia during heel lance in late preterm infants. Pediatrics2012;129(4):657-63. [DOI: 10.1542/peds.2011-2173] [PMID: 22392168]">Simonse 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71 preterm infants, GA 32 weeks to 36 + 6/7 weeks at birth, undergoing heel lance with an automated piercing device </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0096"> <li> <p>1 mL to 2 mL 24% sucrose orally before heel lance (n = 24 were analysed), combined with NNS </p> </li> <li> <p>Breastfed in mother's arms (n = 23)</p> </li> <li> <p>Bottle‐fed breast milk and held in the arms of an experienced nurse (n = 23)</p> </li> </ul> </p> <p>All 46 infants (in groups 2 and 3) were analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0097"> <li> <p>PIPP score</p> </li> <li> <p>COMFORTneo score</p> </li> <li> <p>HR</p> </li> <li> <p>SpO<sub>2</sub> (%) </p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean and 95% CI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>There was no difference in mean PIPP score between neonates receiving breast milk (6.1) and those receiving sucrose (5.5), with a mean difference of 0.6 (95% CI −1.6 to 2.8; P = 0.58). </p> <p>No data were provided for HR and SpO<sub>2</sub>. </p> <p>No adverse events were reported.</p> <p>95% CIs were transformed to SDs and used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: no external funding</p> <p>Declaration of interest: The authors indicated they had</p> <p>no financial relationships relevant to this article to disclose.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0045" title="SlaterR , CornelissenL , FabriziL , PattenD , YoxenJ , WorleyA , et al. Oral sucrose as an analgesic drug for procedural pain in newborn infants: a randomised controlled trial. Lancet2010;376(9748):1225-32. [DOI: 10.1016/S0140-6736(10)61303-7] [PMID: 20817247]">Slater 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44 term infants, GA 37 weeks to 43 weeks, &lt; 8 d old</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0098"> <li> <p>0.5 mL 24% sucrose given via syringe (n = 20)</p> </li> <li> <p>0.5 mL sterile water (n = 24)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0099"> <li> <p>HR change</p> </li> <li> <p>PIPP score</p> </li> <li> <p>Nociceptive‐specific brain activity</p> </li> <li> <p>Latency to change in facial expression (s)</p> </li> <li> <p>Facial nonresponders</p> </li> <li> <p>Nociceptive reflex withdrawal activity</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, 95% CI, mean weight</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only mean baseline HR given: 24% sucrose 132.6 beats/min (124.3 beats/min to 140.9 beats/min); sterile water 131.8 beats/min (122.2 beats/min to 141.5 beats/min) (P = 0.90) </p> <p>Only mean baseline SpO<sub>2</sub> given: 24% sucrose 99.4% (98.8% to 100.1%); sterile water 97.4% (95.0% to 99.8%) (P = 0.13) </p> <p>PIPP score during insertion: baseline PIPP score: 24% sucrose 1.3 (0.8 to 1.7), sterile water 1.3 (0.8 to 1.8) (P = 0.91); PIPP during procedure: 24% sucrose 5.8 (3.7 to 7.8), sterile water 8.5 (7.3 to 9.8) (P = 0.02) </p> <p>No differences in nociceptive‐specific brain activity (P = 0.46), latency to change in facial expression (P = 0.86), mean nociceptive reflex withdrawal activity (P = 0.49) or mean latency to nociceptive reflex withdrawal activity (P = 0.56); difference in facial nonresponders for 24% sucrose 35%, for sterile water 0% (P &lt; 0.0001) </p> <p>Results presented as mean and 95% CIs</p> <p>Data used in RevMan analyses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Medical Research Council</p> <p>Declaration of interest: Authors declared that they had no conflicts of interest.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0046" title="JohnstonCC , SherrardA , StevensB , FranckL , StremlerR , JackA . Do cry features reflect pain intensity in preterm neonates?Biology of the Neonate1999;76(2):120-4. [DOI: 10.1159/000014150] [PMID: 10393997]StevensB , JohnstonC , FranckP , PetryshenP , JackA , FosterG . The efficacy of developmentally sensitive interventions and sucrose for relieving pain in very low birth weight infants. Nursing Research1999;48(1):35-43. [DOI: 10.1097/00006199-199901000-00006] [PMID: 10029400]">Stevens 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>122 preterm neonates, GA 27 weeks to 31 weeks, ≤ 28 d of age</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0100"> <li> <p>Prone positioning 30 min prior to heel lance</p> </li> <li> <p>Pacifier dipped in sterile water and placed into the mouth 2 min prior to heel lance</p> </li> <li> <p>Pacifier dipped in 24% sucrose and placed into the mouth 2 min prior to heel lance</p> </li> <li> <p>Control: containment in SnuggleUp device (n = 122)</p> </li> </ul> </p> <p>All infants were contained in SnuggleUp device for all interventions.</p> <p>Each infant received all 4 interventions in random order (serving as his or her own control); there was 1 control group and 3 intervention groups. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0101"> <li> <p>PIPP scores at 30 s and 60 s</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported means, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Main effect of treatment for mean PIPP scores (P &lt; 0.0001). Post hoc analysis revealed a reduction in PIPP scores 30 s after heel lance in sucrose group (pacifier dipped in 24% sucrose estimated at 0.02 g) (mean 7.87, SD 3.35) compared to control group (mean 9.80, SD 3.55) (P &lt; 0.0001). Reduction in PIPP scores in pacifier and water group (mean 8.44, SD 3.55) compared to control group (mean 9.80, SD 3.55) (P = 0.003). Trend towards lower PIPP scores with sucrose and pacifier group compared to water and pacifier group (P &lt; 0.05) </p> <p>No adverse effects were observed when administering 24% sucrose orally via a pacifier.</p> <p>The first author provided data for 61 infants for PIPP at 30 s after heel lance and for 45 infants at 60 s after heel lance for infants before cross‐over. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: National Institutes of Health, National Institute of Nursing Research</p> <p>(grant NR 03916 R01) and a National Institutes of Health Pediatric Clinical Research Center grant at the University of California San Francisco and Children's Hospital, Oakland research sites (M01 ‐ RR012771) </p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0047" title="StevensB , YamadaJ , BeyeneJ , GibbinsS , PetryshenP , StinsonJ , et al. Consistent management of repeated procedural pain with sucrose in preterm neonates: is it effective and safe for repeated use over time?Clinical Journal of Pain2005;21(6):543-8. [DOI: 10.1097/01.ajp.0000149802.46864.e2] [PMID: 16215340]">Stevens 2005a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66 preterm infants, GA 26 weeks to 30 weeks, PNA &lt; 72 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0102"> <li> <p>Standard care (i.e. positioning and swaddling) (n = 21)</p> </li> <li> <p>Standard care as above + 0.1 mL sterile water via syringe into the mouth immediately followed by a pacifier 2 min prior to painful procedure (n = 23) </p> </li> <li> <p>Standard care as above + 0.1 mL 24% sucrose via syringe into the mouth immediately followed by a pacifier 2 min prior to painful procedure (n = 22) </p> </li> </ul> </p> <p>These interventions were given every time there was a painful procedure during the first 28 d of life. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0103"> <li> <p>PIPP at days 7, 14, 21 and 28 at routine heel lance</p> </li> <li> <p>Adverse events</p> </li> <li> <p>Neurobiological risk status</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Main effect of group (there was a difference in a particular group) (P = 0.03) with differences occurring between the sucrose + pacifier group and the standard care group (at 60 s P = 0.01). Mean PIPP scores were generally higher in the standard care group. </p> <p>Adverse effects: no group differences for adverse events, clinical outcomes or neurobiological risk status </p> <p>No data used in RevMan analyses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0048" title="StevensB , YamadaJ , Campbell-YeoM , GibbinsS , HarrisonD , DionneK , et al. The minimally effective dose of sucrose for procedural pain relief in neonates: a randomized controlled trial. BMC Pediatrics2018;18(1):85. [DOI: 10.1186/s12887-018-1026-x] [DOI: 10.1186/s12887-018-1026-x] [PMID: 29475433]">Stevens 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>245 neonates, 24 weeks' to 42 weeks' GA at birth and &lt; 30 d of life or &lt; 44 weeks' GA </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All interventions given 2 min before heel lance</p> <p> <ul id="CD014806-list-0104"> <li> <p>0.1 mL 24% sucrose (n = 81)</p> </li> <li> <p>0.5 mL 24% sucrose (n = 81)</p> </li> <li> <p>1.0 mL 24% sucrose (n = 83)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0105"> <li> <p>PIPP‐R at 30 s and 60 s</p> </li> <li> <p>Incidence of adverse events (HR &gt; 240 beats/min or HR &lt; 80 beats/min for &gt; 20 s; SpO<sub>2</sub> &lt; 80% for &gt; 20 s; no spontaneous respirations for &gt; 20 s; and choking/gagging) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean (SD) PIPP‐R scores at 30 s were 6.9 (3.5), 6.8 (3.2) and 6.7 (3.4) for 0.1 mL, 0.5 mL and 1.0 mL, respectively. There were no differences in PIPP‐R score between treatment groups at 30 s (P = 0.97) and at 60 s (P = 0.93). </p> <p>There were 5 adverse events reported: 3 infants experienced gagging, 1 had an HR &lt; 80 beats/min and another developed 80% SpO<sub>2</sub> following sucrose administration. There were no differences in proportion of adverse events between the intervention groups (P = 0.62), and all resolved spontaneously.<br/>No data could be used in RevMan analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: The Canadian Institutes of Health Research (MOP‐126167)</p> <p>Declaration of interest:</p> <p>the authors declared that they had no competing interests.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0049" title="StormH , FremmingA . Food intake and oral sucrose in preterms prior to heel prick. Acta Paediatrica2002;91(5):555-60. [DOI: 10.1080/080352502753711687] [PMID: 12113325]">Storm 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48 preterm infants, median GA of 32 weeks, median PNA of 14 d</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0106"> <li> <p>2 mL 15% sucrose (n = 12)</p> </li> <li> <p>1 mL 25% sucrose (n = 12)</p> </li> <li> <p>Milk via NG tube (n = 12)</p> </li> <li> <p>Milk via NG tube + 1 mL 25% sucrose (n = 12)</p> </li> </ul> </p> <p>All infants were given water prior to a second heel lance.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0107"> <li> <p>Differences in crying time for pre‐heel lance to heel lance procedure</p> </li> <li> <p>Changes in HR from pre‐heel lance to heel lance procedure</p> </li> <li> <p>Difference in skin conductance from pre‐heel lance to heel lance procedure</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Less crying in infants receiving 25% sucrose (P &lt; 0.05) and food (milk) + 25% sucrose (P &lt; 0.05) </p> <p>No differences between groups in changes in HR from before heel lance to heel lance procedure (P value not reported) </p> <p>Smaller increase in skin conductance variables compared to their water control session (P value not reported) </p> <p>No data could be included in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: SIDS Society, Oslo, Norway</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0051" title="ThakkarP , AroraK , GoyalK , DasRR , JavadekarB , AiyerS , et al. To evaluate and compare the efficacy of combined sucrose and non-nutritive sucking for analgesia in newborns undergoing minor painful procedure: a randomized controlled trial. Journal of Perinatology2016;36(1):67-70. [DOI: 10.1038/jp.2015.122] [PMID: 26583940]">Thakkar 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>180 full‐term neonates, birthweight &gt; 2000 g and age &gt; 24 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0108"> <li> <p>2 mL 30% sucrose (n = 45)</p> </li> <li> <p>2 mL 30% sucrose + NNS (n = 45)</p> </li> <li> <p>NNS (n = 45)</p> </li> <li> <p>No intervention (n = 45)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0109"> <li> <p>PIPP</p> </li> <li> <p>Total crying time</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median, IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR) PIPP score was 3 (2 to 4) in the sucrose + NNS group compared with 7 (6.5 to 8) in the sucrose only group, 9 (7 to 11) in the NNS group and 13 (10.5 to 15) in the no intervention group. The sucrose + NNS group had a decrease in the median PIPP score compared with other groups (P = 0.000). Median PIPP score decreased with any intervention compared with no intervention (P = 0.000). </p> <p>A total of 5 episodes of adverse events were reported: 1 neonate each in the sucrose group, the NNS group and the sucrose + NNS group desaturated, and 2 neonates desaturated in the no intervention group. </p> <p>No data were used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest:</p> <p>the authors declared no conflict of interest.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0052" title="Tutag LehrV , CortezJ , GreverW , CepedaE , ThomasR , ArandaJV . Randomized placebo controlled trial of sucrose analgesia on neonatal skin blood flow and pain response during heel lance. Clinical Journal of Pain2015;31(5):451-8. [DOI: 10.1097/AJP.0000000000000126] [PMID: 24918475]">Tutag Lehr 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56 term infants ≤ 7 d old: appropriate for GA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0110"> <li> <p>2.0 mL 24% sucrose orally (n = 29)</p> </li> <li> <p>Sterile water orally (n = 27)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0111"> <li> <p>NIPS</p> </li> <li> <p>Mean SBF</p> </li> <li> <p>SBF</p> </li> <li> <p>PU measured by LDI during heel lance</p> </li> <li> <p>HR</p> </li> <li> <p>RR</p> </li> <li> <p>SpO<sub>2</sub> (%) </p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SE, median, IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean SBF and median NIPS scores immediately post‐heel lance were lower in sucrose‐treated infants (SBF: 167.9 PU ± 15.5 PU vs 205.4 PU ± 16.0 PU, P = 0.09; NIPS: 1 (IQR 0 to 4) vs 3 (IQR 0 to 6), P = 0.02), although there was no difference in mean SBF. During heel lance, NIPS score was predictive of SBF. An increase of 1 in NIPS score was associated with 11‐PU increase in SBF (R = 0.21; P = 0.09) for sucrose and 16‐PU increase for placebo‐treated infants (R = 0.20; P = 0.014). </p> <p>Increased SBF assessed by LDI is a pain response among term neonates following routine heel lance that was not completely attenuated by oral sucrose administration. Increased SBF is associated with NIPS scores. Sucrose analgesic efficacy evidenced by decreased NIPS scores for the sucrose group. Association of SBF with NIPS scores suggests LDI is potentially useful for assessing newborn procedural pain. </p> <p>SEs were transformed to SDs and were used in RevMan analyses for SBF.</p> <p>For HR, RR and SpO<sub>2,</sub> results were presented as means and SDs and were used in RevMan analyses. </p> <p>Assessed adverse events including</p> <p>gagging, choking and vomiting, and only 1 infant in the sucrose group was noted to experience a mild episode of 'spitting up'. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: The Gerber Foundation, Fremont, Michigan</p> <p>Declaration of interest: The authors</p> <p>declared no conflict of interest.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0053" title="Unceta-BarrenecheaA , Saitua IturriagaG , Sainz de Rozas AparicioI , Riveira FernándezD . Analgesia when taking heel lance blood in the newborn [Analgesia en la toma sanguínea de talónen los recién nacidos]. Anales de Pediatria (Barcelona)2008;69(6):544-7. [DOI: 10.1016/s1695-4033(08)75237-8] [PMID: 19128767]">Unceta‐Barranechea 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150 term infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0112"> <li> <p>FT</p> </li> <li> <p>NNS + water</p> </li> <li> <p>NNS + 2 mL 24% sucrose</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0113"> <li> <p>Mean crying time between groups</p> </li> <li> <p>Modified NFCS</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Differences in crying time between FT and 2 intervention groups (P &lt; 0.001). No difference between NNS + water and NNS + sucrose groups (P = 0.735) </p> <p>Differences in pain score between control group and 2 intervention groups (P &lt; 0.001). No difference between sucking with placebo and sucking with sucrose groups (P = 0.105) </p> <p>Data used in RevMan analyses</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0054" title="VelumulaPK , ElbakoushF , Tabb C 2nd, FarooqiA , Lulic-BoticaM , JaniS , et al. Breast milk vs 24% sucrose for procedural pain relief in preterm neonates: a non-inferiority randomized controlled trial. Journal of Perinatology2022;42(7):914-9. [DOI: 10.1038/s41372-022-01352-2] [PMID: 35197549]">Velumula 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94 neonates born between 30 1/7 weeks' and 36 6/7 weeks' GA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0114"> <li> <p>0.5 mL 24% sucrose (n = 47)</p> </li> <li> <p>2 mL expressed breast milk via syringe (n = 47)</p> </li> </ul> </p> <p>Infants in both groups also received swaddling 2 min prior to scheduled heel lance.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0115"> <li> <p>PIPP‐R scores at baseline; during the procedure; and at 30 s, 60 s, 90 s and 120 s postprocedure, assessed in real time by two investigators. Final pain score was determined by calculating the average of the two assessors' scores. </p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0116"> <li> <p>Mean, SD</p> </li> <li> <p>Median, IQR</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PIPP‐R scores during procedure ranged from 5 to 12 in the two groups, with a mean (SD) score of 8.3 (1.3). PIPP‐R scores at 30 s and 60 s post‐procedure ranged from 0 to 6 and 0 to 5 with mean (SD) of 4.14 (0.98) and 1.27 (1.88) at 30 s and 60 s, respectively. All infants reached their baseline score of 0 by 90 s post‐procedure. PIPP‐R scores at 60 s were lower in the breast milk group compared to sucrose group. No differences were noted in PIPP‐R scores during the procedure (P = 0.17) and at 30 s post‐procedure (P = 0.39). PIPP‐R scores at 60 s post‐procedure were higher in the sucrose group compared to breast milk group (P &lt; 0.01). </p> <p>No adverse events were noted in any infant in both groups.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Institutional grant from Sarnaik Endowment Grant, Detroit Medical Center </p> <p>Declaration of interest: the authors declared no competing interests.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0055" title="YilmazF , ArikanD . The effects of various interventions to newborns on pain and duration of crying. Journal of Clinical Nursing2010;20(7-8):1008-17. [DOI: 10.1111/j.1365-2702.2010.03356.x] [PMID: 21054600]">Yilmaz 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>120 infants, GA 37 weeks to 42 weeks</p> <p>Mean GA (SD):</p> <p> <ul id="CD014806-list-0117"> <li> <p>control group (n = 30): 39.67 weeks (0.80 weeks);</p> </li> <li> <p>mother’s milk group (n = 30): 39.10 weeks (1.03 weeks);</p> </li> <li> <p>sucrose group (n = 30): 39.10 weeks (0.71 weeks); and</p> </li> <li> <p>pacifier group (n = 30): 39.20 weeks (0.93 weeks)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0118"> <li> <p>Control group: infants lay in their mothers’ lap; no interventions were made before the painful procedure </p> </li> <li> <p>Mother's milk group: 2 mL mother’s milk administered 2 min before the procedure by using an oral syringe and avoiding contact of the syringe with the mouth and lips </p> </li> <li> <p>Sucrose group: 2 mL 20% sucrose via a syringe as above, 2 min before the procedure</p> </li> <li> <p>Pacifier group: given a pacifier</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0119"> <li> <p>NIPS score</p> </li> <li> <p>HR</p> </li> <li> <p>RR</p> </li> <li> <p>Crying time</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No differences in HR and SpO<sub>2</sub> between groups </p> <p>After the procedure, the mean crying time of the sucrose group was shorter than those of the other groups. Comparing the crying times of the control and experimental groups according to the procedure time showed no differences between the values before and during the procedure (F = 1.50, P &gt; 0.05); (F = 2.43, P &gt; 0.05). </p> <p>Before the procedure, the lowest NIPS mean was in the sucrose group, and the highest NIPS mean was in the pacifier group. During the procedure, no differences were found between the groups for NIPS means (P &gt; 0.05). After the procedure, the sucrose group showed the lowest response to pain, while the mother's milk group had the highest response. Comparing the NIPS means of the control and experimental groups according to the procedure times, differences were found between the groups for values obtained before and after the procedure (F = 3.49, P &lt; 0.05); (F = 6.71, P &lt; 0.05). </p> <p>Outcome data were presented according to different procedure times, and no data could be included in RevMan analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Declaration of interest: none</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>ATP: adenosine triphosphate; BF: breastfeeeding; BPSN: Bernese Pain Scale for Neonates; CI: confidence interval; DAN: Douleur Aiguë du Nouveau‐né Scale; FT: facilitated tucking; GA: gestational age; HR: heart rate; HRV: heart rate variability; IQR: interquartile range; KC: kangaroo care; LDI: laser Doppler imager; NAPI: Neurobehavioral Assessment of the Preterm Infant; NESAP: noninvasive electrical stimulation of acupuncture points; NFCS: Neonatal Facial Coding System; NG: nasogastric; NICU: Neonatal Infant Care Unit ; NIPS: Neonatal Infant Pain Scale; NNS: nonnutritive sucking; N‐PASS: Neonatal Pain Agitation and Sedation Scale; O<sub>2</sub>: oxygen; PIPP: Premature Infant Pain Profile; PIPP‐R: Premature Infant Pain Profile – Revised; PMA: postmenstrual age; PNA: postnatal age; PU: perfusion unit; RR: respiratory rate; RSF: Ross Special Formula; SBF: skin blood flow; SD: standard deviation; SE: standard error; SEM: standard error of the mean; SpO<sub>2</sub>: oxygen saturation; SSC: skin‐to‐skin contact; TcPO<sub>2</sub>: transcutaneous oxygen pressure; VAS: visual analogue scale </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of included studies assessing pain during heel lances</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD014806-tbl-0011"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Characteristics of included studies assessing pain during heel lances and venipunctures</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Procedure</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Metrics used</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Results</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Funding sources and declaration of interest</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0034" title="OgawaS , OgiharaT , FujiwaraE , ItoK , NakanoM , NakayamaS , et al. Venepuncture is preferable to heel lance for blood sampling in term neonates. Archives of Disease in Childhood. Fetal and Neonatal Edition2005;90(5):F432-6. [DOI: 10.1136/adc.2004.069328] [PMID: 15871991]">Ogawa 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 healthy full‐term infants:</p> <p> <ul id="CD014806-list-0120"> <li> <p>Heel lance + water group: GA 40 weeks (range 38 weeks to 42 weeks)</p> </li> <li> <p>Heel lance + sucrose group: GA 39 weeks (range 37 weeks to 41 weeks)</p> </li> <li> <p>Venipuncture + water group: GA 39 weeks (range 37 weeks to 41 weeks)</p> </li> <li> <p>Venipuncture + sucrose group: GA 39 weeks (range 37 weeks to 41 weeks)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heel lance or venipuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 min before procedure:</p> <p> <ul id="CD014806-list-0121"> <li> <p>heel lance + 0.1 mL sterile water on infant's tongue via syringe (n = 25);</p> </li> <li> <p>heel lance + 0.1 mL 50% sucrose on infant's tongue via syringe (n = 25);</p> </li> <li> <p>venipuncture + 0.1 mL sterile water on infant's tongue via syringe (n = 25); and</p> </li> <li> <p>venipuncture + 0.1 mL 50% sucrose on infant's tongue via syringe (n = 25).</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Duration of first cry (s), first crying time/total procedure time (%) and the ratio of crying to no crying </p> <p>NFCS score:</p> <p> <ul id="CD014806-list-0122"> <li> <p>1 min after oral administration of water or sucrose;</p> </li> <li> <p>disinfection of skin before heel lance or venipuncture;</p> </li> <li> <p>during skin puncture;</p> </li> <li> <p>during blood sampling;</p> </li> <li> <p>during compression to stop bleeding;</p> </li> <li> <p>during application of plaster; and</p> </li> <li> <p>1 min after application of plaster.</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported medians, range and mean, SD</p> <p>Reported in graph form, median and IQR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reduction in duration of first cry in heel lance group given sucrose compared to heel lance alone (P &lt; 0.001) </p> <p>Reduced NFCS scores in sucrose group during heel lance (median 47, IQR 31 to 60) and during compression to stop bleeding (median 32, IQR 8 to 54) compared to the water group (median 58, IQR 54 to 65; median 52, IQR 41 to 61, respectively) (P &lt; 0.001) </p> <p>Sucrose did not reduce NFCS scores during or after venipuncture</p> <p>We included data for sucrose vs water for heel lance and for venipuncture for duration of first cry. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: not specified</p> <p>Competing interests: none declared</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>GA: gestational age; IQR: interquartile range; NFCS: Neonatal Facial Coding System; SD: standard deviation </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Characteristics of included studies assessing pain during heel lances and venipunctures</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD014806-tbl-0012"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Characteristics of included studies assessing pain during multiple procedures</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Procedure</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Metrics used</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Results</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Funding sources and declaration of interest</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0013" title="GaspardoCM , MiyaseCI , ChimelloJT , MartinezFE , Martins LinharesMB . Is pain relief equally efficacious and free of side effects with repeated doses of oral sucrose in preterm neonates?Pain2008;137(1):16-25. [DOI: 10.1016/j.pain.2007.07.032] [PMID: 17854995]">Gaspardo 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33 preterm infants, median PMA 30 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venipuncture, arterial puncture, heel lance, intravenous cannulation, endotracheal tube introduction, endotracheal tube suctioning, gavage insertion for feeding, removal of electrode leads and tape </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>On day 1, no treatment was given to any neonate in order to collect baseline data. After that, on days 2 to 4 before every minor painful procedure, infants received either: </p> <p> <ul id="CD014806-list-0123"> <li> <p>sucrose (n = 17): 0.5 mL/kg 25% sucrose; or</p> </li> <li> <p>water (n = 16): 0.5 mL/kg sterile water.</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain was assessed over 4 d during morning blood collection (heel lance).</p> <p>Incidence of cry (percentage of neonates crying), HR (percentage of neonates with HR ≥ 160 beats/min), </p> <p>NFCS (percentage of neonates with score ≥ 3), Activated Behavioural State (percentage of neonates with score ≥ 4). The assessment was divided into 5 phases: baseline antisepsis, puncture, dressing and recovery. The neonates’<br/>facial activity (NFCS), behavioural state and HR were evaluated. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No means or SDs reported;</p> <p>NFCS results reported in graph form only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The data analysis used cutoff scores for painful and distressful responses. There were fewer sucrose‐group neonates with facial actions signalling pain than water‐group neonates in puncture phase and in antisepsis phase. There were fewer sucrose‐group neonates crying during antisepsis phase, puncture phase and dressing phase. There was no difference between groups for physiological response. The efficacy of sucrose was maintained for pain relief in preterm neonates, with no side effects. </p> <p>Data could not be used in RevMan analyses.</p> <p>No side effects of using sucrose were detected.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: This study was supported by the FAPESP,</p> <p>the CNPq, and the FAEPA</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0023" title="BoyerK , JohnstonC , WalkerCD , FilionF , SherrardA . Does sucrose analgesia promote physiological stability in preterm neonates?Biology of the Neonate2004;85(1):26-31. [DOI: 10.1159/000074954] [PMID: 14631163]JohnstonCC , FilionF , SniderL , MajnemerA , LimperopolousC , WalkerCD , et al. Routine sucrose analgesia during the first week of life in neonates younger than 31 weeks' postconceptional age. Pediatrics2002;110(3):523-8. [DOI: 10.1542/peds.110.3.523] [PMID: 12205254]">Johnston 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103 infants:</p> <p> <ul id="CD014806-list-0124"> <li> <p>sucrose group: mean PMA 28.18 weeks (1.72 weeks); and</p> </li> <li> <p>water group: mean PMA 28.05 weeks (2.06 weeks).</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Every time the infant was to undergo an invasive (e.g. heel lance, intravenous cannulation, arterial puncture, injection) or noninvasive but presumably uncomfortable procedure (e.g. endotracheal tube suctioning, tape or<br/>lead removal, gavage insertion for feeding), the infant received sucrose or water. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0125"> <li> <p>Sucrose group (n = 51): 0.1 mL 24% sucrose in sterile refrigerated syringe</p> </li> <li> <p>Water group (n = 52): 0.1 mL water in sterile refrigerated syringe</p> </li> </ul> </p> <p>The solution was in a syringe and administered into the infant’s mouth at the beginning of the procedure, 2 min into the procedure and another 2 min into the procedure. If the procedure was &gt; 15 min, up to another 3 doses (0.1 mL each) were to be given 2 min apart. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neurobehavioural development was assessed by the subscales of alertness and orientation and motor development and vigour of the NAPI, SNAP and NBRS. </p> <p>SNAP was measured for each 24‐hour period during the study week, and NBRS was measured at 2 weeks’ PNA and at discharge. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Beta, CI (multiple regression)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>On the basis of analysis of covariance with PMA at birth and the number of invasive procedures as covariates, there were no group differences (between sucrose and water) for any of the secondary outcomes of NBRS at 2 weeks' PNA (P = 0.426) or at discharge (P = 0.965). In the sucrose group only, a higher number of sucrose doses predicted lower scores on motor development and vigour and on alertness and orientation at 36 weeks' PNA, lower motor development and vigour at 40 weeks' PNA, and higher NBRS at 2 weeks' PNA. A higher number of invasive procedures was predictive of higher NBRS both times in the water group. </p> <p>No differences were found between the sucrose and water groups for NAPI.</p> <p>Data could not be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: Fonds de la Recherche en</p> <p>Sante du Quebec (961297‐104), the IWK Foundation, and Health</p> <p>Declaration of interest: not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD014806-bbs2-0050" title="TaddioA , ShahV , HancockR , SmithRW , StephensD , AtenafuE , et al. Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures. Canadian Medical Association Journal2008;179(1):37-43. [DOI: 10.1503/cmaj.071734] [PMID: 18591525]">Taddio 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>240 newborn infants born to nondiabetic and diabetic mothers, PMA ≥ 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 heel lances, venipuncture and IM vitamin K injection; multiple painful stimuli</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD014806-list-0126"> <li> <p>2 mL 24% sucrose given to infants of nondiabetic mothers (n = 60)</p> </li> <li> <p>2 mL 24% sucrose given to infants of diabetic mothers (n = 60)</p> </li> <li> <p>2 mL sterile water given to infants of nondiabetic mothers (n = 60)</p> </li> <li> <p>2 mL sterile water given to infants of diabetic mothers (n = 60)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PIPP scores overall, during IM injection, during venipuncture and during all 3 heel lances </p> <p>Safety</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean, SD, 95% CI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall PIPP scores were lower among newborns given sucrose (mean 6.8, SD 2.9) compared to water (mean 8.1, SD 2.5) (MD −1.3, 95% CI −2.0 to −0.6; P &lt; 0.001). </p> <p>PIPP scores during IM injection did not differ between the sucrose and water group for nondiabetic (P = 0.10) or diabetic mothers (P = 0.15). </p> <p>PIPP scores during venipuncture were lower among infants of nondiabetic mothers who received sucrose compared to water (mean score 5.7, 95% CI 4.7 to 6.7 vs mean score 8.9, 95% CI 7.9 to 9.9; P &lt; 0.001). Similar results were found amongst infants of diabetic mothers (sucrose: mean score 6.8, 95% CI 5.7 to 7.9 vs water: mean score 9.2, 95% CI 8.4 to 10.1; P &lt; 0.001). </p> <p>During the first 3 heel lances, newborns from diabetic mothers receiving sucrose or water did not have different PIPP scores. </p> <p>Results for different painful stimuli were reported separately.</p> <p>Data could be used in RevMan analyses.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Funding source: CIHR grant (MCT 63143) and a Sick Kids Foundation</p> <p>graduate student Research Training Competition Award</p> <p>Competing interests: none declared</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>CI: confidence interval; CIHR: Canadian Institutes of Health Research; CNPq: National Council of Science and Technology Development; FAEPA: Foundation for Support of Teaching, Research and Assistance of the University Hospital of Clinics; FAPESP: Foundation for Support of Research in the State of São Paulo, Brazil; HR: heart rate; IM: intramuscular; MD: mean difference; NAPI: Neurobehavioral Assessment of the Preterm Infant; NBRS: Neuro‐Biological Risk Score; NFCS: Neonatal Facial Coding System; PIPP: Premature Infant Pain Profile; PMA: postmenstrual age; PNA: postnatal age; SD: standard deviation; SNAP: Score for Neonatal Acute Physiology </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Characteristics of included studies assessing pain during multiple procedures</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/full#CD014806-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD014806-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Sucrose (any concentration, any dose) versus placebo, water, or no intervention</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 PIPP scores at 30 seconds after lancing (term and preterm infants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>547</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.74 [‐2.11, ‐1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 PIPP scores at 30 seconds after heel lancing (term infants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.87 [‐1.80, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 PIPP scores at 30 seconds after lancing (preterm infants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>192</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.88 [‐2.32, ‐1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 PIPP scores at 60 seconds after lancing (preterm and term infants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.14 [‐3.34, ‐0.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 DAN scores at 30 seconds after heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.90 [‐8.58, 4.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 NIPS scores during heel lance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.00 [‐2.42, ‐1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Total crying time (in seconds) after lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐30.74 [‐40.73, ‐20.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Duration of first cry (in seconds) after lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐26.66 [‐35.86, ‐17.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 Duration of first cry ‐ until a quiet interval of 5 seconds</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐53.18 [‐66.90, ‐39.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 Duration of first cry ‐ until before first inpiration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.00 [‐17.40, 7.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Heart rate (beats per minute (bpm)) during heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.21 [‐3.95, 8.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Percentage change in heart rate after heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [‐5.81, 7.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Respiratory rate (breaths per minute) during heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.00 [‐7.64, 5.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Oxygen saturation (%) during heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.00 [‐12.79, 2.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Skin blood flow during heel lancing (perfusion units (PU)) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐32.00 [‐68.87, 4.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Nociceptive‐specific brain activity (mean weight) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.05, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Sucrose (any concentration, any dose) versus placebo, water, or no intervention</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD014806-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Sucrose (any concentration, any dose) versus NNS</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 PIPP scores during recovery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [‐0.30, 1.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 DAN scores at 30 seconds after heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.20 [‐7.87, 5.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Crying time (%) during heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.60 [1.41, 17.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Total crying time (in seconds) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>36.00 [27.00, 45.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Duration of first cry (in seconds) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.00 [‐8.78, 4.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Heart rate (bpm) during heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.60 [‐8.17, 2.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Oxygen saturation (%) during heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [‐0.64, 1.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Sucrose (any concentration, any dose) versus NNS</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD014806-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Sucrose + NNS versus NNS (with or without water)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 PIPP scores during heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.90 [‐5.73, ‐4.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 PIPP scores during recovery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.80 [‐4.47, ‐3.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 NFCS during heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐1.47, 0.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.1 Term infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐1.47, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Crying time (%) during heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐32.70 [‐38.37, ‐27.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Crying time (in seconds) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.41 [‐9.87, 7.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.1 Term infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.41 [‐9.87, 7.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 Heart rate (bpm) during heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.60 [‐20.60, ‐10.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.7 Oxygen saturation (%) during heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.30 [1.09, 3.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Sucrose + NNS versus NNS (with or without water)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD014806-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Sucrose (any concentration, any dose) versus glucose (any concentration, any dose)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 PIPP scores at 30 seconds after heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [‐0.70, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 PIPP scores at 60 seconds after heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.79, 0.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Heart rate (bpm) during heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.51 [1.12, 19.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.1 Term infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.51 [1.12, 19.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 Percentage change in heart rate 1 min after heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.58 [‐14.85, 1.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4.1 Term infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.58 [‐14.85, 1.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.5 Total crying time (in seconds) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐34.89 [‐61.67, ‐8.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5.1 Term infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐34.89 [‐61.67, ‐8.11]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Sucrose (any concentration, any dose) versus glucose (any concentration, any dose)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD014806-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Sucrose (any concentration, any dose) versus breastfeeding</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 PIPP scores at 30 seconds after heel lancing (term and preterm infants) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [‐0.49, 1.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Comfortneo scores after lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.60 [‐3.06, ‐2.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Sucrose (any concentration, any dose) versus breastfeeding</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD014806-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Sucrose (any concentration, any dose) versus human milk</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 PIPP‐R scores during heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐0.24, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 PIPP‐R scores at 30 seconds after heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐0.11, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.3 PIPP‐R scores at 60 seconds after heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.34, 1.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.4 DAN scores at 30 seconds after heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.80 [‐8.47, 4.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.5 Crying time (in seconds) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.00 [‐21.07, 5.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5.1 Term infants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.00 [‐21.07, 5.07]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Sucrose (any concentration, any dose) versus human milk</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD014806-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Sucrose versus recorded music</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 Heart rate (bpm) during heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.00 [‐0.43, 16.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.2 Oxygen saturation during heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐1.36, 0.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Sucrose versus recorded music</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD014806-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Sucrose versus laser acupuncture</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 NIPS scores <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.86 [‐1.43, ‐0.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.2 Crying time (in seconds) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐51.29 [‐73.11, ‐29.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Sucrose versus laser acupuncture</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD014806-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Repeated heel lancing: sucrose versus facilitated tucking</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.1 Total Bernese Pain Scale for neonates during heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.27 [‐4.66, 0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.2 Total Bernese Pain Scale for neonates during recovery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.31 [‐1.72, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Repeated heel lancing: sucrose versus facilitated tucking</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD014806-tbl-0022"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Repeated heel lancing: sucrose versus skin‐to‐skin care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.1 PIPP scores at 30 seconds after heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐0.70, 0.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1.1 Lancing #1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐0.70, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1.2 Lancing #2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.56 [‐1.57, 0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1.3 Lancing #3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐1.26, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.2 PIPP scores at 60 seconds after heel lancing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>408</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.36 [‐0.91, 0.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2.1 Lancing #1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.61 [‐1.55, 0.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2.2 Lancing #2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐0.99, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2.3 Lancing #3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐1.48, 0.68]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Repeated heel lancing: sucrose versus skin‐to‐skin care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD014806/references#CD014806-tbl-0022">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD014806&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD014806-note-0024">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD014806-note-0021">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD014806-note-0022">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD014806-note-0020">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD014806-note-0019">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD014806-note-0023">Polski</a> </li> <li class="section-language"> <a class="" href="th#CD014806-note-0018">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD014806-note-0016">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD014806-note-0017">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014806\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD014806\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014806\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD014806"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014806\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD014806\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014806\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD014806\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014806\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD014806"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014806\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD014806\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014806\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD014806"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014806\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD014806\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD014806\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD014806"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=z6k50IFd&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD014806&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD014806';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD014806/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD014806/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD014806%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714910221"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD014806/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714910225"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD014806/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d7a2fab909368',t:'MTc0MDcxNDkxMC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 